0001585364-18-000071.txt : 20180809 0001585364-18-000071.hdr.sgml : 20180809 20180809094814 ACCESSION NUMBER: 0001585364-18-000071 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 89 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180809 DATE AS OF CHANGE: 20180809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO Co plc CENTRAL INDEX KEY: 0001585364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36353 FILM NUMBER: 181003759 BUSINESS ADDRESS: STREET 1: TREASURY BUILDING STREET 2: LOWER GRAND CANAL STREET CITY: DUBLIN STATE: L2 ZIP: L2 2 BUSINESS PHONE: 269-673-8451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 FORMER COMPANY: FORMER CONFORMED NAME: PERRIGO Co Ltd DATE OF NAME CHANGE: 20130828 10-Q 1 cy18q210q.htm 10-Q Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________________________________
 FORM 10-Q
_______________________________________________
[X]
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: June 30, 2018
OR
[  ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission file number 001-36353
_______________________________________________
Perrigo Company plc
(Exact name of registrant as specified in its charter)
_______________________________________________
Ireland
 
Not Applicable
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland
 
-
(Address of principal executive offices)
 
(Zip Code)
+353 1 7094000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
________________________________________ 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such report), and (2) has been subject to such filing requirements for the past 90 days.    YES [X]    NO  [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    YES  [X]   NO [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
[X]
 
Accelerated filer
[ ]
 
Non-accelerated filer
[ ]
(Do not check if smaller reporting company)
Smaller reporting company
[ ]
 
Emerging growth company
[ ]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
[ ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   [ ]  YES  [X] NO
As of August 3, 2018, there were 136,832,585 ordinary shares outstanding.


PERRIGO COMPANY PLC
FORM 10-Q
INDEX
 
PAGE
NUMBER
 
 
PART I. FINANCIAL INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 
 
 
2
 
 
 
3
 
 
 
4
 
 
 
5
 
 
 
6
 
 
 
7
 
 
 
8
 
 
 
9
 
 
 
10
 
 
 
11
 
 
 
12
 
 
 
13
 
 
 
14
 
 
 
15
 
 
 
16
 
 
 
 
 
 
 
 
 
 
 
 
PART II. OTHER INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this report are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements. In particular, statements about our expectations, beliefs, plans, objectives, assumptions, future events or future performance contained in this report, including certain statements contained in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” "forecast," “predict,” “potential” or the negative of those terms or other comparable terminology.

We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control, including: the timing, amount and cost of any share repurchases; future impairment charges; the success of management transition; customer acceptance of new products; competition from other industry participants, some of whom have greater marketing resources or larger market shares in certain product categories than we do; pricing pressure from customers and consumers; potential third-party claims and litigation, including litigation relating to our restatement of previously-filed financial information; potential impacts of ongoing or future government investigations and regulatory initiatives; resolution of uncertain tax positions; the impact of tax reform legislation and healthcare policy; general economic conditions; fluctuations in currency exchange rates and interest rates; the consummation of announced acquisitions or dispositions and the success of such transactions, and our ability to realize the desired benefits thereof; and our ability to execute and achieve the desired benefits of announced cost-reduction efforts and strategic and other initiatives. Statements regarding the separation of our Prescription Pharmaceuticals business, including the expected benefits, anticipated timing, form of any such separation and whether the separation ultimately occurs, are all subject to various risks and uncertainties, including future financial and operating results, our ability to separate the business, the effect of existing interdependencies with our manufacturing and shared service operations, and the tax consequences of the planned separation to us or our shareholders. In addition, we may identify new, or be unable to remediate previously identified, material weaknesses in our internal control over financial reporting. Furthermore, we may incur additional tax liabilities in respect of 2016 and prior years or be found to have breached certain provisions of Irish company law in connection with our restatement of our previously-filed financial statements, which may result in additional expenses and penalties. These and other important factors, including those discussed in our Form 10-K for the year ended December 31, 2017, in this report under “Risk Factors” and in any subsequent filings with the United States Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this report are made only as of the date hereof, and unless otherwise required by applicable securities laws, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

TRADEMARKS, TRADE NAMES AND SERVICE MARKS

This report contains trademarks, trade names and service marks that are the property of Perrigo Company plc, as well as, for informational purposes, trademarks, trade names, and service marks that are the property of other organizations. Solely for convenience, certain trademarks, trade names, and service marks referred to in this report appear without the ®, ™ and SM symbols, but those references are not intended to indicate that we or the applicable owners, as the case may be, will not assert, to the fullest extent under applicable law, our or their rights to such trademarks, trade names, and service marks.

1
Perrigo Company plc - Item 1

PART I.     FINANCIAL INFORMATION

ITEM 1.        FINANCIAL STATEMENTS (UNAUDITED)

PERRIGO COMPANY PLC
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share amounts)
(unaudited)
 
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Net sales
$
1,186.4

 
$
1,237.9

 
$
2,403.4

 
$
2,431.9

Cost of sales
715.4

 
733.3

 
1,439.7

 
1,463.0

Gross profit
471.0

 
504.6

 
963.7

 
968.9

 
 
 
 
 
 
 
 
Operating expenses
 
 
 
 
 
 
 
Distribution
23.8

 
21.6

 
48.5

 
42.7

Research and development
91.9

 
42.6

 
130.3

 
82.3

Selling
155.2

 
155.6

 
316.5

 
310.6

Administration
96.8

 
98.2

 
204.5

 
203.6

Impairment charges
1.7

 
27.4

 
1.7

 
39.6

Restructuring
3.7

 
12.1

 
5.2

 
50.8

Other operating expense (income)
3.2

 
(1.7
)
 
6.1

 
(38.0
)
Total operating expenses
376.3

 
355.8

 
712.8

 
691.6

 
 
 
 
 
 
 
 
Operating income
94.7

 
148.8

 
250.9

 
277.3

 
 
 
 
 
 
 
 
Change in financial assets
(0.6
)
 
38.7

 
9.0

 
21.6

Interest expense, net
32.1

 
45.1

 
63.5

 
98.4

Other expense, net
7.9

 
6.1

 
12.1

 
2.5

Loss on extinguishment of debt
—

 
135.2

 
0.5

 
135.2

Income (loss) before income taxes
55.3

 
(76.3
)
 
165.8

 
19.6

Income tax expense (benefit)
19.1

 
(6.7
)
 
48.8

 
17.6

Net income (loss)
$
36.2

 
$
(69.6
)
 
$
117.0

 
$
2.0

 
 
 
 
 
 
 
 
Earnings (loss) per share
 
 
 
 
 
 
 
Basic
$
0.26

 
$
(0.49
)
 
$
0.84

 
$
0.01

Diluted
$
0.26

 
$
(0.49
)
 
$
0.84

 
$
0.01

 
 
 
 
 
 
 
 
Weighted-average shares outstanding
 
 
 
 
 
 
 
Basic
138.1

 
143.3

 
139.5

 
143.3

Diluted
138.7

 
143.3

 
140.0

 
143.6

 
 
 
 
 
 
 
 
Dividends declared per share
$
0.19

 
$
0.16

 
$
0.38

 
$
0.32


See accompanying Notes to the Condensed Consolidated Financial Statements

2
Perrigo Company plc - Item 1

PERRIGO COMPANY PLC
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in millions)
(unaudited)
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Net income (loss)
$
36.2

 
$
(69.6
)
 
$
117.0

 
$
2.0

Other comprehensive income (loss):
 
 
 
 
 
 
 
Foreign currency translation adjustments
(165.6
)
 
154.7

 
(92.6
)
 
220.1

Change in fair value of derivative financial instruments, net of tax
(3.5
)
 
6.9

 
(4.1
)
 
8.5

Change in fair value of investment securities, net of tax
—

 
(4.8
)
 
—

 
(16.3
)
Change in post-retirement and pension liability, net of tax
(0.2
)
 
—

 
(0.4
)
 
—

Other comprehensive income (loss), net of tax
(169.3
)
 
156.8

 
(97.1
)
 
212.3

Comprehensive income (loss)
$
(133.1
)
 
$
87.2

 
$
19.9

 
$
214.3

See accompanying Notes to the Condensed Consolidated Financial Statements


3
Perrigo Company plc - Item 1

PERRIGO COMPANY PLC
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except per share amounts)
(unaudited)
 
June 30,
2018
 
December 31,
2017
Assets
 
 
 
Cash and cash equivalents
$
526.5

 
$
678.7

Accounts receivable, net of allowance for doubtful accounts of $6.5 and $6.2, respectively
1,129.8

 
1,130.8

Inventories
883.8

 
806.9

Prepaid expenses and other current assets
238.4

 
203.2

Total current assets
2,778.5

 
2,819.6

Property, plant and equipment, net
811.9

 
833.1

Goodwill and other indefinite-lived intangible assets
4,227.1

 
4,265.7

Other intangible assets, net
3,066.0

 
3,290.5

Non-current deferred income taxes
1.0

 
10.4

Other non-current assets
341.1

 
409.5

Total non-current assets
8,447.1

 
8,809.2

Total assets
$
11,225.6

 
$
11,628.8

Liabilities and Shareholders’ Equity
 
 
 
Accounts payable
$
533.4

 
$
450.2

Payroll and related taxes
103.9

 
148.8

Accrued customer programs
451.9

 
419.7

Accrued liabilities
192.8

 
230.8

Accrued income taxes
57.9

 
116.1

Current indebtedness
197.7

 
70.4

Total current liabilities
1,537.6

 
1,436.0

Long-term debt, less current portion
3,085.3

 
3,270.8

Non-current deferred income taxes
290.8

 
321.9

Other non-current liabilities
414.6

 
429.5

Total non-current liabilities
3,790.7

 
4,022.2

Total liabilities
5,328.3

 
5,458.2

Commitments and contingencies - Refer to Note 13

 

Shareholders’ equity
 
 
 
Controlling interest:
 
 
 
Preferred shares, $0.0001 par value per share, 10 shares authorized
—

 
—

Ordinary shares, €0.001 par value per share, 10,000 shares authorized
7,594.3

 
7,892.9

Accumulated other comprehensive income
155.0

 
253.1

Retained earnings (accumulated deficit)
(1,852.2
)
 
(1,975.5
)
Total controlling interest
5,897.1

 
6,170.5

Noncontrolling interest
0.2

 
0.1

Total shareholders’ equity
5,897.3

 
6,170.6

Total liabilities and shareholders' equity
$
11,225.6

 
$
11,628.8

 
 
 
 
Supplemental Disclosures of Balance Sheet Information
 
 
 
Ordinary shares, issued and outstanding
137.6

 
140.8


See accompanying Notes to the Condensed Consolidated Financial Statements

4
Perrigo Company plc - Item 1

PERRIGO COMPANY PLC
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
Cash Flows From (For) Operating Activities
 
 
 
Net income
$
117.0

 
$
2.0

Adjustments to derive cash flows
 
 
 
Depreciation and amortization
217.8

 
220.8

Share-based compensation
22.3

 
14.8

Impairment charges
1.7

 
39.6

Change in financial assets
9.0

 
21.6

Loss on extinguishment of debt
0.5

 
135.2

Restructuring charges
5.2

 
50.8

Deferred income taxes
(14.2
)
 
(8.1
)
Amortization of debt premium
(3.7
)
 
(11.8
)
Other non-cash adjustments, net
5.1

 
(20.6
)
Subtotal
360.7

 
444.3

Increase (decrease) in cash due to:
 
 
 
Accounts receivable
(24.3
)
 
51.8

Inventories
(99.3
)
 
(4.6
)
Accounts payable
89.2

 
(6.0
)
Payroll and related taxes
(48.4
)
 
(37.9
)
Accrued customer programs
33.9

 
(13.8
)
Accrued liabilities
(30.4
)
 
(49.4
)
Accrued income taxes
(20.8
)
 
(85.8
)
Other, net
(5.9
)
 
(13.3
)
Subtotal
(106.0
)
 
(159.0
)
Net cash from operating activities
254.7

 
285.3

Cash Flows From (For) Investing Activities
 
 
 
Proceeds from royalty rights
10.3

 
85.7

Purchase of investment securities
(7.5
)
 
—

Proceeds from sale of securities
—

 
—

Additions to property, plant and equipment
(33.3
)
 
(37.2
)
Net proceeds from sale of business and other assets
1.3

 
37.2

Proceeds from sale of the Tysabri® financial asset
—

 
2,200.0

Other investing, net
—

 
(3.7
)
Net cash from (for) investing activities
(29.2
)
 
2,282.0

Cash Flows From (For) Financing Activities
 
 
 
Issuances of long-term debt
431.0

 
—

Payments on long-term debt
(457.3
)
 
(2,229.1
)
Borrowings (repayments) of revolving credit agreements and other financing, net
(8.2
)
 
—

Deferred financing fees
(2.4
)
 
(4.0
)
Premium on early debt retirement
—

 
(116.1
)
Issuance of ordinary shares
—

 
0.2

Repurchase of ordinary shares
(265.0
)
 
(58.2
)
Cash dividends
(52.8
)
 
(46.0
)
Other financing, net
(7.5
)
 
4.7

Net cash (for) financing activities
(362.2
)
 
(2,448.5
)
Effect of exchange rate changes on cash and cash equivalents
(15.5
)
 
19.7

Net increase (decrease) in cash and cash equivalents
(152.2
)
 
138.5

Cash and cash equivalents, beginning of period
678.7

 
622.3

Cash and cash equivalents, end of period
$
526.5

 
$
760.8


See accompanying Notes to the Condensed Consolidated Financial Statements

5
Perrigo Company plc - Item 1
Note 1



NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

General Information

The Company

Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.

We are a leading global healthcare company, delivering value to our customers and consumers by providing Quality Affordable Healthcare Products®. Founded in 1887 as a packager of home remedies, we have built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. We believe we are one of the world's largest manufacturers of over-the-counter (“OTC”) healthcare products and suppliers of infant formulas for the store brand market. We are a leading provider of branded OTC products throughout Europe, and also a leading producer of generic pharmaceutical topical products such as creams, lotions, gels, and nasal sprays ("extended topical") prescription drugs. We are headquartered in Ireland, and sell our products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China.

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended December 31, 2017. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Recent Accounting Standard Pronouncements
    
Below are recent Accounting Standard Updates ("ASU") that we are still assessing to determine the effect on our Condensed Consolidated Financial Statements. We do not believe that any other recently issued accounting standards could have a material effect on our Condensed Consolidated Financial Statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

6
Perrigo Company plc - Item 1
Note 1


Recently Issued Accounting Standards Not Yet Adopted
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
ASU 2016-02 Leases
 
This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. The guidance is required to be adopted using the modified retrospective approach. Early adoption is permitted.
 
January 1, 2019
 
We have completed our initial scoping reviews and assessment phase to identify our leasing processes and go-forward policy that will be impacted by the new standard. We are continuing the design phase of our new lease integration tool and expect our financial statement disclosures will be expanded to present additional details of our leasing arrangements. At this time, we are unable to reasonably estimate the expected increase in assets and liabilities on our Consolidated Balance Sheets or the impacts to our Consolidated Financial Statements upon adoption. We plan to adopt the amended guidance on the effective date, and we expect the right of use asset and corresponding liability will be material and require certain changes to our systems and processes.
ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
 
This guidance permits tax effects stranded in accumulated other comprehensive income as a result of tax reform to be reclassified to retained earnings. This reclassification is optional and will require additional disclosure regarding whether reclassification is elected or not.
 
January 1, 2019

 
We are currently evaluating the implications of adoption on our Consolidated Financial Statements.
ASU 2016-13 Measurement of Credit Losses on Financial Instruments
 
This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.
 
January 1, 2020
 
We are currently evaluating the implications of adoption on our Consolidated Financial Statements.
ASU 2017-04 Intangibles - Goodwill and Other Simplifying the Test for Goodwill
 
The objective of this update is to reduce the cost and complexity of subsequent goodwill accounting by simplifying the impairment test by removing the Step 2 requirement to perform a hypothetical purchase price allocation when the carrying value of a reporting unit exceeds its fair value. If a reporting unit’s carrying value exceeds its fair value, an entity would record an impairment charge based on that difference, limited to the amount of goodwill attributed to that reporting unit. The proposal would not change the guidance on completing Step 1 of the goodwill impairment test. The proposed guidance would be applied prospectively. Early adoption is permitted.
 
January 1, 2020
 
Upon adoption, this guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment. After adoption, a Step 1 failure will result in an immediate impairment charge based on the carrying value of the reporting unit. We plan to adopt the standard prospectively on the effective date.

NOTE 2 – REVENUE RECOGNITION

We adopted ASU 2014-09 Revenue from Contracts with Customers and its related amendments (collectively, "ASC 606"), as required, on January 1, 2018 using the modified retrospective method for all contracts not completed as of the adoption date. The reported results for the periods in 2018 reflect the application of ASC 606 while the results for the comparable reporting periods in 2017 were prepared under the guidance of Revenue Recognition ("ASC 605"). The adoption of ASC 606 represents a change in accounting principle that closely aligns revenue recognition with the transfer of control of our products and will provide enhanced disclosures of the nature, amount, timing, and uncertainty of revenues and cash flows arising from contracts with customers. In accordance

7
Perrigo Company plc - Item 1
Note 2


with ASC 606, revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration to which we expect to be entitled to receive in exchange for these products.

Product Revenue

We generally recognize product revenue for our contract performance obligations at a point in time, typically upon shipment or delivery of products to customers. For point in time customers for which control transfers on delivery to the customer due to free on board destination terms (“FOB”), an adjustment is recorded to defer revenue recognition over an estimate of days until control transfers at the point of delivery. Where we recognize revenue at a point in time, the transfer of title is the primary indicator that control has transferred. In other limited instances, primarily relating to those contracts that relate to contract manufacturing performed for our customers and certain store branded products, control transfers as the product is manufactured. Control is deemed to transfer over time for these contracts as the product does not have an alternative use and we have a contractual right to payment for performance completed to date. Revenue for contract manufacturing contracts is recognized over the transfer period using an input method that measures progress towards completion of the performance obligation as costs are incurred. For store branded product revenue recognized over time, an output method is used to recognize revenue when production of a unit is completed because product customization occurs when the product is packaged as a finished good under the store brand label of the customer.

Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of chargebacks, rebates, sales returns, shelf stock allowances, administrative fees and other incentive programs. Certain of these accruals and allowances are recorded in the balance sheet as current liabilities and others are recorded as a reduction in accounts receivable. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect the best estimates of the amount of consideration to which we are entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known.

Other Revenue Policies

We receive payments from our customers based on billing schedules established in each contract. Amounts are recorded as accounts receivable when our right to consideration is unconditional. In most cases, the timing of the unconditional right to payment aligns with shipment or delivery of the product and the recognition of revenue; however, for those customers where revenue is recognized at a time prior to shipment or delivery due to over time revenue recognition, a contract asset is recorded and is reclassified to an accounts receivable when it becomes unconditional under the contract upon shipment or delivery to the customer.

We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised products to the customer will be one year or less, which is the case with substantially all customers.

Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenue.  

Shipping and handling costs billed to customers are included in Net sales. Conversely, shipping and handling expenses we incur are included in Cost of sales.


8
Perrigo Company plc - Item 1
Note 2


Disaggregation of Revenue

We generated net sales in the following geographic locations(1) (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
June 30,
2018
U.S.
$
772.3

 
$
1,558.7

Europe(2)
344.3

 
706.2

All other countries(3)
69.8

 
138.5

 
$
1,186.4

 
$
2,403.4


(1) The net sales by geography is derived from the location of the entity that sells to a third party.
(2) Includes Ireland net sales of $5.0 million and $10.4 million for the three and six months ended June 30, 2018, respectively.
(3) Includes net sales generated primarily in Israel, Mexico, Australia and Canada.

The following is a summary of our net sales by category (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
June 30,
2018
CHCA
 
 
 
Cough/Cold/Allergy/Sinus(1)
$
109.3

 
$
250.8

Infant Nutritionals
109.2

 
212.6

Gastrointestinal(1)
103.0

 
195.2

Analgesics(1)
92.2

 
185.9

Smoking Cessation
71.2

 
137.1

Animal Health
31.9

 
58.2

Vitamins, Minerals and Dietary Supplements(1)
4.3

 
7.3

Other CHCA(1),(2)
75.7

 
151.3

Total CHCA
596.8

 
1,198.4

CHCI
 
 
 
Lifestyle
86.1

 
175.8

Cough, Cold, and Allergy
84.7

 
183.4

Personal Care and Derma-Therapeutics
79.7

 
155.3

Anti-Parasite
30.4

 
58.5

Natural Health and Vitamins, Minerals and Dietary Supplements
27.9

 
61.1

Other CHCI(3)
72.2

 
148.3

Total CHCI
381.0

 
782.4

Total RX
208.6

 
422.6

Total net sales
$
1,186.4

 
$
2,403.4


(1)    Includes net sales from our OTC contract manufacturing business.
(2) 
Consists primarily of branded OTC, diabetic care, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.
(3) 
Consists primarily of liquid licensed products, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.


9
Perrigo Company plc - Item 1
Note 2


While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized on an over time basis. Predominately, over time customer contracts exist in contract manufacturing arrangements, which occur in both the Consumer Healthcare Americas ("CHCA") and Consumer Healthcare International ("CHCI") segments. Contract manufacturing revenue was $77.1 million and $146.5 million for the three and six months ended June 30, 2018, respectively.

We also recognized a portion of the store brand OTC product revenues in the CHCA segment on an over time basis; however, the timing between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery.

Contract Balances

The following table provides information about contract assets from contracts with customers (in millions):
 
Balance Sheet Location
 
January 1,
2018
 
June 30,
2018
Short-term contract assets
Prepaid expenses and other current assets
 
$
20.5

 
$
19.2


Impact on financial statements

Condensed Consolidated Statements of Operations

Net sales and Cost of sales were lower in the three and six months ended June 30, 2018 as a result of adopting ASC 606 due to net sales from contract manufacturing and certain OTC product sales being recognized on an over time basis as the performance obligation was satisfied, compared to the previous revenue recognition under ASC 605, which would have occurred when the product was shipped or delivered. This has resulted in the recognition of a contract asset.
 
Three Months Ended
 
Six Months Ended
 
June 30, 2018
 
June 30, 2018
(in millions, except per share amounts)
As reported
 
Adjustments
 
Before adoption of ASC 606
 
As reported
 
Adjustments
 
Before adoption of ASC 606
Net sales
$
1,186.4

 
$
6.9

 
$
1,193.3

 
$
2,403.4

 
$
1.3

 
$
2,404.7

Cost of sales
715.4

 
4.2

 
719.6

 
1,439.7

 
1.1

 
1,440.8

Gross profit
471.0

 
2.7

 
473.7

 
963.7

 
0.2

 
963.9

 
 
 
 
 
 
 
 
 
 
 
 
Operating income
94.7

 
2.7

 
97.4

 
250.9

 
0.2

 
251.1

 
 
 
 
 
 
 
 
 
 
 
 
Income tax expense (benefit)
19.1

 
(0.1
)
 
19.0

 
48.8

 
(0.1
)
 
48.7

Net income
$
36.2

 
$
2.8

 
$
39.0

 
$
117.0

 
$
0.3

 
$
117.3

 
 
 
 
 
 
 
 
 
 
 
 
Earnings per share
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.26

 
$
0.02

 
$
0.28

 
$
0.84

 
$
—

 
$
0.84

Diluted
$
0.26

 
$
0.02

 
$
0.28

 
$
0.84

 
$
—

 
$
0.84


Condensed Consolidated Statements of Comprehensive Income (Loss)
 
Three Months Ended
 
Six Months Ended
 
June 30, 2018
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
 
As reported
 
Adjustments
 
Before adoption of ASC 606
Net income
$
36.2

 
$
2.8

 
$
39.0

 
$
117.0

 
$
0.3

 
$
117.3

Comprehensive income (loss)
$
(133.1
)
 
$
2.8

 
$
(130.3
)
 
$
19.9

 
$
0.3

 
$
20.2



10
Perrigo Company plc - Item 1
Note 2


Condensed Consolidated Balance Sheet
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
Assets
 
 
 
 
 
Inventories
$
883.8

 
$
13.7

 
$
897.5

Prepaid expenses and other current assets
238.4

 
(19.2
)
 
219.2

Total current assets
2,778.5

 
(5.5
)
 
2,773.0

Total assets
$
11,225.6

 
$
(5.5
)
 
$
11,220.1

Liabilities and Shareholders’ Equity
 
 
 
 
 
Other non-current liabilities
$
414.6

 
$
(0.4
)
 
$
414.2

Total non-current liabilities
3,790.7

 
(0.4
)
 
3,790.3

Total liabilities
5,328.3

 
(0.4
)
 
5,327.9

Shareholders’ equity
 
 
 
 
 
Controlling interest:
 
 
 
 
 
Accumulated deficit
(1,852.2
)
 
(5.1
)
 
(1,857.3
)
Total controlling interest
5,897.1

 
(5.1
)
 
5,892.0

Total shareholders’ equity
5,897.3

 
(5.1
)
 
5,892.2

Total liabilities and shareholders' equity
$
11,225.6

 
$
(5.5
)
 
$
11,220.1


Condensed Consolidated Statement of Cash Flows
 
Six Months Ended
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
Cash Flows From (For) Operating Activities
 
 
 
 
 
Net income
$
117.0

 
$
0.3

 
$
117.3

(Decreases) in cash due to:
 
 
 
 
 
Inventories
(99.3
)
 
1.1

 
(98.2
)
Accrued income taxes
(20.8
)
 
(0.1
)
 
(20.9
)
Other, net
(5.9
)
 
(1.3
)
 
(7.2
)
Subtotal
(106.0
)
 
(0.3
)
 
(106.3
)
Net cash from operating activities
$
254.7

 
$
—

 
$
254.7


NOTE 3 – ACQUISITIONS AND DIVESTITURES

Acquisitions during the six months ended June 30, 2018

Nasonex-branded products

On May 29, 2018, we entered into a license agreement with Merck Sharp & Dohme Corp. ("Merck") allowing us to develop and commercialize an OTC version of Nasonex-branded products containing the compound, mometasone furoate monohydrate. The acquisition was accounted for as an asset acquisition based on our assessment that substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset to be used for research and development. In accordance with Accounting Standards Codification Topic 730 Research and Development ("ASC 730"), the non-refundable upfront license fee of $50.0 million was recorded in Research and development ("R&D") expense in our CHCA segment because the intangible research and development asset acquired has no alternative use. The agreement requires us to make contingent payments if we obtain regulatory approval and achieve certain sales milestones. We will also be obligated to make royalty payments on potential future sales. The contingent consideration will be included in the measurement of the cost of the asset when the contingency is resolved, and the consideration is paid or becomes payable. Consideration paid after U.S. Food and Drug Administration ("FDA") approval will be capitalized and amortized to cost of goods sold over the economic life of each product.

11
Perrigo Company plc - Item 1
Note 3


Divestitures during the six months ended July 1, 2017

On January 3, 2017, we sold certain Abbreviated New Drug Applications ("ANDAs") for $15.0 million to a third party, which was recorded as a gain in Other operating expense (income) on the Condensed Consolidated Statements of Operations in our Prescription Pharmaceuticals ("RX") segment.

On February 1, 2017, we completed the sale of the animal health pet treats plant fixed assets within our CHCA segment, which were previously classified as held-for sale. We received $7.7 million in proceeds, which resulted in an immaterial loss.

On April 6, 2017, we completed the sale of our India Active Pharmaceuticals Ingredient ("API") business to Strides Shasun Limited. We received $22.2 million of proceeds, inclusive of an estimated working capital adjustment, which resulted in an immaterial gain recorded in our legacy Other segment. Prior to closing the sale, we determined that the carrying value of the India API business exceeded its fair value less the cost to sell, resulting in an impairment charge of $35.3 million, which was recorded in Impairment charges on the Condensed Consolidated Statements of Operations for the year ended December 31, 2016.

NOTE 4 – GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):
 
 
December 31,
2017
 
Currency translation adjustments
 
June 30,
2018
CHCA
 
$
1,847.4

 
$
(2.0
)
 
$
1,845.4

CHCI
 
1,205.7

 
(30.6
)
 
1,175.1

RX
 
1,122.3

 
(5.3
)
 
1,117.0

Total goodwill
 
$
4,175.4

 
$
(37.9
)
 
$
4,137.5


Animal Health

Following a prior indication of potential impairment during the three months ended December 31, 2017, the animal health reporting unit had an additional indication of potential impairment during the three month ended June 30, 2018 due to its year-to-date financial results failing to meet performance expectations. We performed an impairment test as of June 30, 2018 and determined the fair value of the animal health reporting unit exceeded its net book value and therefore, no impairment was recorded as of the three months ended June 30, 2018.


12
Perrigo Company plc - Item 1
Note 4


Intangible Assets

Other intangible assets and related accumulated amortization consisted of the following (in millions):
 
June 30, 2018
 
December 31, 2017
 
Gross
 
Accumulated Amortization
 
Gross
 
Accumulated Amortization
Definite-lived intangibles:
 
 
 
 
 
 
 
Distribution and license agreements and supply agreements
$
310.0

 
$
188.3

 
$
311.2

 
$
169.8

Developed product technology, formulations, and product rights
1,349.8

 
647.0

 
1,358.4

 
598.7

Customer relationships and distribution networks
1,608.7

 
513.2

 
1,642.0

 
460.6

Trademarks, trade names, and brands
1,304.3

 
159.8

 
1,335.4

 
129.5

Non-compete agreements
14.5

 
13.0

 
14.7

 
12.6

Total definite-lived intangibles
$
4,587.3

 
$
1,521.3

 
$
4,661.7

 
$
1,371.2

Indefinite-lived intangibles:
 
 
 
 
 
 
 
Trademarks, trade names, and brands
$
51.7

 
$
—

 
$
52.1

 
$
—

In-process research and development
37.9

 
—

 
38.2

 
—

Total indefinite-lived intangibles
89.6

 
—

 
90.3

 
—

Total other intangible assets
$
4,676.9

 
$
1,521.3

 
$
4,752.0

 
$
1,371.2


We recorded amortization expense of $85.3 million and $172.4 million for the three and six months ended June 30, 2018, respectively, and $87.2 million and $172.8 million for the three and six months ended July 1, 2017, respectively.

We recorded an impairment charge of $12.2 million on certain In-process Research and Development ("IPR&D") assets, primarily in our RX segment, during the three months ended April 1, 2017 due to changes in the projected development and regulatory timelines for various projects. In addition, we recorded a decrease in the contingent consideration liability associated with certain IPR&D assets in Other operating expense (income) on the Condensed Consolidated Statements of Operations (refer to Note 6).

During the three months ended July 1, 2017, we identified impairment indicators for our Lumara Health, Inc. product assets. The primary impairment indicators included the decline in our 2017 performance expectations and a reduction in our long-range revenue growth forecast. As part of our assessment, we utilized the multi-period excess earnings method to determine fair value. This resulted in an impairment charge of $18.5 million in Impairment charges on the Condensed Consolidated Statements of Operations within our RX segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value.

NOTE 5 – INVENTORIES

Major components of inventory were as follows (in millions):
 
 
June 30,
2018
 
December 31,
2017
Finished goods
$
485.7

 
$
454.3

Work in process
175.6

 
152.8

Raw materials
222.5

 
199.8

Total inventories
$
883.8

 
$
806.9



13
Perrigo Company plc - Item 1
Note 6


NOTE 6 – FAIR VALUE MEASUREMENTS

The following table summarizes the valuation of our financial instruments carried at fair value and measured at fair value on a recurring and non-recurring basis by the above pricing categories (in millions):
 
 
June 30, 2018
 
December 31, 2017
 
 
Level 1
 
Level 2
 
Level 3
 
Level 1
 
Level 2
 
Level 3
Measured at fair value on a recurring basis:
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Investment securities
 
$
8.1

 
$
—

 
$
—

 
$
17.0

 
$
—

 
$
—

Foreign currency forward contracts
 
—

 
2.7

 
—

 
—

 
6.3

 
—

Funds associated with Israeli severance liability
 
—

 
14.2

 
—

 
—

 
16.3

 
—

Royalty Pharma contingent milestone payments
 
—

 
—

 
125.5

 
—

 
—

 
134.5

Total assets
 
$
8.1

 
$
16.9

 
$
125.5

 
$
17.0

 
$
22.6

 
$
134.5

 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
—

 
$
9.1

 
$
—

 
$
—

 
$
3.8

 
$
—

Contingent consideration
 
—

 
—

 
16.2

 
—

 
—

 
22.0

Total liabilities
 
$
—

 
$
9.1

 
$
16.2

 
$
—

 
$
3.8

 
$
22.0

 
 
 
 
 
 
 
 
 
 
 
 
 
Measured at fair value on a non-recurring basis:
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Definite-lived intangible assets
 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
11.5


There were no transfers among Level 1, 2, and 3 during the three and six months ended June 30, 2018 or the year ended December 31, 2017.

Financial Assets

On March 27, 2017, we announced the completed divestment of our Tysabri® financial asset to Royalty Pharma for up to $2.85 billion, consisting of $2.2 billion in cash and $250.0 million and $400.0 million in milestone payments if the royalties on global net sales of Tysabri® that are received by Royalty Pharma meet specific thresholds in 2018 and 2020, respectively. As a result of this transaction, we transferred the entire financial asset to Royalty Pharma and recorded a $17.1 million gain during the three months ended April 1, 2017. We elected to account for the contingent milestone payments using the fair value option method, and these were recorded at an estimated fair value of $184.5 million as of April 1, 2017. We chose the fair value option as we believe it will help investors understand the potential future cash flows we may receive associated with the two contingent milestones.

Royalty Pharma Contingent Milestone Payments

We valued our contingent milestone payments from Royalty Pharma using a modified Black-Scholes Option Pricing Model ("BSOPM"). Key inputs in the BSOPM are the estimated volatility and rate of return of royalties on global net sales of Tysabri® that are received by Royalty Pharma until the contingent milestones are resolved. Volatility and the estimated fair value of the milestones have a positive relationship such that higher volatility translates to a higher estimated fair value of the contingent milestone payments. In the valuation of contingent milestone payments performed, we assumed volatility of 30.0% for each of June 30, 2018 and July 1, 2017, and a rate of return of 8.09% and 8.05% as of June 30, 2018 and July 1, 2017, respectively. We assess volatility and rate of return inputs quarterly by analyzing certain market volatility benchmarks and the risk associated with Royalty Pharma achieving the underlying projected royalties.

The fair value of the Royalty Pharma contingent milestone payments increased by $0.6 million during the three months ended June 30, 2018. This increase included a $2.9 million decrease in the fair value of the 2018 contingent milestone payment, more than offset by a $3.5 million increase in the fair value of the 2020 contingent milestone payment. During the six months ended June 30, 2018, the fair value of the contingent milestone payments decreased by $9.0 million. The net changes in the fair value of the contingent milestone payments were

14
Perrigo Company plc - Item 1
Note 6


due to the fluctuation of the projected global net sales of Tysabri®. Global net sales of Tysabri® are being impacted by competition, namely the launch of Ocrevus® in the U.S. and European markets in 2017 and 2018, respectively.

The fair value of the Royalty Pharma contingent milestone payments decreased $39.2 million in each of the three and six months ended July 1, 2017 as a result of a decrease in the estimated Tysabri® revenues due to the launch of Ocrevus® in the U.S. market late in the first quarter of 2017.

Payment of the contingent milestone payments is dependent on actual global net sales of Tysabri® in 2018 and 2020. Of the $125.5 million of estimated fair value contingent milestone payments as of June 30, 2018, $65.3 million and $60.2 million relates to the 2018 and 2020 contingent milestone payments, respectively. If Tysabri® global net sales do not meet the prescribed threshold in 2018, we will write off the $65.3 million asset as an expense. If the prescribed threshold is exceeded, we will increase the asset to $250.0 million and recognize income of $184.7 million in Change in financial assets on the Condensed Consolidated Statements of Operations. If Tysabri® global net sales do not meet the prescribed threshold in 2020, we will write off the $60.2 million asset as an expense. If the prescribed threshold is exceeded, we will increase the asset to $400.0 million and recognize income of $339.8 million in Change in financial assets on the Condensed Consolidated Statements of Operations.

Global Tysabri® net sales need to exceed $1.85 billion and $1.95 billion in 2018 and 2020, respectively, in order for Royalty Pharma to receive the level of royalties needed to trigger the milestone payments owed to us.

The table below presents a reconciliation for the Royalty Pharma contingent milestone payments measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Change in fair value in the table was recorded in Change in financial assets on the Condensed Consolidated Statements of Operations.
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Royalty Pharma Contingent Milestone Payments
 
 
 
 
 
 
 
Beginning balance
$
124.9

 
$
184.5

 
$
134.5

 
$
—

Additions
—

 
—

 
—

 
184.5

Foreign currency effect
—

 
0.5

 
—

 
0.5

Change in fair value
0.6

 
(39.2
)
 
(9.0
)
 
(39.2
)
Ending balance
$
125.5

 
$
145.8

 
$
125.5

 
$
145.8


Contingent Consideration

Contingent consideration represents milestone payment obligations obtained through product acquisitions, which are valued using estimates based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The estimates are updated quarterly and the liabilities are adjusted to fair value depending on a number of assumptions, including the competitive landscape and regulatory approvals that may impact the future sales of a product. We reduced a contingent consideration liability associated with certain IPR&D assets (refer to Note 4) and recorded a corresponding gain of $15.6 million during the six months ended July 1, 2017. The liability decrease related to a reduction of the probability of achievement assumptions and anticipated cash flows.

15
Perrigo Company plc - Item 1
Note 6


The table below presents a reconciliation for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Net realized losses in the table were recorded in Other operating expense (income) on the Condensed Consolidated Statements of Operations.
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Contingent Consideration
 
 
 
 
 
 
 
Beginning balance
$
18.1

 
$
52.0

 
$
22.0

 
$
69.9

Net realized (gains) losses
(1.8
)
 
(1.3
)
 
(1.4
)
 
(15.6
)
Currency translation adjustments
(0.1
)
 
1.4

 
—

 
1.3

Settlements
—

 
(2.4
)
 
(4.4
)
 
(5.9
)
Ending balance
$
16.2

 
$
49.7

 
$
16.2

 
$
49.7


Fixed Rate Long-term Debt    

Our fixed rate long-term debt consisted of public bonds, a retail bond and a private placement note as follows (in millions):
 
June 30, 2018
 
December 31, 2017
 
Level 1
 
Level 2
 
Level 1
 
Level 2
Public Bonds
 
 
 
 
 
 
 
Carrying Value (excluding discount)
$
2,600.0

 
 
 
$
2,600.0

 
 
Fair value
$
2,525.9

 
 
 
$
2,650.8

 
 
 
 
 
 
 
 
 
 
Retail bond and private placement note
 
 
 
 
 
 
 
Carrying value (excluding premium)
 
 
$
298.0

 
 
 
$
306.0

Fair value
 
 
$
326.7

 
 
 
$
342.1


The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our retail bond and private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities.

The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and variable rate long-term debt, approximate their fair value.


16
Perrigo Company plc - Item 1
Note 7


NOTE 7 – INVESTMENTS

The following table summarizes our equity security measurement category, balance sheet location, and balances (in millions):
Measurement Category
 
Balance Sheet Location
 
June 30,
2018
 
December 31,
2017(2)
Fair value method
 
Prepaid expenses and other current assets
 
$
8.1

 
$
17.0

Fair value method(1)
 
Other non-current assets
 
$
4.6

 
$
6.3

Equity method
 
Other non-current assets
 
$
13.1

 
$
4.9


(1) The June 30, 2018 equity securities are measured at fair value using the Net Asset Value practical expedient.
(2) The December 31, 2017 balances presented reflect historical recognition and measurement investment categories existing prior to the adoption of ASU 2016-01, which include available for sale and cost method securities.

The following table summarizes our equity security expense (income) recognized in earnings (in millions):
 
 
 
 
Three Months Ended
 
Six Months Ended
Measurement Category
 
Income Statement Location
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Fair value method
 
Other expense, net
 
$
6.3

 
$
—

 
$
10.6

 
$
—

Equity method
 
Other expense, net
 
$
(0.9
)
 
$
(0.2
)
 
$
(0.7
)
 
$
(0.3
)

On January 1, 2018, as a result of the adoption of ASU 2016-01, we made a $1.0 million cumulative-effect adjustment to Retained earnings (accumulated deficit) net of tax that consisted of net unrealized losses on previously classified available for sale securities from Other comprehensive income ("OCI").

During the three months ended June 30, 2018, Perrigo Asia Holding Company Limited increased its investment in Zibo Xinhua - Perrigo Pharmaceutical Company Limited by $7.5 million.

NOTE 8 – DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

     All of our designated derivatives were classified as cash flow hedges as of June 30, 2018 and December 31, 2017.

Interest Rate Swaps

During the three months ended July 1, 2017, we repaid $584.4 million of senior notes with an interest rate of 4.000% due 2023 and $309.5 million of senior notes with an interest rate of 5.300% due 2043 (refer to Note 9). As a result of these senior note repayments, the proportionate amount remaining in OCI related to the pre-issuance hedge was reclassified to earnings. Accordingly, we recorded a loss of $5.9 million in Other expense, net, during the three months ended July 1, 2017 for the amount remaining in OCI.

Foreign Currency Forward Contracts

The total notional amount for our foreign currency forward contracts was $594.2 million and $592.3 million as of June 30, 2018 and December 31, 2017, respectively.

Effects of Derivatives on the Financial Statements
    
The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects and are presented in millions.

The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:

17
Perrigo Company plc - Item 1
Note 8


 
Asset Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
June 30,
2018
 
December 31,
2017
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Prepaid expenses and other current assets
 
$
2.1

 
$
4.1

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Prepaid expenses and other current assets
 
$
0.6

 
$
2.2

 
Liability Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
June 30,
2018
 
December 31,
2017
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
5.0

 
$
1.4

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
4.1

 
$
2.4


The gains (losses) recorded in OCI for the effective portion of our designated cash flow hedges were as follows:
 
 
Amount of Gain/(Loss) Recorded in OCI
(Effective Portion)
 
 
Three Months Ended
 
Six Months Ended
Designated Cash Flow Hedges
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Foreign currency forward contracts
 
$
(4.3
)
 
$
2.7

 
$
(4.3
)
 
$
5.2


The gains (losses) reclassified from Accumulated other comprehensive income ("AOCI") into earnings for the effective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Reclassified from AOCI into Earnings
(Effective Portion)
 
 
 
 
Three Months Ended
 
Six Months Ended
Designated Cash Flow Hedges
 
Income Statement Location
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Interest rate swap agreements
 
Interest expense, net
 
$
(0.4
)
 
$
(0.6
)
 
$
(0.9
)
 
$
(1.3
)
 
 
Other expense, net
 
—

 
(5.9
)
 
—

 
(5.9
)
Foreign currency forward contracts
 
Net sales
 
—

 
0.6

 
—

 
0.9

 
 
Cost of sales
 
1.6

 
0.9

 
3.9

 
1.6

 
 
Interest expense, net
 
(1.1
)
 
(0.5
)
 
(2.0
)
 
(1.1
)
 
 
Other expense, net
 
(0.1
)
 
—

 
(0.5
)
 
(0.5
)
Total
 
 
 
$
—

 
$
(5.5
)
 
$
0.5

 
$
(6.3
)

The net of tax amount expected to be reclassified out of AOCI into earnings during the next 12 months is a $5.2 million loss.

The gains (losses) recognized in earnings for the ineffective portion of our designated cash flow hedges were as follows:

18
Perrigo Company plc - Item 1
Note 8


 
 
 
 
Amount of Gain/(Loss) Recognized in Earnings
(Ineffective Portion)
 
 
 
 
Three Months Ended
 
Six Months Ended
Designated Cash Flow Hedges
 
Income Statement
Location
 
July 1,
2017
 
July 1,
2017
Foreign currency forward contracts
 
Other expense, net
 
$
0.1

 
$
1.0


The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized against Earnings
 
 
 
 
Three Months Ended
 
Six Months Ended
Non-Designated Derivatives
 
Income Statement Location
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Foreign currency forward contracts
 
Other expense, net
 
$
11.8

 
$
(5.0
)
 
$
8.6

 
$
(13.9
)
 
 
Interest expense, net
 
0.2

 
(0.7
)
 
(0.7
)
 
(1.1
)
Total
 
 
 
$
12.0

 
$
(5.7
)
 
$
7.9

 
$
(15.0
)

NOTE 9 – INDEBTEDNESS

Total borrowings outstanding are summarized as follows (in millions):
 
 
 
 
 
June 30,
2018
 
December 31,
2017
Term loans
 
 
 
 
 
 
2018 Term loan due March 8, 2020(1)
 
 
$
383.5

 
$
—

 
2014 Term loan due December 5, 2019(1)
 
 
—

 
420.0

 
Total term loans
 
 
383.5

 
420.0

Notes and Bonds
 
 
 
 
 
 
Coupon
Due
 
 
 
 
 
 
5.000%
May 23, 2019(1)
 
 
140.2

 
144.0

 
3.500%
March 15, 2021
 
 
280.4

 
280.4

 
3.500%
December 15, 2021
 
 
309.6

 
309.6

 
5.105%
July 19, 2023(1)
 
 
157.8

 
162.0

 
4.000%
November 15, 2023
 
 
215.6

 
215.6

 
3.900%
December 15, 2024
 
 
700.0

 
700.0

 
4.375%
March 15, 2026
 
 
700.0

 
700.0

 
5.300%
November 15, 2043
 
 
90.5

 
90.5

 
4.900%
December 15, 2044
 
 
303.9

 
303.9

 
Total notes and bonds
 
 
2,898.0

 
2,906.0

Other financing
3.0

 
11.7

Unamortized premium (discount), net
16.6

 
21.4

Deferred financing fees
(18.1
)
 
(17.9
)
Total borrowings outstanding
3,283.0

 
3,341.2

 
Current indebtedness
(197.7
)
 
(70.4
)
Total long-term debt less current portion
$
3,085.3

 
$
3,270.8


(1) 
Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.
    
We are in compliance with all covenants under our debt agreements as of June 30, 2018.

19
Perrigo Company plc - Item 1
Note 9




Revolving Credit Agreements

On December 5, 2014, Perrigo Finance entered into a $600.0 million revolving credit agreement, which increased to $1.0 billion on March 30, 2015 (the "2014 Revolver"). On March 8, 2018, we terminated the 2014 Revolver and entered into a $1.0 billion revolving credit agreement maturing on March 8, 2023 (the "2018 Revolver"). There were no borrowings outstanding under the 2018 Revolver as of June 30, 2018 or under the 2014 Revolver as of December 31, 2017.

Term Loans

On December 5, 2014, Perrigo Finance entered into a term loan agreement consisting of a €500.0 million ($614.3 million) tranche, maturing December 5, 2019. On March 8, 2018, we refinanced the €350.0 million outstanding under the term loan with the proceeds of a new €350.0 million ($431.0 million) term loan, maturing March 8, 2020. In addition, as a result of the refinancing during the three months ended March 31, 2018, we recorded a loss of $0.5 million, consisting of the write-off of deferred financing fees in Loss on extinguishment of debt on the Condensed Consolidated Statements of Operations. During the six months ended June 30, 2018, we made $26.3 million in scheduled principal payments.

Other Financing

Overdraft Facilities

We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in the above table under "Other financing". There were no borrowings outstanding at June 30, 2018. The balance outstanding under the overdraft facilities was $6.9 million at December 31, 2017.

Debt Extinguishment

As a result of early redemption and tender offer transactions during the three months ended July 1, 2017, we recorded a loss of $135.2 million in Loss on extinguishment of debt on our Condensed Consolidated Statements of Operations (in millions):
Premium on debt repayment
 
$
116.1

Transaction costs
 
3.8

Write-off of deferred financing fees
 
10.6

Write-off of remaining discount on bond
 
4.7

Total loss on extinguishment of debt
 
$
135.2



20
Perrigo Company plc - Item 1
Note 10


NOTE 10 – EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY

Earnings per Share

A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Numerator:
 
 
 
 
 
 
 
Net income (loss)
$
36.2

 
$
(69.6
)
 
$
117.0

 
$
2.0

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding for basic EPS
138.1

 
143.3

 
139.5

 
143.3

Dilutive effect of share-based awards*
0.6

 
—

 
0.5

 
0.3

Weighted average shares outstanding for diluted EPS
138.7

 
143.3

 
140.0

 
143.6

 
 
 
 
 
 
 
 
Anti-dilutive share-based awards excluded from computation of diluted EPS
1.7

 
—

 
0.9

 
0.8


* In the period of a net loss, diluted shares equal basic shares.

Shareholders' Equity

Shares

We issued shares related to the exercise and vesting of share-based compensation as follows:
Three Months Ended
 
Six Months Ended
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
74,000

 
31,900

 
127,000

 
46,400


Share Repurchases

In October 2015, the Board of Directors approved a three-year share repurchase plan of up to $2.0 billion. During the three and six months ended June 30, 2018, we repurchased 2.0 million and 3.3 million ordinary shares at an average repurchase price of $79.42 and $80.42 per share, for a total of $156.9 million and $265.0 million, respectively. During the three and six months ended July 1, 2017, we repurchased 812,184 ordinary shares at an average repurchase price of $71.67 per share, for a total of $58.2 million.


21
Perrigo Company plc - Item 1
Note 11


NOTE 11 – ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Changes in our AOCI balances, net of tax were as follows (in millions):
 
Fair value of derivative financial instruments, net of tax
 
Foreign currency translation adjustments
 
Fair value of investment securities, net of tax
 
Post-retirement and pension liability adjustments, net of tax
 
Total AOCI
Balance at December 31, 2017
$
(9.8
)
 
$
260.6

 
$
1.0

 
$
1.3

 
$
253.1

ASU 2016-01 adoption impact
—

 
—

 
(1.0
)
 
—

 
(1.0
)
Balance at December 31, 2017 after adoption impact
$
(9.8
)
 
$
260.6


$
—


$
1.3


$
252.1

OCI before reclassifications
(3.6
)
 
(92.6
)
 
—

 
(0.4
)
 
(96.6
)
Amounts reclassified from AOCI
(0.5
)
 
—

 
—

 
—

 
(0.5
)
Other comprehensive income
$
(4.1
)
 
$
(92.6
)
 
$
—

 
$
(0.4
)
 
$
(97.1
)
Balance at June 30, 2018
$
(13.9
)
 
$
168.0

 
$
—

 
$
0.9

 
$
155.0

    
NOTE 12 – INCOME TAXES

The effective tax rates were as follows:
Three Months Ended
 
Six Months Ended
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
34.5
%
 
8.7
%
 
29.4
%
 
89.9
%

The effective tax rate for the three months ended June 30, 2018 increased in comparison to the prior period due primarily to additional valuation allowances against deferred taxes and uncertain tax positions recorded in foreign jurisdictions. The effective tax rate for the six months ended June 30, 2018 decreased in comparison to the prior period due primarily to the negative impacts of non-deductible fees related to debt cancellation in the prior period.

Our tax rate is subject to adjustment over the balance of the calendar year due to, among other things, the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments based on differing interpretations of the applicable transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; and expiration of or the inability to renew tax rulings or tax holiday incentives.

We file income tax returns in numerous jurisdictions and are therefore subject to audits by tax authorities. Our primary income tax jurisdictions are Ireland, the United States, Israel, Belgium, France, and the United Kingdom.

On August 15, 2017, we filed a complaint in the United States District Court for the Western District of Michigan to recover $163.6 million of Federal income tax, penalties, and interest assessed and collected by the Internal Revenue Service (“IRS”), plus statutory interest thereon from the dates of payment, for the fiscal years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012 (the “2009 tax year,” “2010 tax year,” “2011 tax year,” and “2012 tax year,” respectively). The IRS audits of those years culminated in the issuances of two statutory notices of deficiency: (1) on August 27, 2014 for the 2009 and 2010 tax years and (2) on April 20, 2017 for the 2011 and 2012 tax years. The statutory notices of deficiency both included un-agreed income adjustments related principally to transfer pricing adjustments regarding the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States. In addition, the statutory notice of deficiency for the 2011 and 2012 tax years included the capitalization of certain expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits. We fully paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and filed timely claims for refund on June 11, 2015 and June 7, 2017 for the 2009-2010 tax years and 2011-2012 tax years, respectively. Our claims for refund were disallowed by certified letters dated

22
Perrigo Company plc - Item 1
Note 12


August 18, 2015 and July 11, 2017, for the 2009-2010 tax years and 2011-2012 tax years, respectively. The complaint was timely, based upon the refund claim denials, and seeks refunds of tax, interest, and penalties of $37.2 million for the 2009 tax year, $61.5 million for the 2010 tax year, $40.2 million for the 2011 tax year, and $24.7 million for the 2012 tax year. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended July 1, 2017.

On December 22, 2016, we received a notice of proposed adjustment for the IRS audit of Athena Neurosciences, Inc. (“Athena”), a subsidiary of Elan acquired in 1996, for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. Perrigo acquired Elan in December 2013. This proposed adjustment relates to the deductibility of litigation costs. We disagree with the IRS’s position asserted in the notice of proposed adjustment and intend to contest it.

On July 11, 2017, we received a draft notice of proposed adjustment associated with transfer pricing positions for the IRS audit of Athena for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. Athena was the originator of the patents associated with Tysabri® prior to the acquisition of Athena by Elan in 1996. In response to the draft notice of proposed adjustment, we provided the IRS with substantial additional documentation supporting our position. The amount of adjustments that may be asserted by the IRS in the final notice of proposed adjustment cannot be quantified at this time; however, based on the draft notice received, the amount to be assessed may be material. We disagree with the IRS’s position as asserted in the draft notice of proposed adjustment and intend to contest it.

We have ongoing audits in multiple other jurisdictions the resolution of which remains uncertain. These jurisdictions include, but are not limited to, the United States, Ireland and other jurisdictions in Europe. In addition to the matters discussed above, the IRS is currently auditing our fiscal years ended June 29, 2013, June 28, 2014, and June 27, 2015 (which covers the period of the Elan transaction). The Israel Tax Authority's audit of our fiscal years ended June 29, 2013 and June 28, 2014 concluded with no material impact to the financial statements. The Ireland Tax Authority is currently auditing our years ended December 31, 2012 and December 31, 2013.

Tax Law Changes

On December 22, 2017, the United States enacted the Tax Cuts and Jobs Act (“U.S. Tax Act”). The U.S. Tax Act includes a number of significant changes to existing U.S. tax laws that impact us. These changes include a corporate income tax rate reduction from 35% to 21% and the elimination or reduction of certain U.S. deductions and credits including limitations on the U.S. deductibility of interest expense and executive compensation. The U.S. Tax Act also transitions the U.S. taxation of international earnings from a worldwide system to a modified territorial system. These changes were effective beginning in 2018. The U.S. Tax Act also includes a one-time mandatory deemed repatriation tax on accumulated U.S. owned foreign corporations’ previously untaxed foreign earnings (“Transition Toll Tax”). The Transition Toll Tax may be paid over an eight-year period, starting in 2018, and will not accrue interest.

On December 22, 2017, Staff Accounting Bulletin No. 118 ("SAB 118") was issued to address the application of the U.S. GAAP ASC 740 income tax accounting for tax law changes enacted during 2017, in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the U.S. Tax Act. In accordance with SAB 118, for the year ended December 31, 2017, we recorded an income tax benefit of $2.4 million in connection with the remeasurement of certain deferred tax assets and liabilities and also recorded a $17.5 million increase of current tax expense in connection with the Transition Toll Tax on cumulative U.S. owned foreign earnings of $1.2 billion. The tax impacts represent provisional amounts and are a reasonable estimate. The IRS issued additional guidance related to the U.S. Tax Act during the quarters ended March 31, 2018 and June 30, 2018, which resulted in no changes to the provisional estimates recorded at December 31, 2017. Further work is necessary to perform additional analysis of historical foreign earnings, the impacts of repatriating foreign earnings, and U.S. cumulative temporary differences, as well as potential correlative adjustments. Any subsequent adjustment to these amounts will be recorded to tax expense when the analysis is complete in 2018.


23
Perrigo Company plc - Item 1
Note 12


The U.S. Tax Act subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries. The FASB Staff Q&A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed Income states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred. Given the complexity of the GILTI provisions, we are still evaluating the effects of the GILTI provisions and have not yet determined our accounting policy. At June 30, 2018, we made a reasonable estimate of the tax effect of a GILTI inclusion for 2018, which is not material for the six months ended June 30, 2018. We also estimate that we will not be subject to the base erosion anti-avoidance tax in 2018 and will not record tax benefits for deductions related to foreign-derived intangible income.

On December 22, 2017, the Belgian Parliament approved Belgian tax reform legislation (“Belgium Tax Act”), which was signed by the Belgian King and enacted on December 25, 2017. The Belgium Tax Act provides for a reduction to the corporate income tax rate from 34% to 30%, for 2018 and 2019, as well as a reduced corporate income tax rate of 25% for 2020 and beyond. The Belgium Tax Act also increased the participation exemption on dividend distributions to Belgium entities from 95% to 100%. The Belgium Tax Act also introduces Belgium tax consolidation and other anti-tax avoidance directives. For the year ended December 31, 2017, we recorded additional income tax expense of $24.1 million for the remeasurement of certain deferred tax assets and additional income tax benefit of $33.2 million for the remeasurement of certain deferred tax liabilities as a result of the Belgium Tax Act.

The IRS issued a notice of proposed regulations on August 1, 2018, implementing Section 965 of the Internal Revenue Code as amended by the U.S. Tax Act, which was enacted on December 22, 2017. The regulations affect any U. S. company with direct or indirect ownership interests in certain foreign corporations. We are currently evaluating the impact of the regulations on our financial statements.
    
NOTE 13 – CONTINGENCIES

In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below. We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated. The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters. For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of June 30, 2018, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows. We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve. Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows. 

Antitrust Violations

We were named as a counterclaim co-defendant in the lawsuit Fera Pharmaceuticals, LLC v. Akorn, Inc., et al. in the Southern District of New York, in which Akorn, Inc. (“Akorn”) alleged tortious interference and antitrust violations against us and Fera Pharmaceuticals, LLC (“Fera”). Trial was set for February 2018 in the Southern District of New York. This litigation arose out of our acquisition of bacitracin ophthalmic ointment from Fera in 2013. Akorn asserted claims under Sections 1 and 2 of the Sherman Antitrust Act alleging that we and Fera conspired to monopolize, attempted to monopolize, and did unlawfully monopolize the market for sterile bacitracin ophthalmic ointment in the United States through the use of an exclusive agreement with a supplier of sterile bacitracin active pharmaceutical ingredient. The parties have executed a written settlement of all claims and the case has been dismissed.

Price-Fixing Lawsuits

We have been named as a co-defendant with certain other generic pharmaceutical manufacturers in a number of class actions alleging that we and other manufacturers of the same product engaged in anti-competitive behavior to fix or raise the prices of certain drugs starting, in some instances, as early as June 2013. The products in question are Clobetasol, Desonide, and Econazole. Recently, the same class plaintiffs have filed new complaints

24
Perrigo Company plc - Item 1
Note 13


naming us as a co-defendant, along with 27 other manufacturers, alleging an overarching conspiracy to fix or raise the prices of 15 generic pharmaceutical products starting in 2011. Perrigo manufactures only two of the products at issue, Nystatin cream and Nystatin ointment. We have also recently been named a co-defendant along with 35 other manufacturers in a complaint filed by three supermarket chains alleging that defendants conspired to fix prices of 31 generic pharmaceutical products starting in 2013. These complaints, along with complaints filed against other companies alleging price fixing with respect to more than two dozen other drugs, have been consolidated for pretrial proceedings as part of a case captioned In re Generic Pharmaceuticals Pricing Antitrust Litigation, MDL No. 2724 in the U.S. District Court for the Eastern District of Pennsylvania. Pursuant to the court’s schedule staging various cases in phases, we have moved to dismiss the complaints relating to Clobetasol and Econazole. A schedule for responses to the other complaints will be determined after decisions are rendered on the pending motions to dismiss the class cases. At this stage, we cannot reasonably predict the outcome of the liability, if any, associated with these claims.

Securities Litigation
 
In the United States

On May 18, 2016, a shareholder filed a securities case against us and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (Roofers’ Pension Fund v. Papa, et al.). The plaintiff purported to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive. The original complaint alleged violations of Securities Exchange Act sections 10(b) (and Rule 10b‑5) and 14(e) against both defendants and 20(a) control person liability against Mr. Papa. In general, the allegations concerned the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015. The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged integration problems related to the Omega acquisition in the period from April 21, 2015 through May 11, 2016. On July 19, 2016, a different shareholder filed a securities class action against us and our former CEO, Joseph Papa, also in the District of New Jersey (Wilson v. Papa, et al.). The plaintiff purported to represent a class of persons who sold put options on our shares between April 21, 2015 and May 11, 2016. In general, the allegations and the claims were the same as those made in the original complaint filed in the Roofers' Pension Fund case described above. On December 8, 2016, the court consolidated Roofers' Pension Fund case and the Wilson case under the Roofers' Pension Fund case number. In February 2017, the court selected the lead plaintiffs for the consolidated case and the lead counsel to the putative class. In March 2017, the court entered a scheduling order.

On June 21, 2017, the court-appointed lead plaintiffs filed an amended complaint that superseded the original complaints in the Roofers’ Pension Fund case and the Wilson case. The lead plaintiffs seek to represent a class of shareholders for the period April 21, 2015 through May 3, 2017, and the amended complaint identifies three subclasses - shareholders who purchased shares during the period on the U.S. exchanges; shareholders who purchased shares during the period on the Tel Aviv exchange; and shareholders who owned shares on the final day of the Mylan tender offer November 13, 2015. The amended complaint names as defendants us and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O’Connor). The amended complaint alleges violations of Securities Exchange Act sections 10(b) (and Rule 10b‑5) and 14(e) against all defendants and 20(a) control person liability against the 11 individuals. In general, the allegations concern the actions taken by us and the former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to six generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri® royalty stream. The amended complaint does not include an estimate of damages. In August 2017, the defendants filed motions to dismiss the amended complaint. The plaintiffs filed their opposition in October 2017. The defendants filed replies in support of the motions to dismiss in November 2017. On July 27, 2018, the court issued an opinion and order granting the defendants’ motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O’Connor, and Marc Coucke. The court also dismissed without prejudice claims arising from the Tysabri® accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are Perrigo Company, Joe

25
Perrigo Company plc - Item 1
Note 13


Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issues regarding the Omega acquisition and the alleged price fixing activities with respect to six generic prescription pharmaceuticals. We intend to defend the lawsuit vigorously.

On November 1, 2017, Carmignac Gestion, S.A., filed a securities lawsuit against us and three individuals (former Chairman and CEO Joseph Papa, former CFO Judy Brown, and former Executive Vice President and Board member Marc Coucke). This lawsuit is not a securities class action. The case is styled Carmignac Gestion, S.A. v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey. The complaint asserts claims under Securities Exchange Act sections 10(b) (and Rule 10b-5), 14(e), and 18 against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff’s allegations focus on events during the period from April 2015 through April 2016. Plaintiff contends that the defendants provided inadequate disclosure throughout the period concerning the valuation and integration of Omega, the financial guidance provided by us during that period, our reporting about the generic prescription pharmaceutical business and its prospects, and the activities surrounding the efforts to defeat the Mylan tender offer during 2015. Many of the allegations in this case overlap with the allegations of the June 2017 amended complaint in the Roofers’ Pension Fund case described above. The plaintiff does not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the Roofers' Pension Fund case, and the court granted the stay motion. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.
   
On January 16, 2018, Manning & Napier Advisors, LLC filed a securities lawsuit against us and three individuals (former Chairman and CEO Joseph Papa, former CFO Judy Brown, and former Executive Vice President and Board member Marc Coucke). This lawsuit is not a securities class action. The case is styled Manning & Napier Advisors, LLC v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey. The complaint asserts claims under Securities Exchange Act sections 10(b) (and Rule 10b-5) and 18 against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff’s allegations focus on events during the period from April 2015 through May 2017. Plaintiff contends that the defendants provided inadequate disclosure at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri® financial asset. Many of the allegations in this case overlap with the allegations of the June 2017 amended complaint in the Roofers' Pension Fund case described above. The plaintiff does not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motion to dismiss filed in the Roofers' Pension Fund case, and the court granted the stay motion. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.

On January 26, 2018, two different plaintiff groups (the Mason Capital group and the Pentwater group) each filed a lawsuit against us and the same individuals who are defendants in the amended complaint in the securities class action case described above (Roofers’ Pension Fund case). The same law firm represents these two plaintiff groups, and the two complaints are substantially similar. These two cases are not securities class actions. One case is styled Mason Capital L.P., et al. v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey. The other case is styled Pentwater Equity Opportunities Master Fund Ltd., et al.  v. Perrigo Company plc, et al., and also was filed in the U.S. District Court for the District of New Jersey. Both cases are assigned to the same federal judge that is hearing the class action case and the other individual cases described above (Carmignac and Manning & Napier). Each complaint asserts claims under Securities Exchange Act sections 14(e) (related to tender offer disclosures) against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff’s allegations describe events during the period from April 2015 through May 2017. Plaintiff contends that the defendants provided inadequate disclosure during the tender offer period in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri® financial asset. Many of the factual allegations in these two cases overlap with the allegations of the June 2017 amended complaint in the Roofers' Pension Fund case described above and the allegations in the Carmignac case described above. The plaintiff does not provide an estimate of damages. The parties to each case jointly requested that the court stay each case pending the outcome of a ruling on the motions to dismiss filed in the Roofers’ Pension Fund case. The court

26
Perrigo Company plc - Item 1
Note 13


granted the stay motion in each case. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case. We intend to defend both lawsuits vigorously.

On February 13, 2018, a group of plaintiff investors affiliated with Harel Insurance Investments & Financial Services, Ltd. filed a lawsuit against us and the same individuals who are defendants in the amended complaint in the securities class action case described above (Roofers’ Pension Fund case). This lawsuit is not a securities class action. The new complaint is substantially similar to the amended complaint in the Roofers' Pension Fund case. The relevant period in the new complaint stretches from February 2014 to May 2, 2017. The complaint adds as defendants two individuals who served on our Board prior to 2016. The case is styled Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey and is assigned to the same federal judge that is hearing the class action cases and the four other individual cases described above (Carmignac, Manning & Napier, Mason Capital, and Pentwater). The Harel Insurance Company complaint asserts claims under Securities Exchange Act section 10(b) (and related SEC Rule 10b‑5) and section 14(e) (related to tender offer disclosures) against all defendants as well as 20(a) control person liability against the individual defendants. The complaint also asserts claims based on Israeli securities laws. In general, the plaintiffs' allegations describe events during the period from February 2014 through May 2017. Plaintiffs contend that the defendants provided inadequate disclosure during the tender offer events in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri® financial asset from February 2014 until the withdrawal of past financial statements in April 2017. Many of the factual allegations in this case overlap with the allegations of the June 2017 amended complaint in the Roofers' Pension Fund case described above and the allegations in the four opt out cases also described above. The plaintiffs do not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the Roofers’ Pension Fund case, which was granted by the court. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.

On February 16, 2018, First Manhattan Company filed a securities lawsuit against us and three individuals (former Chairman and CEO Joseph Papa, former CFO Judy Brown, and former Executive Vice President and Board member Marc Coucke). This lawsuit is not a securities class action. The case is styled First Manhattan Co. v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey. The case was assigned to the same judge hearing the class action case and the five other opt out cases. The complaint asserts claims under Securities Exchange Act sections 10(b) (and Rule 10b-5), 14(e), and 18 against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff’s allegations focus on events during the period from April 2015 through May 2017. Plaintiff contends that the defendants provided inadequate disclosure at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri® financial asset. This lawsuit was filed by the same law firm that filed the Manning & Napier Advisors case and the Carmignac case described above and generally makes the same factual assertions as in the Manning & Napier Advisors case. Many of the allegations in this case overlap with the allegations of the June 2017 amended complaint in the Roofers' Pension Fund case described above. The plaintiff does not provide an estimate of damages. On April 20, 2018, the plaintiff filed an amended complaint that did not materially change the factual allegations of the original complaint. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the Roofers’ Pension Fund case. The court granted the stay motion. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.

On April 20, 2018, a group of plaintiff investors affiliated with TIAA-CREF filed a lawsuit against us and the same individuals who are the defendants in the Harel Insurance case complaint. This lawsuit is not a securities class action. The law firm representing the plaintiffs in the Harel Insurance case also represents the TIAA-CREF plaintiff entities in this case, and the new complaint is substantially similar to the Harel Insurance complaint. The relevant period in the new complaint is August 14, 2014 to May 2, 2017 inclusive. The case is styled TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the

27
Perrigo Company plc - Item 1
Note 13


District of New Jersey and is assigned to the same federal judge that is hearing the class action case and the six other individual cases described above (Carmignac, Manning & Napier, Mason Capital, Pentwater, Harel Insurance, and First Manhattan). The TIAA-CREF Investment Management complaint asserts claims under Securities Exchange Act section 10(b) (and related SEC Rule l0b-5), section 14(e) (related to tender offer disclosures) against all defendants as well as section 20(a) control person liability against the individual defendants. In general, plaintiffs' allegations describe events during the period from August 2014 through May 2017. Plaintiffs contend that the defendants provided inadequate disclosure during the tender offer events in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri® financial asset from August 2014 until the withdrawal of past financial statements in April 2017. Many of the factual allegations in this case also overlap with the allegations of the June 2017 amended complaint in the Roofers' Pension Fund case described above. The plaintiffs do not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the Roofers' Pension Fund case. The court granted the stay motion. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.

In Israel

Because our shares are traded on the Tel Aviv exchange under a dual trading arrangement, we are potentially subject to securities litigation in Israel. Three cases were filed; two were voluntarily dismissed and one was stayed. We are consulting Israeli counsel about our response to these allegations and we intend to defend these cases vigorously.

On May 22, 2016, shareholders filed a securities class action against us and five individual defendants: Our former CEO Mr. Papa, our former Executive Vice President and General Manager of the BCH segment Marc Coucke, our then Chief Executive Officer John Hendrickson, our former Board member Gary Kunkle, Jr., and our Board member Laurie Brlas alleging violations of Israeli law in the District Court of Tel Aviv-Jaffa (Schweiger et al. v. Perrigo Company plc, et al.). On June 15, 2016, we filed a motion to stay the case pending the outcome of the securities class action pending in the New Jersey Federal Court. The plaintiffs did not oppose the motion. The Israeli court granted the motion on the same day, and the Schweiger action was stayed. In October 2017, the Schweiger plaintiffs dismissed their claims without prejudice because of the pendency of another class action case filed in Israel (see discussion below of the Israel Elec. Corp. Employees’ Educ. Fund case). The court approved the voluntary dismissal. 

On March 29, 2017, plaintiff Eyal Keinan commenced an action in the District Court of Tel Aviv-Jaffa asserting securities claims against two defendants: Perrigo and its auditor Ernst & Young LLP ("EY"). The case is styled Keinan v. Perrigo Company plc, et al. The action sought certification of a class of purchasers of Perrigo shares on the Israeli exchange beginning February 6, 2014. The proposed closing date for the class was not clear from the complaint though it appeared to extend into 2017. In general, the plaintiff asserted that we improperly accounted for our stream of royalty income from two drugs: Tysabri® and Prialt. The court filings contended that the alleged improper accounting caused the audited financial results for Perrigo to be incorrect for the six month period ended December 31, 2015, and the years ended June 27, 2015 and June 28, 2014 and the other financial data released by us over those years and 2016 to also be inaccurate. The plaintiff maintained that the defendants are liable under Israeli securities law or, in the alternative, under U.S. securities law. The plaintiff indicated an initial, preliminary class damages estimate of 686.0 million NIS (approximately $192.0 million at 1 NIS = $0.28 cent). In January 2018, the Keinan plaintiff announced its intention to dismiss his claims because of the pendency of another class action case filed in Israel (see discussion below of the Israel Elec. Corp. Employees’ Educ. Fund case). The court granted the dismissal on February 11, 2018.

On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled Israel Elec. Corp. Employees’ Educ. Fund v. Perrigo Company plc, et al. The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, EY (the Company’s auditor), and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc

28
Perrigo Company plc - Item 1
Note 13


Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O’Connor). The complaint alleges violations under U.S. securities laws of Securities Exchange Act sections 10(b) (and Rule 10b‑5) and 14(e) against all defendants and 20(a) control person liability against the 11 individuals or, in the alternative, under Israeli securities laws. In general, the allegations concern the actions taken by us and our former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure concerning purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company, alleges price fixing activities with respect to six generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri® royalty stream. The plaintiff indicates an initial, preliminary class damages estimate of 2.7 billion NIS (approximately $760.0 million at 1 NIS = $0.28 cent). We intend to defend the lawsuit vigorously.

On July 12, 2017, the plaintiff in the Israel Elec. Corp. Employees’ Educ. Fund v. Perrigo Company plc, et al. case filed a motion to have all three cases pending in Israel either consolidated or the other two cases dismissed so that the Israel Elec. Corp. Educ. Fund plaintiff can proceed as the sole plaintiff. In October 2017, the Schweiger plaintiffs (see description above) voluntarily dismissed their securities class action without prejudice as part of their response to the motion filed by the Israel Elec. Corp. Educ. Fund plaintiff. A variety of other procedural motions were also pending having to do with the timing of any response by defendants. The court held an initial conference on November 9, 2017 to address the motion filed by the Israel Elec. Corp. Educ. Fund plaintiff. Subsequently, the competing class plaintiffs held discussions and informed the court in January 2018 that they had reached an agreement among themselves such that the Education Fund case will continue and the Keinan plaintiff dismissed its case. The court approved this outcome. At the request of the parties, the court has stayed the Education Fund case pending the final adjudication of the class action case in D.N.J. (the Roofers’ Pension Fund case described above under Securities Litigation In the United States). The court approved the stay.

Eltroxin

During October and November 2011, nine applications to certify a class action lawsuit were filed in various courts in Israel related to Eltroxin, a prescription thyroid medication manufactured by a third party and distributed in Israel by our subsidiary, Perrigo Israel Agencies Ltd. The respondents included our subsidiaries, Perrigo Israel Pharmaceuticals Ltd. and/or Perrigo Israel Agencies Ltd., the manufacturers of the product, and various healthcare providers who provide healthcare services as part of the compulsory healthcare system in Israel.

One of the applications was dismissed and the remaining eight applications were consolidated into one application. The applications arose from the 2011 launch of a reformulated version of Eltroxin in Israel. The consolidated application generally alleges that the respondents (a) failed to timely inform patients, pharmacists and physicians about the change in the formulation; and (b) failed to inform physicians about the need to monitor patients taking the new formulation in order to confirm patients were receiving the appropriate dose of the drug. As a result, claimants allege they incurred the following damages: (a) purchases of product that otherwise would not have been made by patients had they been aware of the reformulation; (b) adverse events to some patients resulting from an imbalance of thyroid functions that could have been avoided; and (c) harm resulting from the patients' lack of informed consent prior to the use of the reformulation.

Several hearings on whether or not to certify the consolidated application took place in December 2013 and January 2014. On May 17, 2015, the District Court certified the motion against Perrigo Israel Agencies Ltd. and dismissed it against the remaining respondents, including Perrigo Israel Pharmaceuticals Ltd.

On June 16, 2015, we submitted a motion for permission to appeal the decision to certify to the Israeli Supreme Court together with a motion to stay the proceedings of the class action until the motion for permission to appeal is adjudicated. We have filed our statement of defense to the underlying proceedings. The underlying proceedings have been stayed pending the outcome of the mediation process and, if necessary, a decision on the motion to appeal.

On November 14, 2017 the parties submitted the agreed settlement agreement to the approval of the Supreme Court, which referred the approval back to the District Court. During three hearings that took place on November 29, 2017, December 13, 2017 and January 11, 2018 the District Court opined that it would approve the settlement agreement subject to certain amendments to be proposed by the Court (which would not impact the monetary settlement reached) and set a hearing for January 30, 2018 to discuss and finalize the proposed changes.

29
Perrigo Company plc - Item 1
Note 13


Meanwhile, the Court ordered the settlement to be (1) provided to the Attorney General for review (standard procedure); and (2) published in the written media (newspapers), to enable the class members to submit any objections or “opt-out” to  the proposed settlement by February 15, 2018.

On February 21, 2018, the District Court held a hearing to, among others, review objections received from class members who had notified the District Court of their desire to opt out of the settlement. In addition, a representative of the Israeli Attorney General’s office notified the District Court that, based upon their preliminary examination of the settlement, they intend to object to the settlement in its current form. The District Court recommended that the parties continue to discuss and minimize objections to the settlement and scheduled another hearing for May 13, 2018.
    
The District Court Justice was appointed as a Supreme Court Justice and ordered to move the case to a different panel. In an effort to reach a decision before the appointment, an additional hearing was held on March 12, 2018 in which the court urged the parties to try and exhaust their negotiations to the fullest and provide an update by May 13, 2018. In addition, the Court ordered the Attorney General to submit its opinion to the settlement agreement by May 30, 2018, which was extended until July 23, 2018.

Tysabri® Product Liability Lawsuits

               We and our collaborator Biogen have been co-defendants in product liability lawsuits arising out of the occurrence of Progressive Multifocal Leukoencephalopathy ("PML"), a serious brain infection, and serious adverse events, including deaths, which occurred in patients taking Tysabri®.  In 2018, the last outstanding PML case was dismissed with prejudice. 

Claim Arising from the Omega Acquisition

On December 16, 2016, we and Perrigo Ireland 2 brought an arbitral claim ("Claim") against Alychlo NV ("Alychlo") and Holdco I BE NV ("Holdco") (together the Sellers) in accordance with clause 26.2 of the Share Purchase Agreement dated November 6, 2014 ("SPA") and the rules of the Belgian Centre for Arbitration and Mediation ("CEPANI"). Our Claim relates to the accuracy and completeness of information about Omega provided by the Sellers as part of the sale process, the withholding of information by the Sellers during that process and breaches of Sellers’ warranties. We are seeking monetary damages from the Sellers. The Sellers served their respective responses to the Claim on February 20, 2017. In its response, Alychlo has asserted a counterclaim for monetary damages contending that we breached a warranty in the SPA and breached the duty of good faith in performing the SPA. There can be no assurance that our Claim will be successful, and Sellers deny liability for the Claim. We deny that Alychlo is entitled to any relief (including monetary relief) under the counterclaim. The arbitration proceedings are confidential as required by the SPA and the rules of the CEPANI.

NOTE 14 – RESTRUCTURING CHARGES

We periodically take action to reduce redundant expenses and improve operating efficiencies. The following reflects our restructuring activity (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Beginning balance
$
12.4

 
$
51.5

 
$
21.4

 
$
19.7

Additional charges
3.7

 
12.1

 
5.2

 
50.8

Payments
(3.1
)
 
(23.6
)
 
(13.8
)
 
(30.7
)
Non-cash adjustments
(0.3
)
 
(0.3
)
 
(0.1
)
 
(0.1
)
Ending balance
$
12.7

 
$
39.7

 
$
12.7

 
$
39.7


Restructuring activity includes severance, lease exit costs, and asset impairments. The charges incurred during the three and six months ended June 30, 2018 were primarily associated with continued costs from actions we took to streamline our organization as announced on February 21, 2017 as well as additional lease exit costs. Of the amount recorded during the six months ended July 1, 2017, $28.0 million was related to the CHCA segment. There were no other material restructuring programs that significantly impacted any other reportable segments for

30
Perrigo Company plc - Item 1
Note 15


the three and six months ended June 30, 2018 or July 1, 2017. All charges are recorded in Restructuring expense on the Condensed Consolidated Financial Statements. The remaining $7.3 million liability for employee severance benefits will be paid within the next year, while the remaining $5.4 million liability for lease exit costs will be paid over the remaining terms of the applicable leases.

NOTE 15 – SEGMENT INFORMATION
    
Our reporting segments are as follows:

•
Consumer Healthcare Americas, comprises our U.S., Mexico and Canada consumer healthcare business (OTC, contract, infant formula and animal health categories).
•
Consumer Healthcare International, comprises our branded consumer healthcare business primarily in Europe and our consumer focused businesses in the United Kingdom, Australia, and Israel. This segment also includes our U.K. liquid licensed products business.
•
Prescription Pharmaceuticals, comprises our U.S. Prescription Pharmaceuticals business.

We also had a legacy operating segment, Other, which contained our API businesses, which we divested. Following the divestitures, there were no substantial assets or operations left in the segment. Our segments reflect the way in which our management makes operating decisions, allocates resources and manages the growth and profitability of the Company.

The below tables show select financial measures by reporting segment (in millions):
 
 
Total Assets
 
 
June 30,
2018
 
December 31,
2017
CHCA
 
$
3,673.0

 
$
3,786.8

CHCI
 
4,799.4

 
5,029.0

RX
 
2,753.2

 
2,813.0

Total
 
$
11,225.6

 
$
11,628.8

 
Three Months Ended
 
June 30, 2018
 
July 1, 2017
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHCA
$
596.8

 
$
57.4

 
$
15.3

 
$
604.9

 
$
104.2

 
$
17.0

CHCI
381.0

 
5.6

 
49.5

 
376.5

 
3.9

 
47.5

RX
208.6

 
56.9

 
20.5

 
240.4

 
69.3

 
22.3

Other
—

 
—

 
—

 
16.1

 
4.1

 
0.4

Unallocated
—

 
(25.2
)
 
—

 
—

 
(32.7
)
 
—

Total
$
1,186.4

 
$
94.7

 
$
85.3

 
$
1,237.9

 
$
148.8

 
$
87.2

 
Six Months Ended
 
June 30, 2018
 
July 1, 2017
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHCA
$
1,198.4

 
$
170.5

 
$
30.5

 
$
1,187.6

 
$
179.2

 
$
34.2

CHCI
782.4

 
20.4

 
100.8

 
751.5

 
4.2

 
93.2

RX
422.6

 
118.7

 
41.1

 
457.8

 
157.5

 
44.6

Other
—

 
—

 
—

 
35.0

 
9.7

 
0.8

Unallocated
—

 
(58.7
)
 
—

 
—

 
(73.3
)
 
—

Total
$
2,403.4

 
$
250.9

 
$
172.4

 
$
2,431.9

 
$
277.3

 
$
172.8



31
Perrigo Company plc - Item 1
Note 16


NOTE 16 – SUBSEQUENT EVENTS

On August 9, 2018, we announced a plan to separate our RX business. We intend to begin the preparations for a spin-off of the RX business to shareholders and will also remain open to other value-enhancing options, including a possible sale, merger or other form of separation. We currently expect the separation of the RX business to be completed during the second half of 2019.

ITEM 2.        MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

EXECUTIVE OVERVIEW

This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the financial statements included in this Form 10-Q and our Form 10-K for the year ended December 31, 2017 (the “2017 Form 10-K”). These historical financial statements may not be indicative of our future performance. This discussion contains a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risks referred to under “Risk Factors” in Item 1A of our 2017 Form 10-K and Part II. Item 1A of this Form 10-Q.

Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.

We are a leading global healthcare company, delivering value to our customers and consumers by providing Quality Affordable Healthcare Products®. Founded in 1887 as a packager of home remedies, we have built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. We believe we are one of the world's largest manufacturers of over-the-counter (“OTC”) healthcare products and suppliers of infant formulas for the store brand market. We are a leading provider of branded OTC products throughout Europe, and also a leading producer of generic pharmaceutical topical products such as creams, lotions, gels, and nasal sprays ("extended topical") prescription drugs. We are headquartered in Ireland, and sell our products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China.

         Our reporting segments are as follows:

•
Consumer Healthcare Americas ("CHCA"), comprises our U.S., Mexico and Canada consumer healthcare business (OTC, contract, infant formula and animal health categories).
•
Consumer Healthcare International ("CHCI"), comprises our branded consumer healthcare business primarily in Europe and our consumer focused businesses in the United Kingdom, Australia, and Israel. This segment also includes our U.K. liquid licensed products business.
•
Prescription Pharmaceuticals ("RX"), comprises our U.S. Prescription Pharmaceuticals business.

Our segments reflect the way in which our management makes operating decisions, allocates resources and manages the growth and profitability of the Company. For results by segment, see "Segment Results" below and Item 1. Note 15.

32
Perrigo Company plc - Item 2
Executive Overview




2018 Highlights

•
On January 1, 2018, we adopted Accounting Standard Updates ("ASU") 2014-09 Revenue from Contracts with Customers and its related amendments (collectively, "ASC 606") using the modified retrospective method. The adoption of ASC 606 represents a change in accounting principle that will more closely align revenue recognition with the transfer of control of products to our customers and will provide financial statement readers with enhanced disclosures (refer to Item 1. Note 2).

•
On January 1, 2018, we adopted ASU 2016-01 Financial Instruments - Recognition and Measurement of Financial Assets and Liabilities (refer to Item 1. Note 7 and Note 11).

•
During the six months ended June 30, 2018, we repurchased $265.0 million worth of shares as part of our authorized share repurchase plan (refer to Item 1. Note 10).

•
On August 9, 2018, we announced a plan to separate our RX business. We intend to begin the preparations for a spin-off of the RX business to shareholders and will also remain open to other value-enhancing options, including a possible sale, merger or other form of separation. We believe the separation, which we currently expect to be completed during the second half of 2019, will enable us to focus on expanding our leading consumer businesses. We anticipate incurring significant costs in connection with the proposed separation, which we cannot quantify until the form of separation is determined.

RESULTS OF OPERATIONS

CONSOLIDATED

Recent Trends and Developments

•
We are performing a growth-driven exercise focused around our core competencies. We are measuring potential business opportunities, including organic and inorganic growth prospects against our strengths and capabilities, as well as identifying gaps and areas for improvement. Following our assessment, we will prioritize potential investment opportunities across the organization and solidify our strategic road-map. Through this exercise, we may further refine our portfolio and the necessary capital resources deployed to deliver consistent shareholder returns.

Consolidated Results

Three Month Comparison
 
Three Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
Net sales
$
1,186.4

 
$
1,237.9

Gross profit
$
471.0

 
$
504.6

Gross profit %
39.7
%
 
40.8
%
Operating expenses
$
376.3

 
$
355.8

Operating expenses %
31.7
%
 
28.7
%
Operating income
$
94.7

 
$
148.8

Operating income %
8.0
%
 
12.0
%

33
Perrigo Company plc - Item 2
Consolidated


chart-c34d066938675ab5879.jpg
 
chart-8daa610072d05bf4b00.jpg
* Total net sales by geography is derived from the location of the entity that sells to a third party.

Net sales decreased $51.5 million, or 4%, over the prior year period as a result of:
    
•
A net decrease in sales of existing products of $72.7 million;
•
The absence of sales of discontinued products of $16.7 million;
•
The absence of Active Pharmaceuticals Ingredient ("API") business sales of $16.1 million in the former Other segment; and
•
The absence of sales attributable to the exited Russian business and prior year distribution phase out initiatives of $7.3 million in the CHCI segment; partially offset by
•
New product sales of $42.3 million; and
•
Favorable foreign currency translation of $19.0 million.

Operating income decreased $54.1 million, or 36%, over the prior year period as a result of:

•
A decrease in gross profit of $33.6 million due primarily to the decrease in net sales and pricing pressure, primarily in the RX segment.

•
An increase in operating expenses of $20.5 million due primarily to:
•
A $50.0 million payment to enter into a license agreement with Merck Sharp & Dohme Corp. ("Merck") in our CHCA segment, offset partially by
•
The absence of $23.3 million of impairment charges related to certain definite-lived intangible assets in our RX segment and the Russian business in our CHCI segment in the prior year period; and
•
Decreased Restructuring expense of $8.4 million related to the cost reduction initiatives taken in the prior year period.

Six Month Comparison
 
Six Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
Net sales
$
2,403.4

 
$
2,431.9

Gross profit
$
963.7

 
$
968.9

Gross profit %
40.1
%
 
39.8
%
Operating expenses
$
712.8

 
$
691.6

Operating expenses %
29.7
%
 
28.4
%
Operating income
$
250.9

 
$
277.3

Operating income %
10.4
%
 
11.4
%

34
Perrigo Company plc - Item 2
Consolidated


chart-5b1b5d21ffb5d7b8cee.jpg

 
chart-abb3553fa84bb6bc41e.jpg
* Total net sales by geography is derived from the location of the entity that sells to a third party.

Net sales decreased $28.5 million, or 1%, over the prior year period as a result of:

•
A net decrease in sales of existing products of $86.4 million;
•
The absence of API business sales of $35.0 million in the former Other segment;
•
The absence of sales attributable to the exited Russian business and prior year distribution phase out initiatives of $29.0 million in the CHCI segment; and
•
The absence of sales of discontinued products of $25.0 million, partially offset by
•
New product sales of $83.5 million; and
•
Favorable foreign currency translation of $63.5 million.

Operating income decreased $26.4 million, or 10%, over the prior year period as a result of:

•
A decrease in gross profit of $5.2 million.

•
An increase in operating expenses of $21.2 million due primarily to:
•
A $50.0 million payment to enter into a license agreement with Merck in our CHCA segment;
•
The absence of $22.9 million in gains in the prior year period related to certain Abbreviated New Drug Applications ("ANDAs") in our RX segment; and
•
Increased acquisition-related charges and contingent consideration adjustments of $22.5 million; partially offset by
•
Decreased Restructuring expense of $45.6 million related to the cost reduction initiatives taken in the prior year period; and
•
The absence of $30.7 million of impairment charges related to certain In-process Research and Development ("IPR&D") and definite-lived intangible assets in our RX segment in the prior year period.


35
Perrigo Company plc - Item 2
CHCA


CONSUMER HEALTHCARE AMERICAS

Recent Trends and Developments

•
On May 29, 2018, we entered into a license agreement with Merck that will allow us to develop and commercialize an OTC version of Nasonex-branded products, as well as other products containing the same active ingredient. In connection with this license agreement, we paid an upfront license fee of $50.0 million. In addition, if we achieve certain development milestones, we will make future milestone and royalty payments (refer to Item 1. Note 3).

Segment Results

Three Month Comparison
 
Three Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
Net sales
$
596.8

 
$
604.9

Gross profit
$
195.3

 
$
203.8

Gross profit %
32.7
%
 
33.7
%
Operating income
$
57.4

 
$
104.2

Operating income %
9.6
%
 
17.2
%

Three Months Ended June 30, 2018 vs. Three Months Ended July 1, 2017

Net sales decreased $8.1 million, or 1%, over the prior year period as a result of:

•
A net decrease in sales of existing products of $18.3 million due primarily to:
•
Lower sales in our animal health and smoking cessation categories; and
•
Ongoing pricing pressure, which we expect to continue for the foreseeable future; partially offset by
•
Higher sales volumes in our cough/cold/allergy/sinus category and infant formula business;
•
The absence of sales of discontinued products of $4.0 million; and
•
The effect of unfavorable foreign currency translation of $1.1 million; partially offset by
•
New product sales of $15.3 million related primarily to esomeprazole magnesium (store brand equivalent to Nexium® 24HR capsules) and infant formula products.

Operating income decreased $46.8 million, or 45%, over the prior year period as a result of:

•
A decrease of $8.5 million in gross profit due primarily to the decrease in net sales and higher cost of sales.

•
An increase of $38.3 million in operating expenses due primarily to:
•
Increased Research and development ("R&D") expense of $48.4 million related primarily to the $50.0 million payment to enter into a license agreement with Merck; partially offset by
•
Decreased Restructuring expense of $4.3 million related to the cost reduction initiatives taken in the prior year period;
•
Absence of fixed asset impairments in the prior year period of $4.1 million; and
•
Decreased Administration expense of $3.6 million due primarily to decreased legal fees.


36
Perrigo Company plc - Item 2
CHCA


Six Month Comparison

 
Six Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
Net sales
$
1,198.4

 
$
1,187.6

Gross profit
$
395.7

 
$
392.1

Gross profit %
33.0
%
 
33.0
%
Operating income
$
170.5

 
$
179.2

Operating income %
14.2
%
 
15.1
%

Six Months Ended June 30, 2018 vs. Six Months Ended July 1, 2017

Net sales increased $10.8 million, or 1%, over the prior year period as a result of:

•
New product sales of $26.5 million related primarily to the launches of esomeprazole magnesium (store brand equivalent to Nexium® 24HR capsules) and infant formula products; partially offset by
•
A net decrease in sales of existing products of $9.9 million due to:
•
Higher sale volumes in our cough/cold/allergy/sinus and infant nutrition categories; more than offset by
•
Lower sales in our animal health and smoking cessation categories; and
•
Ongoing pricing pressure, which we expect to continue for the foreseeable future; and
•
The absence of sales of discontinued products of $5.9 million.

Operating income decreased $8.7 million, or 5%, over the prior year period as a result of:

•
An increase of $3.6 million in gross profit due primarily to the increase in net sales.

•
An increase of $12.3 million in operating expenses due primarily to:
•
Increased R&D expense of $47.0 million related primarily to the $50.0 million payment to enter into the license agreement with Merck; partially offset by
•
Decreased Restructuring expense of $27.6 million related to the cost reduction initiatives taken in the prior year period;
•
Decreased Selling and Administration expense of $4.4 million due primarily to decreased employee-related costs and decreased selling expense in our animal health category; and
•
Absence of fixed asset impairments in the prior year period of $4.1 million.

CONSUMER HEALTHCARE INTERNATIONAL

Segment Results

Three Month Comparison
 
Three Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
Net sales
$
381.0

 
$
376.5

Gross profit
$
181.2

 
$
174.0

Gross profit %
47.5
%
 
46.2
%
Operating income
$
5.6

 
$
3.9

Operating income %
1.5
%
 
1.0
%


37
Perrigo Company plc - Item 2
CHCI


Three Months Ended June 30, 2018 vs. Three Months Ended July 1, 2017

Net sales increased $4.5 million, or 1%, over the prior year period as a result of:

•
The effect of favorable foreign currency translation of $20.1 million; and
•
New product sales of $19.2 million; partially offset by
•
A net decrease in sales of existing products of $19.8 million due primarily to lower sales in the analgesics, anti-parasite and lifestyle categories; partially offset by higher sales volumes in diagnostic products;
•
The absence of sales of discontinued products of $7.7 million; and
•
The absence of $7.3 million in sales attributable to the exited Russian business and prior year distribution phase out initiatives.

Operating income increased $1.7 million, or 42%, over the prior year period as a result of:

•
An increase of $7.2 million in gross profit due primarily to:
•
Increased net sales and benefits from continued insourcing initiatives; and
•
The effect of favorable foreign currency translation.

•
An increase of $5.5 million in operating expenses due primarily to:
•
Increased Selling and Administration expense of $11.9 million due primarily to the effect of unfavorable foreign currency translation; offset by
•
Decreased Restructuring expense of $6.2 million related to the cost reduction initiatives taken in the prior year.

•
Management continues to implement its previously disclosed strategy for brand prioritization, sales force restructuring, and manufacturing in-sourcing, which is expected to reduce selling costs, improve operating margins and focus on higher value OTC products.

Six Month Comparison
 
Six Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
Net sales
$
782.4

 
$
751.5

Gross profit
$
375.7

 
$
343.5

Gross profit %
48.0
%
 
45.7
%
Operating income
$
20.4

 
$
4.2

Operating income %
2.6
%
 
0.6
%

Six Months Ended June 30, 2018 vs. Six Months Ended July 1, 2017

Net sales increased $30.9 million, or 4%, over the prior year period as a result of:

•
The effect of favorable foreign currency translation of $63.3 million; and
•
New product sales of $39.5 million; partially offset by
•
The absence of $29.0 million in sales attributable to the exited Russian business and prior year distribution phase out initiatives;
•
A decrease in sales of existing products of $29.5 million due primarily to lower sales in the cough/cold/allergy and lifestyle categories, partially offset by improved pricing on certain products; and
•
The absence of sales of discontinued products of $13.3 million.

Operating income increased $16.2 million over the prior year period as a result of:

•
An increase of $32.2 million in gross profit due primarily to:
•
Increased net sales and benefits from continued insourcing initiatives; and
•
The effect of favorable foreign currency translation.

38
Perrigo Company plc - Item 2
CHCI



•
An increase of $16.0 million in operating expenses due primarily to:
•
Increased Selling and Administration expense of $23.2 million due primarily to the effect of unfavorable foreign currency translation; and
•
Increased distribution expense of $3.9 million due primarily to a new distribution center and the effect of unfavorable foreign currency translation; offset by
•
Decreased Restructuring expense of $8.5 million related to the cost reduction initiatives taken in the prior year; and
•
The absence of a $3.7 million impairment charge related to the Russian business in the prior year period.

PRESCRIPTION PHARMACEUTICALS

Recent Trends and Developments

•
We continue to experience a significant year-over-year reduction in pricing in our RX segment due to competitive pressures. This softness in pricing is attributable to various factors, including increased focus from customers to capture supply chain productivity savings, competition in specific products, and consolidation of certain customers. We expect this softness to continue to impact the segment for the foreseeable future and we are forecasting a 10%-12% pricing decline in this segment for the year ending December 31, 2018.

•
On August 9, 2018, we announced a plan to separate our RX business. We intend to begin the preparations for a spin-off of the RX business to shareholders and will also remain open to other value-enhancing options, including a possible sale, merger or other form of separation. We currently expect the separation of the RX business to be completed during the second half of 2019.


Segment Results

Three Month Comparison
 
Three Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
Net sales
$
208.6

 
$
240.4

Gross profit
$
94.5

 
$
119.1

Gross profit %
45.3
%
 
49.6
%
Operating income
$
56.9

 
$
69.3

Operating income %
27.3
%
 
28.8
%

Three Months Ended June 30, 2018 vs. Three Months Ended July 1, 2017

Net sales decreased $31.8 million, or 13%, over the prior year period as a result of:

•
Decreased sales of existing products of $34.6 million due primarily to pricing pressure; and
•
The absence of sales of discontinued products of $5.1 million; offset partially by
•
New product sales of $7.8 million due primarily to sales of testosterone 2% topical (generic equivalent to Axiron®).

Operating income decreased $12.4 million, or 18%, over the prior year period as a result of:

•
A decrease of $24.6 million in gross profit due primarily to lower sales and pricing pressure.

•
A decrease of $12.2 million in operating expenses due primarily to:
•
The absence of $19.6 million of impairment charges related to certain definite-lived intangible assets in the prior year period; offset partially by

39
Perrigo Company plc - Item 2
RX


•
An increase of $4.5 million in acquisition-related charges and contingent consideration adjustments.

Six Month Comparison

 
Six Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
Net sales
$
422.6

 
$
457.8

Gross profit
$
192.3

 
$
215.4

Gross profit %
45.5
%
 
47.0
%
Operating income
$
118.7

 
$
157.5

Operating income %
28.1
%
 
34.4
%

Six Months Ended June 30, 2018 vs. Six Months Ended July 1, 2017

Net sales decreased $35.2 million, or 8%, over the prior year period as a result of:

•
Decreased sales of existing products of $47.0 million due primarily to pricing pressure and decreased sales volume of certain products; and
•
The absence of sales of discontinued products of $5.7 million; partially offset by
•
New product sales of $17.5 million due primarily to sales of testosterone 2% topical (generic equivalent to Axiron®).


Operating income decreased $38.8 million, or 25%, over the prior year period as a result of:

•
A decrease of $23.1 million in gross profit due primarily to lower net sales and pricing pressure.

•
An increase of $15.7 million in operating expenses due primarily to:
•
The absence of the following:
•
Gain on the sale of certain ANDAs of $22.9 million;
•
Gain related to contingent consideration of $14.8 million; offset partially by
•
An impairment charge related to certain IPR&D assets of $11.1 million; and
•
An impairment charge related to certain definite-lived intangible assets of $19.6 million in the prior year period; and
•
An increase of $2.9 million in R&D expense due primarily to the timing of clinical studies; and
•
Expenses related to acquisition-related charges and contingent consideration adjustments of $8.8 million; partially offset by
•
Decreased Restructuring expense of $5.6 million due to the cost reduction initiatives taken in the prior year period.

OTHER

We had a legacy operating segment, Other, which contained our API businesses, which we divested in 2017. Following the divestitures, there were no substantial assets or operations left in the segment. During the three and six months ended July 1, 2017, the Other segment had $16.1 million and $35.0 million of net sales and $4.1 million and $9.7 million of operating income, respectively.

Unallocated Expenses

Unallocated expenses are comprised of certain corporate services not allocated to our reporting segments and are recorded in Operating income on the Condensed Consolidated Statements of Operations. Unallocated expenses were as follows (in millions):

40
Perrigo Company plc - Item 2
Unallocated, Interest, Other, and Taxes


Three Months Ended
 
Six Months Ended
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
$
25.2

 
$
31.9

 
$
58.7

 
$
72.5


Effective January 1, 2017, due to the sale of the Tysabri® financial asset, all legal expenses associated with the former Specialty Sciences segment were moved to unallocated expenses.

The decrease of $6.7 million in unallocated expenses during the three months ended June 30, 2018 compared to the prior year period was due to a decrease of $10.3 million of Administration expense driven primarily by an insurance recovery of $7.5 million, partially offset by a $2.4 million increase in Restructuring expense driven by lease exit costs and an increase in share-based compensation expense of $1.2 million driven by the absence of prior year adjustments related to the departure of certain executives.

The decrease of $13.8 million in unallocated expenses during the six months ended June 30, 2018 compared to the prior year period was due to a decrease of $15.5 million of Administration expense driven primarily by an insurance recovery of $16.3 million and a $3.9 million decrease in Restructuring expense related to the cost reduction initiatives taken in the prior year, partially offset by a $5.6 million increase in share-based compensation expense driven by the absence of prior year adjustments related to the departure of certain executives.

Change in Financial Assets, Interest expense, net, and Other expense, net (Consolidated)
 
Three Months Ended
 
Six Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Change in financial assets
$
(0.6
)
 
$
38.7

 
$
9.0

 
$
21.6

Interest expense, net
$
32.1

 
$
45.1

 
$
63.5

 
$
98.4

Other expense, net
$
7.9

 
$
6.1

 
$
12.1

 
$
2.5


Change in Financial Assets

On March 27, 2017, we announced the completed divestment of our Tysabri® financial asset to Royalty Pharma for up to $2.85 billion, consisting of $2.2 billion in cash and $250.0 million and $400.0 million in milestone payments if the royalties on global net sales of Tysabri® that are received by Royalty Pharma meet specific thresholds in 2018 and 2020, respectively. As a result of this transaction, we transferred the entire financial asset to Royalty Pharma and recorded a $17.1 million gain during the three months ended April 1, 2017. We elected to account for the contingent milestone payments using the fair value option method.

The fair value of the Royalty Pharma contingent milestone payments increased by $0.6 million during the three months ended June 30, 2018. This increase included a $2.9 million decrease in the fair value of the 2018 contingent milestone payment, more than offset by a $3.5 million increase in the fair value of the 2020 contingent milestone payment. During the six months ended June 30, 2018, the fair value of the contingent milestone payments decreased by $9.0 million. The net changes in the fair value of the contingent milestone payments were due to the fluctuation of the projected global net sales of Tysabri®. Global net sales of Tysabri® are being impacted by competition, namely the launch of Ocrevus® in the U.S. and European markets in 2017 and 2018, respectively.

The fair value of the Royalty Pharma contingent milestone payments decreased $39.2 million in each of the three and six months ended July 1, 2017 as a result of a decrease in the estimated Tysabri® revenues due to the launch of Ocrevus® in the U.S. market late in the first quarter of 2017 (refer to Item 1. Note 6).

Interest Expense, Net

Interest expense, net was $32.1 million during the three months ended June 30, 2018 compared to $45.1 million for the three months ended July 1, 2017. The $13.0 million decrease was the result of the debt repayments made during the three months ended July 1, 2017 (refer to the "Borrowings and Capital Resources" section below and Item 1. Note 9).


41
Perrigo Company plc - Item 2
Unallocated, Interest, Other, and Taxes


Interest expense, net was $63.5 million during the six months ended June 30, 2018 compared to $98.4 million for the six months ended July 1, 2017. The $34.9 million decrease was the result of the debt repayments made during the six months ended July 1, 2017 (refer to the "Borrowings and Capital Resources" section below and Item 1. Note 9).

Other (Income) Expense, Net

Other expense, net was $7.9 million for the three months ended June 30, 2018 compared to $6.1 million for the three months ended July 1, 2017. The $1.8 million change was due primarily to a $6.3 million loss on investment securities (refer to Item 1. Note 7), $1.6 million of unfavorable changes in revaluation of monetary assets and liabilities held in foreign currencies, and the absence of a $5.9 million loss on hedges related to the extinguishment of debt in the prior year period (refer to Item 1. Note 8).

Other expense, net was $12.1 million during the six months ended June 30, 2018 compared to $2.5 million for the six months ended July 1, 2017. The $9.6 million change was due primarily to a $10.6 million loss on investment securities (refer to Item 1. Note 7), $3.4 million of unfavorable changes in revaluation of monetary assets and liabilities held in foreign currencies, the absence of a $5.9 million loss on hedges related to the extinguishment of debt in the prior year period (refer to Item 1. Note 8), and the absence of a $1.6 million gain recorded on the sale of certain investment securities in the prior year period.

Income Taxes (Consolidated)

The effective tax rates were as follows:
Three Months Ended
 
Six Months Ended
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
34.5
%
 
8.7
%
 
29.4
%
 
89.9
%

The effective tax rate for the three months ended June 30, 2018 increased in comparison to the prior period due primarily to additional valuation allowances against deferred taxes and uncertain tax positions recorded in foreign jurisdictions. The effective tax rate for the six months ended June 30, 2018 decreased in comparison to the prior period due primarily to the negative impacts of non-deductible fees related to debt cancellation in the prior period.

Our tax rate is subject to adjustment over the balance of the fiscal year due to, among other things, the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments based on differing interpretations of the applicable transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; and expiration of or the inability to renew tax rulings or tax holiday incentives.

We file income tax returns in numerous jurisdictions and are therefore subject to audits by tax authorities. Our primary income tax jurisdictions are Ireland, the United States, Israel, Belgium, France, and the United Kingdom.

On August 15, 2017, we filed a complaint in the United States District Court for the Western District of Michigan to recover $163.6 million of Federal income tax, penalties, and interest assessed and collected by the Internal Revenue Service (“IRS”), plus statutory interest thereon from the dates of payment, for the fiscal years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012 (the “2009 tax year,” “2010 tax year,” “2011 tax year,” and “2012 tax year,” respectively). The IRS audits of those years culminated in the issuances of two statutory notices of deficiency: (1) on August 27, 2014 for the 2009 and 2010 tax years and (2) on April 20, 2017 for the 2011 and 2012 tax years. The statutory notices of deficiency both included un-agreed income adjustments related principally to transfer pricing adjustments regarding the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States. In addition, the statutory notice of deficiency for the 2011 and 2012 tax years included the capitalization of certain expenses that were deducted when paid or incurred in defending

42
Perrigo Company plc - Item 2
Unallocated, Interest, Other, and Taxes


against certain patent infringement lawsuits. We fully paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and filed timely claims for refund on June 11, 2015 and June 7, 2017 for the 2009-2010 tax years and 2011-2012 tax years, respectively. Our claims for refund were disallowed by certified letters dated August 18, 2015 and July 11, 2017, for the 2009-2010 tax years and 2011-2012 tax years, respectively. The complaint was timely, based upon the refund claim denials, and seeks refunds of tax, interest, and penalties of $37.2 million for the 2009 tax year, $61.5 million for the 2010 tax year, $40.2 million for the 2011 tax year, and $24.7 million for the 2012 tax year. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended July 1, 2017.

On December 22, 2016, we received a notice of proposed adjustment for the IRS audit of Athena Neurosciences, Inc. (“Athena”), a subsidiary of Elan acquired in 1996, for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. Perrigo acquired Elan in December 2013. This proposed adjustment relates to the deductibility of litigation costs. We disagree with the IRS’s position asserted in the notice of proposed adjustment and intend to contest it.

On July 11, 2017, we received a draft notice of proposed adjustment associated with transfer pricing positions for the IRS audit of Athena for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. Athena was the originator of the patents associated with Tysabri® prior to the acquisition of Athena by Elan in 1996. In response to the draft notice of proposed adjustment, we provided the IRS with substantial additional documentation supporting our position. The amount of adjustments that may be asserted by the IRS in the final notice of proposed adjustment cannot be quantified at this time; however, based on the draft notice received, the amount to be assessed may be material. We disagree with the IRS’s position as asserted in the draft notice of proposed adjustment and intend to contest it.

We have ongoing audits in multiple other jurisdictions the resolution of which remains uncertain. These jurisdictions include, but are not limited to, the United States, Ireland and other jurisdictions in Europe. In addition to the matters discussed above, the IRS is currently auditing our fiscal years ended June 29, 2013, June 28, 2014, and June 27, 2015 (which covers the period of the Elan transaction). The Israel Tax Authority's audit of our fiscal years ended June 29, 2013 and June 28, 2014 concluded with no material impact to the financial statements. The Ireland Tax Authority is currently auditing our years ended December 31, 2012 and December 31, 2013.

Critical Accounting Policies
The determination of certain amounts in our financial statements requires the use of estimates. These estimates are based upon our historical experiences combined with management’s understanding of current facts and circumstances. Although the estimates are considered reasonable based on the currently available information, actual results could differ from the estimates we have used. There have been no material changes to the critical accounting policies disclosed in our 2017 Form 10-K other than those discussed below and revenue recognition policies that we updated upon adoption of ASC 606 (refer to Item 1. Note 2).

Animal Health Goodwill

Following a prior indication of potential impairment during the three months ended December 31, 2017, the animal health reporting unit had an additional indication of potential impairment during the three month ended June 30, 2018 due to its year-to-date financial results failing to meet performance expectations. We performed an impairment test as of June 30, 2018 and determined the fair value of the animal health reporting unit exceeded net book value by an amount less than 5.0%, which was lower than the excess fair value over carrying value as of our prior year testing dates. Therefore, while no impairment was recorded in the three months ended June 30, 2018, the reporting unit’s recent financial performance increased the risk of future impairment. Based on our estimates of fair value and the reported carrying values as of June 30, 2018, a 25 to 50 basis point increase in the discount rate, a 50 basis point decline in the perpetual revenue growth rate, a decline in market multiples, or some combination thereof, may indicate potential impairment of this reporting unit. If we experience additional sustained declines in our sales or erosion of our operating margins, potential indicators of impairment may result, which could require further analysis and may potentially lead to impairment of our animal health goodwill.



43
Perrigo Company plc - Item 2
Financial Condition, Liquidity and Capital Resources


FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES

Cash and Cash Equivalents

chart-df60a6f56d095616beb.jpg
*    Working capital represents current assets less current liabilities, excluding cash and cash equivalents, and current indebtedness.

Cash, cash equivalents, cash flows from operations, and borrowings available under our credit facilities are expected to be sufficient to finance the known and/or foreseeable liquidity and capital expenditures. Although our lenders have made commitments to make funds available to us in a timely fashion under our revolving credit agreements and overdraft facilities, if economic conditions worsen or new information becomes publicly available impacting the institutions’ credit rating or capital ratios, these lenders may be unable or unwilling to lend money pursuant to our existing credit facilities.

Operating Activities
 
Six Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
 
Increase/(Decrease)
Cash Flows From (For) Operating Activities
 
 
 
 
 
Net income
$
117.0

 
$
2.0

 
$
115.0

Non-cash adjustments
243.7

 
442.3

 
(198.6
)
Subtotal
360.7

 
444.3

 
(83.6
)
 
 
 
 
 
 
Increase (decrease) in cash due to:
 
 
 
 
 
Accounts receivable
(24.3
)
 
51.8

 
(76.1
)
Inventories
(99.3
)
 
(4.6
)
 
(94.7
)
Accounts payable
89.2

 
(6.0
)
 
95.2

Payroll and related taxes
(48.4
)
 
(37.9
)
 
(10.5
)
Accrued customer programs
33.9

 
(13.8
)
 
47.7

Accrued liabilities
(30.4
)
 
(49.4
)
 
19.0

Accrued income taxes
(20.8
)
 
(85.8
)
 
65.0

Other, net
(5.9
)
 
(13.3
)
 
7.4

Subtotal
$
(106.0
)
 
$
(159.0
)
 
$
53.0

 
 
 
 
 
 
Net cash from operating activities
$
254.7

 
$
285.3

 
$
(30.6
)

We generated $254.7 million of cash from operating activities during the six months ended June 30, 2018, a $30.6 million decrease over the prior year period, due to the following:

•
Decreased net income after non-cash adjustments;

44
Perrigo Company plc - Item 2
Financial Condition, Liquidity and Capital Resources



•
Changes in inventory due primarily to increased purchasing and manufacturing volumes related to a strategic build-up of inventories in our CHCA segment and insourcing initiatives in our CHCI segment;

•
Changes in accounts receivable due primarily to the timing of sales and receipt of payments, and the discontinuation of our Belgium accounts receivable factoring program; and

•
Changes in payroll and related taxes due primarily to the timing of annual management and employee bonus payouts; partially offset by

•
Changes in accounts payable due primarily to the timing of payments, mix of payment terms, and an increase in inventory;

•
Changes in accrued income taxes due primarily to Federal tax obligation payments made in the current year period, offset by expected tax refunds (refer to Item 1. Note 12);

•
Changes in accrued customer-related programs due primarily to new product launches, which resulted in higher customer related-accruals, pricing dynamics in the RX segment, and the timing of rebate payments; and

•
Changes in accrued liabilities due primarily to legal and professional accruals, and fair market value adjustments related to contingent consideration (refer to Item 1. Note 6).

Investing Activities
 
Six Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
 
Increase/(Decrease)
Cash Flows From (For) Investing Activities
 
 
 
 
 
Proceeds from royalty rights
$
10.3

 
$
85.7

 
$
(75.4
)
Purchase of investment securities
(7.5
)
 
—

 
(7.5
)
Additions to property, plant and equipment
(33.3
)
 
(37.2
)
 
3.9

Net proceeds from sale of business and other assets
1.3

 
37.2

 
(35.9
)
Proceeds from sale of the Tysabri® financial asset
—

 
2,200.0

 
(2,200.0
)
Other investing, net
—

 
(3.7
)
 
3.7

Net cash from (for) investing activities
$
(29.2
)
 
$
2,282.0

 
$
(2,311.2
)

Cash used for investing activities totaled $29.2 million for the six months ended June 30, 2018 compared to cash generated of $2.3 billion in the prior year period. In the current year period, cash used for investing was due primarily to capital expenditures of $33.3 million, and a $7.5 million investment in Zibo Xinhua - Perrigo Pharmaceutical Company Limited (refer to Item 1. Note 7), offset partially by $10.3 million of proceeds from royalty rights. The prior year inflow was due primarily to the completed divestment of our Tysabri® financial asset to Royalty Pharma, for which we received $2.2 billion in cash at closing (refer to Item 1. Note 6).

Cash used for capital expenditures totaled $33.3 million during the six months ended June 30, 2018 compared to $37.2 million in the prior year period. The decrease in cash used for capital expenditures was due primarily to the decrease in the number of projects and the timing of significant projects in the current year compared to the prior year period.


45
Perrigo Company plc - Item 2
Financial Condition, Liquidity and Capital Resources


Financing Activities
 
Six Months Ended
(in millions)
June 30,
2018
 
July 1,
2017
 
Increase/(Decrease)
Cash Flows From (For) Financing Activities
 
 
 
 
 
Issuances of long-term debt
$
431.0

 
$
—

 
$
431.0

Payments on long-term debt
(457.3
)
 
(2,229.1
)
 
1,771.8

Borrowings (repayments) of revolving credit agreements and other financing, net
(8.2
)
 
—

 
(8.2
)
Deferred financing fees
(2.4
)
 
(4.0
)
 
1.6

Premium on early debt retirement
—

 
(116.1
)
 
116.1

Issuance of ordinary shares
—

 
0.2

 
(0.2
)
Repurchase of ordinary shares
(265.0
)
 
(58.2
)
 
(206.8
)
Cash dividends
(52.8
)
 
(46.0
)
 
(6.8
)
Other financing, net
(7.5
)
 
4.7

 
(12.2
)
Net cash (for) financing activities
$
(362.2
)
 
$
(2,448.5
)
 
$
2,086.3


Cash used for financing activities totaled $362.2 million for the six months ended June 30, 2018 compared to $2.4 billion in the prior year period. In the current year period, cash used for financing activities included $457.3 million of repayments on long-term debt offset by $431.0 million of debt issuance related to our 2018 term loan due March 8, 2020, $265.0 million in share repurchases, and $52.8 million paid in dividends. The prior year outflow was due primarily to $2.2 billion of repayments on long-term debt, $116.1 million of discounts on early debt retirement, $58.2 million in shares repurchased, as well as $46.0 million paid in dividends (refer to "Borrowings and Capital Resources" below and Item 1. Note 9).

The declaration and payment of dividends, if any, is subject to the discretion of our Board of Directors and will depend on our earnings, financial condition, availability of distributable reserves, capital and surplus requirements, and other factors our Board of Directors may consider relevant.

In October 2015, the Board of Directors approved a three-year share repurchase plan of up to $2.0 billion. During the three and six months ended June 30, 2018, we repurchased 2.0 million and 3.3 million ordinary shares at an average repurchase price of $79.42 and $80.42 per share, for a total of $156.9 million and $265.0 million, respectively. During the three and six months ended July 1, 2017, we repurchased 812,184 ordinary shares at an average repurchase price of $71.67 per share, for a total of $58.2 million.

Borrowings and Capital Resources

chart-858596d3ff9152e5903.jpg


46
Perrigo Company plc - Item 2
Financial Condition, Liquidity and Capital Resources


Revolving Credit Agreements

On December 5, 2014, Perrigo Finance entered into a $600.0 million revolving credit agreement, which increased to $1.0 billion on March 30, 2015 (the "2014 Revolver"). On March 8, 2018, we terminated the 2014 Revolver and entered into a $1.0 billion revolving credit agreement maturing on March 8, 2023 (the "2018 Revolver"). There were no borrowings outstanding under the 2018 Revolver as of June 30, 2018 or under the 2014 Revolver as of December 31, 2017.

Term Loans and Notes

We had $2.9 billion outstanding under our notes and bonds as of each of June 30, 2018 and December 31, 2017. We had $383.5 million and $420.0 million outstanding under our term loan as of June 30, 2018 and December 31, 2017, respectively.

On December 5, 2014, Perrigo Finance entered into a term loan agreement consisting of a €500.0 million ($614.3 million) tranche, maturing December 5, 2019. On March 8, 2018, we refinanced the €350.0 million outstanding under the term loan with the proceeds of a new €350.0 million ($431.0 million) term loan, maturing March 8, 2020.

Overdraft Facilities

We have overdraft facilities available that we use to support our cash management operations. There were no borrowings outstanding under these facilities at June 30, 2018. The balance outstanding under the overdraft facilities was $6.9 million at December 31, 2017.

Accounts Receivable Factoring

The total amount factored on a non-recourse basis and excluded from accounts receivable was $22.9 million and $27.5 million at June 30, 2018 and December 31, 2017, respectively.

We are in compliance with all covenants under our debt agreements as of June 30, 2018 (refer to Item 1. Note 9 for more information on all of the above debt facilities).

Credit Ratings
    
Our credit ratings on June 30, 2018 were Baa3 (stable) and BBB- (stable) by Moody's Investors Service and Standard and Poor's Rating Services, respectively.

Credit rating agencies review their ratings periodically and, therefore, the credit rating assigned to us by each agency may be subject to revision at any time. Accordingly, we are not able to predict whether current credit ratings will remain as disclosed above. Factors that can affect our credit ratings include changes in operating performance, the economic environment, our financial position, and changes in business strategy. If changes in our credit ratings were to occur, they could impact, among other things, future borrowing costs, access to capital markets, and vendor financing terms.

Contractual Obligations and Commitments

There were no material changes in contractual obligations as of June 30, 2018 from those provided in our
2017 Form 10-K.

ITEM 3.        QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to our quantitative or qualitative disclosures found in Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," of our 2017 Form 10-K.


47
Perrigo Company plc - Item 4
Controls and Procedures


ITEM 4.        CONTROLS AND PROCEDURES

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act) as of June 30, 2018. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of June 30, 2018 because of the material weakness in our internal control over financial reporting described below.

All systems of internal control, no matter how well designed, have inherent limitations. Therefore, even
those systems deemed to be effective can provide only reasonable assurance with respect to financial statement
preparation and presentation. A material weakness is a deficiency, or combination of deficiencies, in internal control
over financial reporting, such that there is a reasonable possibility that a material misstatement of a company’s
annual or interim consolidated financial statements will not be prevented or detected on a timely basis.

Evaluation of the Effectiveness of Internal Control over Financial Reporting

Our management assessed the effectiveness of our internal control over financial reporting as of June 30, 2018. The framework used in carrying out our evaluation was the 2013 Internal Control - Integrated Framework published by the Committee of Sponsoring Organizations ("COSO") of the Treadway Commission. In evaluating our information technology controls, we also used components of the framework contained in the Control Objectives for Information and related Technology, which was developed by the Information Systems Audit and Control Association’s IT Governance Institute, as a complement to the COSO internal control framework.

Management has concluded that our internal control over financial reporting was ineffective as of June 30, 2018. The results of management’s assessment have been reviewed with our Audit Committee.

Income Taxes

The material weakness over the income tax process that was identified during our fiscal year ended December 31, 2017 was not remediated during the three months ended June 30, 2018, and we determined that we did not design or maintain effective controls over our income tax accounting process. Accordingly, there is a reasonable possibility that a material misstatement will not be prevented or detected on a timely basis.

Remediation Plan

We are committed to remediating the control deficiencies that gave rise to the material weakness described above. Management is responsible for implementing changes and improvements to internal control over financial reporting and for remediating the control deficiencies that gave rise to the material weakness.

With oversight from the Audit Committee, we have taken significant steps to remediate our internal control deficiencies in income taxes by redesigning our controls, many of which operated for the first time at December 31, 2017. Our efforts have consisted primarily of strengthening our tax organization and designing a suite of controls related to the components of our income tax process, including valuation allowances, uncertain tax positions and non-routine events and transactions, to enhance our management review controls over income taxes. Because many of our controls operated for the first time at December 31, 2017, we have not had a sufficient period of time to demonstrate operating effectiveness.

Some of the key remediation actions taken include:

•
Reviewing our income tax processes and controls and enhancing the overall design and procedures performed in calculating our income tax provision on an interim and annual basis
•
Significantly strengthening our tax capabilities through a combination of key new hires and providing additional resources
•
Re-designing our management review controls and enhancing the precision of review around the key income tax areas

48
Perrigo Company plc - Item 4
Controls and Procedures



To complete the remediation, we plan, with oversight from the Audit Committee, to continue to:

•
Evaluate the sufficiency of our income tax resources and personnel to determine whether additional enhancements are needed
•
Evaluate whether further enhancements are needed to the design of our income tax procedures and controls
•
Demonstrate consistent operating effectiveness of our management review controls over income taxes over a number of quarterly periods

We expect to implement the remaining remediation actions in 2018. Until the remediation actions are fully implemented and the operational effectiveness of related internal controls is validated through testing, the material weakness described above will continue to exist.

We are committed to achieving and maintaining a strong internal control environment and believe the remediation measures will strengthen our internal control over financial reporting and remediate the material weakness identified.

Changes in Internal Control over Financial Reporting

Other than as described above under "Remediation Plan," there have been no changes in our internal control over financial reporting during the three months ended June 30, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II.     OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

Refer to Part I, Item 1. Note 13 of the Notes to the Condensed Consolidated Financial Statements.

ITEM 1A.    RISK FACTORS

Our Annual Report on Form 10-K for the year ended December 31, 2017 includes a detailed discussion of our risk factors. At the time of this filing, there have been no material changes to the risk factors that were included in the Form 10-K, other than described below.

The plan to separate our RX business from the Company is contingent upon a number of conditions, is subject to change in form or timing, may not achieve the intended benefits, and could adversely affect our business and financial condition.

On August 9, 2018, we announced a plan to separate our RX business from our other operations. The separation may take one of several forms and would be subject to a number of conditions, which could include effectiveness of registration statements or other filing requirements with the U.S. Securities and Exchange Commission, possible legal opinions regarding the tax treatment of the separation, and Board approval. We currently expect the separation to be completed during the second half of 2019, however there can be no assurances as to the form or timing of a separation or if a separation will be consummated.

The proposed separation, regardless of form, would be a complex endeavor and could be affected by unanticipated developments and other factors, such as the impact of the U.S. Tax Cuts and Jobs Act, other tax reform and related existing regulations or future regulations (which may be retroactive), existing interdependencies with our manufacturing and shared-service operations, the outcome of the liability, if any, associated with our price-fixing claims, results of other strategic initiatives, and changes in market conditions, any of which could change, delay or prevent the achievement of our strategic and financial objectives for the Company or our RX business. In addition, the separation of the RX business could impact our ability to retain key employees, comply with existing debt arrangements, maintain our credit ratings or raise future capital.


49
Perrigo Company plc - Item 1A
Risk Factors




Even if the separation is completed, we may not achieve anticipated operational, financial, strategic and other benefits of the separation. After the separation, the combined value and financial performance of the Company and RX business may not equal the value and financial performance of the Company had the separation not occurred.

We will also incur significant costs in connection with the proposed separation, which we cannot quantify until the form of separation is determined. In addition, completion of the separation will require a significant amount of management time and effort, which may disrupt our business or otherwise divert management’s attention from other aspects of our business, including our other strategic initiatives, possible organic or inorganic growth opportunities, and customer and vendor relationships. Any of the foregoing could adversely affect our business, results of operations, liquidity, and financial condition.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Share repurchase activity during the three months ended June 30, 2018 was as follows:

 
Total Number of Shares Purchased
 
Average Price Paid per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Plans
 
Value of Shares Available for Purchase(1)
April 1 - April 30, 2018
1,114,615

 
$
82.43

 
1,114,615

 
 
May 1 - May 31, 2018
860,500

 
$
75.51

 
860,500

 
 
June 1 - June 30, 2018
—

 
$
—

 
—

 
$
1.04
 billion
Total
1,975,115

 
 
 
 
 
$
1.04
 billion

(1) The remaining $1.04 billion in the table represents the amount available to be repurchased under our share repurchase program as of June 30, 2018. Refer to Part II, Item 1. Note 10 of the Notes to the Condensed Consolidated Financial Statements for additional information on our share repurchase program.


50
Perrigo Company plc - Item 6
Exhibits


ITEM 6.    EXHIBITS

Exhibit
Number
 
Description
 
 
 
3.1
 
 
 
 
3.2
 
 
 
 
10.1
 
 
 
 
10.2
 
 
 
 
10.3
 
 
 
 
31.1
 
 
 
 
31.2
 
 
 
 
32
 
 
 
 
101.INS
 
XBRL Instance Document.
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document.
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document.
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document.
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document.
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document.

51

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
PERRIGO COMPANY PLC
 
 
 
(Registrant)
 
 
 
 
Date:
August 9, 2018
 
/s/ Uwe F. Roehrhoff
 
 
 
Uwe F. Roehrhoff
 
 
 
Chief Executive Officer and President
 
 
 
(Principal Executive Officer)
 
 
 
 
Date:
August 9, 2018
 
/s/ Ronald L. Winowiecki
 
 
 
Ronald L. Winowiecki
 
 
 
Chief Financial Officer
 
 
 
(Principal Accounting and Financial Officer)


52
 EX-10.2 2 cy18q210qex102.htm EXHIBIT 10.2 Exhibit


Exhibit 10.2

AMENDMENT AGREEMENT TO THE STOCK ESCROW AGREEMENT DATED 30 MARCH 2015
This AMENDMENT AGREEMENT (the ‘Amendment Agreement”) is made and entered into as 11 June 2018, by and among, Alychlo NV, a limited liability company incorporated under the laws of Belgium, with registered office at Lembergsesteenweg 19, 9820 Merelbeke, and registered under number 0895.140.645 (“Alychlo”), Perrigo Company pic, a public limited liability company incorporated tinder the laws of Ireland (“Perrigo Topco’) and Perrigo Ireland 2, a private company limited by shares incorporated under the laws of Ireland, each with registered office at Treasury Building, Lower Grand Canal Street, Dublin (the •‘Purchaser"!, and Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N A., a federally chartered trust company, (collectively, 'Escrow. Agent) (all collectively referred to as the “Parties'’)
Capitalized terms used herein and not otherwise defined shall have the same meaning ascribed to such terms in that certain share purchase agreement, dated as of November 6, 2014 (the “Purchase Agreement”), by and among Alychlo, Perrigo Topco and Holdco I BE NV (“Holdco”). as amended on March 17, 2015 by amongst others that certain assignment agreement between Perrigo Topco and the Purchaser (the “Assignment Agreement”), and in that certain Stock Escrow Agreement dated March 30, 2015 among Alychlo, Perrigo Topco, the Purchaser and the Escrow Agent (the “Stock Escrow Agreement")
WHEREAS, on June 24, 2016, the Purchaser notified the Escrow Agent of the Purchaser’s pending claim under the Purchase Agreement (“Pending Claim")
WHEREAS, on October 24, 2017, the extraordinary general meeting of Alychlo decided to reduce the registered capital of Alychlo by an amount of EUR 50,000,000 by reimbursing each shareholder an amount of EUR 15,494 26712 per share (the "Reduction") An extract of this decision was published in the Annexes to the Belgian Official Gazette on November 17, 2017.
WHEREAS, further to this Reduction, on January 12, 2018 and in accordance with Article 613 of the Belgian Company Code, the Purchaser and Perrigo Topco requested from Alychlo the constitution of a collateral in relation to the Pending Claim. Alychlo denies that it is required to provide such collateral to the Purchaser and Perrigo Topco as a result of the Reduction,
WHEREAS, after discussions and without prejudice to their respective positions in the context of the Pending Claim, Alychlo, the Purchaser and Perrigo Topco agreed that, in consideration of the Reduction, Alychlo will provide collateral to the Purchaser and Perrigo Topco by adding 425,676 ordinary shares of Perrigo Topco to the 1,081,742 ordinary shares of Perrigo Topco already held in escrow.
NOW THEREFORE, in consideration of the foregoing and of the mutual covenants hereinafter set forth, the Parties hereto agree to amend the Stock Escrow Agreement as follows:

1.    Amendment of the recital of the Stock Escrow Agreement. The recital of the Stock Escrow Agreement is replaced by the following paragraphs:

"WHEREAS, pursuant to the Purchase Agreement Perrigo Topco delivered 1,081,742 shares of the Consideration Perrigo Shares to the Escrow Agent on the date of the Completion Date, to be held subject to and applied as set forth in the Stock Escrow Agreement.

WHEREAS, further to Alychlo’s capital reduction decided by its general meeting on October 24, 2017 (the “Reduction”!, and in accordance with Article 613 of the Belgian Company Code, the Purchaser and Perrigo Topco requested that Alychlo grant them collateral in relation to the Pending Claim.
WHEREAS, the Purchaser, Perrigo Topco and Alychlo agreed that the collateral would constitute an increase of the number of ordinary shares of Perrigo Topco put into escrow hy adding 425,676 additional ordinary shares of Perrigo Topco to the Escrow Account.
WHEREAS, the Purchaser, Perrigo Topco and Alychlo have therefore agreed to add 425,676 ordinary shares of Perrigo Topco to the 1,081,742 ordinary shares of Perrigo Topco already held in escrow for a total of 1,507,418 ordinary shares of Perrigo Topco in escrow (the “Escrow Shares"! and wish such deposit to be subject to the terms and conditions set forth in the Stock Escrow Agreement as amended hy the Amendment Agreement.”
2.     Amendment to Section 9: Notices. Section 9 of the Stock Escrow Agreement is amended to replace the addressees for receipt of notices to Alychlo, Purchaser and Perrigo Topco by deleting the current addressees for Alychlo. Purchaser and Perrigo Topco and inserting the following;
“If to Alychlo:
Alychlo NV
Lembergsesteenweg 19
9820 Merelbckc
Belgium
Marked for the attention of Ms Freya Loncin




With a copy to:
Contrast
Minervastraat 5
B-1930 Zaventem
Belgium
Marked for the attention of Mr Frank Wijckmans and Ms Sofie De Keer
e-mail: frank.wijckmans@contrast-law.be: Sophie.dekeer@contrast-law.be

If to the Purchaser:
Perrigo Ireland 2 Ltd
Treasury Building, Lower Grand Canal Street
Dublin 2
Ireland
E-mail: todd kingma@perrigo.com
marked for the attention of: Todd Kingma
With a copy to:
Fried, Frank, Harris, Shrivcr & Jacobson (London) LLP
41 Lothbury
London EC2R 7HF
England
Marked for the attention of James Kitching / Leigh Mallon
E-mails: James.Kitching@friedfrank.com; leigh.mallon@friedfrank.com
Fried, Frank, Harris, Shriver & Jacobson LLP
801 17,h Street NW
Washington DC
20006
U.S.A,
Marked for the attention of James Wareham ! James Anklam
E-mails: James.wareham@friedfrank.com; James.Anklam@friedfrank.com
Stibbe CVBA/SCRL
25. rue de Loxum
1000 Brussels
Belgium
Marked for the attention of Marc Fyon / Nicolas Résimont
E-mails: Marc.fyon@stibbe.com; Nicolas.resimont@stibbe.com

If to Perrigo Topco:
Perrigo Company Pic
515 Eastern Avenue
Allegan, MI, 49010
E-mail: todd.kingma@perrigo.com
marked for the attention of: Todd Kingma
with a copy to:
Fried, Frank, Harris, Shriver & Jacobson (London) LLP
41 Lothbury
London EC2R 7HF
England
Marked for the attention of James Kitching / Leigh Mallon
E-mails: James.Kitching@friedfrank.com; leigh.mallon@friedfrank.com
Fried, Frank, Harris, Shriver & Jacobson LLP
801 17th Street NW
Washington DC
20006
U.S.A.
Marked for the attention of James Wareham 1 James Anklam
E-mails: James.wareham@friedfrank.com; James.Anklam@friedfrank.com
Stibbe CVBA/SCRL
25, rue de Loxum
1000 Brussels
Belgium
Marked for the attention of Marc Fyon / Nicolas Résimont
E-mails: Marc.Fyon@stibbe.com; Nicolas.Resimont@stibbe.com"




3. Acknowledgments of the Parties
(a)The Parties acknowledge that the increase in the number of Escrow Shares us contemplated by
the Amendment Agreement is not contrary to the provisions of the Purchase Agreement (in particular to article 12 of the Purchase Agreement) and the Stock Escrow Agreement (in particular to article 2(e) and article 12 of the Stock Escrow Agreement)
(b) The Purchaser, Perrigo Topco and Alychlo agree that the Purchaser and Perrigo Topco’s acceptance of 425,676 Escrow Shares as collateral is solely m consideration of the Reduction. This acceptance shall not be considered as (i) an admission or acceptance by Alychlo that it is required to provide any collateral to the Purchaser or Perrigo Topco in consideration of the Reduction or further to any future capital reduction decided by Alychlo’s general meeting or (ii) a general agreement by the Purchaser or Perrigo Topco to this form of collateral, nor to this value. If Alychlo's general meeting would decide to proceed with any new capital reduction, the Purchaser and Perrigo Topco reserve all their rights to request another form of collateral and if needed to go to court, whatever the amount or modalities of the capital reduction, and Alychlo reserves all rights to dispute such request.
(c) The Purchaser, Perrigo Topco and Alychlo acknowledge that (i) the Amendment Agreement is executed without prejudice to their respective positions in the context of the Pending Claim, and (ii) by posting collateral, Alychlo makes no concession regarding the validity of any Pending Claim, or any liability under any Pending Claim.
4. Miscellaneous
(a)All provisions of the Stock Escrow Agreement that arc not modified by the present Amendment Agreement remain fully applicable without limitation or reserve.
(b)This Amendment Agreement shall he subject to the provisions of Sections K to 18 of the Stock Purchase Agreement mutatis mutandis.
(c)For the avoidance of doubt this Amendment Agreement (and any claims or disputes arising out of or related thereto or to the transactions contemplated thereby or to the inducement of any party to enter therein, whether for breach of contract, tortuous conduct, or otherwise and whether predicated cm common law, statute or otherwise) shall in all respects be governed by and construed in accordance with the laws of the State of New York, including all matters of construction, validity and performance, in each case without reference to any conflict of law.' rules that might lead to the application of the laws of any other jurisdiction.
(d)Each party irrevocably submits to the exclusive jurisdiction of (a) the Supreme Court of the State of New York, New York County, and (b) the United States District Court for the Southern District of New York, for the purposes of any suit, action or other proceeding arising out of this Amendment Agreement Each party agrees to commence any such action, suit or proceeding either in the United States District Court for the Southern District of New York or if such suit, action or other proceeding may not be brought in such court for jurisdictional reasons, in the Supreme Court of the State of New York, New York County, Each party further agrees that service of any process, summons, notice, or document by registered mail to such party's respective address set forth in Section 9 of the Stock Escrow Agreement (as amended) shall be effective service of process for any action, suit or proceeding in New York with respect to any matters to which it has submitted to jurisdiction in this Section 4. Each party irrevocably and unconditionally waives any objection to the laying of venue of any action, suit or proceeding arising out of this Amendment Agreement in (J) the Supreme Court of the Stale of New York, New York County, or (ii) the United States District Court for the Southern District of New York, and hereby and thereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.
(e) In case of inconsistencies or discrepancies between the provisions of this Amendment Agreement and those of the Stock Escrow Agreement, and save as expressly amended in this Amendment Agreement, the provisions of the Stock Escrow Agreement shall prevail.
(f) This Amendment Agreement may be executed in one or more counterparts, each of which shall be deemed as original, but all of which together shall constitute one and the same instrument.
[signature pages follow]

2


IN WITNESS WHEREOF, the Parties hereto have executed this Amendment Agreement as of the date set forth above.
(1)
 
ALYCHLO NV
 
 
 
 
 
 
 
By:
/s/ Marc Coucke
 
 
 
 
Name: Marc Coucke
 
 
 
Title: Managing Director/Chairman Board of Directors
 
 
 
 
 
(2)
 
PERRIGO COMPANY PLC
 
 
 
 
 
 
 
By:
/s/ Todd Kingma
 
 
 
 
Name: Todd Kingma
 
 
 
Title: EVP, General Counsel and Secretary
 
 
 
 
 
(3)
 
PERRIGO IRELAND 2 LIMITED
 
 
 
 
 
 
 
By:
/s/ Lou Cherico
 
 
 
 
Name: Lou Cherico
 
 
 
Title: Director
 
 
 
 
 
(4)
 
COMPUTERSHARE INC.
 
 
 
 
 
 
 
By:
/s/ Rose Stroud
 
 
 
 
Name: Rose Stroud
 
 
 
Title: Trust Officer
 
 
 
 
 
(5)
 
COMPUTERSHARE TRUST COMPANY, N.A.
 
 
 
 
 
 
 
By:
/s/ Rose Stroud
 
 
 
 
Name: Rose Stroud
 
 
 
Title: Trust Officer
 
 
 
 
 


1
 EX-10.3 3 cy18q210qex103.htm EXHIBIT 10.3 Exhibit


Exhibit 10.3

AMENDMENT SIX
TO THE
PERRIGO COMPANY
NONQUALIFIED DEFERRED COMPENSATION PLAN
WHEREAS, Perrigo Company, a Michigan corporation (the “Company”), maintains the Perrigo Company Nonqualified Deferred Compensation Plan, as amended and restated effective January 1, 2007 (the “Plan”), and as subsequently amended; and
WHEREAS, the Company deems it desirable to amend the Plan (i) to increase the number of termination accounts from one to two, and (ii) to provide that disability determinations shall be made by the employer’s long-term disability carrier or by the Social Security Administration;
NOW, THEREFORE, pursuant to the amendment authority reserved to the Company and delegated to the Perrigo Company Retirement Plan Committee, the Plan is amended as follows:
1.    Section 1.24 of the Plan (“Disability”) is amended to read as follows for claims involving disability determinations filed after April 1, 2018:
1.24
“Disability” shall mean, for claims involving disability determinations filed after April 1, 2018, (i) the Participant is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving disability benefits under the Participant’s Employer’s long-term disability plan for a period of not less than three months and evidence thereof has been furnished to the Committee, or (ii) the Participant is determined to be totally disabled by the Social Security Administration and evidence of such determination has been furnished to the Committee.
2.    A new Section 1.41 is added to Article I of the Plan (“Definitions”) effective for Plan Years beginning on or after January 1, 2019:
1.41
“Termination Account” shall mean the bookkeeping account maintained by the Employer for the benefit of a Participant to record the Termination Benefit elected by the Participant in connection with his or her commencement of participation in the Plan as set forth in Section 5.2.
3.    Section 5.2 of the Plan (“Payment of Termination Benefit”) is amended by replacing the first sentence thereof with the following effective for Plan Years beginning on or after January 1, 2019:
A Participant, in connection with his or her commencement of participation in the Plan, shall elect on an Election Form to receive the Termination Benefit in a lump sum or pursuant to an Annual Installment Method of up to 15 years, with such election to be reflected in a Termination Account for the benefit of the Participant. For Plan Years beginning on or after January 1, 2019, a Participant in connection with his or her commencement of participation in the Plan may elect to have two such Termination Accounts.




IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its duly authorized officer this 23 day of July 2018.

PERRIGO COMPANY
 
 
 
 
By:
/s/ Lou Cherico
Its:
Chairman, Retirement Committee
    


 EX-31.1 4 cy18q210qex311.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1
CERTIFICATION
I, Uwe F. Roehrhoff, certify that:
1.
I have reviewed this report on Form 10-Q of Perrigo Company plc;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:
a.
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 9, 2018
/s/ Uwe F. Roehrhoff
Uwe F. Roehrhoff
Chief Executive Officer
 



 EX-31.2 5 cy18q210qex312.htm EXHIBIT 31.2 Exhibit


Exhibit 31.2
CERTIFICATION
I, Ronald L. Winowiecki, certify that:
1.
I have reviewed this report on Form 10-Q of Perrigo Company plc;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:
a.
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 9, 2018
/s/ Ronald L. Winowiecki
Ronald L. Winowiecki
Chief Financial Officer
 



 EX-32 6 cy18q210qex32.htm EXHIBIT 32 Exhibit


Exhibit 32
The following statement is being made to the Securities and Exchange Commission solely for the purposes of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), which carries with it certain criminal penalties in the event of a knowing or willful misrepresentation.
Securities and Exchange Commission
450 Fifth Street NW
Washington, D.C. 20549
 
Re:
Perrigo Company plc

Ladies and Gentlemen:
In accordance with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), each of the undersigned hereby certifies that:
(i)
this Quarterly Report on Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(ii)
the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Perrigo Company plc.


 
 
 
 
Date:
August 9, 2018
 
/s/ Uwe F. Roehrhoff
 
 
 
Uwe F. Roehrhoff
 
 
 
Chief Executive Officer and President
 
 
 
 
 
 
 
 
Date:
August 9, 2018
 
/s/ Ronald L. Winowiecki
 
 
 
Ronald L. Winowiecki
 
 
 
Chief Financial Officer
 
 
 





 EX-101.INS 7 prgo-20180630.xml XBRL INSTANCE DOCUMENT 0001585364 2018-01-01 2018-06-30 0001585364 2018-08-03 0001585364 2017-04-02 2017-07-01 0001585364 2018-04-01 2018-06-30 0001585364 2017-01-01 2017-07-01 0001585364 2017-12-31 0001585364 2018-06-30 0001585364 2016-12-31 0001585364 2017-07-01 0001585364 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-04-01 2018-06-30 0001585364 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-06-30 0001585364 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-06-30 0001585364 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-04-01 2018-06-30 0001585364 2018-01-01 0001585364 prgo:OtherGeographicalAreasMember 2018-04-01 2018-06-30 0001585364 srt:EuropeMember 2018-04-01 2018-06-30 0001585364 srt:EuropeMember 2018-01-01 2018-06-30 0001585364 country:US 2018-04-01 2018-06-30 0001585364 country:US 2018-01-01 2018-06-30 0001585364 prgo:OtherGeographicalAreasMember 2018-01-01 2018-06-30 0001585364 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-06-30 0001585364 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-06-30 0001585364 prgo:CHCIMember 2018-01-01 2018-06-30 0001585364 prgo:OtherCHCIMember prgo:CHCIMember 2018-01-01 2018-06-30 0001585364 prgo:InfantNutritionalsMember prgo:ConsumerHealthcareAmericasMember 2018-01-01 2018-06-30 0001585364 prgo:AnalgesicsMember prgo:ConsumerHealthcareAmericasMember 2018-01-01 2018-06-30 0001585364 prgo:GastrointestinalMember prgo:ConsumerHealthcareAmericasMember 2018-01-01 2018-06-30 0001585364 prgo:NaturalHealthandVMSMember prgo:CHCIMember 2018-01-01 2018-06-30 0001585364 prgo:ConsumerHealthcareAmericasMember 2018-01-01 2018-06-30 0001585364 prgo:RXPharmaceuticalsMember 2018-01-01 2018-06-30 0001585364 prgo:AntiParasiteMember prgo:CHCIMember 2018-01-01 2018-06-30 0001585364 prgo:CoughColdandAllergyMember prgo:CHCIMember 2018-04-01 2018-06-30 0001585364 prgo:InfantNutritionalsMember prgo:ConsumerHealthcareAmericasMember 2018-04-01 2018-06-30 0001585364 prgo:CoughColdAllergyandSinusMember prgo:ConsumerHealthcareAmericasMember 2018-01-01 2018-06-30 0001585364 prgo:CHCIMember 2018-04-01 2018-06-30 0001585364 prgo:VitaminsMineralsAndDietarySupplementsMember prgo:ConsumerHealthcareAmericasMember 2018-01-01 2018-06-30 0001585364 prgo:ConsumerHealthcareAmericasMember 2018-04-01 2018-06-30 0001585364 prgo:AnimalHealthMember prgo:ConsumerHealthcareAmericasMember 2018-01-01 2018-06-30 0001585364 prgo:PersonalCareandDermaTherapeuticsMember prgo:CHCIMember 2018-01-01 2018-06-30 0001585364 prgo:SmokingCessationMember prgo:ConsumerHealthcareAmericasMember 2018-04-01 2018-06-30 0001585364 prgo:AnalgesicsMember prgo:ConsumerHealthcareAmericasMember 2018-04-01 2018-06-30 0001585364 prgo:OtherCHCIMember prgo:CHCIMember 2018-04-01 2018-06-30 0001585364 prgo:OtherCHCAMember prgo:ConsumerHealthcareAmericasMember 2018-01-01 2018-06-30 0001585364 prgo:NaturalHealthandVMSMember prgo:CHCIMember 2018-04-01 2018-06-30 0001585364 prgo:AnimalHealthMember prgo:ConsumerHealthcareAmericasMember 2018-04-01 2018-06-30 0001585364 prgo:SmokingCessationMember prgo:ConsumerHealthcareAmericasMember 2018-01-01 2018-06-30 0001585364 prgo:GastrointestinalMember prgo:ConsumerHealthcareAmericasMember 2018-04-01 2018-06-30 0001585364 prgo:OtherCHCAMember prgo:ConsumerHealthcareAmericasMember 2018-04-01 2018-06-30 0001585364 prgo:LifestyleMember prgo:CHCIMember 2018-01-01 2018-06-30 0001585364 prgo:VitaminsMineralsAndDietarySupplementsMember prgo:ConsumerHealthcareAmericasMember 2018-04-01 2018-06-30 0001585364 prgo:AntiParasiteMember prgo:CHCIMember 2018-04-01 2018-06-30 0001585364 prgo:PersonalCareandDermaTherapeuticsMember prgo:CHCIMember 2018-04-01 2018-06-30 0001585364 prgo:CoughColdAllergyandSinusMember prgo:ConsumerHealthcareAmericasMember 2018-04-01 2018-06-30 0001585364 prgo:RXPharmaceuticalsMember 2018-04-01 2018-06-30 0001585364 prgo:LifestyleMember prgo:CHCIMember 2018-04-01 2018-06-30 0001585364 prgo:CoughColdandAllergyMember prgo:CHCIMember 2018-01-01 2018-06-30 0001585364 country:IE 2018-01-01 2018-06-30 0001585364 country:IE 2018-04-01 2018-06-30 0001585364 prgo:OtherMember 2016-01-01 2016-12-31 0001585364 prgo:OtherMember 2017-04-06 2017-04-06 0001585364 prgo:ConsumerHealthcareAmericasMember 2017-02-01 2017-02-01 0001585364 prgo:RXPharmaceuticalsMember 2017-01-03 2017-01-03 0001585364 prgo:ConsumerHealthcareAmericasMember prgo:MerckSharpDohmeLicenseAgreementMember 2018-05-29 2018-05-29 0001585364 prgo:RXPharmaceuticalsMember 2017-04-02 2017-07-01 0001585364 prgo:RXPharmaceuticalsMember 2017-01-01 2017-04-01 0001585364 prgo:ConsumerHealthcareInternationalMember 2018-01-01 2018-06-30 0001585364 prgo:ConsumerHealthcareMember 2017-12-31 0001585364 prgo:RXPharmaceuticalsMember 2018-06-30 0001585364 prgo:ConsumerHealthcareMember 2018-01-01 2018-06-30 0001585364 prgo:ConsumerHealthcareMember 2018-06-30 0001585364 prgo:ConsumerHealthcareInternationalMember 2018-06-30 0001585364 prgo:ConsumerHealthcareInternationalMember 2017-12-31 0001585364 prgo:RXPharmaceuticalsMember 2017-12-31 0001585364 us-gaap:LicensingAgreementsMember 2018-06-30 0001585364 us-gaap:CustomerRelationshipsMember 2018-06-30 0001585364 us-gaap:DevelopedTechnologyRightsMember 2017-12-31 0001585364 prgo:TrademarksTradeNamesandBrandsMember 2017-12-31 0001585364 us-gaap:NoncompeteAgreementsMember 2018-06-30 0001585364 prgo:TrademarksTradeNamesandBrandsMember 2018-06-30 0001585364 us-gaap:NoncompeteAgreementsMember 2017-12-31 0001585364 us-gaap:CustomerRelationshipsMember 2017-12-31 0001585364 us-gaap:LicensingAgreementsMember 2017-12-31 0001585364 prgo:TrademarksTradeNamesandBrandsMember 2018-06-30 0001585364 prgo:TrademarksTradeNamesandBrandsMember 2017-12-31 0001585364 us-gaap:DevelopedTechnologyRightsMember 2018-06-30 0001585364 us-gaap:InProcessResearchAndDevelopmentMember 2017-12-31 0001585364 us-gaap:InProcessResearchAndDevelopmentMember 2018-06-30 0001585364 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001585364 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001585364 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2018-06-30 0001585364 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001585364 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2018-06-30 0001585364 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001585364 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2018-06-30 0001585364 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2017-04-02 2017-07-01 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2017-07-01 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2018-01-01 2018-06-30 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2017-01-01 2017-07-01 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2018-04-01 2018-06-30 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2018-03-31 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2017-04-01 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001585364 prgo:RoyaltyPharmaContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-01-01 2018-06-30 0001585364 prgo:RoyaltyPharmaContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-04-01 2018-06-30 0001585364 prgo:RoyaltyPharmaContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-04-02 2017-07-01 0001585364 prgo:RoyaltyPharmaContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-07-01 0001585364 prgo:RoyaltyPharmaContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-01-01 2017-07-01 0001585364 prgo:RoyaltyPharmaContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-03-31 0001585364 prgo:RoyaltyPharmaContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001585364 prgo:RoyaltyPharmaContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001585364 prgo:RoyaltyPharmaContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001585364 prgo:RoyaltyPharmaContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-04-01 0001585364 prgo:RetailBondsMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-06-30 0001585364 prgo:PublicBondsandPrivatePlacementMember us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-06-30 0001585364 prgo:PublicBondsandPrivatePlacementMember us-gaap:FairValueInputsLevel1Member 2018-06-30 0001585364 prgo:RetailBondsMember us-gaap:FairValueInputsLevel2Member 2018-06-30 0001585364 prgo:RetailBondsMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-12-31 0001585364 prgo:PublicBondsandPrivatePlacementMember us-gaap:FairValueInputsLevel1Member 2017-12-31 0001585364 prgo:RetailBondsMember us-gaap:FairValueInputsLevel2Member 2017-12-31 0001585364 prgo:PublicBondsandPrivatePlacementMember us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-12-31 0001585364 us-gaap:ScenarioForecastMember 2018-01-01 2018-12-31 0001585364 prgo:SpecialtySciencesMember 2017-04-02 2017-07-01 0001585364 us-gaap:ScenarioForecastMember 2020-01-01 2020-12-31 0001585364 prgo:RoyaltyPharmaMember 2017-01-01 2017-07-01 0001585364 prgo:RoyaltyPharmaMember us-gaap:MeasurementInputPriceVolatilityMember 2018-06-30 0001585364 prgo:RoyaltyPharmaMember 2017-03-27 2017-03-27 0001585364 prgo:RoyaltyPharmaMember 2018-01-01 2018-06-30 0001585364 prgo:RoyaltyPharma2018ContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-04-01 2018-06-30 0001585364 us-gaap:ScenarioForecastMember 2020-12-31 0001585364 us-gaap:ScenarioForecastMember 2018-12-31 0001585364 prgo:RoyaltyPharma2020ContingentMilestonePaymentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-04-01 2018-06-30 0001585364 prgo:RoyaltyPharmaMember us-gaap:MeasurementInputPriceVolatilityMember 2017-07-01 0001585364 2017-01-01 2017-12-31 0001585364 us-gaap:OtherNoncurrentAssetsMember 2017-12-31 0001585364 us-gaap:OtherNoncurrentAssetsMember 2018-06-30 0001585364 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2017-12-31 0001585364 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2018-06-30 0001585364 prgo:ZiboXinhuaMember 2018-04-01 2018-06-30 0001585364 us-gaap:AccountingStandardsUpdate201601Member 2017-01-01 2017-12-31 0001585364 prgo:OtherExpenseIncomeNetMember 2017-04-02 2017-07-01 0001585364 prgo:OtherExpenseIncomeNetMember 2018-01-01 2018-06-30 0001585364 prgo:OtherExpenseIncomeNetMember 2018-04-01 2018-06-30 0001585364 prgo:OtherExpenseIncomeNetMember 2017-01-01 2017-07-01 0001585364 us-gaap:AccountingStandardsUpdate201601Member us-gaap:RetainedEarningsMember 2017-12-31 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-02 2017-07-01 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2017-12-31 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-30 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-01-01 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-04-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-04-02 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-06-30 0001585364 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-30 0001585364 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0001585364 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2018-06-30 0001585364 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2017-12-31 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-04-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-04-01 2018-06-30 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueGoodsNetMember 2017-04-02 2017-07-01 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-02 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueGoodsNetMember 2018-01-01 2018-06-30 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-01-01 2018-06-30 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-04-01 2018-06-30 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2017-04-02 2017-07-01 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2017-01-01 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueGoodsNetMember 2017-01-01 2017-07-01 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2017-01-01 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2017-04-02 2017-07-01 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2017-04-02 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2017-04-02 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueGoodsNetMember 2018-04-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2017-01-01 2017-07-01 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2017-01-01 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-01-01 2018-06-30 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-04-01 2018-06-30 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-06-30 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2018-04-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-02 2017-07-01 0001585364 us-gaap:NondesignatedMember 2018-04-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2017-01-01 2017-07-01 0001585364 us-gaap:NondesignatedMember 2018-01-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2017-04-02 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2018-04-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2018-01-01 2018-06-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-04-01 2018-06-30 0001585364 us-gaap:NondesignatedMember 2017-01-01 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-06-30 0001585364 us-gaap:NondesignatedMember 2017-04-02 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-02 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-01 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember 2018-06-30 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2017-07-01 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2017-04-02 2017-07-01 0001585364 us-gaap:ForeignExchangeForwardMember 2017-12-31 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2017-04-02 2017-07-01 0001585364 prgo:A5.105SeniornotedueJuly192023Member 2017-12-31 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2017-12-31 0001585364 prgo:A3.5SeniornotedueDecember152021Member 2018-01-01 2018-06-30 0001585364 prgo:A4.9SeniorLoandue2044Member 2018-06-30 0001585364 prgo:A2018EuroDenominatedTermLoandueMarch82020Member 2017-12-31 0001585364 prgo:A3.500UnsecuredSeniornotesdueMarch152021Member 2018-06-30 0001585364 prgo:A5.105SeniornotedueJuly192023Member 2018-01-01 2018-06-30 0001585364 prgo:A3.5SeniornotedueDecember152021Member 2017-12-31 0001585364 prgo:A5.105SeniornotedueJuly192023Member 2018-06-30 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2018-06-30 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2017-12-31 0001585364 prgo:A5.000UnsecuredSeniornotesdueMay232019Member 2018-06-30 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2018-06-30 0001585364 prgo:A3.9seniornotedue2024Member 2018-01-01 2018-06-30 0001585364 prgo:A2018EuroDenominatedTermLoandueMarch82020Member 2018-06-30 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2018-01-01 2018-06-30 0001585364 prgo:A3.500UnsecuredSeniornotesdueMarch152021Member 2017-12-31 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2017-12-31 0001585364 prgo:A4.375seniornotedueMarch152026Member 2018-06-30 0001585364 prgo:A3.500UnsecuredSeniornotesdueMarch152021Member 2018-01-01 2018-06-30 0001585364 prgo:A2018EuroDenominatedTermLoandueMarch82020Member 2018-01-01 2018-06-30 0001585364 prgo:A4.9SeniorLoandue2044Member 2018-01-01 2018-06-30 0001585364 prgo:A4.375seniornotedueMarch152026Member 2017-12-31 0001585364 prgo:A3.9seniornotedue2024Member 2018-06-30 0001585364 prgo:A3.9seniornotedue2024Member 2017-12-31 0001585364 prgo:A4.9SeniorLoandue2044Member 2017-12-31 0001585364 prgo:A4.375seniornotedueMarch152026Member 2018-01-01 2018-06-30 0001585364 prgo:A3.5SeniornotedueDecember152021Member 2018-06-30 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2018-06-30 0001585364 prgo:A5.000UnsecuredSeniornotesdueMay232019Member 2018-01-01 2018-06-30 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2018-01-01 2018-06-30 0001585364 prgo:A5.000UnsecuredSeniornotesdueMay232019Member 2017-12-31 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2018-01-01 2018-06-30 0001585364 prgo:A2018EuroDenominatedTermLoandueMarch82020Member 2018-03-08 0001585364 prgo:A2014RevolverMember 2014-12-05 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2014-12-05 0001585364 2014-12-05 2014-12-05 0001585364 prgo:A2018RevolverMember 2018-06-30 0001585364 prgo:A2014RevolverMember 2015-03-30 0001585364 2018-01-01 2018-03-31 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2018-03-08 0001585364 prgo:A2018RevolverMember 2018-03-08 0001585364 prgo:A2014RevolverMember 2017-12-31 0001585364 2015-10-30 0001585364 us-gaap:CommonStockMember 2017-04-02 2017-07-01 0001585364 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001585364 2015-10-01 2015-10-31 0001585364 us-gaap:CommonStockMember 2018-01-01 2018-06-30 0001585364 us-gaap:CommonStockMember 2017-01-01 2017-07-01 0001585364 us-gaap:AccountingStandardsUpdate201601Member us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001585364 us-gaap:AccountingStandardsUpdate201601Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001585364 us-gaap:AccountingStandardsUpdate201601Member us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-12-31 0001585364 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001585364 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-06-30 0001585364 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001585364 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-06-30 0001585364 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-06-30 0001585364 us-gaap:AccountingStandardsUpdate201601Member us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001585364 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-30 0001585364 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001585364 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0001585364 us-gaap:AccountingStandardsUpdate201601Member us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001585364 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-12-31 0001585364 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-06-30 0001585364 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001585364 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001585364 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-06-30 0001585364 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-30 0001585364 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-06-30 0001585364 2010-01-01 2010-12-31 0001585364 2017-08-15 2017-08-15 0001585364 prgo:BelgiumTaxingAuthorityMember 2017-01-01 2017-12-31 0001585364 2011-01-01 2011-12-31 0001585364 2012-01-01 2012-12-31 0001585364 2009-01-01 2009-12-31 0001585364 2017-06-28 2017-06-28 0001585364 2017-03-29 2017-03-29 0001585364 2018-03-31 0001585364 2017-04-01 0001585364 prgo:ConsumerHealthcareAmericasMember 2017-01-01 2017-07-01 0001585364 us-gaap:EmployeeSeveranceMember 2018-06-30 0001585364 us-gaap:ContractTerminationMember 2018-06-30 0001585364 prgo:ConsumerHealthcareAmericasMember 2017-12-31 0001585364 prgo:CHCIMember 2018-06-30 0001585364 prgo:ConsumerHealthcareAmericasMember 2018-06-30 0001585364 prgo:CHCIMember 2017-12-31 0001585364 us-gaap:MaterialReconcilingItemsMember 2017-04-02 2017-07-01 0001585364 prgo:CHCIMember 2017-04-02 2017-07-01 0001585364 us-gaap:AllOtherSegmentsMember 2017-04-02 2017-07-01 0001585364 us-gaap:AllOtherSegmentsMember 2018-04-01 2018-06-30 0001585364 us-gaap:MaterialReconcilingItemsMember 2018-04-01 2018-06-30 0001585364 prgo:ConsumerHealthcareAmericasMember 2017-04-02 2017-07-01 0001585364 prgo:CHCIMember 2017-01-01 2017-07-01 0001585364 us-gaap:AllOtherSegmentsMember 2017-01-01 2017-07-01 0001585364 us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-06-30 0001585364 us-gaap:AllOtherSegmentsMember 2018-01-01 2018-06-30 0001585364 us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-07-01 0001585364 prgo:RXPharmaceuticalsMember 2017-01-01 2017-07-01 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:EUR xbrli:shares iso4217:ILS iso4217:USD iso4217:ILS iso4217:EUR false --12-31 Q2 2018 2018-06-30 10-Q 0001585364 136832585 Large Accelerated Filer PERRIGO CO PLC 592300000 594200000 419700000 451900000 250000000 400000000 0 0 0 0.0805 0.0809 500000 500000 0 0 0 16300000 0 0 14200000 0 15600000 4265700000 4227100000 33200000 24100000 -13800000 33900000 1850000000 1950000000 1700000 38000000 -3200000 -6100000 184500000 0 0 134500000 0 0 125500000 65300000 60200000 116100000 2850000000 812184 812184 2000000 3300000 -2400000 1200000000 17500000 3800000 4700000 71.67 71.67 79.42 80.42 450200000 533400000 1130800000 1129800000 116100000 57900000 230800000 192800000 253100000 155000000 444300000 360700000 6200000 6500000 -11800000 -3700000 87200000 47500000 17000000 22300000 400000 0 172800000 93200000 34200000 44600000 800000 0 85300000 49500000 15300000 20500000 0 0 172400000 100800000 30500000 41100000 0 0 0 800000 1700000 900000 27400000 39600000 1700000 1700000 11628800000 5029000000 3786800000 2813000000 11225600000 -5500000 11220100000 4799400000 3673000000 2753200000 2819600000 2778500000 -5500000 2773000000 250000000 400000000 17000000 22600000 134500000 8100000 16900000 125500000 8809200000 8447100000 6300000 17000000 0 0 22000000 0 0 16200000 0.300 0.300 622300000 760800000 678700000 526500000 138500000 -152200000 0.16 0.32 0.19 0.38 0.001 0.001 10000000000 10000000000 140800000 137600000 140800000 137600000 7892900000 7594300000 87200000 214300000 -133100000 2800000 -130300000 19900000 300000 20200000 19200000 20500000 733300000 1463000000 715400000 4200000 719600000 1439700000 1100000 1440800000 0 0 -1000000 -1000000 0 1400000 70400000 197700000 2014 Term loan due December 5, 2019(1) 2018 Term loan due March 8, 2020(1) May 23, 2019(1) July 19, 2023(1) 614300000 500000000 600000000 350000000 431000000 350000000 1000000000 17900000 18100000 0.04 0.053 0.035 0.035 0.039 0.04 0.04375 0.049 0.050 0.051045 0.053 2014-12-05 2021-03-15 2021-12-15 2024-12-15 2023-11-15 2026-03-15 2044-12-15 2043-11-15 -21400000 -16600000 3341200000 3283000000 10400000 1000000 -8100000 -14200000 321900000 290800000 220800000 217800000 4100000 2200000 2100000 600000 1400000 2400000 5000000 4100000 -700000 -5000000 -5700000 -5900000 -1100000 -13900000 -15000000 200000 11800000 12000000 -700000 8600000 7900000 900000 -500000 0 600000 -600000 -5900000 -5500000 1600000 -1100000 -500000 900000 -1300000 -5900000 -6300000 1600000 -1100000 -100000 0 -400000 0 0 3900000 -2000000 -500000 0 -900000 0 500000 100000 1000000 -0.49 0.01 0.26 0.02 0.28 0.84 0.00 0.84 -0.49 0.01 0.26 0.02 0.28 0.84 0.00 0.84 19700000 -15500000 0.087 0.899 0.345 0.294 148800000 103900000 4900000 13100000 4600000 8100000 0 0 -6300000 -10600000 -39200000 -39200000 -2900000 3500000 600000 -9000000 0 184500000 0 0 0 184500000 145800000 134500000 124900000 125500000 1400000 1300000 -100000 0 1300000 15600000 1800000 1400000 2400000 5900000 0 4400000 69900000 52000000 49700000 22000000 18100000 16200000 -38700000 -21600000 600000 -9000000 184700000 339800000 1371200000 129500000 460600000 598700000 169800000 12600000 1521300000 159800000 513200000 647000000 188300000 13000000 0 0 11500000 0 0 0 4661700000 1335400000 1642000000 1358400000 311200000 14700000 4587300000 1304300000 1608700000 1349800000 310000000 14500000 3290500000 3066000000 -5200000 0 3800000 0 0 9100000 0 0 6300000 0 0 2700000 0 0.28 0.2800 17100000 -135200000 -135200000 -500000 0 -500000 98200000 203600000 96800000 204500000 4175400000 1205700000 1847400000 1122300000 4137500000 1175100000 1845400000 1117000000 -37900000 -30600000 -2000000 -5300000 504600000 968900000 471000000 2700000 473700000 963700000 200000 963900000 12200000 18500000 35300000 -76300000 19600000 55300000 165800000 200000 300000 900000 700000 37200000 61500000 40200000 24700000 163600000 -6700000 17600000 19100000 -100000 19000000 48800000 -100000 48700000 -6000000 89200000 -51800000 24300000 -85800000 -20800000 -100000 -20900000 -49400000 -30400000 -37900000 -48400000 4600000 99300000 1100000 98200000 159000000 106000000 300000 106300000 13300000 5900000 1300000 7200000 0 300000 600000 500000 90300000 52100000 38200000 89600000 51700000 37900000 4752000000 4676900000 -45100000 -98400000 -32100000 -63500000 454300000 485700000 806900000 883800000 13700000 897500000 199800000 222500000 152800000 175600000 17000000 0 0 8100000 0 0 5458200000 5328300000 -400000 5327900000 11628800000 11225600000 -5500000 11220100000 1436000000 1537600000 0 3800000 22000000 0 9100000 16200000 4022200000 3790700000 -400000 3790300000 0 0 6900000 0 1000000000 420000000 420000000 0 383500000 0 383500000 342100000 306000000 326700000 298000000 70400000 197700000 3270800000 3085300000 2700000000 760000000 686000000 192000000 100000 200000 -2448500000 -362200000 2282000000 -29200000 285300000 254700000 0 254700000 -69600000 2000000 36200000 2800000 39000000 117000000 300000 117300000 -400000 -3600000 0 -96600000 -92600000 355800000 691600000 376300000 712800000 148800000 3900000 104200000 69300000 4100000 -32700000 277300000 4200000 179200000 157500000 9700000 -73300000 94700000 2700000 97400000 5600000 57400000 56900000 0 -25200000 250900000 200000 251100000 20400000 170500000 118700000 0 -58700000 409500000 341100000 -4800000 -16300000 0 0 0 0 200000 400000 6900000 8500000 -3500000 -4100000 154700000 220100000 -165600000 -92600000 -1000000 156800000 212300000 -169300000 -97100000 -400000 -4100000 0 -97100000 -92600000 2700000 5200000 -4300000 -4300000 429500000 414600000 -400000 414200000 11700000 3000000 -6100000 -2500000 -7900000 -12100000 -20600000 5100000 -2200000000 0 3700000 0 58200000 265000000 23600000 30700000 3100000 13800000 116100000 0 46000000 52800000 4000000 2400000 7500000 0 7500000 37200000 33300000 0.0001 0.0001 10000000 10000000 0 0 203200000 238400000 -19200000 219200000 7700000 15000000 2200000000 22200000 37200000 1300000 200000 0 0 431000000 4700000 -7500000 0 -8200000 -58200000 -58200000 -156900000 -265000000 85700000 10300000 0 0 21600000 42700000 23800000 48500000 833100000 811900000 0 500000 0 500000 0 584400000 309500000 26300000 2229100000 457300000 50000000 42600000 82300000 91900000 130300000 12100000 50800000 28000000 3700000 5200000 19700000 51500000 39700000 21400000 12400000 12700000 5400000 7300000 300000 100000 300000 100000 -1975500000 -1852200000 -5100000 -1857300000 1237900000 376500000 604900000 240400000 16100000 0 2431900000 751500000 1187600000 457800000 35000000 0 1186400000 92200000 31900000 30400000 109300000 84700000 103000000 109200000 86100000 27900000 75700000 72200000 79700000 71200000 4300000 5000000 772300000 69800000 344300000 6900000 1193300000 381000000 596800000 208600000 0 0 2403400000 185900000 58200000 58500000 250800000 183400000 195200000 212600000 175800000 61100000 151300000 148300000 155300000 137100000 7300000 10400000 1558700000 138500000 706200000 1300000 2404700000 782400000 1198400000 422600000 0 0 77100000 146500000 155600000 310600000 155200000 316500000 2906000000 280400000 309600000 700000000 215600000 700000000 303900000 144000000 162000000 90500000 2650800000 2600000000 2898000000 280400000 309600000 700000000 215600000 700000000 303900000 140200000 157800000 90500000 2525900000 2600000000 14800000 22300000 31900 46400 74000 127000 2000000000 P3Y 6170500000 1300000 -9800000 0 252100000 260600000 1300000 -9800000 1000000 253100000 260600000 5897100000 -5100000 5892000000 900000 -13900000 0 155000000 168000000 6170600000 5897300000 -5100000 5892200000 143300000 143600000 138700000 140000000 143300000 143300000 138100000 139500000 10600000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other intangible assets and related accumulated amortization consisted of the following (in millions):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Definite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements and supply agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">310.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">188.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">311.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">169.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,349.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">647.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,358.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">598.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,608.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">513.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,642.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">460.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,304.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">159.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,335.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">129.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">13.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total definite-lived intangibles</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,587.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,521.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,661.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,371.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Indefinite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">51.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">52.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">38.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total indefinite-lived intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">89.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">90.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,676.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,521.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,752.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,371.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) recognized in earnings for the ineffective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:589px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:213px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:173px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings<br clear="none"/>(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">CONTINGENCIES</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Antitrust Violations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We were named as a counterclaim co-defendant in the lawsuit </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Fera Pharmaceuticals, LLC v. Akorn, Inc., et al.</font><font style="font-family:Arial;font-size:10pt;"> in the Southern District of New York, in which Akorn, Inc. (&#8220;Akorn&#8221;) alleged tortious interference and antitrust violations against us and Fera Pharmaceuticals, LLC (&#8220;Fera&#8221;). Trial was set for February 2018 in the Southern District of New York. This litigation arose out of our acquisition of bacitracin ophthalmic ointment from Fera in 2013. Akorn asserted claims under Sections 1 and 2 of the Sherman Antitrust Act alleging that we and Fera conspired to monopolize, attempted to monopolize, and did unlawfully monopolize the market for sterile bacitracin ophthalmic ointment in the United States through the use of an exclusive agreement with a supplier of sterile bacitracin active pharmaceutical ingredient. The parties have executed a written settlement of all claims and the case has been dismissed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Price-Fixing Lawsuits</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have been named as a co-defendant with certain other generic pharmaceutical manufacturers in a number of class actions alleging that we and other manufacturers of the same product engaged in anti-competitive behavior to fix or raise the prices of certain drugs starting, in some instances, as early as June 2013. The products in question are Clobetasol, Desonide, and Econazole. Recently, the same class plaintiffs have filed new complaints naming us as a co-defendant, along with 27 other manufacturers, alleging an overarching conspiracy to fix or raise the prices of 15 generic pharmaceutical products starting in 2011. Perrigo manufactures only two of the products at issue, Nystatin cream and Nystatin ointment. We have also recently been named a co-defendant along with 35 other manufacturers in a complaint filed by three supermarket chains alleging that defendants conspired to fix prices of 31 generic pharmaceutical products starting in 2013. These complaints, along with complaints filed against other companies alleging price fixing with respect to more than two dozen other drugs, have been consolidated for pretrial proceedings as part of a case captioned </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">In re Generic Pharmaceuticals Pricing Antitrust Litigation,</font><font style="font-family:Arial;font-size:10pt;"> MDL No. 2724 in the U.S. District Court for the Eastern District of Pennsylvania. Pursuant to the court&#8217;s schedule staging various cases in phases, we have moved to dismiss the complaints relating to Clobetasol and Econazole. A schedule for responses to the other complaints will be determined after decisions are rendered on the pending motions to dismiss the class cases. At this stage, we cannot reasonably predict the outcome of the liability, if any, associated with these claims.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Securities Litigation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">In the United States </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On May 18, 2016, a shareholder filed a securities case against us and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund v. Papa, et al.)</font><font style="font-family:Arial;font-size:10pt;">.&#160;The plaintiff purported to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The original complaint alleged violations of Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against both defendants and 20(a) control person liability against Mr. Papa.&#160;In general, the allegations concerned the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015.&#160;The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged integration problems related to the Omega acquisition in the period from April 21, 2015 through May 11, 2016.&#160;On July 19, 2016, a different shareholder filed a securities class action against us and our former CEO, Joseph Papa, also in the District of New Jersey (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson v. Papa, et al</font><font style="font-family:Arial;font-size:10pt;">.). The plaintiff purported to represent a class of persons who sold put options on our shares between April 21, 2015 and May 11, 2016. In general, the allegations and the claims were the same as those made in the original complaint filed in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case described above. On December 8, 2016, the court consolidated </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case and the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson</font><font style="font-family:Arial;font-size:10pt;"> case under the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case number. In February 2017, the court selected the lead plaintiffs for the consolidated case and the lead counsel to the putative class. In March 2017, the court entered a scheduling order.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On June 21, 2017, the court-appointed lead plaintiffs filed an amended complaint that superseded the original complaints in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund </font><font style="font-family:Arial;font-size:10pt;">case and the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson</font><font style="font-family:Arial;font-size:10pt;"> case. The lead plaintiffs seek to represent a class of shareholders for the period April 21, 2015 through May 3, 2017, and the amended complaint identifies three subclasses - shareholders who purchased shares during the period on the U.S. exchanges; shareholders who purchased shares during the period on the Tel Aviv exchange; and shareholders who owned shares on the final day of the Mylan tender offer November 13, 2015. The amended complaint names as defendants us and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The amended complaint alleges violations of Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against all defendants and 20(a) control person liability against the </font><font style="font-family:Arial;font-size:10pt;">11</font><font style="font-family:Arial;font-size:10pt;"> individuals. In general, the allegations concern the actions taken by us and the former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to six generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> royalty stream. The amended complaint does not include an estimate of damages. In August 2017, the defendants filed motions to dismiss the amended complaint. The plaintiffs filed their opposition in October 2017. The defendants filed replies in support of the motions to dismiss in November 2017. On July 27, 2018, the court issued an opinion and order granting the defendants&#8217; motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O&#8217;Connor, and Marc Coucke. The court also dismissed without prejudice claims arising from the Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are Perrigo Company, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issues regarding the Omega acquisition and the alleged price fixing activities with respect to six generic prescription pharmaceuticals. We intend to defend the lawsuit vigorously. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On November 1, 2017, Carmignac Gestion, S.A., filed a securities lawsuit against us and </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;"> individuals (former Chairman and CEO Joseph Papa, former CFO Judy Brown, and former Executive Vice President and Board member Marc Coucke). This lawsuit is not a securities class action. The case is styled </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac Gestion, S.A. v. Perrigo Company plc, et al.</font><font style="font-family:Arial;font-size:10pt;">, and was filed in the U.S. District Court for the District of New Jersey. The complaint asserts claims under Securities Exchange Act sections 10(b) (and Rule 10b-5), 14(e), and 18 against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff&#8217;s allegations focus on events during the period from April 2015 through April 2016. Plaintiff contends that the defendants provided inadequate disclosure throughout the period concerning the valuation and integration of Omega, the financial guidance provided by us during that period, our reporting about the generic prescription pharmaceutical business and its prospects, and the activities surrounding the efforts to defeat the Mylan tender offer during 2015. Many of the allegations in this case overlap with the allegations of the June 2017 amended complaint in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case described above. The plaintiff does not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case, and the court granted the stay motion. Because the court has issued a decision in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofer&#8217;s Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160; &#160; </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On January 16, 2018, Manning &amp; Napier Advisors, LLC filed a securities lawsuit against us and three individuals (former Chairman and CEO Joseph Papa, former CFO Judy Brown, and former Executive Vice President and Board member Marc Coucke). This lawsuit is not a securities class action. The case is styled </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Manning &amp; Napier Advisors, LLC v. Perrigo Company plc, et al.</font><font style="font-family:Arial;font-size:10pt;">, and was filed in the U.S. District Court for the District of New Jersey. The complaint asserts claims under Securities Exchange Act sections 10(b) (and Rule 10b-5) and 18 against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff&#8217;s allegations focus on events during the period from April 2015 through May 2017. Plaintiff contends that the defendants provided inadequate disclosure at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> financial asset. Many of the allegations in this case overlap with the allegations of the June 2017 amended complaint in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case described above. The plaintiff does not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motion to dismiss filed in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case, and the court granted the stay motion. Because the court has issued a decision in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofer&#8217;s Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On January 26, 2018, two different plaintiff groups (the Mason Capital group and the Pentwater group) each filed a lawsuit against us and the same individuals who are defendants in the amended complaint in the securities class action case described above (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case). The same law firm represents these two plaintiff groups, and the two complaints are substantially similar. These two cases are not securities class actions. One case is styled </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Mason Capital L.P., et al. v. Perrigo Company plc, et al.</font><font style="font-family:Arial;font-size:10pt;">, and was filed in the U.S. District Court for the District of New Jersey. The other case is styled </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Pentwater Equity Opportunities Master Fund Ltd., et al. &#160;v. Perrigo Company plc, et al.</font><font style="font-family:Arial;font-size:10pt;">, and also was filed in the U.S. District Court for the District of New Jersey. Both cases are assigned to the same federal judge that is hearing the class action case and the other individual cases described above (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac </font><font style="font-family:Arial;font-size:10pt;">and </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Manning &amp; Napier</font><font style="font-family:Arial;font-size:10pt;">).&#160;Each complaint asserts claims under Securities Exchange Act sections 14(e) (related to tender offer disclosures) against all defendants as well as 20(a) control person liability against the individual defendants.&#160;In general, the plaintiff&#8217;s allegations describe events during the period from April 2015 through May 2017.&#160;Plaintiff contends that the defendants provided inadequate disclosure during the tender offer period in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> financial asset. Many of the factual allegations in these two cases overlap with the allegations of the June 2017 amended complaint in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case described above and the allegations in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</font><font style="font-family:Arial;font-size:10pt;"> case described above. The plaintiff does not provide an estimate of damages. The parties to each case jointly requested that the court stay each case pending the outcome of a ruling on the motions to dismiss filed in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case. The court granted the stay motion in each case. Because the court has issued a decision in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofer&#8217;s Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case. We intend to defend both lawsuits vigorously.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On February 13, 2018, a group of plaintiff investors affiliated with Harel Insurance Investments &amp; Financial Services, Ltd. filed a lawsuit against us and the same individuals who are defendants in the amended complaint in the securities class action case described above (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case). This lawsuit is not a securities class action.&#160;The new complaint is substantially similar to the amended complaint in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case.&#160;The relevant period in the new complaint stretches from February 2014 to May 2, 2017.&#160;The complaint adds as defendants two individuals who served on our Board prior to 2016.&#160;The case is styled </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al.</font><font style="font-family:Arial;font-size:10pt;">, and was filed in the U.S. District Court for the District of New Jersey and is assigned to the same federal judge that is hearing the class action cases and the four other individual cases described above (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</font><font style="font-family:Arial;font-size:10pt;">, </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Manning &amp; Napier</font><font style="font-family:Arial;font-size:10pt;">, </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Mason Capital</font><font style="font-family:Arial;font-size:10pt;">, and </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Pentwater</font><font style="font-family:Arial;font-size:10pt;">). The </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Harel Insurance Company</font><font style="font-family:Arial;font-size:10pt;"> complaint asserts claims under Securities Exchange Act section 10(b) (and related SEC Rule 10b&#8209;5) and section 14(e) (related to tender offer disclosures) against all defendants as well as 20(a) control person liability against the individual defendants.&#160;The complaint also asserts claims based on Israeli securities laws.&#160;In general, the plaintiffs' allegations describe events during the period from February 2014 through May 2017.&#160;Plaintiffs contend that the defendants provided inadequate disclosure during the tender offer events in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> financial asset from February 2014 until the withdrawal of past financial statements in April 2017.&#160;Many of the factual allegations in this case overlap with the allegations of the June 2017 amended complaint in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case described above and the allegations in the four opt out cases also described above.&#160;The plaintiffs do not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case, which was granted by the court. Because the court has issued a decision in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofer&#8217;s Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On February 16, 2018, First Manhattan Company filed a securities lawsuit against us and three individuals (former Chairman and CEO Joseph Papa, former CFO Judy Brown, and former Executive Vice President and Board member Marc Coucke). This lawsuit is not a securities class action. The case is styled </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan Co. v. Perrigo Company plc, et al.</font><font style="font-family:Arial;font-size:10pt;">, and was filed in the U.S. District Court for the District of New Jersey. The case was assigned to the same judge hearing the class action case and the five other opt out cases. The complaint asserts claims under Securities Exchange Act sections 10(b) (and Rule 10b-5), 14(e), and 18 against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff&#8217;s allegations focus on events during the period from April 2015 through May 2017. Plaintiff contends that the defendants provided inadequate disclosure at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> financial asset. This lawsuit was filed by the same law firm that filed the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Manning &amp; Napier Advisors</font><font style="font-family:Arial;font-size:10pt;"> case and the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</font><font style="font-family:Arial;font-size:10pt;"> case described above and generally makes the same factual assertions as in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Manning &amp; Napier Advisors</font><font style="font-family:Arial;font-size:10pt;"> case. Many of the allegations in this case overlap with the allegations of the June 2017 amended complaint in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case described above. The plaintiff does not provide an estimate of damages. On April 20, 2018, the plaintiff filed an amended complaint that did not materially change the factual allegations of the original complaint. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case. The court granted the stay motion. Because the court has issued a decision in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofer&#8217;s Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On April 20, 2018, a group of plaintiff investors affiliated with TIAA-CREF filed a lawsuit against us and the same individuals who are the defendants in the Harel Insurance case complaint. This lawsuit is not a securities class action. The law firm representing the plaintiffs in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Harel Insurance</font><font style="font-family:Arial;font-size:10pt;"> case also represents the TIAA-CREF plaintiff entities in this case, and the new complaint is substantially similar to the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Harel Insurance</font><font style="font-family:Arial;font-size:10pt;"> complaint. The relevant period in the new complaint is August 14, 2014 to May 2, 2017 inclusive. The case is styled </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">TIAA-CREF</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Investment Management, LLC., et al. v. Perrigo Company plc, et al</font><font style="font-family:Arial;font-size:10pt;">., and was filed in the U.S. District Court for the District of New Jersey and is assigned to the same federal judge that is hearing the class action case and the six other individual cases described above (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac, Manning &amp; Napier, Mason Capital, Pentwater, Harel Insurance, </font><font style="font-family:Arial;font-size:10pt;">and</font><font style="font-family:Arial;font-size:10pt;font-style:italic;"> First Manhattan</font><font style="font-family:Arial;font-size:10pt;">). The </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">TIAA-CREF</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Investment Management</font><font style="font-family:Arial;font-size:10pt;"> complaint asserts claims under Securities Exchange Act section 10(b) (and related SEC Rule l0b-5), section 14(e) (related to tender offer disclosures) against all defendants as well as section 20(a) control person liability against the individual defendants. In general, plaintiffs' allegations describe events during the period from August 2014 through May 2017. Plaintiffs contend that the defendants provided inadequate disclosure during the tender offer events in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> financial asset from August 2014 until the withdrawal of past financial statements in April 2017. Many of the factual allegations in this case also overlap with the allegations of the June 2017 amended complaint in the</font><font style="font-family:Arial;font-size:10pt;font-style:italic;"> Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case described above. The plaintiffs do not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case. The court granted the stay motion. Because the court has issued a decision in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofer&#8217;s Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">In Israel</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Because our shares are traded on the Tel Aviv exchange under a dual trading arrangement, we are potentially subject to securities litigation in Israel. Three cases were filed; two were voluntarily dismissed and one was stayed. We are consulting Israeli counsel about our response to these allegations and we intend to defend these cases vigorously. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On May 22, 2016, shareholders filed a securities class action against us and five individual defendants: Our former CEO Mr. Papa, our former Executive Vice President and General Manager of the BCH segment Marc Coucke, our then Chief Executive Officer John Hendrickson, our former Board member Gary Kunkle, Jr., and our Board member Laurie Brlas alleging violations of Israeli law in the District Court of Tel Aviv-Jaffa (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Schweiger et al. v. Perrigo Company plc, et al.).</font><font style="font-family:Arial;font-size:10pt;">&#160;On June 15, 2016, we filed a motion to stay the case pending the outcome of the securities class action pending in the New Jersey Federal Court.&#160;The plaintiffs did not oppose the motion. The Israeli court granted the motion on the same day, and the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Schweiger</font><font style="font-family:Arial;font-size:10pt;"> action was stayed. In October 2017, the Schweiger plaintiffs dismissed their claims without prejudice because of the pendency of another class action case filed in Israel (see discussion below of the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Israel Elec. Corp. Employees&#8217; Educ. Fund</font><font style="font-family:Arial;font-size:10pt;"> case). The court approved the voluntary dismissal.&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On March 29, 2017, plaintiff Eyal Keinan commenced an action in the District Court of Tel Aviv-Jaffa asserting securities claims against two defendants: Perrigo and its auditor Ernst &amp; Young LLP ("EY").&#160;The case is styled </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Keinan v. Perrigo Company plc, et al. </font><font style="font-family:Arial;font-size:10pt;">The action sought certification of a class of purchasers of Perrigo shares on the Israeli exchange beginning February 6, 2014. The proposed closing date for the class was not clear from the complaint though it appeared to extend into 2017. In general, the plaintiff asserted that we improperly accounted for our stream of royalty income from two drugs: Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> and Prialt. The court filings contended that the alleged improper accounting caused the audited financial results for Perrigo to be incorrect for the six month period ended December&#160;31, 2015, and the years ended June&#160;27, 2015 and June&#160;28, 2014 and the other financial data released by us over those years and 2016 to also be inaccurate.&#160;The plaintiff maintained that the defendants are liable under Israeli securities law or, in the alternative, under U.S. securities law. The plaintiff indicated an initial, preliminary class damages estimate of </font><font style="font-family:Arial;font-size:10pt;">686.0 million</font><font style="font-family:Arial;font-size:10pt;"> NIS (approximately </font><font style="font-family:Arial;font-size:10pt;">$192.0 million</font><font style="font-family:Arial;font-size:10pt;"> at 1 NIS = </font><font style="font-family:Arial;font-size:10pt;">$0.28 cent</font><font style="font-family:Arial;font-size:10pt;">). In January 2018, the Keinan plaintiff announced its intention to dismiss his claims because of the pendency of another class action case filed in Israel (see discussion below of the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Israel Elec. Corp. Employees&#8217; Educ. Fund</font><font style="font-family:Arial;font-size:10pt;"> case). The court granted the dismissal on February 11, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Israel Elec. Corp. Employees&#8217; Educ. Fund v. Perrigo Company plc, et al. </font><font style="font-family:Arial;font-size:10pt;">The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, EY (the Company&#8217;s auditor), and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The complaint alleges violations under U.S. securities laws of Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against all defendants and 20(a) control person liability against the 11 individuals or, in the alternative, under Israeli securities laws. In general, the allegations concern the actions taken by us and our former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure concerning purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company, alleges price fixing activities with respect to six generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> royalty stream. The plaintiff indicates an initial, preliminary class damages estimate of </font><font style="font-family:Arial;font-size:10pt;">2.7 billion</font><font style="font-family:Arial;font-size:10pt;"> NIS (approximately </font><font style="font-family:Arial;font-size:10pt;">$760.0 million</font><font style="font-family:Arial;font-size:10pt;"> at 1 NIS = </font><font style="font-family:Arial;font-size:10pt;">$0.28 cent</font><font style="font-family:Arial;font-size:10pt;">). We intend to defend the lawsuit vigorously.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On July 12, 2017, the plaintiff in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Israel Elec. Corp. Employees&#8217; Educ. Fund v. Perrigo Company plc, et al.</font><font style="font-family:Arial;font-size:10pt;"> case filed a motion to have all three cases pending in Israel either consolidated or the other two cases dismissed so that the Israel Elec. Corp. Educ. Fund plaintiff can proceed as the sole plaintiff. In October 2017, the Schweiger plaintiffs (see description above) voluntarily dismissed their securities class action without prejudice as part of their response to the motion filed by the Israel Elec. Corp. Educ. Fund plaintiff. A variety of other procedural motions were also pending having to do with the timing of any response by defendants. The court held an initial conference on November 9, 2017 to address the motion filed by the Israel Elec. Corp. Educ. Fund plaintiff. Subsequently, the competing class plaintiffs held discussions and informed the court in January 2018 that they had reached an agreement among themselves such that the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Education Fund</font><font style="font-family:Arial;font-size:10pt;"> case will continue and the Keinan plaintiff dismissed its case. The court approved this outcome. At the request of the parties, the court has stayed the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Education Fund</font><font style="font-family:Arial;font-size:10pt;"> case pending the final adjudication of the class action case in D.N.J. (the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case described above under Securities Litigation In the United States). The court approved the stay.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Eltroxin</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During October and November 2011, nine applications to certify a class action lawsuit were filed in various courts in Israel related to Eltroxin, a prescription thyroid medication manufactured by a third party and distributed in Israel by our subsidiary, Perrigo Israel Agencies Ltd. The respondents included our subsidiaries, Perrigo Israel Pharmaceuticals Ltd. and/or Perrigo Israel Agencies Ltd., the manufacturers of the product, and various healthcare providers who provide healthcare services as part of the compulsory healthcare system in Israel. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">One of the applications was dismissed and the remaining eight applications were consolidated into one application. The applications arose from the 2011 launch of a reformulated version of Eltroxin in Israel. The consolidated application generally alleges that the respondents (a) failed to timely inform patients, pharmacists and physicians about the change in the formulation; and (b) failed to inform physicians about the need to monitor patients taking the new formulation in order to confirm patients were receiving the appropriate dose of the drug. As a result, claimants allege they incurred the following damages: (a) purchases of product that otherwise would not have been made by patients had they been aware of the reformulation; (b) adverse events to some patients resulting from an imbalance of thyroid functions that could have been avoided; and (c) harm resulting from the patients' lack of informed consent prior to the use of the reformulation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Several hearings on whether or not to certify the consolidated application took place in December 2013 and January 2014. On May 17, 2015, the District Court certified the motion against Perrigo Israel Agencies Ltd. and dismissed it against the remaining respondents, including Perrigo Israel Pharmaceuticals Ltd. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On June 16, 2015, we submitted a motion for permission to appeal the decision to certify to the Israeli Supreme Court together with a motion to stay the proceedings of the class action until the motion for permission to appeal is adjudicated. We have filed our statement of defense to the underlying proceedings. The underlying proceedings have been stayed pending the outcome of the mediation process and, if necessary, a decision on the motion to appeal.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On November 14, 2017 the parties submitted the agreed settlement agreement to the approval of the Supreme Court, which referred the approval back to the District Court. During three hearings that took place on November 29, 2017, December 13, 2017 and January 11, 2018 the District Court opined that it would approve the settlement agreement subject to certain amendments to be proposed by the Court (which would not impact the monetary settlement reached) and set a hearing for January 30, 2018 to discuss and finalize the proposed changes. Meanwhile, the Court ordered the settlement to be (1) provided to the Attorney General for review (standard procedure); and (2) published in the written media (newspapers), to enable the class members to submit any objections or &#8220;opt-out&#8221; to&#160; the proposed settlement by February 15, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On February 21, 2018, the District Court held a hearing to, among others, review objections received from class members who had notified the District Court of their desire to opt out of the settlement. In addition, a representative of the Israeli Attorney General&#8217;s office notified the District Court that, based upon their preliminary examination of the settlement, they intend to object to the settlement in its current form. The District Court recommended that the parties continue to discuss and minimize objections to the settlement and scheduled another hearing for May 13, 2018.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The District Court Justice was appointed as a Supreme Court Justice and ordered to move the case to a different panel. In an effort to reach a decision before the appointment,</font><font style="font-family:Arial;font-size:10pt;color:#1f497d;"> </font><font style="font-family:Arial;font-size:10pt;">an additional hearing was held on March 12, 2018 in which</font><font style="font-family:Arial;font-size:10pt;color:#1f497d;"> </font><font style="font-family:Arial;font-size:10pt;">the court urged the parties to try and exhaust their negotiations to the fullest and provide an update by May 13, 2018. In addition, the Court ordered the Attorney General to submit its opinion to the settlement agreement by May 30, 2018, which was extended until July 23, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Tysabri</font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> Product Liability Lawsuits</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;We and our collaborator Biogen have been co-defendants in product liability lawsuits arising out of the occurrence of Progressive Multifocal Leukoencephalopathy ("PML"), a serious brain infection, and serious adverse events, including deaths, which occurred in patients taking Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">. &#160;In 2018, the last outstanding PML case was dismissed with prejudice.&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Claim Arising from the Omega Acquisition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On December 16, 2016, we and Perrigo Ireland 2 brought an arbitral claim ("Claim") against Alychlo NV ("Alychlo") and Holdco I BE NV ("Holdco") (together the Sellers) in accordance with clause 26.2 of the Share Purchase Agreement dated November 6, 2014 ("SPA") and the rules of the Belgian Centre for Arbitration and Mediation ("CEPANI"). Our Claim relates to the accuracy and completeness of information about Omega provided by the Sellers as part of the sale process, the withholding of information by the Sellers during that process and breaches of Sellers&#8217; warranties. We are seeking monetary damages from the Sellers. The Sellers served their respective responses to the Claim on February 20, 2017. In its response, Alychlo has asserted a counterclaim for monetary damages contending that we breached a warranty in the SPA and breached the duty of good faith in performing the SPA. There can be no assurance that our Claim will be successful, and Sellers deny liability for the Claim. We deny that Alychlo is entitled to any relief (including monetary relief) under the counterclaim.&#160;The arbitration proceedings are confidential as required by the SPA and the rules of the CEPANI.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Changes in our AOCI balances, net of tax were as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair value of derivative financial instruments, net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Foreign currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair&#160;value&#160;of investment securities, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Post-retirement and pension liability adjustments, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total AOCI</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">260.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">253.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2016-01 adoption impact</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Balance at December 31, 2017 after adoption impact</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">260.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">252.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">OCI before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(92.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(96.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Amounts reclassified from AOCI</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other comprehensive income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(92.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(97.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Balance at June 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(13.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">168.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">155.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table provides information about contract assets from contracts with customers (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">January&#160;1, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Short-term contract assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INVESTMENTS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes our equity security measurement category, balance sheet location, and balances (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.79643231899266%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measurement Category</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">2017</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fair value method</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fair value method</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Equity method</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:Arial;font-size:8pt;"> The </font><font style="font-family:Arial;font-size:8pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:8pt;"> equity securities are measured at fair value using the Net Asset Value practical expedient.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font><font style="font-family:Arial;font-size:8pt;"> The December 31, 2017 balances presented reflect historical recognition and measurement investment categories existing prior to the adoption of ASU 2016-01, which include available for sale and cost method securities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes our equity security expense (income) recognized in earnings (in millions):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measurement Category</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fair value method</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Equity method</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On January 1, 2018, as a result of the adoption of ASU 2016-01, we made a </font><font style="font-family:Arial;font-size:10pt;">$1.0 million</font><font style="font-family:Arial;font-size:10pt;"> cumulative-effect adjustment to </font><font style="font-family:Arial;font-size:10pt;">Retained earnings (accumulated deficit)</font><font style="font-family:Arial;font-size:10pt;"> net of tax that consisted of net unrealized losses on previously classified available for sale securities from Other comprehensive income ("OCI").</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, Perrigo Asia Holding Company Limited increased its investment in Zibo Xinhua - Perrigo Pharmaceutical Company Limited by $</font><font style="font-family:Arial;font-size:10pt;">7.5 million</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INDEBTEDNESS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total borrowings outstanding are summarized as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.48427672955975%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Term loans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2018 Term loan due March 8, 2020</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">383.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014 Term loan due December 5, 2019</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">420.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total term loans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">383.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">420.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Notes and Bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Coupon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Due</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.000%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">May 23, 2019</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">140.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">144.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.500%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">March&#160;15, 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">280.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">280.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.500%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">309.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">309.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.105%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">July 19, 2023</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">157.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">162.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.000%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;15, 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">215.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">215.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.900%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.375%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">March&#160;15, 2026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.300%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;15, 2043</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">90.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">90.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.900%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">303.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">303.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total notes and bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,898.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,906.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Other financing</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unamortized premium (discount), net</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Deferred financing fees</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(18.1</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(17.9</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total borrowings outstanding</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,283.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,341.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Current indebtedness</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(197.7</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(70.4</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total long-term debt less current portion</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,085.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,270.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We are in compliance with all covenants under our debt agreements as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Revolving Credit Agreements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">December&#160;5, 2014</font><font style="font-family:Arial;font-size:10pt;">, Perrigo Finance entered into a </font><font style="font-family:Arial;font-size:10pt;">$600.0 million</font><font style="font-family:Arial;font-size:10pt;"> revolving credit agreement, which increased to </font><font style="font-family:Arial;font-size:10pt;">$1.0&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> on March 30, 2015 (the "2014 Revolver"). On March 8, 2018, we terminated the 2014 Revolver and entered into a </font><font style="font-family:Arial;font-size:10pt;">$1.0 billion</font><font style="font-family:Arial;font-size:10pt;"> revolving credit agreement maturing on March 8, 2023 (the "2018 Revolver"). There were </font><font style="font-family:Arial;font-size:10pt;">no</font><font style="font-family:Arial;font-size:10pt;"> borrowings outstanding under the 2018 Revolver as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> or under the 2014 Revolver as of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Term Loans</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">December&#160;5, 2014</font><font style="font-family:Arial;font-size:10pt;">, Perrigo Finance entered into a term loan agreement consisting of a </font><font style="font-family:Arial;font-size:10pt;">&#8364;500.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$614.3 million</font><font style="font-family:Arial;font-size:10pt;">) tranche, maturing December 5, 2019. On March 8, 2018, we refinanced the </font><font style="font-family:Arial;font-size:10pt;">&#8364;350.0 million</font><font style="font-family:Arial;font-size:10pt;"> outstanding under the term loan with the proceeds of a new </font><font style="font-family:Arial;font-size:10pt;">&#8364;350.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$431.0&#160;million</font><font style="font-family:Arial;font-size:10pt;">) term loan, maturing March 8, 2020. In addition, as a result of the refinancing during the three months ended March 31, 2018, we recorded a loss of </font><font style="font-family:Arial;font-size:10pt;">$0.5&#160;million</font><font style="font-family:Arial;font-size:10pt;">, consisting of the write-off of deferred financing fees in </font><font style="font-family:Arial;font-size:10pt;">Loss on extinguishment of debt</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations. During the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, we made </font><font style="font-family:Arial;font-size:10pt;">$26.3 million</font><font style="font-family:Arial;font-size:10pt;"> in scheduled principal payments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Other Financing</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Overdraft Facilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in the above table under "Other financing". There were </font><font style="font-family:Arial;font-size:10pt;">no</font><font style="font-family:Arial;font-size:10pt;"> borrowings outstanding at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">. The balance outstanding under the overdraft facilities was </font><font style="font-family:Arial;font-size:10pt;">$6.9 million</font><font style="font-family:Arial;font-size:10pt;"> at December 31, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Debt Extinguishment </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As a result of early redemption and tender offer transactions during the three months ended July&#160;1, 2017, we recorded a loss of </font><font style="font-family:Arial;font-size:10pt;">$135.2 million</font><font style="font-family:Arial;font-size:10pt;"> in </font><font style="font-family:Arial;font-size:10pt;">Loss on extinguishment of debt</font><font style="font-family:Arial;font-size:10pt;"> on our Condensed Consolidated Statements of Operations (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:63.731656184486376%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Premium on debt repayment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">116.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Transaction costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Write-off of deferred financing fees</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Write-off of remaining discount on bond</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total loss on extinguishment of debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">135.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"> &#160;&#160;&#160;&#160; All of our designated derivatives were classified as cash flow hedges as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Interest Rate Swaps </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the three months ended July 1, 2017, we repaid </font><font style="font-family:Arial;font-size:10pt;">$584.4&#160;million</font><font style="font-family:Arial;font-size:10pt;"> of senior notes with an interest rate of </font><font style="font-family:Arial;font-size:10pt;">4.000%</font><font style="font-family:Arial;font-size:10pt;"> due 2023 and </font><font style="font-family:Arial;font-size:10pt;">$309.5 million</font><font style="font-family:Arial;font-size:10pt;"> of senior notes with an interest rate of </font><font style="font-family:Arial;font-size:10pt;">5.300%</font><font style="font-family:Arial;font-size:10pt;"> due 2043 (refer to </font><a style="font-family:Arial;font-size:10pt;" href="#s18F644ED544557D6B02F31402324D267"><font style="font-family:Arial;font-size:10pt;">Note 9</font></a><font style="font-family:Arial;font-size:10pt;">). As a result of these senior note repayments, the proportionate amount remaining in OCI related to the pre-issuance hedge was reclassified to earnings. Accordingly, we recorded a loss of </font><font style="font-family:Arial;font-size:10pt;">$5.9&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in </font><font style="font-family:Arial;font-size:10pt;">Other expense, net</font><font style="font-family:Arial;font-size:10pt;">, during the three months ended July 1, 2017 for the amount remaining in OCI.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Forward Contracts</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;"></font><font style="font-family:Arial;font-size:10pt;">The total notional amount for our foreign currency forward contracts was </font><font style="font-family:Arial;font-size:10pt;">$594.2 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$592.3 million</font><font style="font-family:Arial;font-size:10pt;"> as of </font><font style="font-family:Arial;font-size:10pt;">June 30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Effects of Derivatives on the Financial Statements</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects and are presented in millions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Asset Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) recorded in OCI for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:580px;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI<br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) reclassified from Accumulated other comprehensive income ("AOCI") into earnings for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:731px;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:213px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:173px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings <br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(6.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The net of tax amount expected to be reclassified out of AOCI into earnings during the next 12 months is a </font><font style="font-family:Arial;font-size:10pt;">$5.2 million</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">loss</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) recognized in earnings for the ineffective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:589px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:213px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:173px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings<br clear="none"/>(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized against Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Non-Designated Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(13.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(15.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following is a summary of our net sales by category (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:593px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCA</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cough/Cold/Allergy/Sinus</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">109.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">250.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Infant Nutritionals</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">109.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">212.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Gastrointestinal</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">103.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">195.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Analgesics</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">92.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">185.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Smoking Cessation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">71.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">137.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Animal Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">31.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">58.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Vitamins, Minerals and Dietary Supplements</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other CHCA</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1),(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">151.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total CHCA</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">596.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,198.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCI</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Lifestyle</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">86.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">175.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cough, Cold, and Allergy</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">84.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">183.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Personal Care and Derma-Therapeutics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">79.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">155.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Anti-Parasite</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">58.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Natural Health and Vitamins, Minerals and Dietary Supplements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">61.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other CHCI</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">72.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">148.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total CHCI</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">381.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">782.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total RX</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">208.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">422.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,186.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,403.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;&#160;&#160;&#160;</sup></font><font style="font-family:Arial;font-size:8pt;">Includes net sales from our OTC contract manufacturing business.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Consists primarily of branded OTC, diabetic care, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Consists primarily of liquid licensed products, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</font></div></td></tr></table></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We generated net sales in the following geographic locations</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></font><font style="font-family:Arial;font-size:10pt;">(in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:328px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:134px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">772.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,558.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Europe</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">344.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">706.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">All other countries</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">69.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">138.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,186.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,403.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) </sup></font><font style="font-family:Arial;font-size:8pt;">The net sales by geography is derived from the location of the entity that sells to a third party.</font></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2) </sup></font><font style="font-family:Arial;font-size:8pt;">Includes Ireland net sales of </font><font style="font-family:Arial;font-size:8pt;">$5.0 million</font><font style="font-family:Arial;font-size:8pt;"> and </font><font style="font-family:Arial;font-size:8pt;">$10.4 million</font><font style="font-family:Arial;font-size:8pt;"> for the </font><font style="font-family:Arial;font-size:8pt;">three and six months ended</font><font style="font-family:Arial;font-size:8pt;"> </font><font style="font-family:Arial;font-size:8pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:8pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3) </sup></font><font style="font-family:Arial;font-size:8pt;">Includes net sales generated primarily in Israel, Mexico, Australia and Canada.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Earnings per Share</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(69.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for basic EPS</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">138.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">139.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Dilutive effect of share-based awards*</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for diluted EPS</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">138.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">140.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Anti-dilutive share-based awards excluded from computation of diluted EPS</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">* In the period of a net loss, diluted shares equal basic shares.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Shareholders' Equity</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Shares</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We issued shares related to the exercise and vesting of share-based compensation as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:61.21593291404612%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">74,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,900</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">127,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">46,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Share Repurchases</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In October 2015, the Board of Directors approved a </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;">-year share repurchase plan of up to </font><font style="font-family:Arial;font-size:10pt;">$2.0 billion</font><font style="font-family:Arial;font-size:10pt;">. During the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;color:#252525;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, we repurchased </font><font style="font-family:Arial;font-size:10pt;">2.0 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">3.3 million</font><font style="font-family:Arial;font-size:10pt;"> ordinary shares at an average repurchase price of </font><font style="font-family:Arial;font-size:10pt;">$79.42</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$80.42</font><font style="font-family:Arial;font-size:10pt;"> per share, for a total of </font><font style="font-family:Arial;font-size:10pt;">$156.9&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$265.0 million</font><font style="font-family:Arial;font-size:10pt;">, respectively. During the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">July&#160;1, 2017</font><font style="font-family:Arial;font-size:10pt;">, we repurchased </font><font style="font-family:Arial;font-size:10pt;">812,184</font><font style="font-family:Arial;font-size:10pt;"> ordinary shares at an average repurchase price of </font><font style="font-family:Arial;font-size:10pt;">$71.67</font><font style="font-family:Arial;font-size:10pt;"> per share, for a total of </font><font style="font-family:Arial;font-size:10pt;">$58.2 million</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes our equity security expense (income) recognized in earnings (in millions):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measurement Category</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fair value method</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Equity method</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes the valuation of our financial instruments carried at fair value and measured at fair value on a recurring and non-recurring basis by the above pricing categories (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measured at fair value on a recurring basis:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Investment securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Funds associated with Israeli severance liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Royalty Pharma contingent milestone payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">125.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measured at fair value on a non-recurring basis:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Definite-lived intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The table below presents a reconciliation for the </font><font style="font-family:Arial;font-size:10pt;">Royalty Pharma contingent milestone payments</font><font style="font-family:Arial;font-size:10pt;"> measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Change in fair value in the table was recorded in </font><font style="font-family:Arial;font-size:10pt;">Change in financial assets</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:285px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:85px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:83px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:85px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:85px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Royalty Pharma Contingent Milestone Payments</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">124.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">184.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">184.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency effect</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Change in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(39.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(9.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(39.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">145.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">145.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">FAIR VALUE MEASUREMENTS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes the valuation of our financial instruments carried at fair value and measured at fair value on a recurring and non-recurring basis by the above pricing categories (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measured at fair value on a recurring basis:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Investment securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Funds associated with Israeli severance liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Royalty Pharma contingent milestone payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">125.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measured at fair value on a non-recurring basis:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Definite-lived intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">There were no transfers among Level 1, 2, and 3 during the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> or the year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Financial Assets</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">March&#160;27, 2017</font><font style="font-family:Arial;font-size:10pt;">, we announced the completed divestment of our Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> financial asset to Royalty Pharma for up to </font><font style="font-family:Arial;font-size:10pt;">$2.85 billion</font><font style="font-family:Arial;font-size:10pt;">, consisting of </font><font style="font-family:Arial;font-size:10pt;">$2.2 billion</font><font style="font-family:Arial;font-size:10pt;"> in cash and </font><font style="font-family:Arial;font-size:10pt;">$250.0 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$400.0 million</font><font style="font-family:Arial;font-size:10pt;"> in milestone payments if the royalties on global net sales of Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> that are received by Royalty Pharma meet specific thresholds in 2018 and 2020, respectively. As a result of this transaction, we transferred the entire financial asset to Royalty Pharma and recorded a </font><font style="font-family:Arial;font-size:10pt;">$17.1 million</font><font style="font-family:Arial;font-size:10pt;"> gain during the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> April 1, 2017. We elected to account for the contingent milestone payments using the fair value option method, and these were recorded at an estimated fair value of </font><font style="font-family:Arial;font-size:10pt;">$184.5&#160;million</font><font style="font-family:Arial;font-size:10pt;"> as of April 1, 2017. We chose the fair value option as we believe it will help investors understand the potential future cash flows we may receive associated with the two contingent milestones.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Royalty Pharma Contingent Milestone Payments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We valued our contingent milestone payments from Royalty Pharma using a modified Black-Scholes Option Pricing Model ("BSOPM"). Key inputs in the BSOPM are the estimated volatility and rate of return of royalties on global net sales of Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> that are received by Royalty Pharma until the contingent milestones are resolved. Volatility and the estimated fair value of the milestones have a positive relationship such that higher volatility translates to a higher estimated fair value of the contingent milestone payments. In the valuation of contingent milestone payments performed, we assumed volatility of </font><font style="font-family:Arial;font-size:10pt;">30.0%</font><font style="font-family:Arial;font-size:10pt;"> for each of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">July&#160;1, 2017</font><font style="font-family:Arial;font-size:10pt;">, and a rate of return of </font><font style="font-family:Arial;font-size:10pt;">8.09%</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">8.05%</font><font style="font-family:Arial;font-size:10pt;"> as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">July&#160;1, 2017</font><font style="font-family:Arial;font-size:10pt;">, respectively. We assess volatility and rate of return inputs quarterly by analyzing certain market volatility benchmarks and the risk associated with Royalty Pharma achieving the underlying projected royalties. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The fair value of the Royalty Pharma contingent milestone payments increased by </font><font style="font-family:Arial;font-size:10pt;">$0.6&#160;million</font><font style="font-family:Arial;font-size:10pt;"> during the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">. This increase included a </font><font style="font-family:Arial;font-size:10pt;">$2.9 million</font><font style="font-family:Arial;font-size:10pt;"> decrease in the fair value of the 2018 contingent milestone payment, more than offset by a </font><font style="font-family:Arial;font-size:10pt;">$3.5 million</font><font style="font-family:Arial;font-size:10pt;"> increase in the fair value of the 2020 contingent milestone payment. During the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, the fair value of the contingent milestone payments decreased by </font><font style="font-family:Arial;font-size:10pt;">$9.0&#160;million</font><font style="font-family:Arial;font-size:10pt;">. The net changes in the fair value of the contingent milestone payments were due to the fluctuation of the projected global net sales of Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">. Global net sales of Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> are being impacted by competition, namely the launch of Ocrevus</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> in the U.S. and European markets in 2017 and 2018, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The fair value of the Royalty Pharma contingent milestone payments decreased </font><font style="font-family:Arial;font-size:10pt;">$39.2 million</font><font style="font-family:Arial;font-size:10pt;"> in each of the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">July&#160;1, 2017</font><font style="font-family:Arial;font-size:10pt;"> as a result of a decrease in the estimated Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> revenues due to the launch of Ocrevus</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> in the U.S. market late in the first quarter of 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Payment of the contingent milestone payments is dependent on actual global net sales of Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> in 2018 and 2020. Of the </font><font style="font-family:Arial;font-size:10pt;">$125.5&#160;million</font><font style="font-family:Arial;font-size:10pt;"> of estimated fair value contingent milestone payments as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, </font><font style="font-family:Arial;font-size:10pt;">$65.3&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$60.2&#160;million</font><font style="font-family:Arial;font-size:10pt;"> relates to the 2018 and 2020 contingent milestone payments, respectively. If Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> global net sales do not meet the prescribed threshold in 2018, we will write off the </font><font style="font-family:Arial;font-size:10pt;">$65.3&#160;million</font><font style="font-family:Arial;font-size:10pt;"> asset as an expense. If the prescribed threshold is exceeded, we will increase the asset to </font><font style="font-family:Arial;font-size:10pt;">$250.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and recognize income of </font><font style="font-family:Arial;font-size:10pt;">$184.7&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in </font><font style="font-family:Arial;font-size:10pt;">Change in financial assets</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations. If Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> global net sales do not meet the prescribed threshold in 2020, we will write off the </font><font style="font-family:Arial;font-size:10pt;">$60.2&#160;million</font><font style="font-family:Arial;font-size:10pt;"> asset as an expense. If the prescribed threshold is exceeded, we will increase the asset to </font><font style="font-family:Arial;font-size:10pt;">$400.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and recognize income of </font><font style="font-family:Arial;font-size:10pt;">$339.8&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in </font><font style="font-family:Arial;font-size:10pt;">Change in financial assets</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Global Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> net sales need to exceed </font><font style="font-family:Arial;font-size:10pt;">$1.85&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$1.95&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> in 2018 and 2020, respectively, in order for Royalty Pharma to receive the level of royalties needed to trigger the milestone payments owed to us.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The table below presents a reconciliation for the </font><font style="font-family:Arial;font-size:10pt;">Royalty Pharma contingent milestone payments</font><font style="font-family:Arial;font-size:10pt;"> measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Change in fair value in the table was recorded in </font><font style="font-family:Arial;font-size:10pt;">Change in financial assets</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:285px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:85px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:83px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:85px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:85px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Royalty Pharma Contingent Milestone Payments</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">124.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">184.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">184.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency effect</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Change in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(39.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(9.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(39.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">145.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">145.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Contingent Consideration</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Contingent consideration represents milestone payment obligations obtained through product acquisitions, which are valued using estimates based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The estimates are updated quarterly and the liabilities are adjusted to fair value depending on a number of assumptions, including the competitive landscape and regulatory approvals that may impact the future sales of a product. We reduced a contingent consideration liability associated with certain IPR&amp;D assets (refer to </font><a style="font-family:Arial;font-size:10pt;" href="#s0D04C5F712DB5C16805EA9764C1CFFE9"><font style="font-family:Arial;font-size:10pt;">Note 4</font></a><font style="font-family:Arial;font-size:10pt;">) and recorded a corresponding gain of </font><font style="font-family:Arial;font-size:10pt;">$15.6&#160;million</font><font style="font-family:Arial;font-size:10pt;"> during the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">July&#160;1, 2017</font><font style="font-family:Arial;font-size:10pt;">. The liability decrease related to a reduction of the probability of achievement assumptions and anticipated cash flows. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The table below presents a reconciliation for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Net realized losses in the table were recorded in </font><font style="font-family:Arial;font-size:10pt;">Other operating expense (income)</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:591px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:200px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Contingent Consideration</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">52.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">69.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net realized (gains) losses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(15.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Currency translation adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">49.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">49.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Fixed Rate Long-term Debt</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our fixed rate long-term debt consisted of public bonds, a retail bond and a private placement note as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:520px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:233px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:56px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:56px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:56px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:56px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Public Bonds</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Carrying Value (excluding discount)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,525.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,650.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Retail bond and private placement note</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Carrying value (excluding premium)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">298.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">306.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fair value</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">326.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">342.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our retail bond and private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and variable rate long-term debt, approximate their fair value.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The table below presents a reconciliation for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Net realized losses in the table were recorded in </font><font style="font-family:Arial;font-size:10pt;">Other operating expense (income)</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:591px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:200px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Contingent Consideration</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">52.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">69.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net realized (gains) losses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(15.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Currency translation adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">49.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">49.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">GOODWILL AND OTHER INTANGIBLE ASSETS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:67.50524109014675%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,847.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,845.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,205.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(30.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,175.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">RX</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,122.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,117.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,175.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(37.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,137.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Animal Health</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Following a prior indication of potential impairment during the three months ended December 31, 2017, the animal health reporting unit had an additional indication of potential impairment during the three month ended June 30, 2018 due to its year-to-date financial results failing to meet performance expectations. We performed an impairment test as of June 30, 2018 and determined the fair value of the animal health reporting unit exceeded its net book value and therefore, no impairment was recorded as of the three months ended June 30, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Intangible Assets</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other intangible assets and related accumulated amortization consisted of the following (in millions):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Definite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements and supply agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">310.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">188.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">311.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">169.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,349.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">647.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,358.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">598.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,608.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">513.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,642.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">460.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,304.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">159.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,335.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">129.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">13.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total definite-lived intangibles</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,587.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,521.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,661.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,371.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Indefinite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">51.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">52.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">38.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total indefinite-lived intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">89.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">90.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,676.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,521.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,752.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,371.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We recorded amortization expense of </font><font style="font-family:Arial;font-size:10pt;">$85.3&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$172.4 million</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">for the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, respectively, and </font><font style="font-family:Arial;font-size:10pt;">$87.2&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$172.8 million</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">July&#160;1, 2017</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We recorded an impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$12.2&#160;million</font><font style="font-family:Arial;font-size:10pt;"> on certain In-process Research and Development ("IPR&amp;D") assets, primarily in our </font><font style="font-family:Arial;font-size:10pt;">RX</font><font style="font-family:Arial;font-size:10pt;"> segment, during the three months ended April&#160;1, 2017 due to changes in the projected development and regulatory timelines for various projects. In addition, we recorded a decrease in the contingent consideration liability associated with certain IPR&amp;D assets in </font><font style="font-family:Arial;font-size:10pt;">Other operating expense (income)</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations (refer to </font><a style="font-family:Arial;font-size:10pt;" href="#sF0C21B0D083A5F1BB736A59019A85B24"><font style="font-family:Arial;font-size:10pt;">Note 6</font></a><font style="font-family:Arial;font-size:10pt;">).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the three months ended July&#160;1, 2017, we identified impairment indicators for our Lumara Health, Inc. product assets. The primary impairment indicators included the decline in our 2017 performance expectations and a reduction in our long-range revenue growth forecast. As part of our assessment, we utilized the multi-period excess earnings method to determine fair value. This resulted in an impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$18.5 million</font><font style="font-family:Arial;font-size:10pt;"> in </font><font style="font-family:Arial;font-size:10pt;">Impairment charges</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations within our </font><font style="font-family:Arial;font-size:10pt;">RX</font><font style="font-family:Arial;font-size:10pt;"> segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INCOME TAXES</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effective tax rates were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:387px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:81px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:81px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:81px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:81px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">34.5</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">29.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">89.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;"></font><font style="font-family:Arial;font-size:10pt;">The effective tax rate for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> increased in comparison to the prior period due primarily to additional valuation allowances against deferred taxes and uncertain tax positions recorded in foreign jurisdictions. The effective tax rate for the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> decreased in comparison to the prior period due primarily to the negative impacts of non-deductible fees related to debt cancellation in the prior period.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our tax rate is subject to adjustment over the balance of the calendar year due to, among other things, the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments based on differing interpretations of the applicable transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; and expiration of or the inability to renew tax rulings or tax holiday incentives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We file income tax returns in numerous jurisdictions and are therefore subject to audits by tax authorities. Our primary income tax jurisdictions are Ireland, the United States, Israel, Belgium, France, and the United Kingdom.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On August 15, 2017, we filed a complaint in the United States District Court for the Western District of Michigan to recover </font><font style="font-family:Arial;font-size:10pt;">$163.6 million</font><font style="font-family:Arial;font-size:10pt;"> of Federal income tax, penalties, and interest assessed and collected by the Internal Revenue Service (&#8220;IRS&#8221;), plus statutory interest thereon from the dates of payment, for the fiscal years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012 (the &#8220;2009 tax year,&#8221; &#8220;2010 tax year,&#8221; &#8220;2011 tax year,&#8221; and &#8220;2012 tax year,&#8221; respectively). The IRS audits of those years culminated in the issuances of two statutory notices of deficiency: (1) on August 27, 2014 for the 2009 and 2010 tax years and (2) on April 20, 2017 for the 2011 and 2012 tax years. The statutory notices of deficiency both included un-agreed income adjustments related principally to transfer pricing adjustments regarding the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States. In addition, the statutory notice of deficiency for the 2011 and 2012 tax years included the capitalization of certain expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits. We fully paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and filed timely claims for refund on June 11, 2015 and June 7, 2017 for the 2009-2010 tax years and 2011-2012 tax years, respectively. Our claims for refund were disallowed by certified letters dated August 18, 2015 and July 11, 2017, for the 2009-2010 tax years and 2011-2012 tax years, respectively. The complaint was timely, based upon the refund claim denials, and seeks refunds of tax, interest, and penalties of </font><font style="font-family:Arial;font-size:10pt;">$37.2 million</font><font style="font-family:Arial;font-size:10pt;"> for the 2009 tax year, </font><font style="font-family:Arial;font-size:10pt;">$61.5 million</font><font style="font-family:Arial;font-size:10pt;"> for the 2010 tax year, </font><font style="font-family:Arial;font-size:10pt;">$40.2 million</font><font style="font-family:Arial;font-size:10pt;"> for the 2011 tax year, and </font><font style="font-family:Arial;font-size:10pt;">$24.7&#160;million</font><font style="font-family:Arial;font-size:10pt;"> for the 2012 tax year. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in </font><font style="font-family:Arial;font-size:10pt;">Other non-current assets</font><font style="font-family:Arial;font-size:10pt;"> on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in </font><font style="font-family:Arial;font-size:10pt;">Other non-current assets</font><font style="font-family:Arial;font-size:10pt;"> on our balance sheet during the three months ended July 1, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On December 22, 2016, we received a notice of proposed adjustment for the IRS audit of Athena Neurosciences, Inc. (&#8220;Athena&#8221;), a subsidiary of Elan acquired in 1996, for the years ended December 31, 2011, December 31, 2012, and December 31, 2013.&#160;Perrigo acquired Elan in December 2013.&#160;This proposed adjustment relates to the deductibility of litigation costs.&#160;We disagree with the IRS&#8217;s position asserted in the notice of proposed adjustment and intend to contest it.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On July 11, 2017, we received a draft notice of proposed adjustment associated with transfer pricing positions for the IRS audit of Athena for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. Athena was the originator of the patents associated with Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> prior to the acquisition of Athena by Elan in 1996. In response to the draft notice of proposed adjustment, we provided the IRS with substantial additional documentation supporting our position. The amount of adjustments that may be asserted by the IRS in the final notice of proposed adjustment cannot be quantified at this time; however, based on the draft notice received, the amount to be assessed may be material. We disagree with the IRS&#8217;s position as asserted in the draft notice of proposed adjustment and intend to contest it.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have ongoing audits in multiple other jurisdictions the resolution of which remains uncertain. These jurisdictions include, but are not limited to, the United States, Ireland and other jurisdictions in Europe. In addition to the matters discussed above, the IRS is currently auditing our fiscal years ended June 29, 2013, June 28, 2014, and June 27, 2015 (which covers the period of the Elan transaction). The Israel Tax Authority's audit of our fiscal years ended June 29, 2013 and June 28, 2014 concluded with no material impact to the financial statements. The Ireland Tax Authority is currently auditing our years ended December 31, 2012 and December 31, 2013.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Tax Law Changes</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On December 22, 2017, the United States enacted the Tax Cuts and Jobs Act (&#8220;U.S. Tax Act&#8221;). The U.S. Tax Act includes a number of significant changes to existing U.S. tax laws that impact us. These changes include a corporate income tax rate reduction from </font><font style="font-family:Arial;font-size:10pt;">35%</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">21%</font><font style="font-family:Arial;font-size:10pt;"> and the elimination or reduction of certain U.S. deductions and credits including limitations on the U.S. deductibility of interest expense and executive compensation. The U.S. Tax Act also transitions the U.S. taxation of international earnings from a worldwide system to a modified territorial system. These changes were effective beginning in 2018. The U.S. Tax Act also includes a one-time mandatory deemed repatriation tax on accumulated U.S. owned foreign corporations&#8217; previously untaxed foreign earnings (&#8220;Transition Toll Tax&#8221;). The Transition Toll Tax may be paid over an eight-year period, starting in 2018, and will not accrue interest.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On December 22, 2017, Staff Accounting Bulletin No. 118 ("SAB 118") was issued to address the application of the U.S. GAAP ASC 740 income tax accounting for tax law changes enacted during 2017, in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the U.S. Tax Act. In accordance with SAB 118, for the year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, we recorded an income tax benefit of </font><font style="font-family:Arial;font-size:10pt;">$2.4&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in connection with the remeasurement of certain deferred tax assets and liabilities and also recorded a </font><font style="font-family:Arial;font-size:10pt;">$17.5&#160;million</font><font style="font-family:Arial;font-size:10pt;"> increase of current tax expense in connection with the Transition Toll Tax on cumulative U.S. owned foreign earnings of </font><font style="font-family:Arial;font-size:10pt;">$1.2 billion</font><font style="font-family:Arial;font-size:10pt;">. The tax impacts represent provisional amounts and are a reasonable estimate. The IRS issued additional guidance related to the U.S. Tax Act during the quarters ended March 31, 2018 and June 30, 2018, which resulted in no changes to the provisional estimates recorded at </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">. Further work is necessary to perform additional analysis of historical foreign earnings, the impacts of repatriating foreign earnings, and U.S. cumulative temporary differences, as well as potential correlative adjustments. Any subsequent adjustment to these amounts will be recorded to tax expense when the analysis is complete in 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The U.S. Tax Act subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries. The FASB Staff Q&amp;A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed Income states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred. Given the complexity of the GILTI provisions, we are still evaluating the effects of the GILTI provisions and have not yet determined our accounting policy. At </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, we made a reasonable estimate of the tax effect of a GILTI inclusion for 2018, which is not material for the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">. We also estimate that we will not be subject to the base erosion anti-avoidance tax in 2018 and will not record tax benefits for deductions related to foreign-derived intangible income.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On December 22, 2017, the Belgian Parliament approved Belgian tax reform legislation (&#8220;Belgium Tax Act&#8221;), which was signed by the Belgian King and enacted on December 25, 2017. The Belgium Tax Act provides for a reduction to the corporate income tax rate from </font><font style="font-family:Arial;font-size:10pt;">34%</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">30%</font><font style="font-family:Arial;font-size:10pt;">, for 2018 and 2019, as well as a reduced corporate income tax rate of </font><font style="font-family:Arial;font-size:10pt;">25%</font><font style="font-family:Arial;font-size:10pt;"> for 2020 and beyond. The Belgium Tax Act also increased the participation exemption on dividend distributions to Belgium entities from </font><font style="font-family:Arial;font-size:10pt;">95%</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">100%</font><font style="font-family:Arial;font-size:10pt;">. The Belgium Tax Act also introduces Belgium tax consolidation and other anti-tax avoidance directives. For the year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, we recorded additional income tax expense of </font><font style="font-family:Arial;font-size:10pt;">$24.1 million</font><font style="font-family:Arial;font-size:10pt;"> for the remeasurement of certain deferred tax assets and additional income tax benefit of </font><font style="font-family:Arial;font-size:10pt;">$33.2 million</font><font style="font-family:Arial;font-size:10pt;"> for the remeasurement of certain deferred tax liabilities as a result of the Belgium Tax Act.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The IRS issued a notice of proposed regulations on August 1, 2018, implementing Section 965 of the Internal Revenue Code as amended by the U.S. Tax Act, which was enacted on December 22, 2017. The regulations affect any U. S. company with direct or indirect ownership interests in certain foreign corporations. We are currently evaluating the impact of the regulations on our financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INVENTORIES</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Major components of inventory were as follows (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:59.538784067085956%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Finished goods</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">485.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">454.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">175.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">152.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Raw materials</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">222.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">199.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total inventories</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">883.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">806.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ACQUISITIONS AND DIVESTITURES</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Acquisitions during the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">six months ended</font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Nasonex-branded products</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">May&#160;29, 2018</font><font style="font-family:Arial;font-size:10pt;">, we entered into a license agreement with Merck Sharp &amp; Dohme Corp. ("Merck") allowing us to develop and commercialize an OTC version of Nasonex-branded products containing the compound, mometasone furoate monohydrate. The acquisition was accounted for as an asset acquisition based on our assessment that substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset to be used for research and development. In accordance with Accounting Standards Codification Topic 730 Research and Development ("ASC 730"), the non-refundable upfront license fee of </font><font style="font-family:Arial;font-size:10pt;">$50.0 million</font><font style="font-family:Arial;font-size:10pt;"> was recorded in Research and development ("R&amp;D") expense in our CHCA segment because the intangible research and development asset acquired has no alternative use. The agreement requires us to make contingent payments if we obtain regulatory approval and achieve certain sales milestones. We will also be obligated to make royalty payments on potential future sales. The contingent consideration will be included in the measurement of the cost of the asset when the contingency is resolved, and the consideration is paid or becomes payable. Consideration paid after U.S. Food and Drug Administration ("FDA") approval will be capitalized and amortized to cost of goods sold over the economic life of each product.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Divestitures during the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">six months ended</font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">July&#160;1, 2017</font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">January&#160;3, 2017</font><font style="font-family:Arial;font-size:10pt;">, we sold certain Abbreviated New Drug Applications ("ANDAs") for </font><font style="font-family:Arial;font-size:10pt;">$15.0 million</font><font style="font-family:Arial;font-size:10pt;"> to a third party, which was recorded as a gain in </font><font style="font-family:Arial;font-size:10pt;">Other operating expense (income)</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations in our Prescription Pharmaceuticals ("RX") segment.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">February&#160;1, 2017</font><font style="font-family:Arial;font-size:10pt;">, we completed the sale of the animal health pet treats plant fixed assets within our </font><font style="font-family:Arial;font-size:10pt;">CHCA</font><font style="font-family:Arial;font-size:10pt;"> segment, which were previously classified as held-for sale. We received </font><font style="font-family:Arial;font-size:10pt;">$7.7&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in proceeds, which resulted in an immaterial loss.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">April&#160;6, 2017</font><font style="font-family:Arial;font-size:10pt;">, we completed the sale of our India Active Pharmaceuticals Ingredient ("API") business to Strides Shasun Limited. We received </font><font style="font-family:Arial;font-size:10pt;">$22.2&#160;million</font><font style="font-family:Arial;font-size:10pt;"> of proceeds, inclusive of an estimated working capital adjustment, which resulted in an immaterial gain recorded in our legacy Other segment. Prior to closing the sale, we determined that the carrying value of the India API business exceeded its fair value less the cost to sell, resulting in an impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$35.3&#160;million</font><font style="font-family:Arial;font-size:10pt;">, which was recorded in </font><font style="font-family:Arial;font-size:10pt;">Impairment charges</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations for the year ended December 31, 2016.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standard Pronouncements</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Below are recent Accounting Standard Updates ("ASU") that we are still assessing to determine the effect on our Condensed Consolidated Financial Statements. We do not believe that any other recently issued accounting standards could have a material effect on our Condensed Consolidated Financial Statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2016-02 Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. The guidance is required to be adopted using the modified retrospective approach. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We have completed our initial scoping reviews and assessment phase to identify our leasing processes and go-forward policy that will be impacted by the new standard. We are continuing the design phase of our new lease integration tool and expect our financial statement disclosures will be expanded to present additional details of our leasing arrangements. At this time, we are unable to reasonably estimate the expected increase in assets and liabilities on our Consolidated Balance Sheets or the impacts to our Consolidated Financial Statements upon adoption. We plan to adopt the amended guidance on the effective date, and we expect the right of use asset and corresponding liability will be material and require certain changes to our systems and processes.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance permits tax effects stranded in accumulated other comprehensive income as a result of tax reform to be reclassified to retained earnings. This reclassification is optional and will require additional disclosure regarding whether reclassification is elected or not.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2019</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the implications of adoption on our Consolidated Financial Statements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2016-13 Measurement of Credit Losses on Financial Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the implications of adoption on our Consolidated Financial Statements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2017-04 Intangibles - Goodwill and Other Simplifying the Test for Goodwill </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The objective of this update is to reduce the cost and complexity of subsequent goodwill accounting by simplifying the impairment test by removing the Step 2 requirement to perform a hypothetical purchase price allocation when the carrying value of a reporting unit exceeds its fair value.&#160;If a reporting unit&#8217;s carrying value exceeds its fair value, an entity would record an impairment charge based on that difference, limited to the amount of goodwill attributed to that reporting unit. The proposal would not change the guidance on completing Step 1 of the goodwill impairment test. The proposed guidance would be applied prospectively. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Upon adoption, this guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment. After adoption, a Step 1 failure will result in an immediate impairment charge based on the carrying value of the reporting unit. We plan to adopt the standard prospectively on the effective date.</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">General Information</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">The Company</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We are a leading global healthcare company, delivering value to our customers and consumers by providing Quality Affordable Healthcare Products</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">. Founded in 1887 as a packager of home remedies, we have built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. We believe we are one of the world's largest manufacturers of over-the-counter (&#8220;OTC&#8221;) healthcare products and suppliers of infant formulas for the store brand market. We are a leading provider of branded OTC products throughout Europe, and also a leading producer of generic pharmaceutical topical products such as creams, lotions, gels, and nasal sprays ("extended topical") prescription drugs. We are headquartered in Ireland, and sell our products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standard Pronouncements</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Below are recent Accounting Standard Updates ("ASU") that we are still assessing to determine the effect on our Condensed Consolidated Financial Statements. We do not believe that any other recently issued accounting standards could have a material effect on our Condensed Consolidated Financial Statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2016-02 Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. The guidance is required to be adopted using the modified retrospective approach. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We have completed our initial scoping reviews and assessment phase to identify our leasing processes and go-forward policy that will be impacted by the new standard. We are continuing the design phase of our new lease integration tool and expect our financial statement disclosures will be expanded to present additional details of our leasing arrangements. At this time, we are unable to reasonably estimate the expected increase in assets and liabilities on our Consolidated Balance Sheets or the impacts to our Consolidated Financial Statements upon adoption. We plan to adopt the amended guidance on the effective date, and we expect the right of use asset and corresponding liability will be material and require certain changes to our systems and processes.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance permits tax effects stranded in accumulated other comprehensive income as a result of tax reform to be reclassified to retained earnings. This reclassification is optional and will require additional disclosure regarding whether reclassification is elected or not.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2019</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the implications of adoption on our Consolidated Financial Statements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2016-13 Measurement of Credit Losses on Financial Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the implications of adoption on our Consolidated Financial Statements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2017-04 Intangibles - Goodwill and Other Simplifying the Test for Goodwill </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The objective of this update is to reduce the cost and complexity of subsequent goodwill accounting by simplifying the impairment test by removing the Step 2 requirement to perform a hypothetical purchase price allocation when the carrying value of a reporting unit exceeds its fair value.&#160;If a reporting unit&#8217;s carrying value exceeds its fair value, an entity would record an impairment charge based on that difference, limited to the amount of goodwill attributed to that reporting unit. The proposal would not change the guidance on completing Step 1 of the goodwill impairment test. The proposed guidance would be applied prospectively. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Upon adoption, this guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment. After adoption, a Step 1 failure will result in an immediate impairment charge based on the carrying value of the reporting unit. We plan to adopt the standard prospectively on the effective date.</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) reclassified from Accumulated other comprehensive income ("AOCI") into earnings for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:731px;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:213px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:173px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings <br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(6.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">RESTRUCTURING CHARGES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We periodically take action to reduce redundant expenses and improve operating efficiencies. The following reflects our restructuring activity (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:597px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:184px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">51.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Additional charges</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">50.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(23.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(13.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(30.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-cash adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Restructuring activity includes severance, lease exit costs, and asset impairments. The charges incurred during the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> were primarily associated with continued costs from actions we took to streamline our organization as announced on February 21, 2017 as well as additional lease exit costs. Of the amount recorded during the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">July&#160;1, 2017</font><font style="font-family:Arial;font-size:10pt;">, </font><font style="font-family:Arial;font-size:10pt;">$28.0 million</font><font style="font-family:Arial;font-size:10pt;"> was related to the CHCA segment. There were no other material restructuring programs that significantly impacted any other reportable segments for the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> or </font><font style="font-family:Arial;font-size:10pt;">July&#160;1, 2017</font><font style="font-family:Arial;font-size:10pt;">. All charges are recorded in </font><font style="font-family:Arial;font-size:10pt;">Restructuring</font><font style="font-family:Arial;font-size:10pt;"> expense on the Condensed Consolidated Financial Statements. The remaining </font><font style="font-family:Arial;font-size:10pt;">$7.3&#160;million</font><font style="font-family:Arial;font-size:10pt;"> liability for employee severance benefits will be paid within the next year, while the remaining </font><font style="font-family:Arial;font-size:10pt;">$5.4&#160;million</font><font style="font-family:Arial;font-size:10pt;"> liability for lease exit costs will be paid over the remaining terms of the applicable leases.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Product Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We generally recognize product revenue for our contract performance obligations at a point in time, typically upon shipment or delivery of products to customers. For point in time customers for which control transfers on delivery to the customer due to free on board destination terms (&#8220;FOB&#8221;)</font><font style="font-family:inherit;font-size:10pt;">,</font><font style="font-family:Arial;font-size:10pt;"> an adjustment is recorded to defer revenue recognition over an estimate of days until control transfers at the point of delivery. Where we recognize revenue at a point in time, the transfer of title is the primary indicator that control has transferred. In other limited instances, primarily relating to those contracts that relate to contract manufacturing performed for our customers and certain store branded products, control transfers as the product is manufactured. Control is deemed to transfer over time for these contracts as the product does not have an alternative use and we have a contractual right to payment for performance completed to date. Revenue for contract manufacturing contracts is recognized over the transfer period using an input method that measures progress towards completion of the performance obligation as costs are incurred. For store branded product revenue recognized over time, an output method is used to recognize revenue when production of a unit is completed because product customization occurs when the product is packaged as a finished good under the store brand label of the customer. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of chargebacks, rebates, sales returns, shelf stock allowances, administrative fees and other incentive programs. Certain of these accruals and allowances are recorded in the balance sheet as current liabilities and others are recorded as a reduction in accounts receivable. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect the best estimates of the amount of consideration to which we are entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Other Revenue Policies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We receive payments from our customers based on billing schedules established in each contract. Amounts are recorded as accounts receivable when our right to consideration is unconditional. In most cases, the timing of the unconditional right to payment aligns with shipment or delivery of the product and the recognition of revenue; however, for those customers where revenue is recognized at a time prior to shipment or delivery due to over time revenue recognition, a contract asset is recorded and is reclassified to an accounts receivable when it becomes unconditional under the contract upon shipment or delivery to the customer. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised products to the customer will be one year or less, which is the case with substantially all customers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from&#160;revenue.&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Shipping and handling costs billed to customers are included in </font><font style="font-family:Arial;font-size:10pt;">Net sales</font><font style="font-family:Arial;font-size:10pt;">. Conversely, shipping and handling expenses we incur are included in </font><font style="font-family:Arial;font-size:10pt;">Cost of sales</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">REVENUE RECOGNITION</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We adopted ASU 2014-09 Revenue from Contracts with Customers and its related amendments (collectively, "ASC 606"), as required, on January 1, 2018 using the modified retrospective method for all contracts not completed as of the adoption date. The reported results for the periods in 2018 reflect the application of ASC 606 while the results for the comparable reporting periods in 2017 were prepared under the guidance of Revenue Recognition ("ASC 605"). The adoption of ASC 606 represents a change in accounting principle that closely aligns revenue recognition with the transfer of control of our products and will provide enhanced disclosures of the nature, amount, timing, and uncertainty of revenues and cash flows arising from contracts with customers. In accordance with ASC 606, revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration to which we expect to be entitled to receive in exchange for these products.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Product Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We generally recognize product revenue for our contract performance obligations at a point in time, typically upon shipment or delivery of products to customers. For point in time customers for which control transfers on delivery to the customer due to free on board destination terms (&#8220;FOB&#8221;)</font><font style="font-family:inherit;font-size:10pt;">,</font><font style="font-family:Arial;font-size:10pt;"> an adjustment is recorded to defer revenue recognition over an estimate of days until control transfers at the point of delivery. Where we recognize revenue at a point in time, the transfer of title is the primary indicator that control has transferred. In other limited instances, primarily relating to those contracts that relate to contract manufacturing performed for our customers and certain store branded products, control transfers as the product is manufactured. Control is deemed to transfer over time for these contracts as the product does not have an alternative use and we have a contractual right to payment for performance completed to date. Revenue for contract manufacturing contracts is recognized over the transfer period using an input method that measures progress towards completion of the performance obligation as costs are incurred. For store branded product revenue recognized over time, an output method is used to recognize revenue when production of a unit is completed because product customization occurs when the product is packaged as a finished good under the store brand label of the customer. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of chargebacks, rebates, sales returns, shelf stock allowances, administrative fees and other incentive programs. Certain of these accruals and allowances are recorded in the balance sheet as current liabilities and others are recorded as a reduction in accounts receivable. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect the best estimates of the amount of consideration to which we are entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Other Revenue Policies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We receive payments from our customers based on billing schedules established in each contract. Amounts are recorded as accounts receivable when our right to consideration is unconditional. In most cases, the timing of the unconditional right to payment aligns with shipment or delivery of the product and the recognition of revenue; however, for those customers where revenue is recognized at a time prior to shipment or delivery due to over time revenue recognition, a contract asset is recorded and is reclassified to an accounts receivable when it becomes unconditional under the contract upon shipment or delivery to the customer. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised products to the customer will be one year or less, which is the case with substantially all customers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from&#160;revenue.&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Shipping and handling costs billed to customers are included in </font><font style="font-family:Arial;font-size:10pt;">Net sales</font><font style="font-family:Arial;font-size:10pt;">. Conversely, shipping and handling expenses we incur are included in </font><font style="font-family:Arial;font-size:10pt;">Cost of sales</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Disaggregation of Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We generated net sales in the following geographic locations</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></font><font style="font-family:Arial;font-size:10pt;">(in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:328px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:134px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">772.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,558.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Europe</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">344.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">706.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">All other countries</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">69.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">138.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,186.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,403.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) </sup></font><font style="font-family:Arial;font-size:8pt;">The net sales by geography is derived from the location of the entity that sells to a third party.</font></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2) </sup></font><font style="font-family:Arial;font-size:8pt;">Includes Ireland net sales of </font><font style="font-family:Arial;font-size:8pt;">$5.0 million</font><font style="font-family:Arial;font-size:8pt;"> and </font><font style="font-family:Arial;font-size:8pt;">$10.4 million</font><font style="font-family:Arial;font-size:8pt;"> for the </font><font style="font-family:Arial;font-size:8pt;">three and six months ended</font><font style="font-family:Arial;font-size:8pt;"> </font><font style="font-family:Arial;font-size:8pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:8pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3) </sup></font><font style="font-family:Arial;font-size:8pt;">Includes net sales generated primarily in Israel, Mexico, Australia and Canada.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following is a summary of our net sales by category (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:593px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCA</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cough/Cold/Allergy/Sinus</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">109.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">250.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Infant Nutritionals</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">109.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">212.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Gastrointestinal</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">103.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">195.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Analgesics</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">92.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">185.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Smoking Cessation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">71.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">137.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Animal Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">31.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">58.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Vitamins, Minerals and Dietary Supplements</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other CHCA</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1),(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">151.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total CHCA</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">596.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,198.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCI</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Lifestyle</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">86.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">175.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cough, Cold, and Allergy</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">84.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">183.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Personal Care and Derma-Therapeutics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">79.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">155.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Anti-Parasite</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">58.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Natural Health and Vitamins, Minerals and Dietary Supplements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">61.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other CHCI</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">72.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">148.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total CHCI</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">381.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">782.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total RX</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">208.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">422.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,186.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,403.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;&#160;&#160;&#160;</sup></font><font style="font-family:Arial;font-size:8pt;">Includes net sales from our OTC contract manufacturing business.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Consists primarily of branded OTC, diabetic care, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Consists primarily of liquid licensed products, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized on an over time basis. Predominately, over time customer contracts exist in contract manufacturing arrangements, which occur in both the </font><font style="font-family:Arial;font-size:10pt;">Consumer Healthcare Americas</font><font style="font-family:Arial;font-size:10pt;"> ("CHCA") and </font><font style="font-family:Arial;font-size:10pt;">Consumer Healthcare International</font><font style="font-family:Arial;font-size:10pt;"> ("CHCI") segments. Contract manufacturing revenue was </font><font style="font-family:Arial;font-size:10pt;">$77.1&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$146.5 million</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also recognized a portion of the store brand OTC product revenues in the CHCA segment on an over time basis; however, the timing between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Contract Balances</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table provides information about contract assets from contracts with customers (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">January&#160;1, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Short-term contract assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Impact on financial statements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Condensed Consolidated Statements of Operations</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales and Cost of sales were lower in the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> as a result of adopting ASC 606 due to net sales from contract manufacturing and certain OTC product sales being recognized on an over time basis as the performance obligation was satisfied, compared to the previous revenue recognition under ASC 605, which would have occurred when the product was shipped or delivered. This has resulted in the recognition of a contract asset.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,186.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,193.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,403.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,404.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">715.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">719.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,439.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,440.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">471.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">473.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">963.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">963.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Operating income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">94.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">97.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">250.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">251.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Income tax expense (benefit)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">48.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">48.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Earnings per share</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.02</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Condensed Consolidated Statements of Comprehensive Income (Loss)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Comprehensive income (loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(133.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(130.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Condensed Consolidated Balance Sheet </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.37106918238993%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">883.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">13.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">897.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">238.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(19.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">219.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,778.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,773.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,225.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,220.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Liabilities and Shareholders&#8217; Equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">414.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">414.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total non-current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,790.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,790.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,328.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,327.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Shareholders&#8217; equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Controlling interest:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accumulated deficit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,852.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,857.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total controlling interest</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,897.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,892.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total shareholders&#8217; equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,897.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,892.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities and shareholders' equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,225.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,220.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Condensed Consolidated Statement of Cash Flows</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.76100628930818%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Cash Flows From (For) Operating Activities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(Decreases) in cash due to:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(99.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(98.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(20.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(20.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other, net </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(7.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(106.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(106.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net cash from operating activities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">254.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">254.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Changes in our AOCI balances, net of tax were as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair value of derivative financial instruments, net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Foreign currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair&#160;value&#160;of investment securities, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Post-retirement and pension liability adjustments, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total AOCI</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">260.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">253.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2016-01 adoption impact</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Balance at December 31, 2017 after adoption impact</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">260.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">252.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">OCI before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(92.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(96.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Amounts reclassified from AOCI</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other comprehensive income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(92.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(97.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Balance at June 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(13.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">168.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">155.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our fixed rate long-term debt consisted of public bonds, a retail bond and a private placement note as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:520px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:233px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:56px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:56px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:56px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:56px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Public Bonds</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Carrying Value (excluding discount)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,525.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,650.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Retail bond and private placement note</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Carrying value (excluding premium)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">298.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">306.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fair value</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">326.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">342.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total borrowings outstanding are summarized as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.48427672955975%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Term loans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2018 Term loan due March 8, 2020</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">383.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014 Term loan due December 5, 2019</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">420.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total term loans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">383.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">420.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Notes and Bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Coupon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Due</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.000%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">May 23, 2019</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">140.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">144.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.500%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">March&#160;15, 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">280.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">280.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.500%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">309.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">309.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.105%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">July 19, 2023</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">157.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">162.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.000%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;15, 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">215.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">215.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.900%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.375%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">March&#160;15, 2026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.300%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;15, 2043</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">90.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">90.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.900%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">303.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">303.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total notes and bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,898.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,906.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Other financing</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unamortized premium (discount), net</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Deferred financing fees</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(18.1</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(17.9</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total borrowings outstanding</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,283.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,341.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Current indebtedness</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(197.7</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(70.4</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total long-term debt less current portion</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,085.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,270.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) recorded in OCI for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:580px;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:69px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI<br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Asset Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(69.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for basic EPS</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">138.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">139.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Dilutive effect of share-based awards*</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for diluted EPS</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">138.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">140.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Anti-dilutive share-based awards excluded from computation of diluted EPS</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">* In the period of a net loss, diluted shares equal basic shares.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effective tax rates were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:387px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:81px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:81px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:81px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:81px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">34.5</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">29.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">89.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As a result of early redemption and tender offer transactions during the three months ended July&#160;1, 2017, we recorded a loss of </font><font style="font-family:Arial;font-size:10pt;">$135.2 million</font><font style="font-family:Arial;font-size:10pt;"> in </font><font style="font-family:Arial;font-size:10pt;">Loss on extinguishment of debt</font><font style="font-family:Arial;font-size:10pt;"> on our Condensed Consolidated Statements of Operations (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:63.731656184486376%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Premium on debt repayment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">116.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Transaction costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Write-off of deferred financing fees</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Write-off of remaining discount on bond</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total loss on extinguishment of debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">135.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:67.50524109014675%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,847.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,845.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,205.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(30.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,175.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">RX</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,122.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,117.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,175.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(37.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,137.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Major components of inventory were as follows (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:59.538784067085956%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Finished goods</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">485.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">454.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">175.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">152.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Raw materials</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">222.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">199.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total inventories</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">883.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">806.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2016-02 Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. The guidance is required to be adopted using the modified retrospective approach. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We have completed our initial scoping reviews and assessment phase to identify our leasing processes and go-forward policy that will be impacted by the new standard. We are continuing the design phase of our new lease integration tool and expect our financial statement disclosures will be expanded to present additional details of our leasing arrangements. At this time, we are unable to reasonably estimate the expected increase in assets and liabilities on our Consolidated Balance Sheets or the impacts to our Consolidated Financial Statements upon adoption. We plan to adopt the amended guidance on the effective date, and we expect the right of use asset and corresponding liability will be material and require certain changes to our systems and processes.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance permits tax effects stranded in accumulated other comprehensive income as a result of tax reform to be reclassified to retained earnings. This reclassification is optional and will require additional disclosure regarding whether reclassification is elected or not.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2019</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the implications of adoption on our Consolidated Financial Statements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2016-13 Measurement of Credit Losses on Financial Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the implications of adoption on our Consolidated Financial Statements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">ASU 2017-04 Intangibles - Goodwill and Other Simplifying the Test for Goodwill </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The objective of this update is to reduce the cost and complexity of subsequent goodwill accounting by simplifying the impairment test by removing the Step 2 requirement to perform a hypothetical purchase price allocation when the carrying value of a reporting unit exceeds its fair value.&#160;If a reporting unit&#8217;s carrying value exceeds its fair value, an entity would record an impairment charge based on that difference, limited to the amount of goodwill attributed to that reporting unit. The proposal would not change the guidance on completing Step 1 of the goodwill impairment test. The proposed guidance would be applied prospectively. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Upon adoption, this guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment. After adoption, a Step 1 failure will result in an immediate impairment charge based on the carrying value of the reporting unit. We plan to adopt the standard prospectively on the effective date.</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Condensed Consolidated Statements of Operations</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales and Cost of sales were lower in the </font><font style="font-family:Arial;font-size:10pt;">three and six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> as a result of adopting ASC 606 due to net sales from contract manufacturing and certain OTC product sales being recognized on an over time basis as the performance obligation was satisfied, compared to the previous revenue recognition under ASC 605, which would have occurred when the product was shipped or delivered. This has resulted in the recognition of a contract asset.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,186.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,193.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,403.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,404.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">715.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">719.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,439.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,440.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">471.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">473.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">963.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">963.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Operating income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">94.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">97.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">250.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">251.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Income tax expense (benefit)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">48.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">48.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Earnings per share</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.02</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Condensed Consolidated Statements of Comprehensive Income (Loss)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Comprehensive income (loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(133.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(130.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Condensed Consolidated Balance Sheet </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.37106918238993%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">883.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">13.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">897.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">238.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(19.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">219.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,778.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,773.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,225.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,220.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Liabilities and Shareholders&#8217; Equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">414.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">414.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total non-current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,790.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,790.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,328.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,327.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Shareholders&#8217; equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Controlling interest:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accumulated deficit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,852.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,857.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total controlling interest</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,897.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,892.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total shareholders&#8217; equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,897.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,892.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities and shareholders' equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,225.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,220.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Condensed Consolidated Statement of Cash Flows</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.76100628930818%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Before adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Cash Flows From (For) Operating Activities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(Decreases) in cash due to:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(99.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(98.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(20.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(20.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other, net </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(7.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(106.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(106.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net cash from operating activities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">254.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">254.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized against Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Non-Designated Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(13.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(15.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following reflects our restructuring activity (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:597px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:184px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">51.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Additional charges</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">50.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(23.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(13.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(30.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-cash adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The below tables show select financial measures by reporting segment (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:49.10807974816369%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total Assets</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,673.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,786.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,799.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,029.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">RX</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,753.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,813.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,225.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,628.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July 1, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">596.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">57.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">15.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">604.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">104.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCI</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">381.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">49.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">376.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">47.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">RX</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">208.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">56.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">240.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">69.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unallocated</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(25.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(32.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,186.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">94.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">85.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,237.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">148.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">87.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July 1, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,198.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">170.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,187.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">179.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">34.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCI</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">782.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">100.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">751.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">93.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">RX</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">422.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">118.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">41.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">457.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">157.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">44.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">35.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unallocated</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(58.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(73.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,403.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">250.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">172.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,431.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">277.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">172.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We issued shares related to the exercise and vesting of share-based compensation as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:61.21593291404612%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July&#160;1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">74,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,900</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">127,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">46,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SEGMENT INFORMATION</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our reporting segments are as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-weight:bold;">Consumer Healthcare Americas</font><font style="font-family:Arial;font-size:10pt;">, comprises our U.S., Mexico and Canada consumer healthcare business (OTC, contract, infant formula and animal health categories). </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-weight:bold;">Consumer Healthcare International</font><font style="font-family:Arial;font-size:10pt;">,</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">comprises our branded consumer healthcare business primarily in Europe and our consumer focused businesses in the United Kingdom, Australia, and Israel. This segment also includes our U.K. liquid licensed products business.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-weight:bold;">Prescription Pharmaceuticals</font><font style="font-family:Arial;font-size:10pt;">,</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">comprises our U.S. Prescription Pharmaceuticals business.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also had a legacy operating segment, Other, which contained our API businesses, which we divested. Following the divestitures, there were no substantial assets or operations left in the segment. Our segments reflect the way in which our management makes operating decisions, allocates resources and manages the growth and profitability of the Company. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The below tables show select financial measures by reporting segment (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:49.10807974816369%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total Assets</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,673.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,786.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,799.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,029.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">RX</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,753.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,813.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,225.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,628.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July 1, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">596.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">57.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">15.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">604.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">104.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCI</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">381.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">49.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">376.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">47.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">RX</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">208.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">56.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">240.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">69.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unallocated</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(25.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(32.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,186.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">94.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">85.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,237.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">148.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">87.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">July 1, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,198.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">170.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,187.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">179.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">34.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHCI</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">782.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">100.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">751.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">93.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">RX</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">422.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">118.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">41.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">457.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">157.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">44.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">35.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unallocated</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(58.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(73.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,403.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">250.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">172.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,431.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">277.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">172.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SUBSEQUENT EVENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On August 9, 2018, we announced a plan to separate our RX business. We intend to begin the preparations for a spin-off of the RX business to shareholders and will also remain open to other value-enhancing options, including a possible sale, merger or other form of separation. We currently expect the separation of the RX business to be completed during the second half of 2019.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes our equity security measurement category, balance sheet location, and balances (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.79643231899266%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measurement Category</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">2017</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fair value method</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fair value method</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Equity method</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:Arial;font-size:8pt;"> The </font><font style="font-family:Arial;font-size:8pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:8pt;"> equity securities are measured at fair value using the Net Asset Value practical expedient.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font><font style="font-family:Arial;font-size:8pt;"> The December 31, 2017 balances presented reflect historical recognition and measurement investment categories existing prior to the adoption of ASU 2016-01, which include available for sale and cost method securities.</font></div></div> Includes Ireland net sales of $5.0 million and $10.4 million for the three and six months ended June 30, 2018, respectively. Includes net sales generated primarily in Israel, Mexico, Australia and Canada. Includes net sales from our OTC contract manufacturing business. Consists primarily of liquid licensed products, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales. The June 30, 2018 equity securities are measured at fair value using the Net Asset Value practical expedient. Consists primarily of branded OTC, diabetic care, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales. The December 31, 2017 balances presented reflect historical recognition and measurement investment categories existing prior to the adoption of ASU 2016-01, which include available for sale and cost method securities. In the period of a net loss, diluted shares equal basic shares. The net sales by geography is derived from the location of the entity that sells to a third party. Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate. EX-101.SCH 8 prgo-20180630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2113100 - Disclosure - Accumulated Other Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Acquisitions and Divestitures link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - Acquisitions and Divestitures (Details) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1004501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2415401 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Derivative Instruments and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - Derivative Instruments and Hedging Activities - Other Comprehensive Income Movement (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Derivative Instruments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Earnings Per Share and Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Earnings Per Share and Shareholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Earnings Per Share and Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2407405 - Disclosure - Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Goodwill and Other Intangible Assets - Intangible categories (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Goodwill and Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Income Taxes Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Indebtedness link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Indebtedness - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Indebtedness - Debt Extinguishment (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Indebtedness - Schedule of Borrowings Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Indebtedness - Schedule of Borrowings Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Indebtedness (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Restructuring Charges link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Restructuring Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Restructuring Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 2402404 - Disclosure - Revenue Recognition - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2402408 - Disclosure - Revenue Recognition - Schedule of ASC 606 Impact on Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 2402407 - Disclosure - Revenue Recognition - Schedule of ASC 606 Impact on Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 2402409 - Disclosure - Revenue Recognition - Schedule of ASC 606 Impact on Statement of Cash Flows (Details) link:presentationLink link:calculationLink link:definitionLink 2402406 - Disclosure - Revenue Recognition - Schedule of ASC 606 Impact on Statement of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 2402405 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details) link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 prgo-20180630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 prgo-20180630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 prgo-20180630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Statement of Financial Position [Abstract] Assets Assets [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, net of allowance for doubtful accounts of $6.5 and $6.2, respectively Accounts Receivable, Net, Current Inventories Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property, plant and equipment, net Property, Plant and Equipment, Net Goodwill and other indefinite-lived intangible assets Goodwill And Indefinite Lived Intangibles Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements. Other intangible assets, net Finite-Lived Intangible Assets, Net Non-current deferred income taxes Deferred Income Tax Assets, Net Other non-current assets Other Assets, Noncurrent Total non-current assets Assets, Noncurrent Total assets Assets Liabilities and Shareholders’ Equity Liabilities and Equity [Abstract] Accounts payable Accounts Payable, Current Payroll and related taxes Employee-related Liabilities, Current Accrued customer programs Accrued Customer Programs Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable. Accrued liabilities Accrued Liabilities, Current Accrued income taxes Accrued Income Taxes, Current Current indebtedness Long-term Debt, Current Maturities Total current liabilities Liabilities, Current Long-term debt, less current portion Long-term Debt, Excluding Current Maturities Non-current deferred income taxes Deferred Income Tax Liabilities, Net Other non-current liabilities Other Liabilities, Noncurrent Total non-current liabilities Liabilities, Noncurrent Total liabilities Liabilities Shareholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Controlling interest: Controlling Interest [Abstract] Controlling Interest [Abstract] Preferred shares, $0.0001 par value per share, 10 shares authorized Preferred Stock, Value, Issued Ordinary shares, €0.001 par value per share, 10,000 shares authorized Common Stock, Value, Issued Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Retained earnings (accumulated deficit) Retained Earnings (Accumulated Deficit) Total controlling interest Stockholders' Equity Attributable to Parent Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Total shareholders’ equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and shareholders' equity Liabilities and Equity Commitments and contingencies - Refer to Note 13 Commitments and Contingencies Supplemental Disclosures of Balance Sheet Information Balance Sheet Related Disclosures [Abstract] Ordinary shares, issued (in shares) Common Stock, Shares, Issued Ordinary shares, outstanding (in shares) Common Stock, Shares, Outstanding Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] CHCA Consumer Healthcare [Member] Consumer Healthcare [Member] CHCI Consumer Healthcare International [Member] Consumer Healthcare International [Member] RX RX Pharmaceuticals [Member] RX Pharmaceuticals [Member] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] December 31, 2017 Goodwill Currency translation adjustments Goodwill, Foreign Currency Translation Gain (Loss) June 30, 2018 Accounting Policies [Abstract] Basis of presentation Basis of Accounting, Policy [Policy Text Block] Principles of consolidation Consolidation, Policy [Policy Text Block] Recently Issued Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Product Revenue and Other Revenue Revenue from Contract with Customer [Policy Text Block] Debt Disclosure [Abstract] Schedule of Debt Instruments [Table] Schedule of Debt Instruments [Table] Schedule of Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 2018 Euro-Denominated Term Loan due March 8, 2020 2018 Euro-Denominated Term Loan due March 8, 2020 [Member] 2018 Euro-Denominated Term Loan due March 8, 2020 [Member] 2014 Term loan due December 5, 2019 2014 Euro-Denominated Term Loan due December 5, 2019 [Member] 2014 Euro-Denominated Term Loan due December 5, 2019 [Member] 5.000% Unsecured Senior notes due May 23, 2019 5.000% Unsecured Senior notes due May 23, 2019 [Member] 5.000% Unsecured Senior notes due May 23, 2019 [Member] 3.500% Unsecured Senior notes due March 15, 2021 3.500% Unsecured Senior notes due March 15, 2021 [Member] 3.500% Unsecured Senior notes due March 15, 2021 [Member] 3.5% Senior note due December 15, 2021 3.5% Senior note due December 15, 2021 [Member] 3.5% Senior note due 2021 [Member] 5.105% Senior note due July 19, 2023 5.105% Senior note due July 19, 2023 [Member] 5.105% Senior note due July 19, 2023 [Member] 4.00% Unsecured Senior Notes due November 15, 2023 4.00% Unsecured Senior Notes due November 15, 2023 [Member] 4.00% Unsecured Senior Notes due November 15, 2023 [Member] 3.9% senior note due December 15, 2024 3.9% senior note due 2024 [Member] 3.9% senior note due 2024 [Member] 4.375% senior note due March 15, 2026 4.375% senior note due March 15, 2026 [Member] 4.375% senior note due March 15, 2026 [Member] 5.30% unsecured senior notes due November 15, 2043 5.30% Unsecured Senior Notes due November 15, 2043 [Member] 5.30% Unsecured Senior Notes due November 15, 2043 [Member] 4.9% senior notes due December 15, 2044 4.9% Senior Loan due 2044 [Member] 4.9% Senior Loan due 2044 [Member] 2014 Revolver 2014 Revolver [Member] 2014 Revolver [Member] 2018 Revolver 2018 Revolver [Member] 2018 Revolver [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Series Debt Instrument, Description Term loans Loans Payable Interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Debt due date Debt Instrument, Maturity Date Senior notes Senior Notes Other financing Other Long-term Debt Unamortized premium (discount), net Debt Instrument, Unamortized Discount (Premium), Net Deferred financing fees Debt Instrument, Fee Amount Total borrowings outstanding Debt, Long-term and Short-term, Combined Amount Current indebtedness Debt, Current Premium on debt repayment Premium on debt repayment Premium on debt repayment Transaction costs Transaction costs associated with debt extinguishment Transaction costs associated with debt extinguishment Write-off of deferred financing fees Write off of Deferred Debt Issuance Cost Write-off of remaining discount on bond Write off of unamortized discount Write off of unamortized discount Total loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Revenue from Contract with Customer [Abstract] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Adjustments Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Balances without adoption of ASC 606 Calculated under Revenue Guidance in Effect before Topic 606 [Member] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2014-09 Accounting Standards Update 2014-09 [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Total current assets Total assets Total non-current liabilities Total liabilities Shareholders’ equity Equity [Abstract] Accumulated deficit Retained Earnings (Accumulated Deficit) [Abstract] Accumulated deficit Total controlling interest Net income (loss) Net Income (Loss) Attributable to Parent (Decreases) in cash due to: Net Cash Provided by (Used in) Operating Activities [Abstract] Inventories Increase (Decrease) in Inventories Accrued income taxes Increase (Decrease) in Income Taxes Payable Other, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Subtotal Increase (Decrease) in Operating Capital Net cash from operating activities Net Cash Provided by (Used in) Operating Activities Statement of Comprehensive Income [Abstract] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Change in fair value of derivative financial instruments, net of tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent Change in fair value of investment securities, net of tax Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Change in post-retirement and pension liability, net of tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Indebtedness Debt Disclosure [Text Block] Investments [Abstract] Investments Cost and Equity Method Investments Disclosure [Text Block] Subsequent Events [Abstract] Subsequent events Subsequent Events [Text Block] Restructuring Charges [Abstract] Restructuring and related costs Restructuring and Related Costs [Table Text Block] Earnings Per Share [Abstract] Earnings per share and shareholders' equity Earnings Per Share [Text Block] Inventory Disclosure [Abstract] Schedule of inventory, current Schedule of Inventory, Current [Table Text Block] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] CHCA Consumer Healthcare Americas [Member] Consumer Healthcare Americas [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Employee severance Employee Severance [Member] Lease exit Contract Termination [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Beginning balance Restructuring Reserve Additional charges Restructuring Charges Payments Payments for Restructuring Non-cash adjustments Restructuring Reserve, Settled without Cash Ending balance Segment Reporting [Abstract] Segment information Segment Reporting Disclosure [Text Block] Net sales Revenue from Contract with Customer, Excluding Assessed Tax Cost of sales Cost of Goods and Services Sold Gross profit Gross Profit Operating income Operating Income (Loss) Income tax expense (benefit) Income Tax Expense (Benefit) Earnings per share Earnings Per Share, Basic [Abstract] Basic (in dollars per share) Earnings Per Share, Basic Diluted (in dollars per share) Earnings Per Share, Diluted Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] CHCI CHCI [Member] CHCI [Member] Other Other Segments [Member] Unallocated Segment Reconciling Items [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total Assets Operating Income (Loss) Intangible Asset Amortization Amortization of Intangible Assets Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Cough/Cold/Allergy/Sinus Cough, Cold, Allergy and Sinus [Member] Cough, Cold, Allergy and Sinus [Member] Infant Nutritionals Infant Nutritionals [Member] Infant Nutritionals [Member] Gastrointestinal Gastrointestinal [Member] Gastrointestinal [Member] Analgesics Analgesics [Member] Analgesics [Member] Smoking Cessation Smoking Cessation [Member] Smoking Cessation [Member] Animal Health Animal Health [Member] Animal Health [Member] Vitamins, Minerals and Dietary Supplements Vitamins, Minerals, and Dietary Supplements [Member] Vitamins, Minerals, and Dietary Supplements [Member] Other CHCA Other CHCA [Member] Other CHC [Member] Lifestyle Lifestyle [Member] Lifestyle [Member] Cough, Cold, and Allergy Cough, Cold, and Allergy [Member] Cough, Cold, and Allergy [Member] Personal Care and Derma-Therapeutics Personal Care and Derma-Therapeutics [Member] Personal Care and Derma-Therapeutics [Member] Anti-Parasite Anti-Parasite [Member] Anti-Parasite [Member] Natural Health and Vitamins, Minerals and Dietary Supplements Natural Health and VMS [Member] Natural Health and VMS [Member] Other CHCI Other CHCI [Member] Other CHCI [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Measured at fair value on a recurring basis: Fair Value, Measurements, Recurring [Member] Measured at fair value on a non-recurring basis: Fair Value, Measurements, Nonrecurring [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Assets, Fair Value Disclosure [Abstract] Investment securities Investments, Fair Value Disclosure Foreign currency forward contracts Foreign Currency Contract, Asset, Fair Value Disclosure Funds associated with Israeli severance liability Funds Associated With Israeli Post Employment Benefits Fair Value Disclosure Funds Associated With Israeli Post Employment Benefits Fair Value Disclosure Royalty Pharma contingent milestone payments Potential Contingent Milestone Payments Potential Contingent Milestone Payments Total assets Assets, Fair Value Disclosure Liabilities: Liabilities, Fair Value Disclosure [Abstract] Foreign currency forward contracts Foreign Currency Cash Flow Hedge Liability at Fair Value Contingent consideration Business Combination, Contingent Consideration, Liability Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Definite-lived intangible assets Finite-lived Intangible Assets, Fair Value Disclosure Schedule Of Finite And Indefinite Lived Assets By Major Class [Table] Schedule Of Finite And Indefinite Lived Assets By Major Class [Table] Schedule Of Finite And Indefinite Lived Assets By Major Class [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Distribution and license agreements and supply agreements Licensing Agreements [Member] Developed product technology, formulations, and product rights Developed Technology Rights [Member] Customer relationships and distribution networks Customer Relationships [Member] Trademarks, trade names, and brands Trademarks, Trade Names, and Brands [Member] Trademarks, Trade Names, and Brands [Member] Non-compete agreements Noncompete Agreements [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process research and development In Process Research and Development [Member] Finite And Indefinite Lived Assets By Major Class [Line Items] Finite And Indefinite Lived Assets By Major Class [Line Items] Finite and Indefinite-Lived Assets By Major Class [Line Items] Gross Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Indefinite-lived intangibles: Indefinite-lived Intangible Assets (Excluding Goodwill) Total other intangible assets Intangible Assets, Net (Excluding Goodwill) Intangible assets amortization expense Impairment charge Impairment of Intangible Assets, Finite-lived Income Statement [Abstract] Operating expenses Operating Expenses [Abstract] Distribution Production and Distribution Costs Research and development Research and Development Expense Selling Selling and Marketing Expense Administration General and Administrative Expense Impairment charges Asset Impairment Charges Restructuring charges Other operating expense (income) Other Operating Income (Loss) Other Operating Income (Loss) Total operating expenses Operating Expenses Operating income Change in financial assets Fair Value, Option, Changes in Fair Value, Gain (Loss) Interest expense, net Interest Income (Expense), Net Other expense, net Other Nonoperating Income (Expense) Loss on extinguishment of debt Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Domestic Net income (loss) Earnings (loss) per share Weighted-average shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Dividends declared per share (in dollars per share) Common Stock, Dividends, Per Share, Declared Fair value measurements Fair Value Disclosures [Text Block] Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable Stockholders' Equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Preferred shares, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Preferred shares, authorized Preferred Stock, Shares Authorized Ordinary shares, par value (in EUR per share) Common Stock, Par or Stated Value Per Share Ordinary shares, authorized Common Stock, Shares Authorized Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Accumulated other comprehensive income (loss) Comprehensive Income (Loss) Note [Text Block] Business Combinations [Abstract] Acquisitions and divestitures Mergers, Acquisitions and Dispositions Disclosures [Text Block] Inventories Inventory Disclosure [Text Block] Goodwill and Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Reclassification out of Accumulated Other Comprehensive Income (Loss) [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] ASU 2016-01 Accounting Standards Update 2016-01 [Member] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Fair value of derivative financial instruments, net of tax Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Fair value of investment securities, net of tax Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Post-retirement and pension liability adjustments, net of tax Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] AOCI Attributable to Parent AOCI Attributable to Parent [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Accumulated Other Comprehensive Income [Roll Forward] Accumulated Other Comprehensive Income [Roll Forward] Accumulated Other Comprehensive Income [Roll Forward] Balance at December 31, 2017 ASU 2016-01 adoption impact Cumulative Effect of New Accounting Principle in Period of Adoption OCI before reclassifications OCI, before Reclassifications, Net of Tax, Attributable to Parent Amounts reclassified from AOCI Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Balance at June 30, 2018 Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt instrument, issuance date Debt Instrument, Issuance Date Face amount of debt Debt Instrument, Face Amount Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Borrowings outstanding Long-term Line of Credit Repayments of debt Repayments of Debt Outstanding balance Line of Credit Facility, Fair Value of Amount Outstanding Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative instruments and hedging activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity registrant name Entity Registrant Name Entity central index key Entity Central Index Key Current calendar year end date Current Fiscal Year End Date Entity filer category Entity Filer Category Document type Document Type Document period end date Document Period End Date Document calendar year focus Document Fiscal Year Focus Document calendar period focus Document Fiscal Period Focus Amendment flag Amendment Flag Entity common stock, shares outstanding Entity Common Stock, Shares Outstanding Contract manufacturing revenue Revenue from Contract with Customer, Including Assessed Tax Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Reported Value Measurement Reported Value Measurement [Member] Public bonds Public Bonds and Private Placement [Member] Public Bonds and Private Placement Retail Bonds Retail Bonds [Member] Retail Bonds [Member] Public bonds Retail bond and private placement note Long-term Debt Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated derivatives: Designated as Hedging Instrument [Member] Non-designated derivatives: Not Designated as Hedging Instrument [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Accrued liabilities Other Liabilities [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign currency forward contracts Foreign Exchange Forward [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Asset Derivatives Derivative Asset, Fair Value, Amount Not Offset Against Collateral Liability Derivatives Derivative Liability, Fair Value, Amount Not Offset Against Collateral Finished goods Inventory, Finished Goods, Gross Work in process Inventory, Work in Process, Gross Raw materials Inventory, Raw Materials, Gross Total inventories Schedule of accumulated other comprehensive income (loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Summary of significant accounting policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock Common Stock [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Numerator: Numerator [Abstract] Numerator: [Abstract] Denominator: Denominator [Abstract] Denominator [Abstract] Weighted average shares outstanding for basic EPS Dilutive effect of share-based awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Weighted average shares outstanding for diluted EPS Anti-dilutive share-based awards excluded from computation of diluted EPS Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Share-based compensation arrangement by share-based payment award, options, exercises in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Stock repurchase program approved period, in years Stock Repurchase Program, Period in Force Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Stock repurchase program, number of shares repurchased Stock Repurchase Program, Number of Shares Repurchased Stock Repurchase Program, Number of Shares Repurchased Share price (in dollars per share) Accelerated Share Repurchases, Final Price Paid Per Share Repurchase of equity amount Proceeds from (Repurchase of) Equity Equity securities Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block] Equity security expense (income) Equity Method Investments [Table Text Block] Comprehensive income (loss) Restructuring charges Restructuring and Related Activities Disclosure [Text Block] Schedule of earnings per share, basic and diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of share-based compensation, stock options, activity Share-based Compensation, Stock Options, Activity [Table Text Block] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Interest expense, net Interest Expense [Member] Other expense, net Other Nonoperating Income (Expense) [Member] Net sales Sales Revenue, Goods, Net [Member] Cost of sales Cost of Sales [Member] Interest Rate Swap Interest Rate Swap [Member] Amount of Gain/(Loss) Recorded in OCI (Effective Portion) Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion) Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Amount of Gain/(Loss) Recognized in Earnings (Ineffective Portion) Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Schedule of segment reporting information, by segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Contingencies Commitments and Contingencies Disclosure [Text Block] Income Tax Disclosure [Abstract] Schedule of effective income tax rate reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of goodwill Schedule of Goodwill [Table Text Block] Schedule of finite and indefinite-lived intangible assets Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block] Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Asset Class [Axis] Asset Class [Axis] Asset Class [Domain] Asset Class [Domain] Royalty Pharma Contingent Milestone Payments Royalty Pharma Contingent Milestone Payments [Member] Royalty Pharma Contingent Milestone Payments [Member] Measured on a recurring basis Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Contingent consideration Contingent Consideration Classified as Equity [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Royalty Pharma Contingent Milestone Payments Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract] Beginning balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Additions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases Foreign currency effect Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Effect Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Effect Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Ending balance Contingent Consideration Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Beginning balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Net realized (gains) losses Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Currency translation adjustments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Gain (Loss) Included in Other Comprehensive Income (Loss) Settlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Ending balance Schedule of New Accounting Pronouncements Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Derivative [Table] Derivative [Table] 5.30% Unsecured Senior Notes due November 15, 2043 Derivative [Line Items] Derivative [Line Items] Amount of gain (loss) recognized against earnings Derivative, Gain (Loss) on Derivative, Net Notional amount of derivatives Derivative, Notional Amount Amount expected to be reclassified out of AOCI during the next 12 months Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Income Tax Contingency [Table] Income Tax Contingency [Table] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Belgium Taxing Authority Belgium Taxing Authority [Member] Belgium Taxing Authority [Member] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Effective income tax rate reconciliation, percent Effective Income Tax Rate Reconciliation, Percent Income tax examination, penalties and interest expense Income Tax Examination, Penalties and Interest Expense Income tax benefit Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense (Benefit) Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense (Benefit) Tax expense in connection with Transition Toll Tax Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit) Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit) Foreign earnings Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Provisional Undistributed Accumulated Earnings of Foreign Subsidiary Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Provisional Undistributed Accumulated Earnings of Foreign Subsidiary Income tax expense for remeasurement of deferred tax assets Income Tax Expense, Continuing Operations, Adjustment of Deferred Tax Asset Income Tax Expense, Continuing Operations, Adjustment of Deferred Tax Asset Tax benefit for remeasurement of tax liabilities Income Tax Benefit, Continuing Operations, Adjustment of Deferred Tax Liability Income Tax Benefit, Continuing Operations, Adjustment of Deferred Tax Liability Damages sought by plaintiff Loss Contingency, Damages Sought, Value Foreign currency exchange rate, remeasurement Foreign Currency Exchange Rate, Remeasurement Fair Value, Assets Measured on Recurring and Nonrecurring Basis Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Reconciliation of Level 3 Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Carrying Values and Estimated Fair Values of Debt Instruments Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Schedule of derivative instruments in statement of financial position, fair value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Amount of Gain/(Loss) Recorded in OCI (Effective Portion) Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion) Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Amount of Gain/(Loss) Recognized in Earnings (Ineffective Portion) Schedule of hedge ineffectiveness [Table Text Block] Schedule of hedge ineffectiveness [Table Text Block] Amount of Gain/(Loss) Recognized against Earnings Derivatives Not Designated as Hedging Instruments [Table Text Block] Measurement Input Type [Axis] Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input Type [Domain] Measurement Input, Price Volatility Measurement Input, Price Volatility [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Royalty Pharma Royalty Pharma [Member] Royalty Pharma [Member] Specialty Sciences Specialty Sciences [Member] Specialty Sciences [Member] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Scenario, Forecast Scenario, Forecast [Member] Royalty Pharma 2018 Contingent Milestone Payments Royalty Pharma 2018 Contingent Milestone Payments [Member] Royalty Pharma 2018 Contingent Milestone Payments [Member] Royalty Pharma 2020 Contingent Milestone Payments Royalty Pharma 2020 Contingent Milestone Payments [Member] Royalty Pharma 2020 Contingent Milestone Payments [Member] Transfers among level 1, 2, and 3 Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount Sale price of divestiture - cash plus non-cash Sale price of divestiture - cash plus non-cash Sale price of divestiture - cash plus non-cash Cash proceeds from divestiture of businesses Proceeds from Divestiture of Businesses 2018 milestone payment Contingent Proceeds from Divestiture of Business, Milestone One, Maximum Contingent Proceeds from Divestiture of Business, Milestone One, Maximum 2020 milestone payment Contingent Proceeds from Divestiture of Business, Milestone Two, Maximum Contingent Proceeds from Divestiture of Business, Milestone Two, Maximum Gain related to Royalty Pharma Gain (Loss) on Disposition of Business Potential contingent milestone payments Volatility rate assumed Business Combination, Contingent Consideration, Liability, Measurement Input Rate of return Fair Value Assumptions, Rate of Return Fair Value Assumptions, Rate of Return Increase (decrease) in fair value of milestone payment Fair value adjustment Assets, Fair Value Adjustment Estimated fair valued contingent milestone payment Change in financial assets Net sales threshold for milestone payment Net Sales Threshold For Milestone Payment Net Sales Threshold For Milestone Payment Net gain on reduction of contingent consideration Gain (Loss) on Settlement of Contingent Consideration Gain (Loss) on Settlement of Contingent Consideration Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Zibo Xinhua Zibo Xinhua [Member] Zibo Xinhua [Member] Retained Earnings Retained Earnings [Member] Prepaid expenses and other current assets Other non-current assets Other Noncurrent Assets [Member] Other expense, net Other Expense (Income), Net [Member] Other Expense (Income), Net [Member] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Equity securities, fair value method Equity Securities, FV-NI Equity securities, fair value method, previous year Available-for-sale Securities, Equity Securities Equity securities, equity method, other non-current assets Equity Method Investments Equity securities, fair value method, other expense (income) Equity Securities, FV-NI, Gain (Loss) Equity securities, equity method, other expense (income) Income (Loss) from Equity Method Investments Reclassification from OCI Other Comprehensive Income (Loss), Net of Tax Reclassification to retained earnings Increase in investment in Zibo Xinhua Payments to Acquire Equity Method Investments Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] U.S. UNITED STATES Europe Europe [Member] All other countries Other Geographical Areas [Member] Other Geographical Areas [Member] Ireland IRELAND Revenue recognition Revenue from Contract with Customer [Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Type of Arrangement and Non-arrangement Transactions [Axis] Type of Arrangement and Non-arrangement Transactions [Axis] Arrangements and Non-arrangement Transactions [Domain] Arrangements and Non-arrangement Transactions [Domain] Merck Sharp & Dohme License Agreement Merck Sharp & Dohme License Agreement [Member] Merck Sharp & Dohme License Agreement [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Other Other [Member] Other [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Non-refundable upfront license fee Net proceeds from sale of business and other assets Impairment charge Impairment of Long-Lived Assets to be Disposed of Schedule of debt Schedule of Debt [Table Text Block] Schedule of extinguishment of debt Schedule of Extinguishment of Debt [Table Text Block] Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Contract with Customer Balances Contract with Customer, Asset and Liability [Table Text Block] Statement of Cash Flows [Abstract] Cash Flows From (For) Operating Activities Adjustments to derive cash flows Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Share-based compensation Share-based Compensation Impairment charges Change in financial assets Loss on extinguishment of debt Deferred income taxes Deferred Income Tax Expense (Benefit) Amortization of debt premium Amortization of Debt Discount (Premium) Other non-cash adjustments, net Other Operating Activities, Cash Flow Statement Subtotal Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities Increase (decrease) in cash due to: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Accounts payable Increase (Decrease) in Accounts Payable Payroll and related taxes Increase (Decrease) in Employee Related Liabilities Accrued customer programs Increase Decrease In Accrued Customer Programs The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables. Accrued liabilities Increase (Decrease) in Accrued Liabilities Other, net Subtotal Net cash from operating activities Cash Flows From (For) Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Proceeds from royalty rights Proceeds from Royalties Received Purchase of investment securities Payments to Acquire Marketable Securities Proceeds from sale of securities Proceeds from Sale of Available-for-sale Securities Additions to property, plant and equipment Payments to Acquire Property, Plant, and Equipment Proceeds from sale of the Tysabri® financial asset Payments for (Proceeds from) Investments Other investing, net Payments for (Proceeds from) Other Investing Activities Net cash from (for) investing activities Net Cash Provided by (Used in) Investing Activities Cash Flows From (For) Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Issuances of long-term debt Proceeds from Issuance of Long-term Debt Payments on long-term debt Repayments of Long-term Debt Borrowings (repayments) of revolving credit agreements and other financing, net Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less Deferred financing fees Payments of Financing Costs Premium on early debt retirement Payments of Debt Restructuring Costs Issuance of ordinary shares Proceeds from Issuance of Common Stock Repurchase of ordinary shares Payments for Repurchase of Common Stock Cash dividends Payments of Dividends Other financing, net Proceeds from (Payments for) Other Financing Activities Net cash (for) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Amount of Gain/(Loss) Recognized against Earnings Short-term contract assets Contract with Customer, Asset, Gross, Current Income taxes Income Tax Disclosure [Text Block] EX-101.PRE 12 prgo-20180630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 chart-5b1b5d21ffb5d7b8cee.jpg begin 644 chart-5b1b5d21ffb5d7b8cee.jpg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end GRAPHIC 14 chart-8daa610072d05bf4b00.jpg begin 644 chart-8daa610072d05bf4b00.jpg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end GRAPHIC 15 chart-858596d3ff9152e5903.jpg begin 644 chart-858596d3ff9152e5903.jpg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end GRAPHIC 16 chart-abb3553fa84bb6bc41e.jpg begin 644 chart-abb3553fa84bb6bc41e.jpg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end GRAPHIC 17 chart-c34d066938675ab5879.jpg begin 644 chart-c34d066938675ab5879.jpg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�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end GRAPHIC 18 chart-df60a6f56d095616beb.jpg begin 644 chart-df60a6f56d095616beb.jpg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end XML 19 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2018
Aug. 03, 2018
Document and Entity Information [Abstract]    
Entity registrant name PERRIGO CO PLC  
Entity central index key 0001585364  
Current calendar year end date --12-31  
Entity filer category Large Accelerated Filer  
Document type 10-Q  
Document period end date Jun. 30, 2018  
Document calendar year focus 2018  
Document calendar period focus Q2  
Amendment flag false  
Entity common stock, shares outstanding   136,832,585

XML 20 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Income Statement [Abstract]        
Net sales $ 1,186.4 [1] $ 1,237.9 $ 2,403.4 [1] $ 2,431.9
Cost of sales 715.4 733.3 1,439.7 1,463.0
Gross profit 471.0 504.6 963.7 968.9
Operating expenses        
Distribution 23.8 21.6 48.5 42.7
Research and development 91.9 42.6 130.3 82.3
Selling 155.2 155.6 316.5 310.6
Administration 96.8 98.2 204.5 203.6
Impairment charges 1.7 27.4 1.7 39.6
Restructuring charges 3.7 12.1 5.2 50.8
Other operating expense (income) 3.2 (1.7) 6.1 (38.0)
Total operating expenses 376.3 355.8 712.8 691.6
Operating income 94.7 148.8 250.9 277.3
Change in financial assets (0.6) 38.7 9.0 21.6
Interest expense, net 32.1 45.1 63.5 98.4
Other expense, net 7.9 6.1 12.1 2.5
Loss on extinguishment of debt 0.0 135.2 0.5 135.2
Income (loss) before income taxes 55.3 (76.3) 165.8 19.6
Income tax expense (benefit) 19.1 (6.7) 48.8 17.6
Net income (loss) $ 36.2 $ (69.6) $ 117.0 $ 2.0
Earnings (loss) per share        
Basic (in dollars per share) $ 0.26 $ (0.49) $ 0.84 $ 0.01
Diluted (in dollars per share) $ 0.26 $ (0.49) $ 0.84 $ 0.01
Weighted-average shares outstanding        
Basic (in shares) 138.1 143.3 139.5 143.3
Diluted (in shares) 138.7 143.3 140.0 143.6
Dividends declared per share (in dollars per share) $ 0.19 $ 0.16 $ 0.38 $ 0.32
[1] The net sales by geography is derived from the location of the entity that sells to a third party.
XML 21 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ 36.2 $ (69.6) $ 117.0 $ 2.0
Other comprehensive income (loss):        
Foreign currency translation adjustments (165.6) 154.7 (92.6) 220.1
Change in fair value of derivative financial instruments, net of tax (3.5) 6.9 (4.1) 8.5
Change in fair value of investment securities, net of tax 0.0 (4.8) 0.0 (16.3)
Change in post-retirement and pension liability, net of tax (0.2) 0.0 (0.4) 0.0
Other comprehensive income (loss), net of tax (169.3) 156.8 (97.1) 212.3
Comprehensive income (loss) $ (133.1) $ 87.2 $ 19.9 $ 214.3
XML 22 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Jun. 30, 2018
Dec. 31, 2017
Assets    
Cash and cash equivalents $ 526.5 $ 678.7
Accounts receivable, net of allowance for doubtful accounts of $6.5 and $6.2, respectively 1,129.8 1,130.8
Inventories 883.8 806.9
Prepaid expenses and other current assets 238.4 203.2
Total current assets 2,778.5 2,819.6
Property, plant and equipment, net 811.9 833.1
Goodwill and other indefinite-lived intangible assets 4,227.1 4,265.7
Other intangible assets, net 3,066.0 3,290.5
Non-current deferred income taxes 1.0 10.4
Other non-current assets 341.1 409.5
Total non-current assets 8,447.1 8,809.2
Total assets 11,225.6 11,628.8
Liabilities and Shareholders’ Equity    
Accounts payable 533.4 450.2
Payroll and related taxes 103.9 148.8
Accrued customer programs 451.9 419.7
Accrued liabilities 192.8 230.8
Accrued income taxes 57.9 116.1
Current indebtedness 197.7 70.4
Total current liabilities 1,537.6 1,436.0
Long-term debt, less current portion 3,085.3 3,270.8
Non-current deferred income taxes 290.8 321.9
Other non-current liabilities 414.6 429.5
Total non-current liabilities 3,790.7 4,022.2
Total liabilities 5,328.3 5,458.2
Controlling interest:    
Preferred shares, $0.0001 par value per share, 10 shares authorized 0.0 0.0
Ordinary shares, €0.001 par value per share, 10,000 shares authorized 7,594.3 7,892.9
Accumulated other comprehensive income 155.0 253.1
Retained earnings (accumulated deficit) (1,852.2) (1,975.5)
Total controlling interest 5,897.1 6,170.5
Noncontrolling interest 0.2 0.1
Total shareholders’ equity 5,897.3 6,170.6
Total liabilities and shareholders' equity 11,225.6 11,628.8
Commitments and contingencies - Refer to Note 13
Supplemental Disclosures of Balance Sheet Information    
Ordinary shares, issued (in shares) 137.6 140.8
Ordinary shares, outstanding (in shares) 137.6 140.8
XML 23 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (Parenthetical)
$ in Millions
Jun. 30, 2018
USD ($)
$ / shares
shares
Jun. 30, 2018
€ / shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2017
€ / shares
Statement of Financial Position [Abstract]        
Allowance for doubtful accounts | $ $ 6.5   $ 6.2  
Stockholders' Equity:        
Preferred shares, par value (in USD per share) | $ / shares $ 0.0001   $ 0.0001  
Preferred shares, authorized 10,000,000   10,000,000  
Ordinary shares, par value (in EUR per share) | € / shares   € 0.001   € 0.001
Ordinary shares, authorized 10,000,000,000   10,000,000,000  
XML 24 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Cash Flows From (For) Operating Activities    
Net income (loss) $ 117.0 $ 2.0
Adjustments to derive cash flows    
Depreciation and amortization 217.8 220.8
Share-based compensation 22.3 14.8
Impairment charges 1.7 39.6
Change in financial assets 9.0 21.6
Loss on extinguishment of debt 0.5 135.2
Restructuring charges 5.2 50.8
Deferred income taxes (14.2) (8.1)
Amortization of debt premium (3.7) (11.8)
Other non-cash adjustments, net 5.1 (20.6)
Subtotal 360.7 444.3
Increase (decrease) in cash due to:    
Accounts receivable (24.3) 51.8
Inventories (99.3) (4.6)
Accounts payable 89.2 (6.0)
Payroll and related taxes (48.4) (37.9)
Accrued customer programs 33.9 (13.8)
Accrued liabilities (30.4) (49.4)
Accrued income taxes (20.8) (85.8)
Other, net (5.9) (13.3)
Subtotal (106.0) (159.0)
Net cash from operating activities 254.7 285.3
Cash Flows From (For) Investing Activities    
Proceeds from royalty rights 10.3 85.7
Purchase of investment securities (7.5) 0.0
Proceeds from sale of securities 0.0 0.0
Additions to property, plant and equipment (33.3) (37.2)
Net proceeds from sale of business and other assets 1.3 37.2
Proceeds from sale of the Tysabri® financial asset 0.0 2,200.0
Other investing, net 0.0 (3.7)
Net cash from (for) investing activities (29.2) 2,282.0
Cash Flows From (For) Financing Activities    
Issuances of long-term debt 431.0 0.0
Payments on long-term debt (457.3) (2,229.1)
Borrowings (repayments) of revolving credit agreements and other financing, net (8.2) 0.0
Deferred financing fees (2.4) (4.0)
Premium on early debt retirement 0.0 (116.1)
Issuance of ordinary shares 0.0 0.2
Repurchase of ordinary shares (265.0) (58.2)
Cash dividends (52.8) (46.0)
Other financing, net (7.5) 4.7
Net cash (for) financing activities (362.2) (2,448.5)
Effect of exchange rate changes on cash and cash equivalents (15.5) 19.7
Net increase (decrease) in cash and cash equivalents (152.2) 138.5
Cash and cash equivalents, beginning of period 678.7 622.3
Cash and cash equivalents, end of period $ 526.5 $ 760.8
XML 25 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Summary of significant accounting policies
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

General Information

The Company

Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.

We are a leading global healthcare company, delivering value to our customers and consumers by providing Quality Affordable Healthcare Products®. Founded in 1887 as a packager of home remedies, we have built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. We believe we are one of the world's largest manufacturers of over-the-counter (“OTC”) healthcare products and suppliers of infant formulas for the store brand market. We are a leading provider of branded OTC products throughout Europe, and also a leading producer of generic pharmaceutical topical products such as creams, lotions, gels, and nasal sprays ("extended topical") prescription drugs. We are headquartered in Ireland, and sell our products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China.

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended December 31, 2017. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Recent Accounting Standard Pronouncements
    
Below are recent Accounting Standard Updates ("ASU") that we are still assessing to determine the effect on our Condensed Consolidated Financial Statements. We do not believe that any other recently issued accounting standards could have a material effect on our Condensed Consolidated Financial Statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.
Recently Issued Accounting Standards Not Yet Adopted
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
ASU 2016-02 Leases
 
This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. The guidance is required to be adopted using the modified retrospective approach. Early adoption is permitted.
 
January 1, 2019
 
We have completed our initial scoping reviews and assessment phase to identify our leasing processes and go-forward policy that will be impacted by the new standard. We are continuing the design phase of our new lease integration tool and expect our financial statement disclosures will be expanded to present additional details of our leasing arrangements. At this time, we are unable to reasonably estimate the expected increase in assets and liabilities on our Consolidated Balance Sheets or the impacts to our Consolidated Financial Statements upon adoption. We plan to adopt the amended guidance on the effective date, and we expect the right of use asset and corresponding liability will be material and require certain changes to our systems and processes.
ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
 
This guidance permits tax effects stranded in accumulated other comprehensive income as a result of tax reform to be reclassified to retained earnings. This reclassification is optional and will require additional disclosure regarding whether reclassification is elected or not.
 
January 1, 2019

 
We are currently evaluating the implications of adoption on our Consolidated Financial Statements.
ASU 2016-13 Measurement of Credit Losses on Financial Instruments
 
This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.
 
January 1, 2020
 
We are currently evaluating the implications of adoption on our Consolidated Financial Statements.
ASU 2017-04 Intangibles - Goodwill and Other Simplifying the Test for Goodwill
 
The objective of this update is to reduce the cost and complexity of subsequent goodwill accounting by simplifying the impairment test by removing the Step 2 requirement to perform a hypothetical purchase price allocation when the carrying value of a reporting unit exceeds its fair value. If a reporting unit’s carrying value exceeds its fair value, an entity would record an impairment charge based on that difference, limited to the amount of goodwill attributed to that reporting unit. The proposal would not change the guidance on completing Step 1 of the goodwill impairment test. The proposed guidance would be applied prospectively. Early adoption is permitted.
 
January 1, 2020
 
Upon adoption, this guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment. After adoption, a Step 1 failure will result in an immediate impairment charge based on the carrying value of the reporting unit. We plan to adopt the standard prospectively on the effective date.
XML 26 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition
 6 Months Ended
Jun. 30, 2018
Revenue from Contract with Customer [Abstract]  
Revenue recognition
REVENUE RECOGNITION

We adopted ASU 2014-09 Revenue from Contracts with Customers and its related amendments (collectively, "ASC 606"), as required, on January 1, 2018 using the modified retrospective method for all contracts not completed as of the adoption date. The reported results for the periods in 2018 reflect the application of ASC 606 while the results for the comparable reporting periods in 2017 were prepared under the guidance of Revenue Recognition ("ASC 605"). The adoption of ASC 606 represents a change in accounting principle that closely aligns revenue recognition with the transfer of control of our products and will provide enhanced disclosures of the nature, amount, timing, and uncertainty of revenues and cash flows arising from contracts with customers. In accordance with ASC 606, revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration to which we expect to be entitled to receive in exchange for these products.

Product Revenue

We generally recognize product revenue for our contract performance obligations at a point in time, typically upon shipment or delivery of products to customers. For point in time customers for which control transfers on delivery to the customer due to free on board destination terms (“FOB”), an adjustment is recorded to defer revenue recognition over an estimate of days until control transfers at the point of delivery. Where we recognize revenue at a point in time, the transfer of title is the primary indicator that control has transferred. In other limited instances, primarily relating to those contracts that relate to contract manufacturing performed for our customers and certain store branded products, control transfers as the product is manufactured. Control is deemed to transfer over time for these contracts as the product does not have an alternative use and we have a contractual right to payment for performance completed to date. Revenue for contract manufacturing contracts is recognized over the transfer period using an input method that measures progress towards completion of the performance obligation as costs are incurred. For store branded product revenue recognized over time, an output method is used to recognize revenue when production of a unit is completed because product customization occurs when the product is packaged as a finished good under the store brand label of the customer.

Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of chargebacks, rebates, sales returns, shelf stock allowances, administrative fees and other incentive programs. Certain of these accruals and allowances are recorded in the balance sheet as current liabilities and others are recorded as a reduction in accounts receivable. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect the best estimates of the amount of consideration to which we are entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known.

Other Revenue Policies

We receive payments from our customers based on billing schedules established in each contract. Amounts are recorded as accounts receivable when our right to consideration is unconditional. In most cases, the timing of the unconditional right to payment aligns with shipment or delivery of the product and the recognition of revenue; however, for those customers where revenue is recognized at a time prior to shipment or delivery due to over time revenue recognition, a contract asset is recorded and is reclassified to an accounts receivable when it becomes unconditional under the contract upon shipment or delivery to the customer.

We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised products to the customer will be one year or less, which is the case with substantially all customers.

Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenue.  

Shipping and handling costs billed to customers are included in Net sales. Conversely, shipping and handling expenses we incur are included in Cost of sales.

Disaggregation of Revenue

We generated net sales in the following geographic locations(1) (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
June 30,
2018
U.S.
$
772.3

 
$
1,558.7

Europe(2)
344.3

 
706.2

All other countries(3)
69.8

 
138.5

 
$
1,186.4

 
$
2,403.4


(1) The net sales by geography is derived from the location of the entity that sells to a third party.
(2) Includes Ireland net sales of $5.0 million and $10.4 million for the three and six months ended June 30, 2018, respectively.
(3) Includes net sales generated primarily in Israel, Mexico, Australia and Canada.

The following is a summary of our net sales by category (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
June 30,
2018
CHCA
 
 
 
Cough/Cold/Allergy/Sinus(1)
$
109.3

 
$
250.8

Infant Nutritionals
109.2

 
212.6

Gastrointestinal(1)
103.0

 
195.2

Analgesics(1)
92.2

 
185.9

Smoking Cessation
71.2

 
137.1

Animal Health
31.9

 
58.2

Vitamins, Minerals and Dietary Supplements(1)
4.3

 
7.3

Other CHCA(1),(2)
75.7

 
151.3

Total CHCA
596.8

 
1,198.4

CHCI
 
 
 
Lifestyle
86.1

 
175.8

Cough, Cold, and Allergy
84.7

 
183.4

Personal Care and Derma-Therapeutics
79.7

 
155.3

Anti-Parasite
30.4

 
58.5

Natural Health and Vitamins, Minerals and Dietary Supplements
27.9

 
61.1

Other CHCI(3)
72.2

 
148.3

Total CHCI
381.0

 
782.4

Total RX
208.6

 
422.6

Total net sales
$
1,186.4

 
$
2,403.4


(1)    Includes net sales from our OTC contract manufacturing business.
(2) 
Consists primarily of branded OTC, diabetic care, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.
(3) 
Consists primarily of liquid licensed products, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.

While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized on an over time basis. Predominately, over time customer contracts exist in contract manufacturing arrangements, which occur in both the Consumer Healthcare Americas ("CHCA") and Consumer Healthcare International ("CHCI") segments. Contract manufacturing revenue was $77.1 million and $146.5 million for the three and six months ended June 30, 2018, respectively.

We also recognized a portion of the store brand OTC product revenues in the CHCA segment on an over time basis; however, the timing between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery.

Contract Balances

The following table provides information about contract assets from contracts with customers (in millions):
 
Balance Sheet Location
 
January 1,
2018
 
June 30,
2018
Short-term contract assets
Prepaid expenses and other current assets
 
$
20.5

 
$
19.2



Impact on financial statements

Condensed Consolidated Statements of Operations

Net sales and Cost of sales were lower in the three and six months ended June 30, 2018 as a result of adopting ASC 606 due to net sales from contract manufacturing and certain OTC product sales being recognized on an over time basis as the performance obligation was satisfied, compared to the previous revenue recognition under ASC 605, which would have occurred when the product was shipped or delivered. This has resulted in the recognition of a contract asset.
 
Three Months Ended
 
Six Months Ended
 
June 30, 2018
 
June 30, 2018
(in millions, except per share amounts)
As reported
 
Adjustments
 
Before adoption of ASC 606
 
As reported
 
Adjustments
 
Before adoption of ASC 606
Net sales
$
1,186.4

 
$
6.9

 
$
1,193.3

 
$
2,403.4

 
$
1.3

 
$
2,404.7

Cost of sales
715.4

 
4.2

 
719.6

 
1,439.7

 
1.1

 
1,440.8

Gross profit
471.0

 
2.7

 
473.7

 
963.7

 
0.2

 
963.9

 
 
 
 
 
 
 
 
 
 
 
 
Operating income
94.7

 
2.7

 
97.4

 
250.9

 
0.2

 
251.1

 
 
 
 
 
 
 
 
 
 
 
 
Income tax expense (benefit)
19.1

 
(0.1
)
 
19.0

 
48.8

 
(0.1
)
 
48.7

Net income
$
36.2

 
$
2.8

 
$
39.0

 
$
117.0

 
$
0.3

 
$
117.3

 
 
 
 
 
 
 
 
 
 
 
 
Earnings per share
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.26

 
$
0.02

 
$
0.28

 
$
0.84

 
$
—

 
$
0.84

Diluted
$
0.26

 
$
0.02

 
$
0.28

 
$
0.84

 
$
—

 
$
0.84



Condensed Consolidated Statements of Comprehensive Income (Loss)
 
Three Months Ended
 
Six Months Ended
 
June 30, 2018
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
 
As reported
 
Adjustments
 
Before adoption of ASC 606
Net income
$
36.2

 
$
2.8

 
$
39.0

 
$
117.0

 
$
0.3

 
$
117.3

Comprehensive income (loss)
$
(133.1
)
 
$
2.8

 
$
(130.3
)
 
$
19.9

 
$
0.3

 
$
20.2



Condensed Consolidated Balance Sheet
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
Assets
 
 
 
 
 
Inventories
$
883.8

 
$
13.7

 
$
897.5

Prepaid expenses and other current assets
238.4

 
(19.2
)
 
219.2

Total current assets
2,778.5

 
(5.5
)
 
2,773.0

Total assets
$
11,225.6

 
$
(5.5
)
 
$
11,220.1

Liabilities and Shareholders’ Equity
 
 
 
 
 
Other non-current liabilities
$
414.6

 
$
(0.4
)
 
$
414.2

Total non-current liabilities
3,790.7

 
(0.4
)
 
3,790.3

Total liabilities
5,328.3

 
(0.4
)
 
5,327.9

Shareholders’ equity
 
 
 
 
 
Controlling interest:
 
 
 
 
 
Accumulated deficit
(1,852.2
)
 
(5.1
)
 
(1,857.3
)
Total controlling interest
5,897.1

 
(5.1
)
 
5,892.0

Total shareholders’ equity
5,897.3

 
(5.1
)
 
5,892.2

Total liabilities and shareholders' equity
$
11,225.6

 
$
(5.5
)
 
$
11,220.1



Condensed Consolidated Statement of Cash Flows
 
Six Months Ended
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
Cash Flows From (For) Operating Activities
 
 
 
 
 
Net income
$
117.0

 
$
0.3

 
$
117.3

(Decreases) in cash due to:
 
 
 
 
 
Inventories
(99.3
)
 
1.1

 
(98.2
)
Accrued income taxes
(20.8
)
 
(0.1
)
 
(20.9
)
Other, net
(5.9
)
 
(1.3
)
 
(7.2
)
Subtotal
(106.0
)
 
(0.3
)
 
(106.3
)
Net cash from operating activities
$
254.7

 
$
—

 
$
254.7
XML 27 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisitions and Divestitures
 6 Months Ended
Jun. 30, 2018
Business Combinations [Abstract]  
Acquisitions and divestitures
ACQUISITIONS AND DIVESTITURES

Acquisitions during the six months ended June 30, 2018

Nasonex-branded products

On May 29, 2018, we entered into a license agreement with Merck Sharp & Dohme Corp. ("Merck") allowing us to develop and commercialize an OTC version of Nasonex-branded products containing the compound, mometasone furoate monohydrate. The acquisition was accounted for as an asset acquisition based on our assessment that substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset to be used for research and development. In accordance with Accounting Standards Codification Topic 730 Research and Development ("ASC 730"), the non-refundable upfront license fee of $50.0 million was recorded in Research and development ("R&D") expense in our CHCA segment because the intangible research and development asset acquired has no alternative use. The agreement requires us to make contingent payments if we obtain regulatory approval and achieve certain sales milestones. We will also be obligated to make royalty payments on potential future sales. The contingent consideration will be included in the measurement of the cost of the asset when the contingency is resolved, and the consideration is paid or becomes payable. Consideration paid after U.S. Food and Drug Administration ("FDA") approval will be capitalized and amortized to cost of goods sold over the economic life of each product.
Divestitures during the six months ended July 1, 2017

On January 3, 2017, we sold certain Abbreviated New Drug Applications ("ANDAs") for $15.0 million to a third party, which was recorded as a gain in Other operating expense (income) on the Condensed Consolidated Statements of Operations in our Prescription Pharmaceuticals ("RX") segment.

On February 1, 2017, we completed the sale of the animal health pet treats plant fixed assets within our CHCA segment, which were previously classified as held-for sale. We received $7.7 million in proceeds, which resulted in an immaterial loss.

On April 6, 2017, we completed the sale of our India Active Pharmaceuticals Ingredient ("API") business to Strides Shasun Limited. We received $22.2 million of proceeds, inclusive of an estimated working capital adjustment, which resulted in an immaterial gain recorded in our legacy Other segment. Prior to closing the sale, we determined that the carrying value of the India API business exceeded its fair value less the cost to sell, resulting in an impairment charge of $35.3 million, which was recorded in Impairment charges on the Condensed Consolidated Statements of Operations for the year ended December 31, 2016.
XML 28 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Other Intangible Assets
 6 Months Ended
Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets
GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):
 
 
December 31,
2017
 
Currency translation adjustments
 
June 30,
2018
CHCA
 
$
1,847.4

 
$
(2.0
)
 
$
1,845.4

CHCI
 
1,205.7

 
(30.6
)
 
1,175.1

RX
 
1,122.3

 
(5.3
)
 
1,117.0

Total goodwill
 
$
4,175.4

 
$
(37.9
)
 
$
4,137.5



Animal Health

Following a prior indication of potential impairment during the three months ended December 31, 2017, the animal health reporting unit had an additional indication of potential impairment during the three month ended June 30, 2018 due to its year-to-date financial results failing to meet performance expectations. We performed an impairment test as of June 30, 2018 and determined the fair value of the animal health reporting unit exceeded its net book value and therefore, no impairment was recorded as of the three months ended June 30, 2018.

Intangible Assets

Other intangible assets and related accumulated amortization consisted of the following (in millions):
 
June 30, 2018
 
December 31, 2017
 
Gross
 
Accumulated Amortization
 
Gross
 
Accumulated Amortization
Definite-lived intangibles:
 
 
 
 
 
 
 
Distribution and license agreements and supply agreements
$
310.0

 
$
188.3

 
$
311.2

 
$
169.8

Developed product technology, formulations, and product rights
1,349.8

 
647.0

 
1,358.4

 
598.7

Customer relationships and distribution networks
1,608.7

 
513.2

 
1,642.0

 
460.6

Trademarks, trade names, and brands
1,304.3

 
159.8

 
1,335.4

 
129.5

Non-compete agreements
14.5

 
13.0

 
14.7

 
12.6

Total definite-lived intangibles
$
4,587.3

 
$
1,521.3

 
$
4,661.7

 
$
1,371.2

Indefinite-lived intangibles:
 
 
 
 
 
 
 
Trademarks, trade names, and brands
$
51.7

 
$
—

 
$
52.1

 
$
—

In-process research and development
37.9

 
—

 
38.2

 
—

Total indefinite-lived intangibles
89.6

 
—

 
90.3

 
—

Total other intangible assets
$
4,676.9

 
$
1,521.3

 
$
4,752.0

 
$
1,371.2



We recorded amortization expense of $85.3 million and $172.4 million for the three and six months ended June 30, 2018, respectively, and $87.2 million and $172.8 million for the three and six months ended July 1, 2017, respectively.

We recorded an impairment charge of $12.2 million on certain In-process Research and Development ("IPR&D") assets, primarily in our RX segment, during the three months ended April 1, 2017 due to changes in the projected development and regulatory timelines for various projects. In addition, we recorded a decrease in the contingent consideration liability associated with certain IPR&D assets in Other operating expense (income) on the Condensed Consolidated Statements of Operations (refer to Note 6).

During the three months ended July 1, 2017, we identified impairment indicators for our Lumara Health, Inc. product assets. The primary impairment indicators included the decline in our 2017 performance expectations and a reduction in our long-range revenue growth forecast. As part of our assessment, we utilized the multi-period excess earnings method to determine fair value. This resulted in an impairment charge of $18.5 million in Impairment charges on the Condensed Consolidated Statements of Operations within our RX segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value.
XML 29 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventories
 6 Months Ended
Jun. 30, 2018
Inventory Disclosure [Abstract]  
Inventories
INVENTORIES

Major components of inventory were as follows (in millions):
 
 
June 30,
2018
 
December 31,
2017
Finished goods
$
485.7

 
$
454.3

Work in process
175.6

 
152.8

Raw materials
222.5

 
199.8

Total inventories
$
883.8

 
$
806.9
XML 30 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements
 6 Months Ended
Jun. 30, 2018
Fair Value Disclosures [Abstract]  
Fair value measurements
FAIR VALUE MEASUREMENTS

The following table summarizes the valuation of our financial instruments carried at fair value and measured at fair value on a recurring and non-recurring basis by the above pricing categories (in millions):
 
 
June 30, 2018
 
December 31, 2017
 
 
Level 1
 
Level 2
 
Level 3
 
Level 1
 
Level 2
 
Level 3
Measured at fair value on a recurring basis:
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Investment securities
 
$
8.1

 
$
—

 
$
—

 
$
17.0

 
$
—

 
$
—

Foreign currency forward contracts
 
—

 
2.7

 
—

 
—

 
6.3

 
—

Funds associated with Israeli severance liability
 
—

 
14.2

 
—

 
—

 
16.3

 
—

Royalty Pharma contingent milestone payments
 
—

 
—

 
125.5

 
—

 
—

 
134.5

Total assets
 
$
8.1

 
$
16.9

 
$
125.5

 
$
17.0

 
$
22.6

 
$
134.5

 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
—

 
$
9.1

 
$
—

 
$
—

 
$
3.8

 
$
—

Contingent consideration
 
—

 
—

 
16.2

 
—

 
—

 
22.0

Total liabilities
 
$
—

 
$
9.1

 
$
16.2

 
$
—

 
$
3.8

 
$
22.0

 
 
 
 
 
 
 
 
 
 
 
 
 
Measured at fair value on a non-recurring basis:
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Definite-lived intangible assets
 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
11.5



There were no transfers among Level 1, 2, and 3 during the three and six months ended June 30, 2018 or the year ended December 31, 2017.

Financial Assets

On March 27, 2017, we announced the completed divestment of our Tysabri® financial asset to Royalty Pharma for up to $2.85 billion, consisting of $2.2 billion in cash and $250.0 million and $400.0 million in milestone payments if the royalties on global net sales of Tysabri® that are received by Royalty Pharma meet specific thresholds in 2018 and 2020, respectively. As a result of this transaction, we transferred the entire financial asset to Royalty Pharma and recorded a $17.1 million gain during the three months ended April 1, 2017. We elected to account for the contingent milestone payments using the fair value option method, and these were recorded at an estimated fair value of $184.5 million as of April 1, 2017. We chose the fair value option as we believe it will help investors understand the potential future cash flows we may receive associated with the two contingent milestones.

Royalty Pharma Contingent Milestone Payments

We valued our contingent milestone payments from Royalty Pharma using a modified Black-Scholes Option Pricing Model ("BSOPM"). Key inputs in the BSOPM are the estimated volatility and rate of return of royalties on global net sales of Tysabri® that are received by Royalty Pharma until the contingent milestones are resolved. Volatility and the estimated fair value of the milestones have a positive relationship such that higher volatility translates to a higher estimated fair value of the contingent milestone payments. In the valuation of contingent milestone payments performed, we assumed volatility of 30.0% for each of June 30, 2018 and July 1, 2017, and a rate of return of 8.09% and 8.05% as of June 30, 2018 and July 1, 2017, respectively. We assess volatility and rate of return inputs quarterly by analyzing certain market volatility benchmarks and the risk associated with Royalty Pharma achieving the underlying projected royalties.

The fair value of the Royalty Pharma contingent milestone payments increased by $0.6 million during the three months ended June 30, 2018. This increase included a $2.9 million decrease in the fair value of the 2018 contingent milestone payment, more than offset by a $3.5 million increase in the fair value of the 2020 contingent milestone payment. During the six months ended June 30, 2018, the fair value of the contingent milestone payments decreased by $9.0 million. The net changes in the fair value of the contingent milestone payments were due to the fluctuation of the projected global net sales of Tysabri®. Global net sales of Tysabri® are being impacted by competition, namely the launch of Ocrevus® in the U.S. and European markets in 2017 and 2018, respectively.

The fair value of the Royalty Pharma contingent milestone payments decreased $39.2 million in each of the three and six months ended July 1, 2017 as a result of a decrease in the estimated Tysabri® revenues due to the launch of Ocrevus® in the U.S. market late in the first quarter of 2017.

Payment of the contingent milestone payments is dependent on actual global net sales of Tysabri® in 2018 and 2020. Of the $125.5 million of estimated fair value contingent milestone payments as of June 30, 2018, $65.3 million and $60.2 million relates to the 2018 and 2020 contingent milestone payments, respectively. If Tysabri® global net sales do not meet the prescribed threshold in 2018, we will write off the $65.3 million asset as an expense. If the prescribed threshold is exceeded, we will increase the asset to $250.0 million and recognize income of $184.7 million in Change in financial assets on the Condensed Consolidated Statements of Operations. If Tysabri® global net sales do not meet the prescribed threshold in 2020, we will write off the $60.2 million asset as an expense. If the prescribed threshold is exceeded, we will increase the asset to $400.0 million and recognize income of $339.8 million in Change in financial assets on the Condensed Consolidated Statements of Operations.

Global Tysabri® net sales need to exceed $1.85 billion and $1.95 billion in 2018 and 2020, respectively, in order for Royalty Pharma to receive the level of royalties needed to trigger the milestone payments owed to us.

The table below presents a reconciliation for the Royalty Pharma contingent milestone payments measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Change in fair value in the table was recorded in Change in financial assets on the Condensed Consolidated Statements of Operations.
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Royalty Pharma Contingent Milestone Payments
 
 
 
 
 
 
 
Beginning balance
$
124.9

 
$
184.5

 
$
134.5

 
$
—

Additions
—

 
—

 
—

 
184.5

Foreign currency effect
—

 
0.5

 
—

 
0.5

Change in fair value
0.6

 
(39.2
)
 
(9.0
)
 
(39.2
)
Ending balance
$
125.5

 
$
145.8

 
$
125.5

 
$
145.8



Contingent Consideration

Contingent consideration represents milestone payment obligations obtained through product acquisitions, which are valued using estimates based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The estimates are updated quarterly and the liabilities are adjusted to fair value depending on a number of assumptions, including the competitive landscape and regulatory approvals that may impact the future sales of a product. We reduced a contingent consideration liability associated with certain IPR&D assets (refer to Note 4) and recorded a corresponding gain of $15.6 million during the six months ended July 1, 2017. The liability decrease related to a reduction of the probability of achievement assumptions and anticipated cash flows.
The table below presents a reconciliation for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Net realized losses in the table were recorded in Other operating expense (income) on the Condensed Consolidated Statements of Operations.
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Contingent Consideration
 
 
 
 
 
 
 
Beginning balance
$
18.1

 
$
52.0

 
$
22.0

 
$
69.9

Net realized (gains) losses
(1.8
)
 
(1.3
)
 
(1.4
)
 
(15.6
)
Currency translation adjustments
(0.1
)
 
1.4

 
—

 
1.3

Settlements
—

 
(2.4
)
 
(4.4
)
 
(5.9
)
Ending balance
$
16.2

 
$
49.7

 
$
16.2

 
$
49.7



Fixed Rate Long-term Debt    

Our fixed rate long-term debt consisted of public bonds, a retail bond and a private placement note as follows (in millions):
 
June 30, 2018
 
December 31, 2017
 
Level 1
 
Level 2
 
Level 1
 
Level 2
Public Bonds
 
 
 
 
 
 
 
Carrying Value (excluding discount)
$
2,600.0

 
 
 
$
2,600.0

 
 
Fair value
$
2,525.9

 
 
 
$
2,650.8

 
 
 
 
 
 
 
 
 
 
Retail bond and private placement note
 
 
 
 
 
 
 
Carrying value (excluding premium)
 
 
$
298.0

 
 
 
$
306.0

Fair value
 
 
$
326.7

 
 
 
$
342.1



The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our retail bond and private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities.

The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and variable rate long-term debt, approximate their fair value.
XML 31 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments
 6 Months Ended
Jun. 30, 2018
Investments [Abstract]  
Investments
INVESTMENTS

The following table summarizes our equity security measurement category, balance sheet location, and balances (in millions):
Measurement Category
 
Balance Sheet Location
 
June 30,
2018
 
December 31,
2017(2)
Fair value method
 
Prepaid expenses and other current assets
 
$
8.1

 
$
17.0

Fair value method(1)
 
Other non-current assets
 
$
4.6

 
$
6.3

Equity method
 
Other non-current assets
 
$
13.1

 
$
4.9


(1) The June 30, 2018 equity securities are measured at fair value using the Net Asset Value practical expedient.
(2) The December 31, 2017 balances presented reflect historical recognition and measurement investment categories existing prior to the adoption of ASU 2016-01, which include available for sale and cost method securities.

The following table summarizes our equity security expense (income) recognized in earnings (in millions):
 
 
 
 
Three Months Ended
 
Six Months Ended
Measurement Category
 
Income Statement Location
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Fair value method
 
Other expense, net
 
$
6.3

 
$
—

 
$
10.6

 
$
—

Equity method
 
Other expense, net
 
$
(0.9
)
 
$
(0.2
)
 
$
(0.7
)
 
$
(0.3
)


On January 1, 2018, as a result of the adoption of ASU 2016-01, we made a $1.0 million cumulative-effect adjustment to Retained earnings (accumulated deficit) net of tax that consisted of net unrealized losses on previously classified available for sale securities from Other comprehensive income ("OCI").

During the three months ended June 30, 2018, Perrigo Asia Holding Company Limited increased its investment in Zibo Xinhua - Perrigo Pharmaceutical Company Limited by $7.5 million.
XML 32 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Instruments and Hedging Activities
 6 Months Ended
Jun. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative instruments and hedging activities
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

     All of our designated derivatives were classified as cash flow hedges as of June 30, 2018 and December 31, 2017.

Interest Rate Swaps

During the three months ended July 1, 2017, we repaid $584.4 million of senior notes with an interest rate of 4.000% due 2023 and $309.5 million of senior notes with an interest rate of 5.300% due 2043 (refer to Note 9). As a result of these senior note repayments, the proportionate amount remaining in OCI related to the pre-issuance hedge was reclassified to earnings. Accordingly, we recorded a loss of $5.9 million in Other expense, net, during the three months ended July 1, 2017 for the amount remaining in OCI.

Foreign Currency Forward Contracts

The total notional amount for our foreign currency forward contracts was $594.2 million and $592.3 million as of June 30, 2018 and December 31, 2017, respectively.

Effects of Derivatives on the Financial Statements
    
The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects and are presented in millions.

The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:
 
Asset Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
June 30,
2018
 
December 31,
2017
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Prepaid expenses and other current assets
 
$
2.1

 
$
4.1

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Prepaid expenses and other current assets
 
$
0.6

 
$
2.2

 
Liability Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
June 30,
2018
 
December 31,
2017
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
5.0

 
$
1.4

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
4.1

 
$
2.4



The gains (losses) recorded in OCI for the effective portion of our designated cash flow hedges were as follows:
 
 
Amount of Gain/(Loss) Recorded in OCI
(Effective Portion)
 
 
Three Months Ended
 
Six Months Ended
Designated Cash Flow Hedges
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Foreign currency forward contracts
 
$
(4.3
)
 
$
2.7

 
$
(4.3
)
 
$
5.2



The gains (losses) reclassified from Accumulated other comprehensive income ("AOCI") into earnings for the effective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Reclassified from AOCI into Earnings
(Effective Portion)
 
 
 
 
Three Months Ended
 
Six Months Ended
Designated Cash Flow Hedges
 
Income Statement Location
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Interest rate swap agreements
 
Interest expense, net
 
$
(0.4
)
 
$
(0.6
)
 
$
(0.9
)
 
$
(1.3
)
 
 
Other expense, net
 
—

 
(5.9
)
 
—

 
(5.9
)
Foreign currency forward contracts
 
Net sales
 
—

 
0.6

 
—

 
0.9

 
 
Cost of sales
 
1.6

 
0.9

 
3.9

 
1.6

 
 
Interest expense, net
 
(1.1
)
 
(0.5
)
 
(2.0
)
 
(1.1
)
 
 
Other expense, net
 
(0.1
)
 
—

 
(0.5
)
 
(0.5
)
Total
 
 
 
$
—

 
$
(5.5
)
 
$
0.5

 
$
(6.3
)


The net of tax amount expected to be reclassified out of AOCI into earnings during the next 12 months is a $5.2 million loss.

The gains (losses) recognized in earnings for the ineffective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized in Earnings
(Ineffective Portion)
 
 
 
 
Three Months Ended
 
Six Months Ended
Designated Cash Flow Hedges
 
Income Statement
Location
 
July 1,
2017
 
July 1,
2017
Foreign currency forward contracts
 
Other expense, net
 
$
0.1

 
$
1.0



The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized against Earnings
 
 
 
 
Three Months Ended
 
Six Months Ended
Non-Designated Derivatives
 
Income Statement Location
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Foreign currency forward contracts
 
Other expense, net
 
$
11.8

 
$
(5.0
)
 
$
8.6

 
$
(13.9
)
 
 
Interest expense, net
 
0.2

 
(0.7
)
 
(0.7
)
 
(1.1
)
Total
 
 
 
$
12.0

 
$
(5.7
)
 
$
7.9

 
$
(15.0
)
XML 33 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Indebtedness
 6 Months Ended
Jun. 30, 2018
Debt Disclosure [Abstract]  
Indebtedness
INDEBTEDNESS

Total borrowings outstanding are summarized as follows (in millions):
 
 
 
 
 
June 30,
2018
 
December 31,
2017
Term loans
 
 
 
 
 
 
2018 Term loan due March 8, 2020(1)
 
 
$
383.5

 
$
—

 
2014 Term loan due December 5, 2019(1)
 
 
—

 
420.0

 
Total term loans
 
 
383.5

 
420.0

Notes and Bonds
 
 
 
 
 
 
Coupon
Due
 
 
 
 
 
 
5.000%
May 23, 2019(1)
 
 
140.2

 
144.0

 
3.500%
March 15, 2021
 
 
280.4

 
280.4

 
3.500%
December 15, 2021
 
 
309.6

 
309.6

 
5.105%
July 19, 2023(1)
 
 
157.8

 
162.0

 
4.000%
November 15, 2023
 
 
215.6

 
215.6

 
3.900%
December 15, 2024
 
 
700.0

 
700.0

 
4.375%
March 15, 2026
 
 
700.0

 
700.0

 
5.300%
November 15, 2043
 
 
90.5

 
90.5

 
4.900%
December 15, 2044
 
 
303.9

 
303.9

 
Total notes and bonds
 
 
2,898.0

 
2,906.0

Other financing
3.0

 
11.7

Unamortized premium (discount), net
16.6

 
21.4

Deferred financing fees
(18.1
)
 
(17.9
)
Total borrowings outstanding
3,283.0

 
3,341.2

 
Current indebtedness
(197.7
)
 
(70.4
)
Total long-term debt less current portion
$
3,085.3

 
$
3,270.8



(1) 
Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.
    
We are in compliance with all covenants under our debt agreements as of June 30, 2018.

Revolving Credit Agreements

On December 5, 2014, Perrigo Finance entered into a $600.0 million revolving credit agreement, which increased to $1.0 billion on March 30, 2015 (the "2014 Revolver"). On March 8, 2018, we terminated the 2014 Revolver and entered into a $1.0 billion revolving credit agreement maturing on March 8, 2023 (the "2018 Revolver"). There were no borrowings outstanding under the 2018 Revolver as of June 30, 2018 or under the 2014 Revolver as of December 31, 2017.

Term Loans

On December 5, 2014, Perrigo Finance entered into a term loan agreement consisting of a €500.0 million ($614.3 million) tranche, maturing December 5, 2019. On March 8, 2018, we refinanced the €350.0 million outstanding under the term loan with the proceeds of a new €350.0 million ($431.0 million) term loan, maturing March 8, 2020. In addition, as a result of the refinancing during the three months ended March 31, 2018, we recorded a loss of $0.5 million, consisting of the write-off of deferred financing fees in Loss on extinguishment of debt on the Condensed Consolidated Statements of Operations. During the six months ended June 30, 2018, we made $26.3 million in scheduled principal payments.

Other Financing

Overdraft Facilities

We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in the above table under "Other financing". There were no borrowings outstanding at June 30, 2018. The balance outstanding under the overdraft facilities was $6.9 million at December 31, 2017.

Debt Extinguishment

As a result of early redemption and tender offer transactions during the three months ended July 1, 2017, we recorded a loss of $135.2 million in Loss on extinguishment of debt on our Condensed Consolidated Statements of Operations (in millions):
Premium on debt repayment
 
$
116.1

Transaction costs
 
3.8

Write-off of deferred financing fees
 
10.6

Write-off of remaining discount on bond
 
4.7

Total loss on extinguishment of debt
 
$
135.2
XML 34 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share and Shareholders' Equity
 6 Months Ended
Jun. 30, 2018
Earnings Per Share [Abstract]  
Earnings per share and shareholders' equity
EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY

Earnings per Share

A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Numerator:
 
 
 
 
 
 
 
Net income (loss)
$
36.2

 
$
(69.6
)
 
$
117.0

 
$
2.0

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding for basic EPS
138.1

 
143.3

 
139.5

 
143.3

Dilutive effect of share-based awards*
0.6

 
—

 
0.5

 
0.3

Weighted average shares outstanding for diluted EPS
138.7

 
143.3

 
140.0

 
143.6

 
 
 
 
 
 
 
 
Anti-dilutive share-based awards excluded from computation of diluted EPS
1.7

 
—

 
0.9

 
0.8



* In the period of a net loss, diluted shares equal basic shares.

Shareholders' Equity

Shares

We issued shares related to the exercise and vesting of share-based compensation as follows:
Three Months Ended
 
Six Months Ended
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
74,000

 
31,900

 
127,000

 
46,400



Share Repurchases

In October 2015, the Board of Directors approved a three-year share repurchase plan of up to $2.0 billion. During the three and six months ended June 30, 2018, we repurchased 2.0 million and 3.3 million ordinary shares at an average repurchase price of $79.42 and $80.42 per share, for a total of $156.9 million and $265.0 million, respectively. During the three and six months ended July 1, 2017, we repurchased 812,184 ordinary shares at an average repurchase price of $71.67 per share, for a total of $58.2 million.
XML 35 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Accumulated Other Comprehensive Income (Loss)
 6 Months Ended
Jun. 30, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated other comprehensive income (loss)
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Changes in our AOCI balances, net of tax were as follows (in millions):
 
Fair value of derivative financial instruments, net of tax
 
Foreign currency translation adjustments
 
Fair value of investment securities, net of tax
 
Post-retirement and pension liability adjustments, net of tax
 
Total AOCI
Balance at December 31, 2017
$
(9.8
)
 
$
260.6

 
$
1.0

 
$
1.3

 
$
253.1

ASU 2016-01 adoption impact
—

 
—

 
(1.0
)
 
—

 
(1.0
)
Balance at December 31, 2017 after adoption impact
$
(9.8
)
 
$
260.6


$
—


$
1.3


$
252.1

OCI before reclassifications
(3.6
)
 
(92.6
)
 
—

 
(0.4
)
 
(96.6
)
Amounts reclassified from AOCI
(0.5
)
 
—

 
—

 
—

 
(0.5
)
Other comprehensive income
$
(4.1
)
 
$
(92.6
)
 
$
—

 
$
(0.4
)
 
$
(97.1
)
Balance at June 30, 2018
$
(13.9
)
 
$
168.0

 
$
—

 
$
0.9

 
$
155.0
XML 36 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes
 6 Months Ended
Jun. 30, 2018
Income Tax Disclosure [Abstract]  
Income taxes
INCOME TAXES

The effective tax rates were as follows:
Three Months Ended
 
Six Months Ended
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
34.5
%
 
8.7
%
 
29.4
%
 
89.9
%


The effective tax rate for the three months ended June 30, 2018 increased in comparison to the prior period due primarily to additional valuation allowances against deferred taxes and uncertain tax positions recorded in foreign jurisdictions. The effective tax rate for the six months ended June 30, 2018 decreased in comparison to the prior period due primarily to the negative impacts of non-deductible fees related to debt cancellation in the prior period.

Our tax rate is subject to adjustment over the balance of the calendar year due to, among other things, the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments based on differing interpretations of the applicable transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; and expiration of or the inability to renew tax rulings or tax holiday incentives.

We file income tax returns in numerous jurisdictions and are therefore subject to audits by tax authorities. Our primary income tax jurisdictions are Ireland, the United States, Israel, Belgium, France, and the United Kingdom.

On August 15, 2017, we filed a complaint in the United States District Court for the Western District of Michigan to recover $163.6 million of Federal income tax, penalties, and interest assessed and collected by the Internal Revenue Service (“IRS”), plus statutory interest thereon from the dates of payment, for the fiscal years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012 (the “2009 tax year,” “2010 tax year,” “2011 tax year,” and “2012 tax year,” respectively). The IRS audits of those years culminated in the issuances of two statutory notices of deficiency: (1) on August 27, 2014 for the 2009 and 2010 tax years and (2) on April 20, 2017 for the 2011 and 2012 tax years. The statutory notices of deficiency both included un-agreed income adjustments related principally to transfer pricing adjustments regarding the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States. In addition, the statutory notice of deficiency for the 2011 and 2012 tax years included the capitalization of certain expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits. We fully paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and filed timely claims for refund on June 11, 2015 and June 7, 2017 for the 2009-2010 tax years and 2011-2012 tax years, respectively. Our claims for refund were disallowed by certified letters dated August 18, 2015 and July 11, 2017, for the 2009-2010 tax years and 2011-2012 tax years, respectively. The complaint was timely, based upon the refund claim denials, and seeks refunds of tax, interest, and penalties of $37.2 million for the 2009 tax year, $61.5 million for the 2010 tax year, $40.2 million for the 2011 tax year, and $24.7 million for the 2012 tax year. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended July 1, 2017.

On December 22, 2016, we received a notice of proposed adjustment for the IRS audit of Athena Neurosciences, Inc. (“Athena”), a subsidiary of Elan acquired in 1996, for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. Perrigo acquired Elan in December 2013. This proposed adjustment relates to the deductibility of litigation costs. We disagree with the IRS’s position asserted in the notice of proposed adjustment and intend to contest it.

On July 11, 2017, we received a draft notice of proposed adjustment associated with transfer pricing positions for the IRS audit of Athena for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. Athena was the originator of the patents associated with Tysabri® prior to the acquisition of Athena by Elan in 1996. In response to the draft notice of proposed adjustment, we provided the IRS with substantial additional documentation supporting our position. The amount of adjustments that may be asserted by the IRS in the final notice of proposed adjustment cannot be quantified at this time; however, based on the draft notice received, the amount to be assessed may be material. We disagree with the IRS’s position as asserted in the draft notice of proposed adjustment and intend to contest it.

We have ongoing audits in multiple other jurisdictions the resolution of which remains uncertain. These jurisdictions include, but are not limited to, the United States, Ireland and other jurisdictions in Europe. In addition to the matters discussed above, the IRS is currently auditing our fiscal years ended June 29, 2013, June 28, 2014, and June 27, 2015 (which covers the period of the Elan transaction). The Israel Tax Authority's audit of our fiscal years ended June 29, 2013 and June 28, 2014 concluded with no material impact to the financial statements. The Ireland Tax Authority is currently auditing our years ended December 31, 2012 and December 31, 2013.

Tax Law Changes

On December 22, 2017, the United States enacted the Tax Cuts and Jobs Act (“U.S. Tax Act”). The U.S. Tax Act includes a number of significant changes to existing U.S. tax laws that impact us. These changes include a corporate income tax rate reduction from 35% to 21% and the elimination or reduction of certain U.S. deductions and credits including limitations on the U.S. deductibility of interest expense and executive compensation. The U.S. Tax Act also transitions the U.S. taxation of international earnings from a worldwide system to a modified territorial system. These changes were effective beginning in 2018. The U.S. Tax Act also includes a one-time mandatory deemed repatriation tax on accumulated U.S. owned foreign corporations’ previously untaxed foreign earnings (“Transition Toll Tax”). The Transition Toll Tax may be paid over an eight-year period, starting in 2018, and will not accrue interest.

On December 22, 2017, Staff Accounting Bulletin No. 118 ("SAB 118") was issued to address the application of the U.S. GAAP ASC 740 income tax accounting for tax law changes enacted during 2017, in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the U.S. Tax Act. In accordance with SAB 118, for the year ended December 31, 2017, we recorded an income tax benefit of $2.4 million in connection with the remeasurement of certain deferred tax assets and liabilities and also recorded a $17.5 million increase of current tax expense in connection with the Transition Toll Tax on cumulative U.S. owned foreign earnings of $1.2 billion. The tax impacts represent provisional amounts and are a reasonable estimate. The IRS issued additional guidance related to the U.S. Tax Act during the quarters ended March 31, 2018 and June 30, 2018, which resulted in no changes to the provisional estimates recorded at December 31, 2017. Further work is necessary to perform additional analysis of historical foreign earnings, the impacts of repatriating foreign earnings, and U.S. cumulative temporary differences, as well as potential correlative adjustments. Any subsequent adjustment to these amounts will be recorded to tax expense when the analysis is complete in 2018.

The U.S. Tax Act subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries. The FASB Staff Q&A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed Income states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred. Given the complexity of the GILTI provisions, we are still evaluating the effects of the GILTI provisions and have not yet determined our accounting policy. At June 30, 2018, we made a reasonable estimate of the tax effect of a GILTI inclusion for 2018, which is not material for the six months ended June 30, 2018. We also estimate that we will not be subject to the base erosion anti-avoidance tax in 2018 and will not record tax benefits for deductions related to foreign-derived intangible income.

On December 22, 2017, the Belgian Parliament approved Belgian tax reform legislation (“Belgium Tax Act”), which was signed by the Belgian King and enacted on December 25, 2017. The Belgium Tax Act provides for a reduction to the corporate income tax rate from 34% to 30%, for 2018 and 2019, as well as a reduced corporate income tax rate of 25% for 2020 and beyond. The Belgium Tax Act also increased the participation exemption on dividend distributions to Belgium entities from 95% to 100%. The Belgium Tax Act also introduces Belgium tax consolidation and other anti-tax avoidance directives. For the year ended December 31, 2017, we recorded additional income tax expense of $24.1 million for the remeasurement of certain deferred tax assets and additional income tax benefit of $33.2 million for the remeasurement of certain deferred tax liabilities as a result of the Belgium Tax Act.

The IRS issued a notice of proposed regulations on August 1, 2018, implementing Section 965 of the Internal Revenue Code as amended by the U.S. Tax Act, which was enacted on December 22, 2017. The regulations affect any U. S. company with direct or indirect ownership interests in certain foreign corporations. We are currently evaluating the impact of the regulations on our financial statements.
XML 37 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Contingencies
 6 Months Ended
Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Contingencies
CONTINGENCIES

In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below. We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated. The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters. For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of June 30, 2018, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows. We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve. Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows. 

Antitrust Violations

We were named as a counterclaim co-defendant in the lawsuit Fera Pharmaceuticals, LLC v. Akorn, Inc., et al. in the Southern District of New York, in which Akorn, Inc. (“Akorn”) alleged tortious interference and antitrust violations against us and Fera Pharmaceuticals, LLC (“Fera”). Trial was set for February 2018 in the Southern District of New York. This litigation arose out of our acquisition of bacitracin ophthalmic ointment from Fera in 2013. Akorn asserted claims under Sections 1 and 2 of the Sherman Antitrust Act alleging that we and Fera conspired to monopolize, attempted to monopolize, and did unlawfully monopolize the market for sterile bacitracin ophthalmic ointment in the United States through the use of an exclusive agreement with a supplier of sterile bacitracin active pharmaceutical ingredient. The parties have executed a written settlement of all claims and the case has been dismissed.

Price-Fixing Lawsuits

We have been named as a co-defendant with certain other generic pharmaceutical manufacturers in a number of class actions alleging that we and other manufacturers of the same product engaged in anti-competitive behavior to fix or raise the prices of certain drugs starting, in some instances, as early as June 2013. The products in question are Clobetasol, Desonide, and Econazole. Recently, the same class plaintiffs have filed new complaints naming us as a co-defendant, along with 27 other manufacturers, alleging an overarching conspiracy to fix or raise the prices of 15 generic pharmaceutical products starting in 2011. Perrigo manufactures only two of the products at issue, Nystatin cream and Nystatin ointment. We have also recently been named a co-defendant along with 35 other manufacturers in a complaint filed by three supermarket chains alleging that defendants conspired to fix prices of 31 generic pharmaceutical products starting in 2013. These complaints, along with complaints filed against other companies alleging price fixing with respect to more than two dozen other drugs, have been consolidated for pretrial proceedings as part of a case captioned In re Generic Pharmaceuticals Pricing Antitrust Litigation, MDL No. 2724 in the U.S. District Court for the Eastern District of Pennsylvania. Pursuant to the court’s schedule staging various cases in phases, we have moved to dismiss the complaints relating to Clobetasol and Econazole. A schedule for responses to the other complaints will be determined after decisions are rendered on the pending motions to dismiss the class cases. At this stage, we cannot reasonably predict the outcome of the liability, if any, associated with these claims.

Securities Litigation
 
In the United States

On May 18, 2016, a shareholder filed a securities case against us and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (Roofers’ Pension Fund v. Papa, et al.). The plaintiff purported to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive. The original complaint alleged violations of Securities Exchange Act sections 10(b) (and Rule 10b‑5) and 14(e) against both defendants and 20(a) control person liability against Mr. Papa. In general, the allegations concerned the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015. The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged integration problems related to the Omega acquisition in the period from April 21, 2015 through May 11, 2016. On July 19, 2016, a different shareholder filed a securities class action against us and our former CEO, Joseph Papa, also in the District of New Jersey (Wilson v. Papa, et al.). The plaintiff purported to represent a class of persons who sold put options on our shares between April 21, 2015 and May 11, 2016. In general, the allegations and the claims were the same as those made in the original complaint filed in the Roofers' Pension Fund case described above. On December 8, 2016, the court consolidated Roofers' Pension Fund case and the Wilson case under the Roofers' Pension Fund case number. In February 2017, the court selected the lead plaintiffs for the consolidated case and the lead counsel to the putative class. In March 2017, the court entered a scheduling order.

On June 21, 2017, the court-appointed lead plaintiffs filed an amended complaint that superseded the original complaints in the Roofers’ Pension Fund case and the Wilson case. The lead plaintiffs seek to represent a class of shareholders for the period April 21, 2015 through May 3, 2017, and the amended complaint identifies three subclasses - shareholders who purchased shares during the period on the U.S. exchanges; shareholders who purchased shares during the period on the Tel Aviv exchange; and shareholders who owned shares on the final day of the Mylan tender offer November 13, 2015. The amended complaint names as defendants us and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O’Connor). The amended complaint alleges violations of Securities Exchange Act sections 10(b) (and Rule 10b‑5) and 14(e) against all defendants and 20(a) control person liability against the 11 individuals. In general, the allegations concern the actions taken by us and the former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to six generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri® royalty stream. The amended complaint does not include an estimate of damages. In August 2017, the defendants filed motions to dismiss the amended complaint. The plaintiffs filed their opposition in October 2017. The defendants filed replies in support of the motions to dismiss in November 2017. On July 27, 2018, the court issued an opinion and order granting the defendants’ motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O’Connor, and Marc Coucke. The court also dismissed without prejudice claims arising from the Tysabri® accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are Perrigo Company, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issues regarding the Omega acquisition and the alleged price fixing activities with respect to six generic prescription pharmaceuticals. We intend to defend the lawsuit vigorously.

On November 1, 2017, Carmignac Gestion, S.A., filed a securities lawsuit against us and three individuals (former Chairman and CEO Joseph Papa, former CFO Judy Brown, and former Executive Vice President and Board member Marc Coucke). This lawsuit is not a securities class action. The case is styled Carmignac Gestion, S.A. v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey. The complaint asserts claims under Securities Exchange Act sections 10(b) (and Rule 10b-5), 14(e), and 18 against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff’s allegations focus on events during the period from April 2015 through April 2016. Plaintiff contends that the defendants provided inadequate disclosure throughout the period concerning the valuation and integration of Omega, the financial guidance provided by us during that period, our reporting about the generic prescription pharmaceutical business and its prospects, and the activities surrounding the efforts to defeat the Mylan tender offer during 2015. Many of the allegations in this case overlap with the allegations of the June 2017 amended complaint in the Roofers’ Pension Fund case described above. The plaintiff does not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the Roofers' Pension Fund case, and the court granted the stay motion. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.
   
On January 16, 2018, Manning & Napier Advisors, LLC filed a securities lawsuit against us and three individuals (former Chairman and CEO Joseph Papa, former CFO Judy Brown, and former Executive Vice President and Board member Marc Coucke). This lawsuit is not a securities class action. The case is styled Manning & Napier Advisors, LLC v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey. The complaint asserts claims under Securities Exchange Act sections 10(b) (and Rule 10b-5) and 18 against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff’s allegations focus on events during the period from April 2015 through May 2017. Plaintiff contends that the defendants provided inadequate disclosure at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri® financial asset. Many of the allegations in this case overlap with the allegations of the June 2017 amended complaint in the Roofers' Pension Fund case described above. The plaintiff does not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motion to dismiss filed in the Roofers' Pension Fund case, and the court granted the stay motion. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.

On January 26, 2018, two different plaintiff groups (the Mason Capital group and the Pentwater group) each filed a lawsuit against us and the same individuals who are defendants in the amended complaint in the securities class action case described above (Roofers’ Pension Fund case). The same law firm represents these two plaintiff groups, and the two complaints are substantially similar. These two cases are not securities class actions. One case is styled Mason Capital L.P., et al. v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey. The other case is styled Pentwater Equity Opportunities Master Fund Ltd., et al.  v. Perrigo Company plc, et al., and also was filed in the U.S. District Court for the District of New Jersey. Both cases are assigned to the same federal judge that is hearing the class action case and the other individual cases described above (Carmignac and Manning & Napier). Each complaint asserts claims under Securities Exchange Act sections 14(e) (related to tender offer disclosures) against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff’s allegations describe events during the period from April 2015 through May 2017. Plaintiff contends that the defendants provided inadequate disclosure during the tender offer period in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri® financial asset. Many of the factual allegations in these two cases overlap with the allegations of the June 2017 amended complaint in the Roofers' Pension Fund case described above and the allegations in the Carmignac case described above. The plaintiff does not provide an estimate of damages. The parties to each case jointly requested that the court stay each case pending the outcome of a ruling on the motions to dismiss filed in the Roofers’ Pension Fund case. The court granted the stay motion in each case. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case. We intend to defend both lawsuits vigorously.

On February 13, 2018, a group of plaintiff investors affiliated with Harel Insurance Investments & Financial Services, Ltd. filed a lawsuit against us and the same individuals who are defendants in the amended complaint in the securities class action case described above (Roofers’ Pension Fund case). This lawsuit is not a securities class action. The new complaint is substantially similar to the amended complaint in the Roofers' Pension Fund case. The relevant period in the new complaint stretches from February 2014 to May 2, 2017. The complaint adds as defendants two individuals who served on our Board prior to 2016. The case is styled Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey and is assigned to the same federal judge that is hearing the class action cases and the four other individual cases described above (Carmignac, Manning & Napier, Mason Capital, and Pentwater). The Harel Insurance Company complaint asserts claims under Securities Exchange Act section 10(b) (and related SEC Rule 10b‑5) and section 14(e) (related to tender offer disclosures) against all defendants as well as 20(a) control person liability against the individual defendants. The complaint also asserts claims based on Israeli securities laws. In general, the plaintiffs' allegations describe events during the period from February 2014 through May 2017. Plaintiffs contend that the defendants provided inadequate disclosure during the tender offer events in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri® financial asset from February 2014 until the withdrawal of past financial statements in April 2017. Many of the factual allegations in this case overlap with the allegations of the June 2017 amended complaint in the Roofers' Pension Fund case described above and the allegations in the four opt out cases also described above. The plaintiffs do not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the Roofers’ Pension Fund case, which was granted by the court. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.

On February 16, 2018, First Manhattan Company filed a securities lawsuit against us and three individuals (former Chairman and CEO Joseph Papa, former CFO Judy Brown, and former Executive Vice President and Board member Marc Coucke). This lawsuit is not a securities class action. The case is styled First Manhattan Co. v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey. The case was assigned to the same judge hearing the class action case and the five other opt out cases. The complaint asserts claims under Securities Exchange Act sections 10(b) (and Rule 10b-5), 14(e), and 18 against all defendants as well as 20(a) control person liability against the individual defendants. In general, the plaintiff’s allegations focus on events during the period from April 2015 through May 2017. Plaintiff contends that the defendants provided inadequate disclosure at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri® financial asset. This lawsuit was filed by the same law firm that filed the Manning & Napier Advisors case and the Carmignac case described above and generally makes the same factual assertions as in the Manning & Napier Advisors case. Many of the allegations in this case overlap with the allegations of the June 2017 amended complaint in the Roofers' Pension Fund case described above. The plaintiff does not provide an estimate of damages. On April 20, 2018, the plaintiff filed an amended complaint that did not materially change the factual allegations of the original complaint. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the Roofers’ Pension Fund case. The court granted the stay motion. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.

On April 20, 2018, a group of plaintiff investors affiliated with TIAA-CREF filed a lawsuit against us and the same individuals who are the defendants in the Harel Insurance case complaint. This lawsuit is not a securities class action. The law firm representing the plaintiffs in the Harel Insurance case also represents the TIAA-CREF plaintiff entities in this case, and the new complaint is substantially similar to the Harel Insurance complaint. The relevant period in the new complaint is August 14, 2014 to May 2, 2017 inclusive. The case is styled TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al., and was filed in the U.S. District Court for the District of New Jersey and is assigned to the same federal judge that is hearing the class action case and the six other individual cases described above (Carmignac, Manning & Napier, Mason Capital, Pentwater, Harel Insurance, and First Manhattan). The TIAA-CREF Investment Management complaint asserts claims under Securities Exchange Act section 10(b) (and related SEC Rule l0b-5), section 14(e) (related to tender offer disclosures) against all defendants as well as section 20(a) control person liability against the individual defendants. In general, plaintiffs' allegations describe events during the period from August 2014 through May 2017. Plaintiffs contend that the defendants provided inadequate disclosure during the tender offer events in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to six generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri® financial asset from August 2014 until the withdrawal of past financial statements in April 2017. Many of the factual allegations in this case also overlap with the allegations of the June 2017 amended complaint in the Roofers' Pension Fund case described above. The plaintiffs do not provide an estimate of damages. We intend to defend the lawsuit vigorously. The parties jointly requested that the court stay this case pending the outcome of a ruling on the motions to dismiss filed in the Roofers' Pension Fund case. The court granted the stay motion. Because the court has issued a decision in the Roofer’s Pension Fund case, the parties to the case described in this paragraph will confer to discuss how that ruling affects this case and the scheduling issues for this case.

In Israel

Because our shares are traded on the Tel Aviv exchange under a dual trading arrangement, we are potentially subject to securities litigation in Israel. Three cases were filed; two were voluntarily dismissed and one was stayed. We are consulting Israeli counsel about our response to these allegations and we intend to defend these cases vigorously.

On May 22, 2016, shareholders filed a securities class action against us and five individual defendants: Our former CEO Mr. Papa, our former Executive Vice President and General Manager of the BCH segment Marc Coucke, our then Chief Executive Officer John Hendrickson, our former Board member Gary Kunkle, Jr., and our Board member Laurie Brlas alleging violations of Israeli law in the District Court of Tel Aviv-Jaffa (Schweiger et al. v. Perrigo Company plc, et al.). On June 15, 2016, we filed a motion to stay the case pending the outcome of the securities class action pending in the New Jersey Federal Court. The plaintiffs did not oppose the motion. The Israeli court granted the motion on the same day, and the Schweiger action was stayed. In October 2017, the Schweiger plaintiffs dismissed their claims without prejudice because of the pendency of another class action case filed in Israel (see discussion below of the Israel Elec. Corp. Employees’ Educ. Fund case). The court approved the voluntary dismissal. 

On March 29, 2017, plaintiff Eyal Keinan commenced an action in the District Court of Tel Aviv-Jaffa asserting securities claims against two defendants: Perrigo and its auditor Ernst & Young LLP ("EY"). The case is styled Keinan v. Perrigo Company plc, et al. The action sought certification of a class of purchasers of Perrigo shares on the Israeli exchange beginning February 6, 2014. The proposed closing date for the class was not clear from the complaint though it appeared to extend into 2017. In general, the plaintiff asserted that we improperly accounted for our stream of royalty income from two drugs: Tysabri® and Prialt. The court filings contended that the alleged improper accounting caused the audited financial results for Perrigo to be incorrect for the six month period ended December 31, 2015, and the years ended June 27, 2015 and June 28, 2014 and the other financial data released by us over those years and 2016 to also be inaccurate. The plaintiff maintained that the defendants are liable under Israeli securities law or, in the alternative, under U.S. securities law. The plaintiff indicated an initial, preliminary class damages estimate of 686.0 million NIS (approximately $192.0 million at 1 NIS = $0.28 cent). In January 2018, the Keinan plaintiff announced its intention to dismiss his claims because of the pendency of another class action case filed in Israel (see discussion below of the Israel Elec. Corp. Employees’ Educ. Fund case). The court granted the dismissal on February 11, 2018.

On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled Israel Elec. Corp. Employees’ Educ. Fund v. Perrigo Company plc, et al. The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, EY (the Company’s auditor), and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O’Connor). The complaint alleges violations under U.S. securities laws of Securities Exchange Act sections 10(b) (and Rule 10b‑5) and 14(e) against all defendants and 20(a) control person liability against the 11 individuals or, in the alternative, under Israeli securities laws. In general, the allegations concern the actions taken by us and our former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure concerning purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company, alleges price fixing activities with respect to six generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri® royalty stream. The plaintiff indicates an initial, preliminary class damages estimate of 2.7 billion NIS (approximately $760.0 million at 1 NIS = $0.28 cent). We intend to defend the lawsuit vigorously.

On July 12, 2017, the plaintiff in the Israel Elec. Corp. Employees’ Educ. Fund v. Perrigo Company plc, et al. case filed a motion to have all three cases pending in Israel either consolidated or the other two cases dismissed so that the Israel Elec. Corp. Educ. Fund plaintiff can proceed as the sole plaintiff. In October 2017, the Schweiger plaintiffs (see description above) voluntarily dismissed their securities class action without prejudice as part of their response to the motion filed by the Israel Elec. Corp. Educ. Fund plaintiff. A variety of other procedural motions were also pending having to do with the timing of any response by defendants. The court held an initial conference on November 9, 2017 to address the motion filed by the Israel Elec. Corp. Educ. Fund plaintiff. Subsequently, the competing class plaintiffs held discussions and informed the court in January 2018 that they had reached an agreement among themselves such that the Education Fund case will continue and the Keinan plaintiff dismissed its case. The court approved this outcome. At the request of the parties, the court has stayed the Education Fund case pending the final adjudication of the class action case in D.N.J. (the Roofers’ Pension Fund case described above under Securities Litigation In the United States). The court approved the stay.

Eltroxin

During October and November 2011, nine applications to certify a class action lawsuit were filed in various courts in Israel related to Eltroxin, a prescription thyroid medication manufactured by a third party and distributed in Israel by our subsidiary, Perrigo Israel Agencies Ltd. The respondents included our subsidiaries, Perrigo Israel Pharmaceuticals Ltd. and/or Perrigo Israel Agencies Ltd., the manufacturers of the product, and various healthcare providers who provide healthcare services as part of the compulsory healthcare system in Israel.

One of the applications was dismissed and the remaining eight applications were consolidated into one application. The applications arose from the 2011 launch of a reformulated version of Eltroxin in Israel. The consolidated application generally alleges that the respondents (a) failed to timely inform patients, pharmacists and physicians about the change in the formulation; and (b) failed to inform physicians about the need to monitor patients taking the new formulation in order to confirm patients were receiving the appropriate dose of the drug. As a result, claimants allege they incurred the following damages: (a) purchases of product that otherwise would not have been made by patients had they been aware of the reformulation; (b) adverse events to some patients resulting from an imbalance of thyroid functions that could have been avoided; and (c) harm resulting from the patients' lack of informed consent prior to the use of the reformulation.

Several hearings on whether or not to certify the consolidated application took place in December 2013 and January 2014. On May 17, 2015, the District Court certified the motion against Perrigo Israel Agencies Ltd. and dismissed it against the remaining respondents, including Perrigo Israel Pharmaceuticals Ltd.

On June 16, 2015, we submitted a motion for permission to appeal the decision to certify to the Israeli Supreme Court together with a motion to stay the proceedings of the class action until the motion for permission to appeal is adjudicated. We have filed our statement of defense to the underlying proceedings. The underlying proceedings have been stayed pending the outcome of the mediation process and, if necessary, a decision on the motion to appeal.

On November 14, 2017 the parties submitted the agreed settlement agreement to the approval of the Supreme Court, which referred the approval back to the District Court. During three hearings that took place on November 29, 2017, December 13, 2017 and January 11, 2018 the District Court opined that it would approve the settlement agreement subject to certain amendments to be proposed by the Court (which would not impact the monetary settlement reached) and set a hearing for January 30, 2018 to discuss and finalize the proposed changes. Meanwhile, the Court ordered the settlement to be (1) provided to the Attorney General for review (standard procedure); and (2) published in the written media (newspapers), to enable the class members to submit any objections or “opt-out” to  the proposed settlement by February 15, 2018.

On February 21, 2018, the District Court held a hearing to, among others, review objections received from class members who had notified the District Court of their desire to opt out of the settlement. In addition, a representative of the Israeli Attorney General’s office notified the District Court that, based upon their preliminary examination of the settlement, they intend to object to the settlement in its current form. The District Court recommended that the parties continue to discuss and minimize objections to the settlement and scheduled another hearing for May 13, 2018.
    
The District Court Justice was appointed as a Supreme Court Justice and ordered to move the case to a different panel. In an effort to reach a decision before the appointment, an additional hearing was held on March 12, 2018 in which the court urged the parties to try and exhaust their negotiations to the fullest and provide an update by May 13, 2018. In addition, the Court ordered the Attorney General to submit its opinion to the settlement agreement by May 30, 2018, which was extended until July 23, 2018.

Tysabri® Product Liability Lawsuits

               We and our collaborator Biogen have been co-defendants in product liability lawsuits arising out of the occurrence of Progressive Multifocal Leukoencephalopathy ("PML"), a serious brain infection, and serious adverse events, including deaths, which occurred in patients taking Tysabri®.  In 2018, the last outstanding PML case was dismissed with prejudice. 

Claim Arising from the Omega Acquisition

On December 16, 2016, we and Perrigo Ireland 2 brought an arbitral claim ("Claim") against Alychlo NV ("Alychlo") and Holdco I BE NV ("Holdco") (together the Sellers) in accordance with clause 26.2 of the Share Purchase Agreement dated November 6, 2014 ("SPA") and the rules of the Belgian Centre for Arbitration and Mediation ("CEPANI"). Our Claim relates to the accuracy and completeness of information about Omega provided by the Sellers as part of the sale process, the withholding of information by the Sellers during that process and breaches of Sellers’ warranties. We are seeking monetary damages from the Sellers. The Sellers served their respective responses to the Claim on February 20, 2017. In its response, Alychlo has asserted a counterclaim for monetary damages contending that we breached a warranty in the SPA and breached the duty of good faith in performing the SPA. There can be no assurance that our Claim will be successful, and Sellers deny liability for the Claim. We deny that Alychlo is entitled to any relief (including monetary relief) under the counterclaim. The arbitration proceedings are confidential as required by the SPA and the rules of the CEPANI.
XML 38 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring Charges
 6 Months Ended
Jun. 30, 2018
Restructuring Charges [Abstract]  
Restructuring charges
RESTRUCTURING CHARGES

We periodically take action to reduce redundant expenses and improve operating efficiencies. The following reflects our restructuring activity (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Beginning balance
$
12.4

 
$
51.5

 
$
21.4

 
$
19.7

Additional charges
3.7

 
12.1

 
5.2

 
50.8

Payments
(3.1
)
 
(23.6
)
 
(13.8
)
 
(30.7
)
Non-cash adjustments
(0.3
)
 
(0.3
)
 
(0.1
)
 
(0.1
)
Ending balance
$
12.7

 
$
39.7

 
$
12.7

 
$
39.7



Restructuring activity includes severance, lease exit costs, and asset impairments. The charges incurred during the three and six months ended June 30, 2018 were primarily associated with continued costs from actions we took to streamline our organization as announced on February 21, 2017 as well as additional lease exit costs. Of the amount recorded during the six months ended July 1, 2017, $28.0 million was related to the CHCA segment. There were no other material restructuring programs that significantly impacted any other reportable segments for the three and six months ended June 30, 2018 or July 1, 2017. All charges are recorded in Restructuring expense on the Condensed Consolidated Financial Statements. The remaining $7.3 million liability for employee severance benefits will be paid within the next year, while the remaining $5.4 million liability for lease exit costs will be paid over the remaining terms of the applicable leases.
XML 39 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information
 6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Segment information
SEGMENT INFORMATION
    
Our reporting segments are as follows:

•
Consumer Healthcare Americas, comprises our U.S., Mexico and Canada consumer healthcare business (OTC, contract, infant formula and animal health categories).
•
Consumer Healthcare International, comprises our branded consumer healthcare business primarily in Europe and our consumer focused businesses in the United Kingdom, Australia, and Israel. This segment also includes our U.K. liquid licensed products business.
•
Prescription Pharmaceuticals, comprises our U.S. Prescription Pharmaceuticals business.

We also had a legacy operating segment, Other, which contained our API businesses, which we divested. Following the divestitures, there were no substantial assets or operations left in the segment. Our segments reflect the way in which our management makes operating decisions, allocates resources and manages the growth and profitability of the Company.

The below tables show select financial measures by reporting segment (in millions):
 
 
Total Assets
 
 
June 30,
2018
 
December 31,
2017
CHCA
 
$
3,673.0

 
$
3,786.8

CHCI
 
4,799.4

 
5,029.0

RX
 
2,753.2

 
2,813.0

Total
 
$
11,225.6

 
$
11,628.8

 
Three Months Ended
 
June 30, 2018
 
July 1, 2017
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHCA
$
596.8

 
$
57.4

 
$
15.3

 
$
604.9

 
$
104.2

 
$
17.0

CHCI
381.0

 
5.6

 
49.5

 
376.5

 
3.9

 
47.5

RX
208.6

 
56.9

 
20.5

 
240.4

 
69.3

 
22.3

Other
—

 
—

 
—

 
16.1

 
4.1

 
0.4

Unallocated
—

 
(25.2
)
 
—

 
—

 
(32.7
)
 
—

Total
$
1,186.4

 
$
94.7

 
$
85.3

 
$
1,237.9

 
$
148.8

 
$
87.2


 
Six Months Ended
 
June 30, 2018
 
July 1, 2017
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHCA
$
1,198.4

 
$
170.5

 
$
30.5

 
$
1,187.6

 
$
179.2

 
$
34.2

CHCI
782.4

 
20.4

 
100.8

 
751.5

 
4.2

 
93.2

RX
422.6

 
118.7

 
41.1

 
457.8

 
157.5

 
44.6

Other
—

 
—

 
—

 
35.0

 
9.7

 
0.8

Unallocated
—

 
(58.7
)
 
—

 
—

 
(73.3
)
 
—

Total
$
2,403.4

 
$
250.9

 
$
172.4

 
$
2,431.9

 
$
277.3

 
$
172.8
XML 40 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events
 6 Months Ended
Jun. 30, 2018
Subsequent Events [Abstract]  
Subsequent events
SUBSEQUENT EVENTS

On August 9, 2018, we announced a plan to separate our RX business. We intend to begin the preparations for a spin-off of the RX business to shareholders and will also remain open to other value-enhancing options, including a possible sale, merger or other form of separation. We currently expect the separation of the RX business to be completed during the second half of 2019.
XML 41 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Policies)
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Basis of presentation
Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended December 31, 2017.
Principles of consolidation
In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Recently Issued Accounting Standards
Recent Accounting Standard Pronouncements
    
Below are recent Accounting Standard Updates ("ASU") that we are still assessing to determine the effect on our Condensed Consolidated Financial Statements. We do not believe that any other recently issued accounting standards could have a material effect on our Condensed Consolidated Financial Statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.
Recently Issued Accounting Standards Not Yet Adopted
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
ASU 2016-02 Leases
 
This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. The guidance is required to be adopted using the modified retrospective approach. Early adoption is permitted.
 
January 1, 2019
 
We have completed our initial scoping reviews and assessment phase to identify our leasing processes and go-forward policy that will be impacted by the new standard. We are continuing the design phase of our new lease integration tool and expect our financial statement disclosures will be expanded to present additional details of our leasing arrangements. At this time, we are unable to reasonably estimate the expected increase in assets and liabilities on our Consolidated Balance Sheets or the impacts to our Consolidated Financial Statements upon adoption. We plan to adopt the amended guidance on the effective date, and we expect the right of use asset and corresponding liability will be material and require certain changes to our systems and processes.
ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
 
This guidance permits tax effects stranded in accumulated other comprehensive income as a result of tax reform to be reclassified to retained earnings. This reclassification is optional and will require additional disclosure regarding whether reclassification is elected or not.
 
January 1, 2019

 
We are currently evaluating the implications of adoption on our Consolidated Financial Statements.
ASU 2016-13 Measurement of Credit Losses on Financial Instruments
 
This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.
 
January 1, 2020
 
We are currently evaluating the implications of adoption on our Consolidated Financial Statements.
ASU 2017-04 Intangibles - Goodwill and Other Simplifying the Test for Goodwill
 
The objective of this update is to reduce the cost and complexity of subsequent goodwill accounting by simplifying the impairment test by removing the Step 2 requirement to perform a hypothetical purchase price allocation when the carrying value of a reporting unit exceeds its fair value. If a reporting unit’s carrying value exceeds its fair value, an entity would record an impairment charge based on that difference, limited to the amount of goodwill attributed to that reporting unit. The proposal would not change the guidance on completing Step 1 of the goodwill impairment test. The proposed guidance would be applied prospectively. Early adoption is permitted.
 
January 1, 2020
 
Upon adoption, this guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment. After adoption, a Step 1 failure will result in an immediate impairment charge based on the carrying value of the reporting unit. We plan to adopt the standard prospectively on the effective date.
Product Revenue and Other Revenue
Product Revenue

We generally recognize product revenue for our contract performance obligations at a point in time, typically upon shipment or delivery of products to customers. For point in time customers for which control transfers on delivery to the customer due to free on board destination terms (“FOB”), an adjustment is recorded to defer revenue recognition over an estimate of days until control transfers at the point of delivery. Where we recognize revenue at a point in time, the transfer of title is the primary indicator that control has transferred. In other limited instances, primarily relating to those contracts that relate to contract manufacturing performed for our customers and certain store branded products, control transfers as the product is manufactured. Control is deemed to transfer over time for these contracts as the product does not have an alternative use and we have a contractual right to payment for performance completed to date. Revenue for contract manufacturing contracts is recognized over the transfer period using an input method that measures progress towards completion of the performance obligation as costs are incurred. For store branded product revenue recognized over time, an output method is used to recognize revenue when production of a unit is completed because product customization occurs when the product is packaged as a finished good under the store brand label of the customer.

Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of chargebacks, rebates, sales returns, shelf stock allowances, administrative fees and other incentive programs. Certain of these accruals and allowances are recorded in the balance sheet as current liabilities and others are recorded as a reduction in accounts receivable. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect the best estimates of the amount of consideration to which we are entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known.

Other Revenue Policies

We receive payments from our customers based on billing schedules established in each contract. Amounts are recorded as accounts receivable when our right to consideration is unconditional. In most cases, the timing of the unconditional right to payment aligns with shipment or delivery of the product and the recognition of revenue; however, for those customers where revenue is recognized at a time prior to shipment or delivery due to over time revenue recognition, a contract asset is recorded and is reclassified to an accounts receivable when it becomes unconditional under the contract upon shipment or delivery to the customer.

We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised products to the customer will be one year or less, which is the case with substantially all customers.

Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenue.  

Shipping and handling costs billed to customers are included in Net sales. Conversely, shipping and handling expenses we incur are included in Cost of sales.
XML 42 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of New Accounting Pronouncements
As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.
Recently Issued Accounting Standards Not Yet Adopted
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
ASU 2016-02 Leases
 
This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. The guidance is required to be adopted using the modified retrospective approach. Early adoption is permitted.
 
January 1, 2019
 
We have completed our initial scoping reviews and assessment phase to identify our leasing processes and go-forward policy that will be impacted by the new standard. We are continuing the design phase of our new lease integration tool and expect our financial statement disclosures will be expanded to present additional details of our leasing arrangements. At this time, we are unable to reasonably estimate the expected increase in assets and liabilities on our Consolidated Balance Sheets or the impacts to our Consolidated Financial Statements upon adoption. We plan to adopt the amended guidance on the effective date, and we expect the right of use asset and corresponding liability will be material and require certain changes to our systems and processes.
ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
 
This guidance permits tax effects stranded in accumulated other comprehensive income as a result of tax reform to be reclassified to retained earnings. This reclassification is optional and will require additional disclosure regarding whether reclassification is elected or not.
 
January 1, 2019

 
We are currently evaluating the implications of adoption on our Consolidated Financial Statements.
ASU 2016-13 Measurement of Credit Losses on Financial Instruments
 
This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.
 
January 1, 2020
 
We are currently evaluating the implications of adoption on our Consolidated Financial Statements.
ASU 2017-04 Intangibles - Goodwill and Other Simplifying the Test for Goodwill
 
The objective of this update is to reduce the cost and complexity of subsequent goodwill accounting by simplifying the impairment test by removing the Step 2 requirement to perform a hypothetical purchase price allocation when the carrying value of a reporting unit exceeds its fair value. If a reporting unit’s carrying value exceeds its fair value, an entity would record an impairment charge based on that difference, limited to the amount of goodwill attributed to that reporting unit. The proposal would not change the guidance on completing Step 1 of the goodwill impairment test. The proposed guidance would be applied prospectively. Early adoption is permitted.
 
January 1, 2020
 
Upon adoption, this guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment. After adoption, a Step 1 failure will result in an immediate impairment charge based on the carrying value of the reporting unit. We plan to adopt the standard prospectively on the effective date.
Condensed Consolidated Statements of Operations

Net sales and Cost of sales were lower in the three and six months ended June 30, 2018 as a result of adopting ASC 606 due to net sales from contract manufacturing and certain OTC product sales being recognized on an over time basis as the performance obligation was satisfied, compared to the previous revenue recognition under ASC 605, which would have occurred when the product was shipped or delivered. This has resulted in the recognition of a contract asset.
 
Three Months Ended
 
Six Months Ended
 
June 30, 2018
 
June 30, 2018
(in millions, except per share amounts)
As reported
 
Adjustments
 
Before adoption of ASC 606
 
As reported
 
Adjustments
 
Before adoption of ASC 606
Net sales
$
1,186.4

 
$
6.9

 
$
1,193.3

 
$
2,403.4

 
$
1.3

 
$
2,404.7

Cost of sales
715.4

 
4.2

 
719.6

 
1,439.7

 
1.1

 
1,440.8

Gross profit
471.0

 
2.7

 
473.7

 
963.7

 
0.2

 
963.9

 
 
 
 
 
 
 
 
 
 
 
 
Operating income
94.7

 
2.7

 
97.4

 
250.9

 
0.2

 
251.1

 
 
 
 
 
 
 
 
 
 
 
 
Income tax expense (benefit)
19.1

 
(0.1
)
 
19.0

 
48.8

 
(0.1
)
 
48.7

Net income
$
36.2

 
$
2.8

 
$
39.0

 
$
117.0

 
$
0.3

 
$
117.3

 
 
 
 
 
 
 
 
 
 
 
 
Earnings per share
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.26

 
$
0.02

 
$
0.28

 
$
0.84

 
$
—

 
$
0.84

Diluted
$
0.26

 
$
0.02

 
$
0.28

 
$
0.84

 
$
—

 
$
0.84



Condensed Consolidated Statements of Comprehensive Income (Loss)
 
Three Months Ended
 
Six Months Ended
 
June 30, 2018
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
 
As reported
 
Adjustments
 
Before adoption of ASC 606
Net income
$
36.2

 
$
2.8

 
$
39.0

 
$
117.0

 
$
0.3

 
$
117.3

Comprehensive income (loss)
$
(133.1
)
 
$
2.8

 
$
(130.3
)
 
$
19.9

 
$
0.3

 
$
20.2



Condensed Consolidated Balance Sheet
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
Assets
 
 
 
 
 
Inventories
$
883.8

 
$
13.7

 
$
897.5

Prepaid expenses and other current assets
238.4

 
(19.2
)
 
219.2

Total current assets
2,778.5

 
(5.5
)
 
2,773.0

Total assets
$
11,225.6

 
$
(5.5
)
 
$
11,220.1

Liabilities and Shareholders’ Equity
 
 
 
 
 
Other non-current liabilities
$
414.6

 
$
(0.4
)
 
$
414.2

Total non-current liabilities
3,790.7

 
(0.4
)
 
3,790.3

Total liabilities
5,328.3

 
(0.4
)
 
5,327.9

Shareholders’ equity
 
 
 
 
 
Controlling interest:
 
 
 
 
 
Accumulated deficit
(1,852.2
)
 
(5.1
)
 
(1,857.3
)
Total controlling interest
5,897.1

 
(5.1
)
 
5,892.0

Total shareholders’ equity
5,897.3

 
(5.1
)
 
5,892.2

Total liabilities and shareholders' equity
$
11,225.6

 
$
(5.5
)
 
$
11,220.1



Condensed Consolidated Statement of Cash Flows
 
Six Months Ended
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
Cash Flows From (For) Operating Activities
 
 
 
 
 
Net income
$
117.0

 
$
0.3

 
$
117.3

(Decreases) in cash due to:
 
 
 
 
 
Inventories
(99.3
)
 
1.1

 
(98.2
)
Accrued income taxes
(20.8
)
 
(0.1
)
 
(20.9
)
Other, net
(5.9
)
 
(1.3
)
 
(7.2
)
Subtotal
(106.0
)
 
(0.3
)
 
(106.3
)
Net cash from operating activities
$
254.7

 
$
—

 
$
254.7
XML 43 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition (Tables)
 6 Months Ended
Jun. 30, 2018
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following is a summary of our net sales by category (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
June 30,
2018
CHCA
 
 
 
Cough/Cold/Allergy/Sinus(1)
$
109.3

 
$
250.8

Infant Nutritionals
109.2

 
212.6

Gastrointestinal(1)
103.0

 
195.2

Analgesics(1)
92.2

 
185.9

Smoking Cessation
71.2

 
137.1

Animal Health
31.9

 
58.2

Vitamins, Minerals and Dietary Supplements(1)
4.3

 
7.3

Other CHCA(1),(2)
75.7

 
151.3

Total CHCA
596.8

 
1,198.4

CHCI
 
 
 
Lifestyle
86.1

 
175.8

Cough, Cold, and Allergy
84.7

 
183.4

Personal Care and Derma-Therapeutics
79.7

 
155.3

Anti-Parasite
30.4

 
58.5

Natural Health and Vitamins, Minerals and Dietary Supplements
27.9

 
61.1

Other CHCI(3)
72.2

 
148.3

Total CHCI
381.0

 
782.4

Total RX
208.6

 
422.6

Total net sales
$
1,186.4

 
$
2,403.4


(1)    Includes net sales from our OTC contract manufacturing business.
(2) 
Consists primarily of branded OTC, diabetic care, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.
(3) 
Consists primarily of liquid licensed products, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.
We generated net sales in the following geographic locations(1) (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
June 30,
2018
U.S.
$
772.3

 
$
1,558.7

Europe(2)
344.3

 
706.2

All other countries(3)
69.8

 
138.5

 
$
1,186.4

 
$
2,403.4


(1) The net sales by geography is derived from the location of the entity that sells to a third party.
(2) Includes Ireland net sales of $5.0 million and $10.4 million for the three and six months ended June 30, 2018, respectively.
(3) Includes net sales generated primarily in Israel, Mexico, Australia and Canada.
Contract with Customer Balances
The following table provides information about contract assets from contracts with customers (in millions):
 
Balance Sheet Location
 
January 1,
2018
 
June 30,
2018
Short-term contract assets
Prepaid expenses and other current assets
 
$
20.5

 
$
19.2
Schedule of New Accounting Pronouncements
As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.
Recently Issued Accounting Standards Not Yet Adopted
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
ASU 2016-02 Leases
 
This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. The guidance is required to be adopted using the modified retrospective approach. Early adoption is permitted.
 
January 1, 2019
 
We have completed our initial scoping reviews and assessment phase to identify our leasing processes and go-forward policy that will be impacted by the new standard. We are continuing the design phase of our new lease integration tool and expect our financial statement disclosures will be expanded to present additional details of our leasing arrangements. At this time, we are unable to reasonably estimate the expected increase in assets and liabilities on our Consolidated Balance Sheets or the impacts to our Consolidated Financial Statements upon adoption. We plan to adopt the amended guidance on the effective date, and we expect the right of use asset and corresponding liability will be material and require certain changes to our systems and processes.
ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
 
This guidance permits tax effects stranded in accumulated other comprehensive income as a result of tax reform to be reclassified to retained earnings. This reclassification is optional and will require additional disclosure regarding whether reclassification is elected or not.
 
January 1, 2019

 
We are currently evaluating the implications of adoption on our Consolidated Financial Statements.
ASU 2016-13 Measurement of Credit Losses on Financial Instruments
 
This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.
 
January 1, 2020
 
We are currently evaluating the implications of adoption on our Consolidated Financial Statements.
ASU 2017-04 Intangibles - Goodwill and Other Simplifying the Test for Goodwill
 
The objective of this update is to reduce the cost and complexity of subsequent goodwill accounting by simplifying the impairment test by removing the Step 2 requirement to perform a hypothetical purchase price allocation when the carrying value of a reporting unit exceeds its fair value. If a reporting unit’s carrying value exceeds its fair value, an entity would record an impairment charge based on that difference, limited to the amount of goodwill attributed to that reporting unit. The proposal would not change the guidance on completing Step 1 of the goodwill impairment test. The proposed guidance would be applied prospectively. Early adoption is permitted.
 
January 1, 2020
 
Upon adoption, this guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment. After adoption, a Step 1 failure will result in an immediate impairment charge based on the carrying value of the reporting unit. We plan to adopt the standard prospectively on the effective date.
Condensed Consolidated Statements of Operations

Net sales and Cost of sales were lower in the three and six months ended June 30, 2018 as a result of adopting ASC 606 due to net sales from contract manufacturing and certain OTC product sales being recognized on an over time basis as the performance obligation was satisfied, compared to the previous revenue recognition under ASC 605, which would have occurred when the product was shipped or delivered. This has resulted in the recognition of a contract asset.
 
Three Months Ended
 
Six Months Ended
 
June 30, 2018
 
June 30, 2018
(in millions, except per share amounts)
As reported
 
Adjustments
 
Before adoption of ASC 606
 
As reported
 
Adjustments
 
Before adoption of ASC 606
Net sales
$
1,186.4

 
$
6.9

 
$
1,193.3

 
$
2,403.4

 
$
1.3

 
$
2,404.7

Cost of sales
715.4

 
4.2

 
719.6

 
1,439.7

 
1.1

 
1,440.8

Gross profit
471.0

 
2.7

 
473.7

 
963.7

 
0.2

 
963.9

 
 
 
 
 
 
 
 
 
 
 
 
Operating income
94.7

 
2.7

 
97.4

 
250.9

 
0.2

 
251.1

 
 
 
 
 
 
 
 
 
 
 
 
Income tax expense (benefit)
19.1

 
(0.1
)
 
19.0

 
48.8

 
(0.1
)
 
48.7

Net income
$
36.2

 
$
2.8

 
$
39.0

 
$
117.0

 
$
0.3

 
$
117.3

 
 
 
 
 
 
 
 
 
 
 
 
Earnings per share
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.26

 
$
0.02

 
$
0.28

 
$
0.84

 
$
—

 
$
0.84

Diluted
$
0.26

 
$
0.02

 
$
0.28

 
$
0.84

 
$
—

 
$
0.84



Condensed Consolidated Statements of Comprehensive Income (Loss)
 
Three Months Ended
 
Six Months Ended
 
June 30, 2018
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
 
As reported
 
Adjustments
 
Before adoption of ASC 606
Net income
$
36.2

 
$
2.8

 
$
39.0

 
$
117.0

 
$
0.3

 
$
117.3

Comprehensive income (loss)
$
(133.1
)
 
$
2.8

 
$
(130.3
)
 
$
19.9

 
$
0.3

 
$
20.2



Condensed Consolidated Balance Sheet
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
Assets
 
 
 
 
 
Inventories
$
883.8

 
$
13.7

 
$
897.5

Prepaid expenses and other current assets
238.4

 
(19.2
)
 
219.2

Total current assets
2,778.5

 
(5.5
)
 
2,773.0

Total assets
$
11,225.6

 
$
(5.5
)
 
$
11,220.1

Liabilities and Shareholders’ Equity
 
 
 
 
 
Other non-current liabilities
$
414.6

 
$
(0.4
)
 
$
414.2

Total non-current liabilities
3,790.7

 
(0.4
)
 
3,790.3

Total liabilities
5,328.3

 
(0.4
)
 
5,327.9

Shareholders’ equity
 
 
 
 
 
Controlling interest:
 
 
 
 
 
Accumulated deficit
(1,852.2
)
 
(5.1
)
 
(1,857.3
)
Total controlling interest
5,897.1

 
(5.1
)
 
5,892.0

Total shareholders’ equity
5,897.3

 
(5.1
)
 
5,892.2

Total liabilities and shareholders' equity
$
11,225.6

 
$
(5.5
)
 
$
11,220.1



Condensed Consolidated Statement of Cash Flows
 
Six Months Ended
 
June 30, 2018
(in millions)
As reported
 
Adjustments
 
Before adoption of ASC 606
Cash Flows From (For) Operating Activities
 
 
 
 
 
Net income
$
117.0

 
$
0.3

 
$
117.3

(Decreases) in cash due to:
 
 
 
 
 
Inventories
(99.3
)
 
1.1

 
(98.2
)
Accrued income taxes
(20.8
)
 
(0.1
)
 
(20.9
)
Other, net
(5.9
)
 
(1.3
)
 
(7.2
)
Subtotal
(106.0
)
 
(0.3
)
 
(106.3
)
Net cash from operating activities
$
254.7

 
$
—

 
$
254.7
XML 44 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Other Intangible Assets (Tables)
 6 Months Ended
Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill
Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):
 
 
December 31,
2017
 
Currency translation adjustments
 
June 30,
2018
CHCA
 
$
1,847.4

 
$
(2.0
)
 
$
1,845.4

CHCI
 
1,205.7

 
(30.6
)
 
1,175.1

RX
 
1,122.3

 
(5.3
)
 
1,117.0

Total goodwill
 
$
4,175.4

 
$
(37.9
)
 
$
4,137.5
Schedule of finite and indefinite-lived intangible assets
Other intangible assets and related accumulated amortization consisted of the following (in millions):
 
June 30, 2018
 
December 31, 2017
 
Gross
 
Accumulated Amortization
 
Gross
 
Accumulated Amortization
Definite-lived intangibles:
 
 
 
 
 
 
 
Distribution and license agreements and supply agreements
$
310.0

 
$
188.3

 
$
311.2

 
$
169.8

Developed product technology, formulations, and product rights
1,349.8

 
647.0

 
1,358.4

 
598.7

Customer relationships and distribution networks
1,608.7

 
513.2

 
1,642.0

 
460.6

Trademarks, trade names, and brands
1,304.3

 
159.8

 
1,335.4

 
129.5

Non-compete agreements
14.5

 
13.0

 
14.7

 
12.6

Total definite-lived intangibles
$
4,587.3

 
$
1,521.3

 
$
4,661.7

 
$
1,371.2

Indefinite-lived intangibles:
 
 
 
 
 
 
 
Trademarks, trade names, and brands
$
51.7

 
$
—

 
$
52.1

 
$
—

In-process research and development
37.9

 
—

 
38.2

 
—

Total indefinite-lived intangibles
89.6

 
—

 
90.3

 
—

Total other intangible assets
$
4,676.9

 
$
1,521.3

 
$
4,752.0

 
$
1,371.2
XML 45 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventories (Tables)
 6 Months Ended
Jun. 30, 2018
Inventory Disclosure [Abstract]  
Schedule of inventory, current
Major components of inventory were as follows (in millions):
 
 
June 30,
2018
 
December 31,
2017
Finished goods
$
485.7

 
$
454.3

Work in process
175.6

 
152.8

Raw materials
222.5

 
199.8

Total inventories
$
883.8

 
$
806.9
XML 46 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements (Tables)
 6 Months Ended
Jun. 30, 2018
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring and Nonrecurring Basis
The following table summarizes the valuation of our financial instruments carried at fair value and measured at fair value on a recurring and non-recurring basis by the above pricing categories (in millions):
 
 
June 30, 2018
 
December 31, 2017
 
 
Level 1
 
Level 2
 
Level 3
 
Level 1
 
Level 2
 
Level 3
Measured at fair value on a recurring basis:
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Investment securities
 
$
8.1

 
$
—

 
$
—

 
$
17.0

 
$
—

 
$
—

Foreign currency forward contracts
 
—

 
2.7

 
—

 
—

 
6.3

 
—

Funds associated with Israeli severance liability
 
—

 
14.2

 
—

 
—

 
16.3

 
—

Royalty Pharma contingent milestone payments
 
—

 
—

 
125.5

 
—

 
—

 
134.5

Total assets
 
$
8.1

 
$
16.9

 
$
125.5

 
$
17.0

 
$
22.6

 
$
134.5

 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
—

 
$
9.1

 
$
—

 
$
—

 
$
3.8

 
$
—

Contingent consideration
 
—

 
—

 
16.2

 
—

 
—

 
22.0

Total liabilities
 
$
—

 
$
9.1

 
$
16.2

 
$
—

 
$
3.8

 
$
22.0

 
 
 
 
 
 
 
 
 
 
 
 
 
Measured at fair value on a non-recurring basis:
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Definite-lived intangible assets
 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
11.5
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
The table below presents a reconciliation for the Royalty Pharma contingent milestone payments measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Change in fair value in the table was recorded in Change in financial assets on the Condensed Consolidated Statements of Operations.
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Royalty Pharma Contingent Milestone Payments
 
 
 
 
 
 
 
Beginning balance
$
124.9

 
$
184.5

 
$
134.5

 
$
—

Additions
—

 
—

 
—

 
184.5

Foreign currency effect
—

 
0.5

 
—

 
0.5

Change in fair value
0.6

 
(39.2
)
 
(9.0
)
 
(39.2
)
Ending balance
$
125.5

 
$
145.8

 
$
125.5

 
$
145.8
Reconciliation of Level 3 Liabilities
The table below presents a reconciliation for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Net realized losses in the table were recorded in Other operating expense (income) on the Condensed Consolidated Statements of Operations.
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Contingent Consideration
 
 
 
 
 
 
 
Beginning balance
$
18.1

 
$
52.0

 
$
22.0

 
$
69.9

Net realized (gains) losses
(1.8
)
 
(1.3
)
 
(1.4
)
 
(15.6
)
Currency translation adjustments
(0.1
)
 
1.4

 
—

 
1.3

Settlements
—

 
(2.4
)
 
(4.4
)
 
(5.9
)
Ending balance
$
16.2

 
$
49.7

 
$
16.2

 
$
49.7
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
Our fixed rate long-term debt consisted of public bonds, a retail bond and a private placement note as follows (in millions):
 
June 30, 2018
 
December 31, 2017
 
Level 1
 
Level 2
 
Level 1
 
Level 2
Public Bonds
 
 
 
 
 
 
 
Carrying Value (excluding discount)
$
2,600.0

 
 
 
$
2,600.0

 
 
Fair value
$
2,525.9

 
 
 
$
2,650.8

 
 
 
 
 
 
 
 
 
 
Retail bond and private placement note
 
 
 
 
 
 
 
Carrying value (excluding premium)
 
 
$
298.0

 
 
 
$
306.0

Fair value
 
 
$
326.7

 
 
 
$
342.1
XML 47 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments (Tables)
 6 Months Ended
Jun. 30, 2018
Investments [Abstract]  
Equity securities
The following table summarizes our equity security measurement category, balance sheet location, and balances (in millions):
Measurement Category
 
Balance Sheet Location
 
June 30,
2018
 
December 31,
2017(2)
Fair value method
 
Prepaid expenses and other current assets
 
$
8.1

 
$
17.0

Fair value method(1)
 
Other non-current assets
 
$
4.6

 
$
6.3

Equity method
 
Other non-current assets
 
$
13.1

 
$
4.9


(1) The June 30, 2018 equity securities are measured at fair value using the Net Asset Value practical expedient.
(2) The December 31, 2017 balances presented reflect historical recognition and measurement investment categories existing prior to the adoption of ASU 2016-01, which include available for sale and cost method securities.
Equity security expense (income)
The following table summarizes our equity security expense (income) recognized in earnings (in millions):
 
 
 
 
Three Months Ended
 
Six Months Ended
Measurement Category
 
Income Statement Location
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Fair value method
 
Other expense, net
 
$
6.3

 
$
—

 
$
10.6

 
$
—

Equity method
 
Other expense, net
 
$
(0.9
)
 
$
(0.2
)
 
$
(0.7
)
 
$
(0.3
)
XML 48 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Instruments and Hedging Activities (Tables)
 6 Months Ended
Jun. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of derivative instruments in statement of financial position, fair value
The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:
 
Asset Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
June 30,
2018
 
December 31,
2017
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Prepaid expenses and other current assets
 
$
2.1

 
$
4.1

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Prepaid expenses and other current assets
 
$
0.6

 
$
2.2

 
Liability Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
June 30,
2018
 
December 31,
2017
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
5.0

 
$
1.4

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
4.1

 
$
2.4
Amount of Gain/(Loss) Recorded in OCI (Effective Portion)
The gains (losses) recorded in OCI for the effective portion of our designated cash flow hedges were as follows:
 
 
Amount of Gain/(Loss) Recorded in OCI
(Effective Portion)
 
 
Three Months Ended
 
Six Months Ended
Designated Cash Flow Hedges
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Foreign currency forward contracts
 
$
(4.3
)
 
$
2.7

 
$
(4.3
)
 
$
5.2
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion)
The gains (losses) reclassified from Accumulated other comprehensive income ("AOCI") into earnings for the effective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Reclassified from AOCI into Earnings
(Effective Portion)
 
 
 
 
Three Months Ended
 
Six Months Ended
Designated Cash Flow Hedges
 
Income Statement Location
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Interest rate swap agreements
 
Interest expense, net
 
$
(0.4
)
 
$
(0.6
)
 
$
(0.9
)
 
$
(1.3
)
 
 
Other expense, net
 
—

 
(5.9
)
 
—

 
(5.9
)
Foreign currency forward contracts
 
Net sales
 
—

 
0.6

 
—

 
0.9

 
 
Cost of sales
 
1.6

 
0.9

 
3.9

 
1.6

 
 
Interest expense, net
 
(1.1
)
 
(0.5
)
 
(2.0
)
 
(1.1
)
 
 
Other expense, net
 
(0.1
)
 
—

 
(0.5
)
 
(0.5
)
Total
 
 
 
$
—

 
$
(5.5
)
 
$
0.5

 
$
(6.3
)
Amount of Gain/(Loss) Recognized in Earnings (Ineffective Portion)
The gains (losses) recognized in earnings for the ineffective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized in Earnings
(Ineffective Portion)
 
 
 
 
Three Months Ended
 
Six Months Ended
Designated Cash Flow Hedges
 
Income Statement
Location
 
July 1,
2017
 
July 1,
2017
Foreign currency forward contracts
 
Other expense, net
 
$
0.1

 
$
1.0
Amount of Gain/(Loss) Recognized against Earnings
The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized against Earnings
 
 
 
 
Three Months Ended
 
Six Months Ended
Non-Designated Derivatives
 
Income Statement Location
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Foreign currency forward contracts
 
Other expense, net
 
$
11.8

 
$
(5.0
)
 
$
8.6

 
$
(13.9
)
 
 
Interest expense, net
 
0.2

 
(0.7
)
 
(0.7
)
 
(1.1
)
Total
 
 
 
$
12.0

 
$
(5.7
)
 
$
7.9

 
$
(15.0
)
XML 49 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Indebtedness (Tables)
 6 Months Ended
Jun. 30, 2018
Debt Disclosure [Abstract]  
Schedule of debt
Total borrowings outstanding are summarized as follows (in millions):
 
 
 
 
 
June 30,
2018
 
December 31,
2017
Term loans
 
 
 
 
 
 
2018 Term loan due March 8, 2020(1)
 
 
$
383.5

 
$
—

 
2014 Term loan due December 5, 2019(1)
 
 
—

 
420.0

 
Total term loans
 
 
383.5

 
420.0

Notes and Bonds
 
 
 
 
 
 
Coupon
Due
 
 
 
 
 
 
5.000%
May 23, 2019(1)
 
 
140.2

 
144.0

 
3.500%
March 15, 2021
 
 
280.4

 
280.4

 
3.500%
December 15, 2021
 
 
309.6

 
309.6

 
5.105%
July 19, 2023(1)
 
 
157.8

 
162.0

 
4.000%
November 15, 2023
 
 
215.6

 
215.6

 
3.900%
December 15, 2024
 
 
700.0

 
700.0

 
4.375%
March 15, 2026
 
 
700.0

 
700.0

 
5.300%
November 15, 2043
 
 
90.5

 
90.5

 
4.900%
December 15, 2044
 
 
303.9

 
303.9

 
Total notes and bonds
 
 
2,898.0

 
2,906.0

Other financing
3.0

 
11.7

Unamortized premium (discount), net
16.6

 
21.4

Deferred financing fees
(18.1
)
 
(17.9
)
Total borrowings outstanding
3,283.0

 
3,341.2

 
Current indebtedness
(197.7
)
 
(70.4
)
Total long-term debt less current portion
$
3,085.3

 
$
3,270.8



(1) 
Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.
Schedule of extinguishment of debt
As a result of early redemption and tender offer transactions during the three months ended July 1, 2017, we recorded a loss of $135.2 million in Loss on extinguishment of debt on our Condensed Consolidated Statements of Operations (in millions):
Premium on debt repayment
 
$
116.1

Transaction costs
 
3.8

Write-off of deferred financing fees
 
10.6

Write-off of remaining discount on bond
 
4.7

Total loss on extinguishment of debt
 
$
135.2
XML 50 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share and Shareholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2018
Earnings Per Share [Abstract]  
Schedule of earnings per share, basic and diluted
A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Numerator:
 
 
 
 
 
 
 
Net income (loss)
$
36.2

 
$
(69.6
)
 
$
117.0

 
$
2.0

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding for basic EPS
138.1

 
143.3

 
139.5

 
143.3

Dilutive effect of share-based awards*
0.6

 
—

 
0.5

 
0.3

Weighted average shares outstanding for diluted EPS
138.7

 
143.3

 
140.0

 
143.6

 
 
 
 
 
 
 
 
Anti-dilutive share-based awards excluded from computation of diluted EPS
1.7

 
—

 
0.9

 
0.8



* In the period of a net loss, diluted shares equal basic shares.
Schedule of share-based compensation, stock options, activity
We issued shares related to the exercise and vesting of share-based compensation as follows:
Three Months Ended
 
Six Months Ended
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
74,000

 
31,900

 
127,000

 
46,400
XML 51 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Accumulated Other Comprehensive Income (Loss) (Tables)
 6 Months Ended
Jun. 30, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Schedule of accumulated other comprehensive income (loss)
Changes in our AOCI balances, net of tax were as follows (in millions):
 
Fair value of derivative financial instruments, net of tax
 
Foreign currency translation adjustments
 
Fair value of investment securities, net of tax
 
Post-retirement and pension liability adjustments, net of tax
 
Total AOCI
Balance at December 31, 2017
$
(9.8
)
 
$
260.6

 
$
1.0

 
$
1.3

 
$
253.1

ASU 2016-01 adoption impact
—

 
—

 
(1.0
)
 
—

 
(1.0
)
Balance at December 31, 2017 after adoption impact
$
(9.8
)
 
$
260.6


$
—


$
1.3


$
252.1

OCI before reclassifications
(3.6
)
 
(92.6
)
 
—

 
(0.4
)
 
(96.6
)
Amounts reclassified from AOCI
(0.5
)
 
—

 
—

 
—

 
(0.5
)
Other comprehensive income
$
(4.1
)
 
$
(92.6
)
 
$
—

 
$
(0.4
)
 
$
(97.1
)
Balance at June 30, 2018
$
(13.9
)
 
$
168.0

 
$
—

 
$
0.9

 
$
155.0
XML 52 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes Income Taxes (Tables)
 6 Months Ended
Jun. 30, 2018
Income Tax Disclosure [Abstract]  
Schedule of effective income tax rate reconciliation
The effective tax rates were as follows:
Three Months Ended
 
Six Months Ended
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
34.5
%
 
8.7
%
 
29.4
%
 
89.9
%
XML 53 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring Charges (Tables)
 6 Months Ended
Jun. 30, 2018
Restructuring Charges [Abstract]  
Restructuring and related costs
The following reflects our restructuring activity (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Beginning balance
$
12.4

 
$
51.5

 
$
21.4

 
$
19.7

Additional charges
3.7

 
12.1

 
5.2

 
50.8

Payments
(3.1
)
 
(23.6
)
 
(13.8
)
 
(30.7
)
Non-cash adjustments
(0.3
)
 
(0.3
)
 
(0.1
)
 
(0.1
)
Ending balance
$
12.7

 
$
39.7

 
$
12.7

 
$
39.7
XML 54 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Schedule of segment reporting information, by segment
The below tables show select financial measures by reporting segment (in millions):
 
 
Total Assets
 
 
June 30,
2018
 
December 31,
2017
CHCA
 
$
3,673.0

 
$
3,786.8

CHCI
 
4,799.4

 
5,029.0

RX
 
2,753.2

 
2,813.0

Total
 
$
11,225.6

 
$
11,628.8

 
Three Months Ended
 
June 30, 2018
 
July 1, 2017
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHCA
$
596.8

 
$
57.4

 
$
15.3

 
$
604.9

 
$
104.2

 
$
17.0

CHCI
381.0

 
5.6

 
49.5

 
376.5

 
3.9

 
47.5

RX
208.6

 
56.9

 
20.5

 
240.4

 
69.3

 
22.3

Other
—

 
—

 
—

 
16.1

 
4.1

 
0.4

Unallocated
—

 
(25.2
)
 
—

 
—

 
(32.7
)
 
—

Total
$
1,186.4

 
$
94.7

 
$
85.3

 
$
1,237.9

 
$
148.8

 
$
87.2


 
Six Months Ended
 
June 30, 2018
 
July 1, 2017
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHCA
$
1,198.4

 
$
170.5

 
$
30.5

 
$
1,187.6

 
$
179.2

 
$
34.2

CHCI
782.4

 
20.4

 
100.8

 
751.5

 
4.2

 
93.2

RX
422.6

 
118.7

 
41.1

 
457.8

 
157.5

 
44.6

Other
—

 
—

 
—

 
35.0

 
9.7

 
0.8

Unallocated
—

 
(58.7
)
 
—

 
—

 
(73.3
)
 
—

Total
$
2,403.4

 
$
250.9

 
$
172.4

 
$
2,431.9

 
$
277.3

 
$
172.8
XML 55 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Schedule of Revenue by Geographic Location (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Disaggregation of Revenue [Line Items]        
Net sales $ 1,186.4 [1] $ 1,237.9 $ 2,403.4 [1] $ 2,431.9
U.S.        
Disaggregation of Revenue [Line Items]        
Net sales [1] 772.3   1,558.7  
Europe        
Disaggregation of Revenue [Line Items]        
Net sales [1],[2] 344.3   706.2  
All other countries        
Disaggregation of Revenue [Line Items]        
Net sales [1],[3] 69.8   138.5  
Ireland        
Disaggregation of Revenue [Line Items]        
Net sales $ 5.0   $ 10.4  
[1] The net sales by geography is derived from the location of the entity that sells to a third party.
[2] Includes Ireland net sales of $5.0 million and $10.4 million for the three and six months ended June 30, 2018, respectively.
[3] Includes net sales generated primarily in Israel, Mexico, Australia and Canada.
XML 56 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Schedule of Revenue by Product (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Disaggregation of Revenue [Line Items]        
Net sales $ 1,186.4 [1] $ 1,237.9 $ 2,403.4 [1] $ 2,431.9
CHCA        
Disaggregation of Revenue [Line Items]        
Net sales 596.8 604.9 1,198.4 1,187.6
CHCA | Cough/Cold/Allergy/Sinus        
Disaggregation of Revenue [Line Items]        
Net sales [2] 109.3   250.8  
CHCA | Infant Nutritionals        
Disaggregation of Revenue [Line Items]        
Net sales 109.2   212.6  
CHCA | Gastrointestinal        
Disaggregation of Revenue [Line Items]        
Net sales [2] 103.0   195.2  
CHCA | Analgesics        
Disaggregation of Revenue [Line Items]        
Net sales [2] 92.2   185.9  
CHCA | Smoking Cessation        
Disaggregation of Revenue [Line Items]        
Net sales 71.2   137.1  
CHCA | Animal Health        
Disaggregation of Revenue [Line Items]        
Net sales 31.9   58.2  
CHCA | Vitamins, Minerals and Dietary Supplements        
Disaggregation of Revenue [Line Items]        
Net sales [2] 4.3   7.3  
CHCA | Other CHCA        
Disaggregation of Revenue [Line Items]        
Net sales [2],[3] 75.7   151.3  
CHCI        
Disaggregation of Revenue [Line Items]        
Net sales 381.0 376.5 782.4 751.5
CHCI | Lifestyle        
Disaggregation of Revenue [Line Items]        
Net sales 86.1   175.8  
CHCI | Cough, Cold, and Allergy        
Disaggregation of Revenue [Line Items]        
Net sales 84.7   183.4  
CHCI | Personal Care and Derma-Therapeutics        
Disaggregation of Revenue [Line Items]        
Net sales 79.7   155.3  
CHCI | Anti-Parasite        
Disaggregation of Revenue [Line Items]        
Net sales 30.4   58.5  
CHCI | Natural Health and Vitamins, Minerals and Dietary Supplements        
Disaggregation of Revenue [Line Items]        
Net sales 27.9   61.1  
CHCI | Other CHCI        
Disaggregation of Revenue [Line Items]        
Net sales [4] 72.2   148.3  
RX        
Disaggregation of Revenue [Line Items]        
Net sales $ 208.6 $ 240.4 $ 422.6 $ 457.8
[1] The net sales by geography is derived from the location of the entity that sells to a third party.
[2] Includes net sales from our OTC contract manufacturing business.
[3] Consists primarily of branded OTC, diabetic care, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.
[4] Consists primarily of liquid licensed products, diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.
XML 57 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2018
Revenue from Contract with Customer [Abstract]    
Contract manufacturing revenue $ 77.1 $ 146.5
XML 58 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Schedule of Contract Balances (Details) - USD ($)
$ in Millions
Jun. 30, 2018
Jan. 01, 2018
Revenue from Contract with Customer [Abstract]    
Short-term contract assets $ 19.2 $ 20.5
XML 59 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Schedule of ASC 606 Impact on Statement of Operations (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Net sales $ 1,186.4 [1] $ 1,237.9 $ 2,403.4 [1] $ 2,431.9
Cost of sales 715.4 733.3 1,439.7 1,463.0
Gross profit 471.0 504.6 963.7 968.9
Operating income 94.7 148.8 250.9 277.3
Income tax expense (benefit) 19.1 (6.7) 48.8 17.6
Net income (loss) $ 36.2 $ (69.6) $ 117.0 $ 2.0
Earnings per share        
Basic (in dollars per share) $ 0.26 $ (0.49) $ 0.84 $ 0.01
Diluted (in dollars per share) $ 0.26 $ (0.49) $ 0.84 $ 0.01
Adjustments | Accounting Standards Update 2014-09        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Net sales $ 6.9   $ 1.3  
Cost of sales 4.2   1.1  
Gross profit 2.7   0.2  
Operating income 2.7   0.2  
Income tax expense (benefit) (0.1)   (0.1)  
Net income (loss) $ 2.8   $ 0.3  
Earnings per share        
Basic (in dollars per share) $ 0.02   $ 0.00  
Diluted (in dollars per share) $ 0.02   $ 0.00  
Balances without adoption of ASC 606        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Net sales $ 1,193.3   $ 2,404.7  
Cost of sales 719.6   1,440.8  
Gross profit 473.7   963.9  
Operating income 97.4   251.1  
Income tax expense (benefit) 19.0   48.7  
Net income (loss) $ 39.0   $ 117.3  
Earnings per share        
Basic (in dollars per share) $ 0.28   $ 0.84  
Diluted (in dollars per share) $ 0.28   $ 0.84  
[1] The net sales by geography is derived from the location of the entity that sells to a third party.
XML 60 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Schedule of ASC 606 Impact on Comprehensive Income (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Net income (loss) $ 36.2 $ (69.6) $ 117.0 $ 2.0
Comprehensive income (loss) (133.1) $ 87.2 19.9 $ 214.3
Adjustments | Accounting Standards Update 2014-09        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Net income (loss) 2.8   0.3  
Comprehensive income (loss) 2.8   0.3  
Balances without adoption of ASC 606        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Net income (loss) 39.0   117.3  
Comprehensive income (loss) $ (130.3)   $ 20.2  
XML 61 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Schedule of ASC 606 Impact on Balance Sheet (Details) - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Assets    
Inventories $ 883.8 $ 806.9
Prepaid expenses and other current assets 238.4 203.2
Total current assets 2,778.5 2,819.6
Total assets 11,225.6 11,628.8
Liabilities and Shareholders’ Equity    
Other non-current liabilities 414.6 429.5
Total non-current liabilities 3,790.7 4,022.2
Total liabilities 5,328.3 5,458.2
Accumulated deficit    
Accumulated deficit (1,852.2) (1,975.5)
Total controlling interest 5,897.1 6,170.5
Total shareholders’ equity 5,897.3 6,170.6
Total liabilities and shareholders' equity 11,225.6 $ 11,628.8
Adjustments | Accounting Standards Update 2014-09    
Assets    
Inventories 13.7  
Prepaid expenses and other current assets (19.2)  
Total current assets (5.5)  
Total assets (5.5)  
Liabilities and Shareholders’ Equity    
Other non-current liabilities (0.4)  
Total non-current liabilities (0.4)  
Total liabilities (0.4)  
Accumulated deficit    
Accumulated deficit (5.1)  
Total controlling interest (5.1)  
Total shareholders’ equity (5.1)  
Total liabilities and shareholders' equity (5.5)  
Balances without adoption of ASC 606    
Assets    
Inventories 897.5  
Prepaid expenses and other current assets 219.2  
Total current assets 2,773.0  
Total assets 11,220.1  
Liabilities and Shareholders’ Equity    
Other non-current liabilities 414.2  
Total non-current liabilities 3,790.3  
Total liabilities 5,327.9  
Accumulated deficit    
Accumulated deficit (1,857.3)  
Total controlling interest 5,892.0  
Total shareholders’ equity 5,892.2  
Total liabilities and shareholders' equity $ 11,220.1  
XML 62 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Schedule of ASC 606 Impact on Statement of Cash Flows (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Net income (loss) $ 36.2 $ (69.6) $ 117.0 $ 2.0
(Decreases) in cash due to:        
Inventories     (99.3) (4.6)
Accrued income taxes     (20.8) (85.8)
Other, net     (5.9) (13.3)
Subtotal     (106.0) (159.0)
Net cash from operating activities     254.7 $ 285.3
Adjustments | Accounting Standards Update 2014-09        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Net income (loss) 2.8   0.3  
(Decreases) in cash due to:        
Inventories     (1.1)  
Accrued income taxes     (0.1)  
Other, net     (1.3)  
Subtotal     (0.3)  
Net cash from operating activities     0.0  
Balances without adoption of ASC 606        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Net income (loss) $ 39.0   117.3  
(Decreases) in cash due to:        
Inventories     (98.2)  
Accrued income taxes     (20.9)  
Other, net     (7.2)  
Subtotal     (106.3)  
Net cash from operating activities     $ 254.7  
XML 63 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisitions and Divestitures (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
May 29, 2018
Apr. 06, 2017
Feb. 01, 2017
Jan. 03, 2017
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Dec. 31, 2016
Business Acquisition [Line Items]                  
Non-refundable upfront license fee         $ 91.9 $ 42.6 $ 130.3 $ 82.3  
Net proceeds from sale of business and other assets             $ 1.3 $ 37.2  
RX                  
Business Acquisition [Line Items]                  
Net proceeds from sale of business and other assets       $ 15.0          
CHCA                  
Business Acquisition [Line Items]                  
Net proceeds from sale of business and other assets     $ 7.7            
Other                  
Business Acquisition [Line Items]                  
Net proceeds from sale of business and other assets   $ 22.2              
Impairment charge                 $ 35.3
Merck Sharp & Dohme License Agreement | CHCA                  
Business Acquisition [Line Items]                  
Non-refundable upfront license fee $ 50.0                
XML 64 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Other Intangible Assets - Goodwill (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2018
USD ($)
Goodwill [Roll Forward]  
December 31, 2017 $ 4,175.4
Currency translation adjustments (37.9)
June 30, 2018 4,137.5
CHCA  
Goodwill [Roll Forward]  
December 31, 2017 1,847.4
Currency translation adjustments (2.0)
June 30, 2018 1,845.4
CHCI  
Goodwill [Roll Forward]  
December 31, 2017 1,205.7
Currency translation adjustments (30.6)
June 30, 2018 1,175.1
RX  
Goodwill [Roll Forward]  
December 31, 2017 1,122.3
Currency translation adjustments (5.3)
June 30, 2018 $ 1,117.0
XML 65 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Other Intangible Assets - Intangible categories (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Apr. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Dec. 31, 2017
Finite And Indefinite Lived Assets By Major Class [Line Items]            
Gross $ 4,587.3     $ 4,587.3   $ 4,661.7
Accumulated Amortization 1,521.3     1,521.3   1,371.2
Indefinite-lived intangibles: 89.6     89.6   90.3
Total other intangible assets 4,676.9     4,676.9   4,752.0
Intangible assets amortization expense 85.3 $ 87.2   172.4 $ 172.8  
Trademarks, trade names, and brands            
Finite And Indefinite Lived Assets By Major Class [Line Items]            
Indefinite-lived intangibles: 51.7     51.7   52.1
In-process research and development            
Finite And Indefinite Lived Assets By Major Class [Line Items]            
Indefinite-lived intangibles: 37.9     37.9   38.2
Distribution and license agreements and supply agreements            
Finite And Indefinite Lived Assets By Major Class [Line Items]            
Gross 310.0     310.0   311.2
Accumulated Amortization 188.3     188.3   169.8
Developed product technology, formulations, and product rights            
Finite And Indefinite Lived Assets By Major Class [Line Items]            
Gross 1,349.8     1,349.8   1,358.4
Accumulated Amortization 647.0     647.0   598.7
Customer relationships and distribution networks            
Finite And Indefinite Lived Assets By Major Class [Line Items]            
Gross 1,608.7     1,608.7   1,642.0
Accumulated Amortization 513.2     513.2   460.6
Trademarks, trade names, and brands            
Finite And Indefinite Lived Assets By Major Class [Line Items]            
Gross 1,304.3     1,304.3   1,335.4
Accumulated Amortization 159.8     159.8   129.5
Non-compete agreements            
Finite And Indefinite Lived Assets By Major Class [Line Items]            
Gross 14.5     14.5   14.7
Accumulated Amortization 13.0     13.0   $ 12.6
RX            
Finite And Indefinite Lived Assets By Major Class [Line Items]            
Intangible assets amortization expense $ 20.5 22.3   $ 41.1 $ 44.6  
Impairment charge   $ 18.5 $ 12.2      
XML 66 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventories (Details) - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Inventory Disclosure [Abstract]    
Finished goods $ 485.7 $ 454.3
Work in process 175.6 152.8
Raw materials 222.5 199.8
Total inventories $ 883.8 $ 806.9
XML 67 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Financial Instruments at Fair Value (Details) - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Measured at fair value on a recurring basis: | Level 1    
Assets:    
Investment securities $ 8.1 $ 17.0
Foreign currency forward contracts 0.0 0.0
Funds associated with Israeli severance liability 0.0 0.0
Royalty Pharma contingent milestone payments 0.0 0.0
Total assets 8.1 17.0
Liabilities:    
Foreign currency forward contracts 0.0 0.0
Contingent consideration 0.0 0.0
Total liabilities 0.0 0.0
Measured at fair value on a recurring basis: | Level 2    
Assets:    
Investment securities 0.0 0.0
Foreign currency forward contracts 2.7 6.3
Funds associated with Israeli severance liability 14.2 16.3
Royalty Pharma contingent milestone payments 0.0 0.0
Total assets 16.9 22.6
Liabilities:    
Foreign currency forward contracts 9.1 3.8
Contingent consideration 0.0 0.0
Total liabilities 9.1 3.8
Measured at fair value on a recurring basis: | Level 3    
Assets:    
Investment securities 0.0 0.0
Foreign currency forward contracts 0.0 0.0
Funds associated with Israeli severance liability 0.0 0.0
Royalty Pharma contingent milestone payments 125.5 134.5
Total assets 125.5 134.5
Liabilities:    
Foreign currency forward contracts 0.0 0.0
Contingent consideration 16.2 22.0
Total liabilities 16.2 22.0
Measured at fair value on a non-recurring basis: | Level 1    
Liabilities:    
Definite-lived intangible assets 0.0 0.0
Measured at fair value on a non-recurring basis: | Level 2    
Liabilities:    
Definite-lived intangible assets 0.0 0.0
Measured at fair value on a non-recurring basis: | Level 3    
Liabilities:    
Definite-lived intangible assets $ 0.0 $ 11.5
XML 68 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Additional Information (Details)
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 27, 2017
USD ($)
Jun. 30, 2018
USD ($)
Jul. 01, 2017
USD ($)
Jun. 30, 2018
USD ($)
Jul. 01, 2017
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Mar. 31, 2018
USD ($)
Apr. 01, 2017
USD ($)
Dec. 31, 2016
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Transfers among level 1, 2, and 3   $ 0   $ 0       $ 0      
Cash proceeds from divestiture of businesses       1,300,000 $ 37,200,000            
Change in financial assets   600,000 $ (38,700,000) (9,000,000) (21,600,000)            
Net gain on reduction of contingent consideration         15,600,000            
Measured on a recurring basis | Level 3                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Potential contingent milestone payments   125,500,000   125,500,000       134,500,000      
Royalty Pharma Contingent Milestone Payments | Measured on a recurring basis | Level 3                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Potential contingent milestone payments                   $ 184,500,000  
Increase (decrease) in fair value of milestone payment   600,000 (39,200,000) (9,000,000) (39,200,000)            
Estimated fair valued contingent milestone payment   125,500,000 145,800,000 $ 125,500,000 $ 145,800,000     $ 134,500,000 $ 124,900,000 $ 184,500,000 $ 0
Royalty Pharma 2018 Contingent Milestone Payments | Measured on a recurring basis | Level 3                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Increase (decrease) in fair value of milestone payment   (2,900,000)                  
Royalty Pharma 2020 Contingent Milestone Payments | Measured on a recurring basis | Level 3                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Increase (decrease) in fair value of milestone payment   $ 3,500,000                  
Scenario, Forecast                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Potential contingent milestone payments           $ 60,200,000 $ 65,300,000        
Fair value adjustment           400,000,000 250,000,000        
Change in financial assets           339,800,000 184,700,000        
Net sales threshold for milestone payment           $ 1,950,000,000 $ 1,850,000,000        
Specialty Sciences                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Gain related to Royalty Pharma     $ 17,100,000                
Royalty Pharma                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Sale price of divestiture - cash plus non-cash $ 2,850,000,000                    
Cash proceeds from divestiture of businesses 2,200,000,000                    
2018 milestone payment 250,000,000                    
2020 milestone payment $ 400,000,000                    
Rate of return       8.09% 8.05%            
Measurement Input, Price Volatility | Royalty Pharma                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Volatility rate assumed   0.300 0.300 0.300 0.300            
XML 69 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details) - Measured on a recurring basis - Level 3 - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Contingent consideration        
Contingent Consideration        
Beginning balance $ 18.1 $ 52.0 $ 22.0 $ 69.9
Net realized (gains) losses (1.8) (1.3) (1.4) (15.6)
Currency translation adjustments (0.1) 1.4 0.0 1.3
Settlements 0.0 (2.4) (4.4) (5.9)
Ending balance 16.2 49.7 16.2 49.7
Royalty Pharma Contingent Milestone Payments        
Royalty Pharma Contingent Milestone Payments        
Beginning balance 124.9 184.5 134.5 0.0
Additions 0.0 0.0 0.0 184.5
Foreign currency effect 0.0 0.5 0.0 0.5
Change in fair value 0.6 (39.2) (9.0) (39.2)
Ending balance $ 125.5 $ 145.8 $ 125.5 $ 145.8
XML 70 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details) - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Public bonds $ 2,898.0 $ 2,906.0
Public bonds | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Public bonds 2,525.9 2,650.8
Retail Bonds | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Retail bond and private placement note 326.7 342.1
Reported Value Measurement | Public bonds | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Public bonds 2,600.0 2,600.0
Reported Value Measurement | Retail Bonds | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Retail bond and private placement note $ 298.0 $ 306.0
XML 71 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Dec. 31, 2017
ASU 2016-01          
Schedule of Equity Method Investments [Line Items]          
Reclassification from OCI         $ 1.0
Other expense, net          
Schedule of Equity Method Investments [Line Items]          
Equity securities, fair value method, other expense (income) $ 6.3 $ 0.0 $ 10.6 $ 0.0  
Equity securities, equity method, other expense (income) (0.9) $ (0.2) (0.7) $ (0.3)  
Prepaid expenses and other current assets          
Schedule of Equity Method Investments [Line Items]          
Equity securities, fair value method 8.1   8.1    
Equity securities, fair value method, previous year [1]         17.0
Other non-current assets          
Schedule of Equity Method Investments [Line Items]          
Equity securities, fair value method [2] 4.6   4.6    
Equity securities, fair value method, previous year [1]         6.3
Equity securities, equity method, other non-current assets 13.1   $ 13.1   4.9 [1]
Retained Earnings | ASU 2016-01          
Schedule of Equity Method Investments [Line Items]          
Reclassification to retained earnings         $ 1.4
Zibo Xinhua          
Schedule of Equity Method Investments [Line Items]          
Increase in investment in Zibo Xinhua $ 7.5        
[1] The December 31, 2017 balances presented reflect historical recognition and measurement investment categories existing prior to the adoption of ASU 2016-01, which include available for sale and cost method securities.
[2] The June 30, 2018 equity securities are measured at fair value using the Net Asset Value practical expedient.
XML 72 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Instruments and Hedging Activities - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jul. 01, 2017
Jul. 01, 2017
Jun. 30, 2018
Dec. 31, 2017
Derivative [Line Items]        
Amount of gain (loss) recognized against earnings   $ 5.9    
Amount expected to be reclassified out of AOCI during the next 12 months     $ (5.2)  
4.00% Unsecured Senior Notes due November 15, 2023        
Derivative [Line Items]        
Repayments of debt $ 584.4      
Interest rate, stated percentage 4.00% 4.00%    
5.30% Unsecured Senior Notes due November 15, 2043        
Derivative [Line Items]        
Repayments of debt $ 309.5      
Interest rate, stated percentage 5.30% 5.30%    
Foreign currency forward contracts        
Derivative [Line Items]        
Notional amount of derivatives     $ 594.2 $ 592.3
XML 73 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Instruments and Hedging Activities - Balance Sheet Location (Details) - Foreign currency forward contracts - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Designated derivatives: | Prepaid expenses and other current assets    
Derivatives, Fair Value [Line Items]    
Asset Derivatives $ 2.1 $ 4.1
Designated derivatives: | Accrued liabilities    
Derivatives, Fair Value [Line Items]    
Liability Derivatives 5.0 1.4
Non-designated derivatives: | Prepaid expenses and other current assets    
Derivatives, Fair Value [Line Items]    
Asset Derivatives 0.6 2.2
Non-designated derivatives: | Accrued liabilities    
Derivatives, Fair Value [Line Items]    
Liability Derivatives $ 4.1 $ 2.4
XML 74 R56.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Instruments and Hedging Activities - Other Comprehensive Income Movement (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Other expense, net | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings (Ineffective Portion)   $ 0.1   $ 1.0
Designated derivatives:        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion) $ 0.0 (5.5) $ 0.5 (6.3)
Designated derivatives: | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Amount of Gain/(Loss) Recorded in OCI (Effective Portion) (4.3) 2.7 (4.3) 5.2
Designated derivatives: | Interest expense, net | Interest Rate Swap        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion) (0.4) (0.6) (0.9) (1.3)
Designated derivatives: | Interest expense, net | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion) (1.1) (0.5) (2.0) (1.1)
Designated derivatives: | Other expense, net | Interest Rate Swap        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion) 0.0 (5.9) 0.0 (5.9)
Designated derivatives: | Other expense, net | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion) (0.1) 0.0 (0.5) (0.5)
Designated derivatives: | Net sales | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion) 0.0 0.6 0.0 0.9
Designated derivatives: | Cost of sales | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion) $ 1.6 $ 0.9 $ 3.9 $ 1.6
XML 75 R57.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized against Earnings       $ (5.9)
Non-designated derivatives:        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized against Earnings $ 12.0 $ (5.7) $ 7.9 (15.0)
Foreign currency forward contracts | Other expense, net | Non-designated derivatives:        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized against Earnings 11.8 (5.0) 8.6 (13.9)
Foreign currency forward contracts | Interest expense, net | Non-designated derivatives:        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized against Earnings $ 0.2 $ (0.7) $ (0.7) $ (1.1)
XML 76 R58.htm IDEA: XBRL DOCUMENT v3.10.0.1
Indebtedness - Schedule of Borrowings Outstanding (Details) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2018
Dec. 31, 2017
Debt Instrument [Line Items]    
Term loans $ 383.5 $ 420.0
Senior notes 2,898.0 2,906.0
Other financing 3.0 11.7
Unamortized premium (discount), net 16.6 21.4
Deferred financing fees (18.1) (17.9)
Total borrowings outstanding 3,283.0 3,341.2
Current indebtedness (197.7) (70.4)
Long-term debt, less current portion $ 3,085.3 3,270.8
2018 Euro-Denominated Term Loan due March 8, 2020    
Debt Instrument [Line Items]    
Series [1] 2018 Term loan due March 8, 2020(1)  
Term loans $ 383.5 0.0
2014 Term loan due December 5, 2019    
Debt Instrument [Line Items]    
Series [1] 2014 Term loan due December 5, 2019(1)  
Term loans $ 0.0 420.0
5.000% Unsecured Senior notes due May 23, 2019    
Debt Instrument [Line Items]    
Series [1] May 23, 2019(1)  
Interest rate, stated percentage 5.00%  
Senior notes $ 140.2 144.0
3.500% Unsecured Senior notes due March 15, 2021    
Debt Instrument [Line Items]    
Interest rate, stated percentage 3.50%  
Debt due date Mar. 15, 2021  
Senior notes $ 280.4 280.4
3.5% Senior note due December 15, 2021    
Debt Instrument [Line Items]    
Interest rate, stated percentage 3.50%  
Debt due date Dec. 15, 2021  
Senior notes $ 309.6 309.6
5.105% Senior note due July 19, 2023    
Debt Instrument [Line Items]    
Series [1] July 19, 2023(1)  
Interest rate, stated percentage 5.1045%  
Senior notes $ 157.8 162.0
4.00% Unsecured Senior Notes due November 15, 2023    
Debt Instrument [Line Items]    
Interest rate, stated percentage 4.00%  
Debt due date Nov. 15, 2023  
Senior notes $ 215.6 215.6
3.9% senior note due December 15, 2024    
Debt Instrument [Line Items]    
Interest rate, stated percentage 3.90%  
Debt due date Dec. 15, 2024  
Senior notes $ 700.0 700.0
4.375% senior note due March 15, 2026    
Debt Instrument [Line Items]    
Interest rate, stated percentage 4.375%  
Debt due date Mar. 15, 2026  
Senior notes $ 700.0 700.0
5.30% unsecured senior notes due November 15, 2043    
Debt Instrument [Line Items]    
Interest rate, stated percentage 5.30%  
Debt due date Nov. 15, 2043  
Senior notes $ 90.5 90.5
4.9% senior notes due December 15, 2044    
Debt Instrument [Line Items]    
Interest rate, stated percentage 4.90%  
Debt due date Dec. 15, 2044  
Senior notes $ 303.9 $ 303.9
[1] Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.
XML 77 R59.htm IDEA: XBRL DOCUMENT v3.10.0.1
Indebtedness - Additional Information (Details)
 3 Months Ended 6 Months Ended
Dec. 05, 2014
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Jul. 01, 2017
USD ($)
Jun. 30, 2018
USD ($)
Jul. 01, 2017
USD ($)
Mar. 08, 2018
USD ($)
Mar. 08, 2018
EUR (€)
Dec. 31, 2017
USD ($)
Mar. 30, 2015
USD ($)
Dec. 05, 2014
EUR (€)
Debt Instrument [Line Items]                      
Debt instrument, issuance date Dec. 05, 2014                    
Loss on extinguishment of debt   $ 0 $ 500,000 $ 135,200,000 $ 500,000 $ 135,200,000          
Outstanding balance   0     0       $ 6,900,000    
2014 Term loan due December 5, 2019                      
Debt Instrument [Line Items]                      
Face amount of debt $ 614,300,000             € 350,000,000     € 500,000,000
2018 Euro-Denominated Term Loan due March 8, 2020                      
Debt Instrument [Line Items]                      
Face amount of debt             $ 431,000,000 € 350,000,000      
Repayments of debt         26,300,000            
2014 Revolver                      
Debt Instrument [Line Items]                      
Face amount of debt $ 600,000,000                    
Maximum borrowing capacity                   $ 1,000,000,000  
Borrowings outstanding                 $ 0    
2018 Revolver                      
Debt Instrument [Line Items]                      
Face amount of debt             $ 1,000,000,000        
Borrowings outstanding   $ 0     $ 0            
XML 78 R60.htm IDEA: XBRL DOCUMENT v3.10.0.1
Indebtedness - Debt Extinguishment (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Mar. 31, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Debt Disclosure [Abstract]          
Premium on debt repayment     $ 116.1    
Transaction costs     3.8    
Write-off of deferred financing fees     10.6    
Write-off of remaining discount on bond     4.7    
Total loss on extinguishment of debt $ 0.0 $ 0.5 $ 135.2 $ 0.5 $ 135.2
XML 79 R61.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share and Shareholders' Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Oct. 31, 2015
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Oct. 30, 2015
Numerator:            
Net income (loss)   $ 36,200,000 $ (69,600,000) $ 117,000,000 $ 2,000,000  
Denominator:            
Weighted average shares outstanding for basic EPS   138,100,000 143,300,000 139,500,000 143,300,000  
Dilutive effect of share-based awards (in shares) [1]   600,000 0 500,000 300,000  
Weighted average shares outstanding for diluted EPS   138,700,000 143,300,000 140,000,000 143,600,000  
Anti-dilutive share-based awards excluded from computation of diluted EPS   1,700,000 0 900,000 800,000  
Share-based compensation arrangement by share-based payment award, options, exercises in period (in shares)   74,000 31,900 127,000 46,400  
Stock repurchase program approved period, in years 3 years          
Stock repurchase program, authorized amount           $ 2,000,000,000
Share price (in dollars per share)   $ 79.42 $ 71.67 $ 80.42 $ 71.67  
Repurchase of equity amount   $ 156,900,000 $ 58,200,000 $ 265,000,000 $ 58,200,000  
Common Stock            
Denominator:            
Stock repurchase program, number of shares repurchased   2,000,000 812,184 3,300,000 812,184  
[1] In the period of a net loss, diluted shares equal basic shares.
XML 80 R62.htm IDEA: XBRL DOCUMENT v3.10.0.1
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Dec. 31, 2017
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     $ 6,170.5    
Other comprehensive income (loss), net of tax $ (169.3) $ 156.8 (97.1) $ 212.3  
Balance at June 30, 2018 5,897.1   5,897.1    
Fair value of derivative financial instruments, net of tax          
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     (9.8)    
OCI before reclassifications     (3.6)    
Amounts reclassified from AOCI     (0.5)    
Other comprehensive income (loss), net of tax     (4.1)    
Balance at June 30, 2018 (13.9)   (13.9)    
Foreign currency translation adjustments          
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     260.6    
OCI before reclassifications     (92.6)    
Amounts reclassified from AOCI     0.0    
Other comprehensive income (loss), net of tax     (92.6)    
Balance at June 30, 2018 168.0   168.0    
Fair value of investment securities, net of tax          
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     1.0    
OCI before reclassifications     0.0    
Amounts reclassified from AOCI     0.0    
Other comprehensive income (loss), net of tax     0.0    
Balance at June 30, 2018 0.0   0.0    
Post-retirement and pension liability adjustments, net of tax          
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     1.3    
OCI before reclassifications     (0.4)    
Amounts reclassified from AOCI     0.0    
Other comprehensive income (loss), net of tax     (0.4)    
Balance at June 30, 2018 0.9   0.9    
AOCI Attributable to Parent          
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     253.1    
OCI before reclassifications     (96.6)    
Amounts reclassified from AOCI     (0.5)    
Other comprehensive income (loss), net of tax     (97.1)    
Balance at June 30, 2018 $ 155.0   155.0    
ASU 2016-01 | Fair value of derivative financial instruments, net of tax          
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     (9.8)    
ASU 2016-01 adoption impact         $ 0.0
ASU 2016-01 | Foreign currency translation adjustments          
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     260.6    
ASU 2016-01 adoption impact         0.0
ASU 2016-01 | Fair value of investment securities, net of tax          
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     0.0    
ASU 2016-01 adoption impact         (1.0)
ASU 2016-01 | Post-retirement and pension liability adjustments, net of tax          
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     1.3    
ASU 2016-01 adoption impact         0.0
ASU 2016-01 | AOCI Attributable to Parent          
Accumulated Other Comprehensive Income [Roll Forward]          
Balance at December 31, 2017     $ 252.1    
ASU 2016-01 adoption impact         $ (1.0)
XML 81 R63.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Aug. 15, 2017
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Dec. 31, 2017
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Income Tax Contingency [Line Items]                    
Effective income tax rate reconciliation, percent   34.50% 8.70% 29.40% 89.90%          
Income tax examination, penalties and interest expense $ 163.6           $ 24.7 $ 40.2 $ 61.5 $ 37.2
Income tax benefit           $ 2.4        
Tax expense in connection with Transition Toll Tax           17.5        
Foreign earnings           1,200.0        
Belgium Taxing Authority                    
Income Tax Contingency [Line Items]                    
Income tax expense for remeasurement of deferred tax assets           24.1        
Tax benefit for remeasurement of tax liabilities           $ 33.2        
XML 82 R64.htm IDEA: XBRL DOCUMENT v3.10.0.1
Contingencies (Details)
₪ in Millions, $ in Millions
Jun. 28, 2017
USD ($)
Jun. 28, 2017
ILS (₪)
Mar. 29, 2017
USD ($)
Mar. 29, 2017
ILS (₪)
Jun. 30, 2018
$ / ₪
Commitments and Contingencies Disclosure [Abstract]          
Damages sought by plaintiff $ 760.0 ₪ 2,700.0 $ 192.0 ₪ 686.0  
Foreign currency exchange rate, remeasurement         0.2800
XML 83 R65.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring Charges (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Restructuring Reserve [Roll Forward]        
Beginning balance $ 12.4 $ 51.5 $ 21.4 $ 19.7
Additional charges 3.7 12.1 5.2 50.8
Payments (3.1) (23.6) (13.8) (30.7)
Non-cash adjustments (0.3) (0.3) (0.1) (0.1)
Ending balance 12.7 $ 39.7 12.7 39.7
Employee severance        
Restructuring Reserve [Roll Forward]        
Ending balance 7.3   7.3  
Lease exit        
Restructuring Reserve [Roll Forward]        
Ending balance $ 5.4   $ 5.4  
CHCA        
Restructuring Reserve [Roll Forward]        
Additional charges       $ 28.0
XML 84 R66.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Dec. 31, 2017
Segment Reporting Information [Line Items]          
Total Assets $ 11,225.6   $ 11,225.6   $ 11,628.8
Net sales 1,186.4 [1] $ 1,237.9 2,403.4 [1] $ 2,431.9  
Operating Income (Loss) 94.7 148.8 250.9 277.3  
Intangible Asset Amortization 85.3 87.2 172.4 172.8  
CHCA          
Segment Reporting Information [Line Items]          
Total Assets 3,673.0   3,673.0   3,786.8
Net sales 596.8 604.9 1,198.4 1,187.6  
Operating Income (Loss) 57.4 104.2 170.5 179.2  
Intangible Asset Amortization 15.3 17.0 30.5 34.2  
CHCI          
Segment Reporting Information [Line Items]          
Total Assets 4,799.4   4,799.4   5,029.0
Net sales 381.0 376.5 782.4 751.5  
Operating Income (Loss) 5.6 3.9 20.4 4.2  
Intangible Asset Amortization 49.5 47.5 100.8 93.2  
RX          
Segment Reporting Information [Line Items]          
Total Assets 2,753.2   2,753.2   $ 2,813.0
Net sales 208.6 240.4 422.6 457.8  
Operating Income (Loss) 56.9 69.3 118.7 157.5  
Intangible Asset Amortization 20.5 22.3 41.1 44.6  
Other          
Segment Reporting Information [Line Items]          
Net sales 0.0 16.1 0.0 35.0  
Operating Income (Loss) 0.0 4.1 0.0 9.7  
Intangible Asset Amortization 0.0 0.4 0.0 0.8  
Unallocated          
Segment Reporting Information [Line Items]          
Net sales 0.0 0.0 0.0 0.0  
Operating Income (Loss) (25.2) (32.7) (58.7) (73.3)  
Intangible Asset Amortization $ 0.0 $ 0.0 $ 0.0 $ 0.0  
[1] The net sales by geography is derived from the location of the entity that sells to a third party.
EXCEL 85 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

,>\C @_]!%W MTJ7UM?F-\'/9"&O/I&KXIBV?&)-4$7J.(BS433TN*GJ2>KI2<]Y?5_U"LG:X MBMWQ_T#V!U!+ P04 " N3@E-U-T9OYP# #<#P &0 'AL+W=OR]F$G7B6 M%O2QM*I3GB?EOSG-V&5J(_M]X2G='WB]X,XFQV1/GRG_=7PLQ9O;6MFF.2VJ ME!5627=3^PZ-'W!4$R3B=THO5>?9JE-Y8>RU?OF^G=I>'1'-Z(;7)A+Q=:8+ MFF6U)1''7V74;GW6Q.[SN_5[F;Q(YB6IZ()E?](M/TSMV+:V=)><,O[$+@]4 M)138ELK^!SW33,#K2(2/#3WI=D)D:+!!*P( MN"7$WE6"KPA^2Q#!7B,012 ?!'*5$"A"<*N'4!'"6SU$BA!]$,*KA%@1XI8@ M';A--61YEPE/9I.27:RRZ=!C4E\$-(Y% VWJ1=DOG1NX_-[(V M(6$ 9^*#9^Y+/ND=100;(* !(@WX/0,Q;" #01 !",MRP8SDIA"*VG/10BZ M"$T7&.9'(#^Z/<<8-!"; 1!/Z^P&$W5R#!VMM9>Q<0Z:E95I!7E.J/75-3.] M;$9@-B,@&^V*+1I,W''QS7.TLBY'1K "I%V"%6@ITC("+?EP4LB#U<ZO4\0*"QW" -GBW4-Q,:1Q [25? ZJ!\,K T($ >BM>0< .%(U]L& M$W2[G'F B/]-NA0-WB$/V6KCX! M]2.&A0M%MU30!)D5C(Q8PL'[!6L@@D20Z <3&WZ0;_8VH'(&:@W8(KH$/0!1 MX:'6A-4007(X\!N,8>G!WNV]B6'MP0B(0NNHM0+USLTA WY@@<*00 T<&(9E M!?M?R!:6 VS* 2&QUDL*U,TVWBS $,(:.!(.!+C('[ MJ2O*' "10/_YGTFY3XO*>F%< M#"]RQM@QQJDX.<\1I3^(4;M]R>B.UX^1>"Z;>;-YX>RH9FFW'>AG_P%02P,$ M% @ +DX)3?5SM(:+ @ 7@D !D !X;"]W;W)K&ULE5;;CMHP$/V5*.^-XUP! 1*7K5JIE="NVCX;,!!M$J>V(=N_K^V8 M0,) Z0NQS;G,3#RQQS7C[^) J70^BKP4$_<@935"2&P.M"#"8Q4MU3\[Q@LB MU93OD:@X)5M#*G(4^'Z""I*5[G1LUE9\.F9'F6O)U^W$]75$-*<;J26(>ISH@N:Y5E)Q_+:B;NNIB=?CL_IGD[Q* M9DT$7;#\5[:5AXD[<)TMW9%C+E]9_87:A&+7L=E_HR>:*[B.1'EL6"[,K[,Y M"LD*JZ)"** MF8("Z?/%'( " R""I+=W![?%'$1>!-L,09LA8)/V;"#,H/=>'V,Z@6 ?;E8? MD+BS-?"=?L?/5QV#S3K#P1-UMZ#KPH?^T+NS03#<;CA\HO00*/'[WZ?'H&XP M<.OBV]X-T_".!-R8./Z/XL-=AX&V2WH?[*4%=7;],/+Z7T,0%GC]G-#565)0 MOC<'NW V[%B:6\75:GMYF 7F++K FYO'=\+W62F<-9/J1#/GSHXQ254TOJ>* M7/B-Q/)*GN;0>V5:OH74$L#!!0 ( "Y."4VIH51 M+0( #T' 9 >&PO=V]R:W-H965T:-F+CEU*V:X3$H82:B("UT*@W)\9K(M64GY%H.9"C(=4416&8 MH9I4C5_D9FW'BYQ=)*T:V'%/7.J:\#\O0%FW\;%_6WBMSJ74"ZC(6W*&[R!_ MM#NN9FA0.58U-*)BC"-@R^JLZRG+C+WWO""=R MH?*5=9_!%I3ZGJW^*UR!*KAVHKYQ8%287^]P$9+55D59J_ULMT9L"KV,5YD$OFNS,.U6M M4*O7(LFB'%VUD,6\])AHA)D@MG-$E@X0I P,+B*GB\CPDSL7L5L@=@K$1B"^ M$TC< HE3('$X2")#'')"/,G9'4:21U&,G< IE3('L^BH53 M8.%PL)A$T6/249F3L+8]8CE"X."!C:73QM)A8^D66#D%5L\'@4-W:@*(@>F'G0J=AA9O5 PMUF./J/2-R-AN,G=H<%/>H"&\D<%,UV M"!J=8_IB^4;XN6J$MV=2'8GFX#HQ)D$)AH':CJ6ZRX8)A9/4PX4:\_Y [R>2 MM?:R0L.-6?P%4$L#!!0 ( "Y."4TS-^NA> , &,0 9 >&PO=V]R M:W-H965T82)T$'. 4GN?[[&O!Q8"^!O!S@S(YWAV5@;W%CQ6MYHI0;;UF:ETOSQ/EY M;MOE[D2SN+38F>;BEP,KLIB+R^)HE^>"QOLZ*$MM[#B^G<5);JX6]=ISL5JP M"T^3G#X71GG)LKCXMZ8INRU-9+XO_$B.)UXMV*O%.3[2GY3_.C\7XLIN6?9) M1O,R8;E1T,/2?$+S+9Y5 37B=T)O9>?RUNOBZ7YI.E1%-Z8Y7%+$X M7.F&IFG%)/+X*TG-=L\JL'O^SOZY+EX4\Q*7=,/2/\F>GY9F:!I[>H@O*?_! M;E^H+,@S#5G]-WJEJ8!7F8@]=BPMZ[_&[E)REDD6D4H6OS7')*^/-\G_'@8' M8!F VP"Q][T 5P:X'P'D;@"1 63J#IX,\)0=[*;V6LPHYO%J4;";433]<(ZK MMD-S3]RN7;58WYWZ-Z%G*5:O*Q(X"_M:$4G,NL'@#@:[?4BD0U"+L$4";188 MRF*-]1WZ&VP !%%R&"79WB7II>F"8KEU/.F)-5 G 0E(3>#V"#!,X($$GI8! M]@)%J@83U)B\QC@64I1H,+,.9J .'TS#!X1P88( ) BF"Q&"!"$@A*?T;:@5 MJ73VID&$'<0GSU)HHA#04\%L 2+?&E!D!A8T R0=:$[DP(^R,UU4-. &")#5 M5>T Z<422T%M !2V M4VIE!M 91G#14&&LP3PH"\W@ %_/ C]P%YX< M*A>I @,H[;F/),KKHM2WSMA^_<)@NT.ZWY$@&*" #0;-ILN+88?!S@1Y)5DMCQRXYKR3IK+83\1.N!BQE?8WF&P2L1V*";N;=#_IF M_/X>%\N#5:2#.BV;L;2XX.\N1 MWF[_K[#Z#U!+ P04 " N3@E-N6<9>90" P"0 &0 'AL+W=OHHKFN#((.BS, M)9AO@2<<).)7CBZT,S9$*3N,W\7DVWYA.B(C5*"4"0K(7V>T1D4AF'@>?Q2I MV<84CMWQE?V++)X7LX,4K7'Q.]^S;&%&IK%'!W@JV"N^?$6JH, T5/7?T1D5 M'"XRX3%27%#Y--(39;A4+#R5$GXT[[R2[XOBO[KI'5SEX+8.//8S!T\Y>#<' M_ZF#KQS\L1$"Y1#T(MA-[5+,#60PB0F^&*3IAQJ*M@/S@"]7*HQR=>0WKB?E MUG/B1R"VSX)(858-QNU@7.\>LAE";B0V3Z#-PM5EL7*'$>X#K#4(OY?#IR3; MIR1W:7I:L3SI[]V)Y>H)?"V!+PG\;@+!K)=D@PDEII*826#-]%$";91@$,6/ M/#W!5$LP'5]GJ"4(/Z]SU6!FG3I!?]%#G11A;]F'H-#J:]I@@BX1"/0%1=J" M(HVD#UIGIB68C9<4./H_U1DAJ@)%756!%?5T5:@[/8+^'SUDBJQI3U<-: *\ M1]T*'FQ!0"/N@]4!VOUC"=S_D%?_;P-OC+S>H-DN."UZ]A68KX'&OA'7 7FZW.B;N\0/ M2(YY18T=9OR,DB?) 6.&>/*.Q1LLX]>7=E*@ Q/#D(])&ULE9G;;N,V$(9?Q?!])?$H*7 ,;&P4+= "BRVVO59L)C96 MLEQ)B;=O7YWB6IQ_NG(N8AU^#H<6B:\T,8 MUKN#*[(Z*,_NU-YY*:LB:]K3ZC6LSY7+]GVC(@]E%-FPR(ZGY7K57_M7EY7(KEQX4OQ]=#TUT(UZMS]NK^<,W7\^>J/0NO M5O;'PIWJ8WE:5.[E7<;E^>=I=:/OT>CRVN?7#;P?SG-5N4^9_'??-X7&9 M+!=[]Y*]YW\LZ3MH]=F=?]_\7NK6[*8K32NE)D MWX??XZG_O8SV/YKA!G)L(.\ZZIT@\Z';V=]W%?K+[>^WTU.W5][5.["I\[PR-FLV@D3<:<56$ MK?5K%Q)UL9&DN9QVL*4*:W /"@Y"]>W59! Q-J"A =T;T!,#B3<+@R;N-:=> MHQ(5&&\H@RJ]46D985<,=,4 5U+/E4%C;CJ12>KYNP6B-++8%0M=L=25-/)< ML:07Y?DQ*)(;A1 !$YT8^A$#/X3G1TQ[L8'W(&^I2(I 8U<2Z$I"7!':&_ F M(;W\))+ 0+HX"'=W\,3E(,'E.4.]BWSM!$8\2$_C3->HF\R5;]Q+& M(Y@6/PD)PJ<8$SCOB3L2G\"93X#4E^KI@)^ 2)+)0X:8+"YPZA,H]_EI>!3] M* \+FOZ8-"QP\A,H^S'I4^"\)>([PH/SC: )!X2'BFAXD"'.%YQN!,@W-#PI M*8"1'QJ:D]@:*7&ND337Z)3!3^*$(,7\X$A,L$0$^\$!(A(<:(@I!1*G JFH M"4/ZH2(3<3./\X5$2R5_?2+I6DGH*"#+/DT>!*&9%>7=1-PK N9=W<&[PKPK@"D),Q"Q85;,ZPS"U \S%#'U26&6U1R6 M%7COB5*RM!YE"2N;.H1I5HAF+D:89G4'S0K3K-#[AI_6@8BD=: Q$5.E%"9> M@;)-'SE$/%,^%"9>S2%>4>*%B0/_Q5/1^BXL0X#&O&M0WPW#N\:\ZSMXUYAW M/8=W*&*"K#'O>@[O2"28VJV9KQQS>->4=RD,X5U3WJ>RJ4.8=PUX%TSUUIAW M?0?O&O.NYU1O(#*">Z@QRWI.]48BP;P5:LRRGL.RINOT./)7ZIJ2''/K18-) M-J!R"Z;X&TRRN8-D@TDV)Z QTB^4XOVXM/LMO>\J];\[!IQT+OM(ZT=_H=R?"_+H;]S-^SZO5XJA?/ M9=.41;_]]5*6C6O];[E8+@XNVU]/UP-^XC#25.>QSW2\+I1N_X7 M4$L#!!0 ( "Y."4TG$A]D+@, (X. 9 >&PO=V]R:W-H965T M%N+-AI5YPL6PW#K5OJ3)NB'EF8-=-W#R)"WLR:AYMBPG(W;@65K096E5ASQ/ MRG\/-&.GL8WL\X.W=+OC]0-G,MHG6_J3\E_[92E&3J>R3G-:5"DKK))NQO8W M=+_ #:%!_$[IJ;JXM^JEO#/V40_FZ['MUC.B&5WQ6B(1ER.=TBRKE<0\_DI1 MN[-9$R_OS^JS9O%B,>])1:ST386+&L:OZMU:'B+)TZ*YGMHW_ID&$[ DX([0.D=+()) M3 F>)'BF!%\2?%-"( F!*2&4A-"4$$E"9$J()2$V)2#W'#G7F-(%&QE3SN%& M:KR=-K&:3'U,>#(9E>QDE6VQ[9.ZIM&]8 GQ^FF3^\U+D:V5>'J<^)B,G&.M M)#$/+0;W,%X?,QUBB.?W,8\ )G;[F.\ )@KZF)F!K2<#G6=H78K.',(H.B^0 MK;B/>85TPCYF 6&B#N.(0';1Q' T<:- +A2\*(05"*Q &@6O-P=E+0\ AKBP M%0^VX@T4/"7IIBTD;B!% U%2Y7&(\-WZIV34$(:(CP'DS$SPR42PYP0?=H(/ MN!$I7F@QOMX+LYN(%W\PWR"^,ML GFTP#%D

MO2 DJ6M0 M@"CF(]*ZI?4#L"^:?[L0NN<$?IH-)O-EU5_VC396=)Q9<&[@;:"B0Q02*Y'/ MP$2BRY(3*N]/,EX?NMWB]'2LAURT!$>7 M)I'ZZ)+*:8T30H"-Q)APL5F^#G=)D-*Z/BV:#EX"63:5 MAZ!K(:E&(4P4DC MK"+YMF!3CJXZY0_IQ VIDLH&W\^FYZ,MHAQ:IS'4S&E$P.TPH$+UZB09*D<^ M(%;<\)NOWP2J3N'$$0:+B>-9&LG4"UNKCF[/]>SQ?U585K\K;ZW0R'T^MZC"A\ MP@1>#JN;B[QZ:O4FN/B3L\'L;/ZWJS-@ 5)3^EX(^PW@,0(7YNIJ#!<_W;OW MU6PT/7/+J0#)F3D_KX:+^F*.TM_O%F&/X*_IYE:V6OQ>59,/U6_5Y+KZR_7H M; "_?3-9/FZK<[CHR5$Z!YG\:7HU&@HD^N*) 9QZH;W3<&\E"VEU0^/9*Q%I M4:E=I!YV< :/I(\;C(?+Z0I_FYRE"OX.ZJQ)E6@EE]9;+YE%A('1T7 ,Y9KA M6#2",4EW1)?.,9;4>\>]PU)X2GVJ;7-Y-1C-EF'.HINX+D,?IS+T-J6(-\S%;&JA!!LD(A+^0VW@FJ9- MDDTTW5A"6J9#WK\+:R*W(WILFIO:E!Z4$.XUE7#XAF%BG=+&>2$B&/V$D]*U M5O?C!H^DQT_3R>>Z*6'Y1*K0]Z/YU71>G;T[OT,1OUS1X_Z.Q89F;+VZNG>$ M"MQZ+J*FRFJ0%(++J$!:L$"Y;XFYT<)T71NK.Z18[=".L^GE7[_LT^*.:>W@QA\/=V-(U+,UG\#1PQ$'R^30^*=N4G)?SN4YE43?U M"'#WB767!G9,$@0V@49>> -G;+-=()+I7_8KZ?OF_2$BW6.HJP#G&Y'#3A)N M,$$:-PN^$>!-"]G.R]M\F$AWG30BH..M(Q0[IJQQVI%5(W.4IO!.,'A63X%U MWE^PN)B>O9G\5C666*^X7W[*2K[]-%W:#??D6I-46;[Y;=4W-MM0(9@&*4> MXP715#N5RTQ(9&7=4B>%'D!M-[3X^[YID3J:F &''A%*E4\3"\'/CD83R=(X MI[*M[GEH4?A>>Z"%BB9*+T!.2A<8"H1(D]>B&%(ZE?=-P2>DQ=[O!9B&0C+% M/(J.:"0]2:65H#920"CZ@A;W/;8M:0'B)/PQN!Q-&O=@,A@O1M4VQVIT),IAH@S,6Q!8-<97&M\R5 M(4Q<=-?M'MAC##''EZ,W8#Q;1C3C2&LL%'4>!^P)<[PTD$Z?\&P.+[A((K7" M&H6(!$_,&,(MJ:D5 B4FEM-DBO5-.R97EY (R=1S/*7]L=&"1[8:\X*1IH60 M8*K=;]PEL$>^RXX)^&>DML"1=084*+AHZ2819"S(RB)"N6^^.^R@/G=I2Y_P M 2EBI-.,ZE!3"RO0V^6D&%9,MUJ/7+-J,*]\M?SWFTESW>9@G:=MAIO7^W+. MA.:>$S"/%-,T$:(ME1)<#.VL)!$SZWF.,C(L M0M%HH'2+=;X+!#Y4PVKTVU:'D(;G$0QB6F/,C)06)'B35PY:D,+\..6X10[V MPO5X/'I7!VIPB!B7PGLNP,P6314*!4,PQK*"N9A[MQ,T9M=ITM(J3K@M:R M.;C$IQ;.P<,CM'%HN0//OJBL UY:ZU3:P=L95CUGA"GU&)2^<"G; M>+YPTU M +V,)58$'0Y61]V<)4;0)B*'%' :PT@81J**5EMK%;-L+9OXN<_P\'2X598) MX3'B0E#FC&/"U53UC ;3,@N-H)9H[$[IF@>#C*H'0_4/B^-HP?66'OEHTA@[ MAO-"1BYT)&4;%=/W2YW7@>OQ>/2(+(6E1,%A@)IP$A1AN%&/:4"=;%F%C':/ M1[B\&D^_5%4]\_1QYP)ZPI#@#4;4*^^)#TQDDP715"$:X1=28MAD5-ADL0)\KFH%-6C+W>'5XIX#]93&?;'%"]FYHP#_88"X:" MUTPRXT1'72%=B[K43G > 7=?!QF(."N=((I8$DCJ]6[R#+P:].BR+ ,]&<::N+@\+]ZGLOYW1X*AHQ3ZUP 3LN MG/0NALR:*5@1"W^U;*Y]!.F:8H3)9S>X&BT&XXT%2U A;=70RJ=E<\I@)G*I M;!JF7@;%>5MTK@>JQ^+0Y^1)I[575D4LP=BD1JMFC MO,EG)I@G6.-4;2%2?8%3N?B2.*K+<=K/?6"')W@4D8&F&8Q,!HP53;L]\DP" MS7&9(D)M-7R/HV*JJ+C_2#'2>@TQ%(/4Q(@ ]HU.8SRERW-1. -=5+(P70.5 M!X#;%4I]/84<$V25DF80\E0Z K1=E:[(LO"XK?YH6YJFNSH8 MN^GEY73R\6(PJ^9FL9B-?KE>I.#'IVG].PN?>=94%IG9+(V7ZBS1?#BLB1#3 MRE(LM:06,\IP]JF5M7=L/:D7/C:9B,U9*IIA);&$1(VSUHJ<+;*0W.JO.'%V"$/X;CZS,0)-N-H\%1 <-' M;@V7'F%LKW1^6F[WU.5)HCS($UP7D;K&>9B MM34>5$61">*DC$*\5.+=/ >VU;":SS]4\RH-W@2CI=GCE*YR;S]P1($[Q44: MS8[!TO0R+[4#O5MNAVD)1CPG!;LFVQ .*D5I)QUX^CQM';)-,!>%Z,KJ#]72 MO?/,N#T?:\6HM0ZJ9B6NM?%^-ID=J*H<1EUH('ZD@G%H93 TR8O! M)>M ]7@LNI=%@45!5%"D'G6%;.0H8V&5+,=0""G*<]D8B[JP>IE ;6JC'HIZ M='=ADC2Y6SI*@PJ&61/R"E*L4;FP]I05LZP>@F5K>+LKJ)%47E-,P+ 'Y2)! M[F9;3H=R?N>I;DFG[1+>'ON;2X 8N)9R'X%I-7!MMK^U$K),-],6@V+'\';Z M3!0'CAVQS#G.E7)V-3E+$EMV8)\*6MK*Z\"[S"Y\23W9\XOJ+%WR#9=S"ZT% M@!ADXCP3B$[]Q,UR;B-]R7>\I;*J#8QM .VT&H2(PAIO(XO.:>=<3@X@1U L M:,I4,3]Q T W7D3H$#C#&&L*?&6U9YHCET>S@@%32&&%6L37S9>O#U07S4), M)1K -8(D-U[8@%D6JJ#WBF9(I8HE8UL#=8P^YN!!%,9'$I3GGGH:+=8BA\2Y M*@>5X&):S.//X/#BAU:D'2/$I"U',7JD+9$YJN9;>I:5+J9;]I+EP^#WGP'H M&6"^H50T4J5QDTY1T'O)(DG+:!H;$>SOHHX&ZV)O;BL46X#9.2-4>&0=U\#D M& 5FP0?(00K&A2]GX"0S95LP_V,Z^W5E>6]&3@9G*V/DFC$I*.$V37$NE=:5!4'IX+X3$SR8@R*; 3!C?WUPO?N4=X?>(^6$/=9X&! M'X@(50'D%8G"4Q%"[F5#$84R(P.J^7Y&X8$"Z4Z8.HTM(@727E))* &7"%'9 M!&(IIK'X=R*DH?=. 1/G$C9B?"CGK,$]OA_*Z:<*G-/'Q73XZ\5T#'#/ MEP.%-N/IR!-@0GM.*)AWR$73N-!,.VS+E2)8D*++O0^DQX'?Q?[681E2]X"U M(BK$0$[FNKJ (RGC(AB\U_O>UM[!/TJ*K$&(D\YQY;@UR!#OO<@M. :T7-G. MS>^'&I[NK Y/J'C)D:/)8XC,H"@8S46DX$D85$ZL3$-J[UNX6Q)P.7!_PWAV M &:SD3.CN;#42@>LUTA!:[$HE#-FM"C&+V'8%,(N^0$R0P@/KJ['&FL+T-(< M_#(\EID+S&DQ"&AM"+^J0(WB$NBHD4_9-B.CE)YHE!I80Y14= 41NDEV0,1] M-B?,Z9QHM2*D&4$]EQUQ<)>#'&?34; /65@ MU0--P6(/M8S0#7%%H+I<-MEA*1PVB9]-1B 5L(I6IJI>B135SM"&Q" ^6NP; MT1$.69_&;Z>3X3;FF(Z81JRX U=/&LV(L3BW1@I6CIEDB!1;#EK!V +.+J-, MI&0.E=0'94VJ5/2TJ82BCB/96EQW/]V]0SB/WEO.P(+KH2)2&H.<1HA2XW(1 M@E;1E_-'.N(\.SN4PW/3B#0<@T;#W G?N9M79_7%T]XVPM$_ZS62^F%W7C1"K F*3[A_@.QW_UK8$X\W;>#MK10UB MEGH=F 1WR6LF5\M_M:2%Z+B#R@VDZV-P^XB[,% /8X#N)(8OG!^\(?SP'>FT;C38NW-SF;C^'>BHQ/7 _9M6.VBNTKPDX31# M@G!C&UXCU#)>CJLNHX>;@;=;U.Z)][N7B>.@+34ZAF# Q*:",F\I-LI)X6Q9 MN[]'K'X>_#&ZO+ZTT]EL^ONR81#^!=$$PP MOMH/'8(JKN"CD>LR^QR77(?4&N<30Q E5TVBDH32O*"J*'C>&JBGO%D"FR@! M,^09%U:':)C-?>+WRYNE'/6<0/6 HI0$@K;LUTU2&U!T?_8;.0*5]4]0QBTNSD!7] M![,]Z)W%J0T?>,R6$P,P1PQMNI8)Y5GK:I-C9 M\+(I\WQW$LPG1U2JXB=I&H2SH1D41L%#P44$GS2UX1M2?JNT7:J?0Z",B/$$ MI3%FT30.K*!>NL+TD<4\RQ80-H:P,T+$!/=&*^K!B4M+%T)HC#-JD;1EVE_+ MKGO; ^*V\;8T22T@#_K>2_":)34FSSNTT:*"CI3(8IAQ.QS;0-J9!@W41&'3 M$ 86 [/6Y\PR19:QPCVF2!6+ =>!=#Y?KL[[G.*P?G Y^%S-/TZO/U\L:NYI MVYSS;]<3HNX KFZGQ(WA1B!N'&$L&*TIR7N!/+#8[=*CT7B^6GE]#_ >L/: MP]UN;+ 9C6-@_(K 0#VQO'D/!Q=EN55,/ ,*M0&8IAP]Q)&@,.!6,)NV"W#F MH[=Y/%+@8,[?/PBA6G3L>>[3W+0<,WH#$B-*X%9G,7AO.7[@F9#K$N<8(&1=1I; M&GP HY^X7.9#21"XN-'WDPQ=D+VM%FXPOW@_F_XV.JO.[)>_S5/W? 2793($ MJIOA8O3;=H./+27:(1P=UK2N(0<+/ ^D]JP+M"JF]/K;:1" LV#74HE71%E(L9C46L9;Y[L2QDISBMQJ@] MXJ!2;YN-3G!KD8Z!(*7S.%:+3)DB):5AL3YTN\*I[YP9C2Z3PFTFIDU1C('O&T(>/<@,*4>%'-+9'5[*$TQM M[:TS!N0R:!?P:7D>>ZW2C)!](2L3)*)(A MF" 1I1AQEM=F*JM08=G1HN+E<8 =Y5"W 58S2Y9Y)ZN%5D3H^+9:@ORKJ_FTRJX"._YVLX-S:G2G>E]8+6D9ID_I+ M560\.-(8!V#8BE@$$EXE">M)\.EML^JB OGY6[642WV3MH"GI>PUKS3.NOWE]&>FT="IZ)=.Z#JI,#&*5V=2F7!^GR1X( MF-W&9NCAYKZA-3Z-;4J=/X;%9$;RO%!%4.R+]@G*B_6J!1";0]CI(TI)*7%$ MR$A"8%*J//T,_$;%"RM&P&W>,80]WJ+RUH$\YY')$ 6AQ-J&AD2D::=E)72Q ME&8'$':NI*/<8@(&CN661T,T\8VS /\WN$QUX\*16@_"1T0IO+?>:>V"Y0P+ MJH3*9?>(:"?*MM]R#7T+&%M"6

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
G(^P2.K&5(JS"E* SBB+181>"-;,217:ABI_U\UR'.X*QW98A.ZU MC V% TKMLFBUU0"/Y]YX$NEE6&9$D,*=E$76F;S>/8@"K8@"I&15[;Y>P8M@:U03H\I4)_J->6Q=KC M59L+LVL08>D>:C9VV7$<^Q]S2\(P#O:R_VEV'R"^Z/K3C*>D2H+E3_UD_^=/ ME ^LPI>>K;SFO8M]RR:*JAD$/XGSMB.:165A*_<*P=$Y=0)J[["WGK&WN$IYV3FG("U5B- MWDIG$#59/;5*F;!6HS&LL:2HH-0K":L!A/#DQ-5VHZ/Q/: M2G4A3%EVAHDG)D; JT'B D?46Q((BL:M0D ?4;HBNSN[KE(DK"BO OUEFT_3 M&MOLE='-<=9O=UGX;7^AU_SVRF9W.!./+&*2E1[9)H9(MCCC;XR,RZ)-F42= MW6J/]E,"_IQ9LSCS;RY3CS,OVNUP5CDP)=_53(5%T44Z?-&^@*21FG*=O1:@5DB_$"9#;7(D= J=/HND*F@";)("SS9RD\ HR( M<$?NM>*VO0J* +Y+U2G!]&UOMGY!U^ZIHKTEY M,G;1V*VJD8O[DRI>J]/F.#F.+'M5QKT4=9SUJ;'S235*"NQ3.+V M2JO4Q*I4^&6 O)\:&ET2&F4$2:(!48' WB3-:).;YPA5L)CS2YCB'?Z:24Y$ M6L\VCO,M& KWXAIF>;VL2>71]ML*>ONX-;XK#R?+BA_JGY-./*7S:J)ZVQT0 M+971_G]"]%@^R=R'T%%+^5$6-:NLT0_!,*5H&HW8$6WE;K\6 K_'BJJ4>8%7 M 6'3W"4I1R,Q1(^,_1T.'X126; 08T#VV"Y:!)58EM3B9;P]]:[=8$ZZB:6! M\MMO8FX8C- PYI-, 54?]*1V33P):&;G*:7:*D"A=AR49-0$*EPR)?L%X();V^!/N=>?LEV5S-%9$4 MG&9",PJK[#^LLC3$*%L0+.G83,6)^4=EDGK5J+ZCATT 5)@%R]03A+.<1X E M6?4T @3)=#GZ#9P3B<+S]$&W*>WZ-C$Z+>$"H_ !P!U=5RKK''KO;\YT4_ M2;B?">64)SBFO#9?6\@F6[H'BU:,P(T6@I MN\04+2B_5:0NF\H3!^ON^IGB&1CJUG*#&0M/[S@QO>XL*WY MC+EUPH6@K]\0))S3I6O$"?TX4*@S3A@-DN*$%"=:#CE/O!TI,9D=F2$'F6T]>*05(VU ;11V6630-YJ$=DL2IE85T:"''Z$/GA>'_\J M_$SL.O86)<*JCM#YIF#L;-VH.&A'J2N?TJA$M@59^J37FM;BD9+XHOA\8F#3 M2)^O"FA$Z[+8WI8\ZF+EV9!372&GFGSHR(>>A[L-$V/N;RXN3B^_]*^WRG&9 M,^,C^9G?)5/GY64[5V[L%R^6]B3V?QKOS%-\Y^:DS[!3)S]FZY4R:Y.N),XX MB%IT)F*5EC!MEAA3&@K-=CM=*^L%YAYU637:M66Y+IF3CG86UD:K-UJ;6T%+4V#\W; M9I[$A5*Y3'4^)ESPW)"2RGC!5_%"7*23$JBE$5-$:E9:@K MSRYX)_6*RUZ_*Q8O<9R\V+]]?_@;#>X@\Z\Q!>/A4S3KSAP_ <^AX[E..=Z)CDRT-%TZ/O[4 MZ,2,]R02=DO[.T9FK'C1BI4&Q@H.C6^):)T)4UY'H4A)]1<2N:/-:7FNE\A8 MR3/M7S329)%U6$O1B3,ZH*;V2/-E#69(#QA<.RQK$&G0413 0YTSIB'(GZD>V$!-.O!)%?W;L"Q&;I7C10-A@ MFT:/S">@IU[GP!))@:.8$YOBTXMGC>V?/ M&HZ1/['I!ZCO9YIR>\RW!1=!4<@BJ\*F7ZO M?!IY_B92(3Z1$X_IPYT\.3;D/"]\ *8[F#@L2M5G_'GF:$O,\' >DGV!;$#N MI2BV5'U1%1I**5(^B=0"LX'#I4(E,0_" @]$YJC$F'TPL#Z!=X_C+0 UB"MA M2MLTE>Q6=)!O:H@\ QOYT?5HDZ771F>*=J+3$6=^ZD4;_+/-)]/! W-SF34@ M"X75#H(\;Q@XV(]?JDYP-LYP6C*@+.<&] D]D(U51AF;X!_P/[%\_P6]5=Q MLF,_>WF-,L-C/N/V,'8@/(>C?U"+;I([W[-WS*=(HJMCRKTP>72RA7YZ#4T; MVYK - E%1'X=Z9$+ &5CSKG=4;#"ZR+3WGU=_>W+%C:5%\D^,$1-#PV.^, M\Z;><<*2&W*P/VL97Z/>[($ZT+(?>R*A-VEIG63#1HHN \.. R" 1H$E=V)D MF&>VJ;V,CD;E]F0D;V$D9]VRQ#)&/9X6PRE4[!UD(#KG]NYR_Z\7F\A\,3%\ M=D,P"9;.V<9YFJ&;\^F.3%98\V&&8"# 7^6N39*UF+5:9T)WF"8:F['#U(0- M7//KZK#T8B9!M#_1S)M?\B3 M_>8EYS,>IV?CJE=U3E:= ^]PS(.8ZY4USO2=ZO^E3@V(F\;,U-TI]R@N"308 MJ'QY\(";1 .'%AI;;F2QN"J ..,;''^4=8O9*M;-CC&7YXT+W_?P*$LQYF)?')5@M"IU2-J*:^<*P3IF MLZ9?MO56-;%9<*.RNQE1DHWZ/IIFP+_"HBIK-XX11SPDX@"TG]GYR(XX='P7 M$$DZ ?@<:2T/+&D\*_&()K"D M28D\\%T9D_6MQ^7I&=E$D= OC EOQB-FT( MK$.PK"<^R^:!C9><9EY+V"AU5](S81 M_BHWQ]^/F].L=T$,BN[D=,\:A^3D;)"X5 8[M?0V-G"QT:QE-F6RXELD!R__ M=A=9YS>[ESCFCU+]L2"3&Y'9'XSF(BSE3KM2'0^EBHOT@7*TTT;^Z1Z7[Z:1 MJ&4T2:>?KHO)I3(U!8XSJLEV[TX'"H+(YXVEP8"SL;/PN2G/#_1IT5A)#*MKC MD9'*X=##\^FWGOA=./ Q@1-3.6M)H%^HR+!6UF7V[$!K M-OR4\.4ST N3_#FFXLF=J <0 YDWP2>N\OHFOK#10/5#Z;7>86^^OWJ!'IB![*,?D5_G-DWKOP+6'D:S8 5K[BV8Y!7>W&?N5 MBA;&%@J";:(N0?48->; Z% "[ @_9.A#;;P_)Y'+"$:2WD))MBJ"2ESI)(7) MSYAIF>A#O+PRN)QU_(/QL^=:F)^7 -@$5*.L;?&4ON:(\=@Q'U!R=PJ=P.!XUM#2U0KK7$BHVNN'@ FT&B YY><2\5!=H>PZC4QK1#F1*< M?8K4&W//^3P;K5"/@X']D-D%7O9*I8 R\_.2$AQ (- 6@0I\Q!0="W#YQZ9, M,E95*G'4.*I9R5S@1T=SS!F"TEP)P20#6R-[];,?B$DV&YD$3[/'E^P$S@@7 M9H_,YG(K>P7WRU%2Y6CG;A%1:G?BZ\@D$G=6;J.X>_9&[F& /\E007D'$0X= M,!Q589% RS140OH(O!69#[&PSB:KSXTA\Z9,[ZHX9)<8IED!P\#PB*N>8ZXL MC)0A3AP$L"RH;;BH%H<"0<25_3P=/_N6:7&!X9W8R,+.RAD7H%O=;VAJK-!5\3*C%^MEB=, M83W&]TO[8NI9,HSKIEO$F)8#)JLOEP+S2&IJ=T;%TB4EE5< R(3['?%Q%+;M M/JGD)!G,>R<)&V\DJ>0HA2;1Y@ZZ:T\66MYN:*M46>EH#X1 M!U*SRN9 +H@ M\JWR9_Z$_P9&QUVT4>I^(??* MLZKC@U=D0-]?/CG:9-8+AW? 'Q@IB-I(R$W&I[&0@018#63)C-D1O 0V@>M^ M13?15!Y-E#V%Z-9225"I9]V6G<]P(]3HQBE52U(ZHS3#V:3P>-OG11,B,D82 M/W5FLR@%]0P(UB(S []>QZK0L;A_ASZ2E5AQ)M\A:J["QQXM/B\==&B*U=XI! 5!XFL529["IG-*HPEZ7.&'1+ X72E[:?Y?9B.B1E M BS_+8/444SEA3(0M/23;4H3@W0@12 6(]"S^%$:[IF*WIFZYW22A-#:Q2+= MD6['D=1,(7(J(M*FP<@D'I,3!'84H4QBE?'YLZNXH38'"'(-$GRN!,54,V+IPF_R?:PLAFQL0:(\XP6YKV M/TUS6=$#E@9*%#A2<:-EE,B4@R)*@#I0F3&3V%@:9'+.H]"T>M]Q=!)"8K%9 MDRDW@T@4'"%+2#+OC(+&\>%%F'04MVQ"F(BGV&K$4TQ+Q%59H -L]G\B!J(H M"UY:V2#Z'P5W8$!V5)L>D01MX#AJEHY$S>K8.$F;DT0K>1& A>V 91G7">+( M//%H@7U]C.W8ANI@/+6O($XB5:MPX/ZF#C/E%[A[RX3#. MQ4ES!F7J4WQ#;%',R\],BIS*>'MQ: A>M>A8L'"J]*KES62)B&\<_\IN)*3# MK<7>:)Q4X";H-H_9 MVTK:$J?G7:GZ0$1FZ>;)=*&F3G0JD0FQ^^U'+6FDZ[X,'US(3--U)\ ^1_'E M#TE>]P>U-;AX- 1QZIO4.]/YY[]%DND.L&WS@>MQW.QX;[D/X$2ET1O3/9WM M5QYO)*0)_-$>,.XN6;)$.F/9NJ:R^%1L'YCD 9.PT)+]B('ZD0MMXQ'?_R0GAR6AK5EQ#)) M-*SK-3(/4M;7Q=E+6:MU$0E:LLFERC@NTC*.8LVN"J'0-%!XEFE^)/L*Q)LV MF-V"]4Z 5*I;!1KBWL *T#1457;'1W(%C]*"J0O[V1S;+KO]$WZ,/ARIH-UO ML.PF/)>][ZN?U1?PZW&R>2##J (,6\\_04S#@AA/=0*64@JOQ1W-YEF]F41= ML:B/?8YVA]E%8HNJG;4D2!KUP8#WWGV^B(8D=[' ?T[V(]X+^\'",Q'A 9YJ MC'&AIIRT+_Z8A/=A]OW/%[9PL#8I&L7ZVZW&&)/.I+SZW1;S)H" /B835EU'V%,M13QTMK0A<%& M33,2FH T#))$Y7C:SW%X%E@H2ZVHK#M4Z>,/+E;&<>175,O"PT6(-XO@3DD' M3'GAZ(@S1QYL'YV5HA(:$F:2J<0#W+XS<87 YU-V0K**PGG.V"YQT9B\62Z0 MO$ ^-*:,Y:O#1*+<$96@;F-[NN/4RDC(HWXZB?)/(^5<=PR>$97L[EG4 MNG$D&^FI[M$R@]GR,BP>471!))6,O>PAQG__]$/HGSYP/GUWZ4[ ;Y7;$!?. M\%)&VJ*=[:NDT/ >(/:][9I??_GG/W[*W FVP!B3>A_%C6PT<^L&Z;6*4[X% M7\3HYZ/K*S0W_M7\Z_[JB%E#^(*;P6FS<=[I&>][9_WW[>YUM]'M=\YZAM$U M6JV+?J=S?O3+G#+(PO:][*>.3>*^N!/NK(3]_2CU!15^<7GYQ\<_/ES<]Z_8 MI_O?^E_8Y:>/G[_T?^O?WMW\V6GRAD6Y1Z /0(*E#/%O4=V*'Z56^2CI<9F@?_).2PX&EO4);QUNG6(J\:P!!LA3"S]G7.*B_[!_C>\#7P =_2Q\ M\A?:!3A:Y^>C)HS5^L%Z>:I7DRW-;1R[2*-%I$"6/Z MCSE<:LM<<_% \J4B=C@)D?U1)"FD_08QP M>.%$A613\VH#\A>-Y,2^E6%?UX.OG"@EQ7S&$QT3%.(T6@/S+DZ MT/MFTLJ;WD/S M>F]GQ$@E)S_R:.63E_=U=)+F@+4D0<]A0D_SK%$_RYT:>M9<@VC8;]B.)80A MA"&$>3,EC'J#\(7PA?"%\"4G?&D1OA"^$+X0ON3C(75:=8,0)L\(\:ST-,H< M";ZX^T,6O)PV#,:'KNK2JIK/;,!#:<;F'O8L-MBAT"MI225(4Y]">X4^51$[ M2O[1MT](,DD(=- M6:/X_.8-F&CMO9YR[>6T] 4E*.Y)X U6) J@9OW>=LVOO_SS'S^E MUSI2&<@6EI_A+_,YN0ZHZ""IOHC1ST?75[B-\:_F7_=71\P:PA?<#$[;[XWW MS7:KV[]LG!O7C?-&]ZK?,XRNT6HVC?[9V=$OF@B?W8HG]L6=\-4@ MF+G=MAQQ.A827K7C<."L6#NU'+P MG"AWQ�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end

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�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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 87 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 89 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 309 261 1 true 92 0 false 8 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.perrigo.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 2 false false R3.htm 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss Condensed Consolidated Statements of Comprehensive Income (Loss) Statements 3 false false R4.htm 1004000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 4 false false R5.htm 1004501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 1005000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 2101100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 2102100 - Disclosure - Revenue Recognition Sheet http://www.perrigo.com/role/RevenueRecognition Revenue Recognition Notes 8 false false R9.htm 2103100 - Disclosure - Acquisitions and Divestitures Sheet http://www.perrigo.com/role/AcquisitionsAndDivestitures Acquisitions and Divestitures Notes 9 false false R10.htm 2103100 - Disclosure - Goodwill and Other Intangible Assets Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssets Goodwill and Other Intangible Assets Notes 10 false false R11.htm 2105100 - Disclosure - Inventories Sheet http://www.perrigo.com/role/Inventories Inventories Notes 11 false false R12.htm 2107100 - Disclosure - Fair Value Measurements Sheet http://www.perrigo.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 2108100 - Disclosure - Investments Sheet http://www.perrigo.com/role/Investments Investments Notes 13 false false R14.htm 2109100 - Disclosure - Derivative Instruments and Hedging Activities Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities Derivative Instruments and Hedging Activities Notes 14 false false R15.htm 2111100 - Disclosure - Indebtedness Sheet http://www.perrigo.com/role/Indebtedness Indebtedness Notes 15 false false R16.htm 2112100 - Disclosure - Earnings Per Share and Shareholders' Equity Sheet http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity Earnings Per Share and Shareholders' Equity Notes 16 false false R17.htm 2113100 - Disclosure - Accumulated Other Comprehensive Income (Loss) Sheet http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income (Loss) Notes 17 false false R18.htm 2114100 - Disclosure - Income Taxes Sheet http://www.perrigo.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 2115100 - Disclosure - Contingencies Sheet http://www.perrigo.com/role/Contingencies Contingencies Notes 19 false false R20.htm 2117100 - Disclosure - Restructuring Charges Sheet http://www.perrigo.com/role/RestructuringCharges Restructuring Charges Notes 20 false false R21.htm 2118100 - Disclosure - Segment Information Sheet http://www.perrigo.com/role/SegmentInformation Segment Information Notes 21 false false R22.htm 2119100 - Disclosure - Subsequent Events Sheet http://www.perrigo.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 2301302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 2302301 - Disclosure - Revenue Recognition (Tables) Sheet http://www.perrigo.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.perrigo.com/role/RevenueRecognition 25 false false R26.htm 2303301 - Disclosure - Goodwill and Other Intangible Assets (Tables) Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssetsTables Goodwill and Other Intangible Assets (Tables) Tables http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssets 26 false false R27.htm 2305301 - Disclosure - Inventories (Tables) Sheet http://www.perrigo.com/role/InventoriesTables Inventories (Tables) Tables http://www.perrigo.com/role/Inventories 27 false false R28.htm 2307301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.perrigo.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.perrigo.com/role/FairValueMeasurements 28 false false R29.htm 2308301 - Disclosure - Investments (Tables) Sheet http://www.perrigo.com/role/InvestmentsTables Investments (Tables) Tables http://www.perrigo.com/role/Investments 29 false false R30.htm 2309301 - Disclosure - Derivative Instruments and Hedging Activities (Tables) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables Derivative Instruments and Hedging Activities (Tables) Tables http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities 30 false false R31.htm 2311301 - Disclosure - Indebtedness (Tables) Sheet http://www.perrigo.com/role/IndebtednessTables Indebtedness (Tables) Tables http://www.perrigo.com/role/Indebtedness 31 false false R32.htm 2312301 - Disclosure - Earnings Per Share and Shareholders' Equity (Tables) Sheet http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables Earnings Per Share and Shareholders' Equity (Tables) Tables http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity 32 false false R33.htm 2313301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income (Loss) (Tables) Tables http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss 33 false false R34.htm 2314301 - Disclosure - Income Taxes Income Taxes (Tables) Sheet http://www.perrigo.com/role/IncomeTaxesIncomeTaxesTables Income Taxes Income Taxes (Tables) Tables 34 false false R35.htm 2317301 - Disclosure - Restructuring Charges (Tables) Sheet http://www.perrigo.com/role/RestructuringChargesTables Restructuring Charges (Tables) Tables http://www.perrigo.com/role/RestructuringCharges 35 false false R36.htm 2318301 - Disclosure - Segment Information (Tables) Sheet http://www.perrigo.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.perrigo.com/role/SegmentInformation 36 false false R37.htm 2402402 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details) Sheet http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails Revenue Recognition - Schedule of Revenue by Geographic Location (Details) Details 37 false false R38.htm 2402403 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details) Sheet http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails Revenue Recognition - Schedule of Revenue by Product (Details) Details 38 false false R39.htm 2402404 - Disclosure - Revenue Recognition - Additional Information (Details) Sheet http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails Revenue Recognition - Additional Information (Details) Details 39 false false R40.htm 2402405 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details) Sheet http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails Revenue Recognition - Schedule of Contract Balances (Details) Details 40 false false R41.htm 2402406 - Disclosure - Revenue Recognition - Schedule of ASC 606 Impact on Statement of Operations (Details) Sheet http://www.perrigo.com/role/RevenueRecognitionScheduleOfAsc606ImpactOnStatementOfOperationsDetails Revenue Recognition - Schedule of ASC 606 Impact on Statement of Operations (Details) Details 41 false false R42.htm 2402407 - Disclosure - Revenue Recognition - Schedule of ASC 606 Impact on Comprehensive Income (Details) Sheet http://www.perrigo.com/role/RevenueRecognitionScheduleOfAsc606ImpactOnComprehensiveIncomeDetails Revenue Recognition - Schedule of ASC 606 Impact on Comprehensive Income (Details) Details 42 false false R43.htm 2402408 - Disclosure - Revenue Recognition - Schedule of ASC 606 Impact on Balance Sheet (Details) Sheet http://www.perrigo.com/role/RevenueRecognitionScheduleOfAsc606ImpactOnBalanceSheetDetails Revenue Recognition - Schedule of ASC 606 Impact on Balance Sheet (Details) Details 43 false false R44.htm 2402409 - Disclosure - Revenue Recognition - Schedule of ASC 606 Impact on Statement of Cash Flows (Details) Sheet http://www.perrigo.com/role/RevenueRecognitionScheduleOfAsc606ImpactOnStatementOfCashFlowsDetails Revenue Recognition - Schedule of ASC 606 Impact on Statement of Cash Flows (Details) Details 44 false false R45.htm 2403401 - Disclosure - Acquisitions and Divestitures (Details) Sheet http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails Acquisitions and Divestitures (Details) Details http://www.perrigo.com/role/AcquisitionsAndDivestitures 45 false false R46.htm 2403402 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details) Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails Goodwill and Other Intangible Assets - Goodwill (Details) Details 46 false false R47.htm 2403403 - Disclosure - Goodwill and Other Intangible Assets - Intangible categories (Details) Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssetsIntangibleCategoriesDetails Goodwill and Other Intangible Assets - Intangible categories (Details) Details 47 false false R48.htm 2405402 - Disclosure - Inventories (Details) Sheet http://www.perrigo.com/role/InventoriesDetails Inventories (Details) Details http://www.perrigo.com/role/InventoriesTables 48 false false R49.htm 2407402 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details) Sheet http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails Fair Value Measurements - Financial Instruments at Fair Value (Details) Details 49 false false R50.htm 2407403 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 50 false false R51.htm 2407404 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details) Sheet http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details) Details 51 false false R52.htm 2407405 - Disclosure - Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details) Sheet http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details) Details 52 false false R53.htm 2408402 - Disclosure - Investments (Details) Sheet http://www.perrigo.com/role/InvestmentsDetails Investments (Details) Details http://www.perrigo.com/role/InvestmentsTables 53 false false R54.htm 2409402 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails Derivative Instruments and Hedging Activities - Additional Information (Details) Details 54 false false R55.htm 2409403 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails Derivative Instruments and Hedging Activities - Balance Sheet Location (Details) Details 55 false false R56.htm 2409404 - Disclosure - Derivative Instruments and Hedging Activities - Other Comprehensive Income Movement (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesOtherComprehensiveIncomeMovementDetails Derivative Instruments and Hedging Activities - Other Comprehensive Income Movement (Details) Details 56 false false R57.htm 2409405 - Disclosure - Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details) Details 57 false false R58.htm 2411402 - Disclosure - Indebtedness - Schedule of Borrowings Outstanding (Details) Sheet http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails Indebtedness - Schedule of Borrowings Outstanding (Details) Details 58 false false R59.htm 2411403 - Disclosure - Indebtedness - Additional Information (Details) Sheet http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails Indebtedness - Additional Information (Details) Details 59 false false R60.htm 2411404 - Disclosure - Indebtedness - Debt Extinguishment (Details) Sheet http://www.perrigo.com/role/IndebtednessDebtExtinguishmentDetails Indebtedness - Debt Extinguishment (Details) Details 60 false false R61.htm 2412402 - Disclosure - Earnings Per Share and Shareholders' Equity (Details) Sheet http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails Earnings Per Share and Shareholders' Equity (Details) Details http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables 61 false false R62.htm 2413402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails Accumulated Other Comprehensive Income (Loss) (Details) Details http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables 62 false false R63.htm 2414402 - Disclosure - Income Taxes (Details) Sheet http://www.perrigo.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.perrigo.com/role/IncomeTaxesIncomeTaxesTables 63 false false R64.htm 2415401 - Disclosure - Contingencies (Details) Sheet http://www.perrigo.com/role/ContingenciesDetails Contingencies (Details) Details http://www.perrigo.com/role/Contingencies 64 false false R65.htm 2417402 - Disclosure - Restructuring Charges (Details) Sheet http://www.perrigo.com/role/RestructuringChargesDetails Restructuring Charges (Details) Details http://www.perrigo.com/role/RestructuringChargesTables 65 false false R66.htm 2418402 - Disclosure - Segment Information (Details) Sheet http://www.perrigo.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.perrigo.com/role/SegmentInformationTables 66 false false All Reports Book All Reports prgo-20180630.xml prgo-20180630.xsd prgo-20180630_cal.xml prgo-20180630_def.xml prgo-20180630_lab.xml prgo-20180630_pre.xml http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true ZIP 91 0001585364-18-000071-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001585364-18-000071-xbrl.zip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